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Abstract 
 
Schwann cells are found in close proximity with axons from an early developmental 
stage, where, in adult nerve, they exist as either myelinating or non-myelinating 
Schwann cells.  Reciprocal, contact-dependent signalling, between Schwann cells 
and axons, is central to the regulation of Schwann cell proliferation, survival and 
differentiation, as well as axonal survival.  Cell adhesion molecules (CAMs) mediate 
homotypic and heterotypic interactions. They are required during development, in 
homeostatic nerve and in nerve repair following injury.  Dysregulation of signal 
pathways and resulting aberrant CAM expression, can lead to irreversible Schwann 
cell/axonal dissociation, which is a hallmark of various peripheral neuropathies and 
nerve sheath tumours, e.g. neurofibromas in NF1 patients. 
 
In this thesis, I conducted a microarray screen to identify early mediators of Schwann 
cell/axonal interaction, using a Large-T (LT)-expressing Schwann cell that had 
spontaneously lost the ability to interact with axons, termed LT-derived (LTD) cells.  
This analysis revealed that multiple cell adhesion genes had become dysregulated 
including N-cadherin, Semaphorin-4F, Necl-4, NCAM and L1-CAM.  This shift in 
adhesion profile suggested that a transcription factor, for example Sox2, might be the 
genetic lesion responsible; however, Sox2 was found not to be responsible for the 
LTD phenotype, although over-expression of Sox2 altered N-cadherin localisation at 
Schwann cell-cell junctions.   
 
Further study showed that N-cadherin was required for homotypic interactions and 
was an important mediator of heterotypic interactions, where heterologous N-
cadherin expression in fibroblasts was sufficient to induce fibroblasts to recognise 
and partially associate with axons.  In addition, N-cadherin was implicated in the 
regulation of the cell cycle; while N-cadherin silencing, in Schwann cells prior to 
axonal contact, was found to impede myelination in vitro.  Finally, this work showed 
that N-cadherin and Semaphorin-4F operate at distinct stages of the interaction 
process, with N-cadherin mediating axonal recognition and Semaphorin-4F involved 
in stabilising the Schwann cell/axonal association. 
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Chapter One: Introduction 
 
1.1 Chapter introduction 
 
Intercellular communication is a fundamental and defining property of multi-cellular 
organisms, in which tight behavioural control of individual cells is asserted for the 
benefit of the organism as a whole (Alberts et al., 2008).   Direct cell-cell 
communications are important in all aspects of organisational behaviour.  In 
development, cell-cell communications play essential roles in the regulation of 
multiple cellular processes including cell growth, proliferation, survival, migration 
and differentiation, all of which are required to generate the various tissue 
architectures comprising the body.  In the adult, tissue homeostasis is tightly 
maintained by cell-cell communications that ensure processes of cell growth, 
proliferation and survival are appropriately balanced.  This is essential for 
maintaining the size and structure of adult tissues undergoing continual turnover as 
well as to ensure that quiescence is maintained in non-dividing tissues.   
 
Cell-cell communication is also essential for the detection of tissue injury and is later 
utilised to direct post-injury responses so that some degree of repair to damaged 
tissue can be accomplished.  While this response can be relatively effective in some 
epithelial tissues, for instance wound-healing in the skin, post-trauma regeneration in 
more complex and differentiated tissue architectures is a rare phenomenon in 
mammalian biology.  For example, injury to nerves of the central nervous system 
(CNS) invariably results in some degree of permanent paralysis with little prospect 
of repair (Leskovar et al., 2000).  However, in contrast to the CNS, the peripheral 
nervous system (PNS) is capable of remarkably effective regeneration following 
nerve injury.  A major difference between the PNS and the CNS in this regard, is the 
presence of Schwann cells, which associate with, ensheath and support almost all 
axons of the PNS (Armati, 2007; Jessen & Mirsky, 2005) (refer to page 26 for 
exceptions).  Central to PNS recovery, following nerve injury, is the extraordinary 
ability of these highly specialised, differentiated Schwann cells to undergo a 
programme of dedifferentiation to generate proliferating stem-cell like progenitors, 
which then facilitate and direct the functional repair of the nerve (Harrisingh et al., 
2004; Parrinello et al., 2010; Scherer & Salzer, 2001). This capacity for self-renewal, 
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more usually the reserve of stem cells, is a rare property for differentiated 
mammalian cells, and has only been observed in a few other mammalian cell types, 
including hepatoctyes (Overturf et al., 1997), pancreatic β-cells (Dor et al., 2004) 
and endothelial cells.   
 
Our understanding of the importance of Schwann cell biology to PNS nerve function 
has advanced considerably since their initial discovery by Theodore Schwann in 
1839.  However, over the next century, myelin was still generally thought of as little 
more than an insulating fatty layer, which was secreted by Schwann cells or indeed 
the axon – in fact, myelin was mistakenly named under this misapprehension, as the 
word is derived from the Greek myelos, which literally translates as marrow, i.e. 
implying that its origins were from the axon (Rosenbluth, 1999).  The true 
complexity behind the bidirectional relationship elicited by Schwann cells and axons 
only began to emerge following Geren’s (1954) seminal paper describing the 
repeated wrapping of the Schwann cell membrane about the axon in chick nerve 
myelination.  Since then, the physical and signalling interdependence of Schwann 
cells and axons has received significant attention, especially in regard to myelination, 
but also during development, e.g. survival, proliferation and differentiation, as well 
as in later nerve homeostasis and the post-injury response discussed earlier.  The 
importance of Schwann cell/axonal interactions in the PNS is underlined by 
consequences of dysregulation in the interaction programme, which can lead to 
cancer or a range of de-myelination neuropathies.  Thus, identifying the molecular 
mediators involved, and determining their mechanism of action, will be central to our 
understanding of how this complex tissue develops, how it can regenerate following 
PNS nerve injury and how dysregulation results in PNS pathology.  Additionally, 
CNS myelination shares many facets with PNS myelination, raising the intriguing 
possibility that mediators of PNS regeneration may in the future, be utilised in 
therapeutic approaches to clinically encourage CNS regeneration following injury or 
pathology.  
 
1.2 The scope and aims of this review 
 
The central theme of this introductory chapter will focus on the close reciprocal 
relationship that exists between Schwann cells and axons.  In particular, I will 
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discuss the functional importance of this relationship for the PNS in terms of 
development, homeostasis, injury and pathology.  I will begin by briefly describing 
the cell-types that comprise the functional PNS nerve and how these components 
create the radial and cylindrical architecture of peripheral nerve.  I will then explore 
the development of the PNS in relation to Schwann cells and axons; detailing the 
essential roles played by contact-dependent cell-cell communication in all aspects of 
Schwann cell behaviour, while also emphasising the importance of the bidirectional 
nature of Schwann cell/axonal signalling in relation to axonal survival and 
regeneration.  Integral to all these processes, are mediators of cell-cell signalling and 
adhesion; with this in mind, I will also set out our current understanding of the 
molecules that mediate and maintain Schwann cell/axonal interactions.  I will then 
consider the cellular response elicited by Schwann cells following PNS injury and 
their role in PNS regeneration; contrasting this behaviour with the irreversible loss of 
Schwann cell/axonal interaction that occurs in nerve sheath tumours and various 
inherited de-myelinating neuropathies of the PNS.  Finally, I will summarise the 
important principles behind Schwann cell/axonal interactions and identify 
deficiencies in current knowledge and outline the investigative aims and rational of 
this thesis. 
 
1.3 The biology of the peripheral nervous system (PNS) 
 
The PNS is defined as the component of the nervous system extra to the CNS, where 
the CNS is defined as comprising the brain, i.e. the cerebellum, cerebrum and 
brainstem, as well as the spinal cord, with both structures enveloped by meninges 
and bathed in cerebral-spinal fluid (Purves et al., 2001).  Thus, while the CNS is 
confined to the cranial and dorsal cavities of the body, the PNS interfaces the CNS 
and extends bilaterally to connect with all the sensors and effectors of the body.  
Included within the PNS, are 31 pairs of spinal nerves, 12 pairs of cranial nerves, the 
autonomic nervous system and the peripheral ganglia (neuronal clusters extra to the 
CNS) (Bryne, 1997).  While the CNS functions to receive, integrate and process 
information in order to execute behavioural responses, the PNS operates to 
bidirectionally convey information (required for that response) and instructions (the 
response) back and forth, respectively, between the CNS and the sensors and 
effectors.  Examples of sensors include: Meissner’s corpsule (light touch); Merkle’s 
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corpsule (touch); free-terminal nociceptors (pain); Pacinian corpsule (deep pressure); 
Ruffini corpsule (temperature).  Examples of effectors include striated, smooth and 
cardiac muscle as well as various exocrine and endocrine glands (Vander et al., 
2001).     
 
1.3.1 The structure and composition of peripheral nerves 
 
In this review, I will focus on the portion of the nerve that contains nerve fibres 
rather than the ganglia or synapses, because this is the region in which axons are 
associated with Schwann cells.  In cross-section, the peripheral nerve is a 
heterogeneous, tubular tissue; exhibiting a complex microarchitecture, constituting 
an array of cell-types including axons, Schwann cells, fibroblasts, endothelial cells 
(composing the vasculature) and various inflammatory cells, for example 
macrophages and mast cells.   
 
The peripheral nerve is composed of three major compartments, the epineurium, 
perineurium and endoneurium (Pina-Oviedo & Ortiz-Hidalgo, 2008), which 
collectively protect the primary functional subunit of PNS nerve - the nerve fibre - 
from mechanical stresses.  The nerve fibre consists of either a single axon (in 
myelinated fibres) or multiple axons (in non-myelinated fibres), that are ensheathed 
by Schwann cells, in the majority of cases (see page 26 for exceptions), and which 
are surrounded by a Schwann cell-derived basal lamina.  In longitudinal section, both 
myelinated and non-myelinated fibres contain multiple Schwann cells dispersed 
along their length with no part of the axon exposed, even between adjacent Schwann 
cells.  In cross-section, bundles of nerve fibres, small blood vessels, resident immune 
cells and fibroblasts are held within a collagenous matrix called the endoneurium, 
which altogether form a nerve fascicle.  The nerve fascicle is delimited by an outer 
multi-layered sheath comprising perineurial cells and collagen-rich extracellular 
matrix (ECM), which collectively is called the perineurium (Choi & Kim, 2008; 
Parmantier et al., 1999; Pina-Oviedo & Ortiz-Hidalgo, 2008).  Larger nerves consists 
of multiple fascicles that together with larger blood vessels are contained by an outer 
protective sheath, composed of irregular fibrous and adipose tissue called the 
epineurium (Pina-Oviedo & Ortiz-Hidalgo, 2008) (Figure 1.1). 
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Figure 1.1 Schematic showing a cross-section through a large peripheral 
nerve.  The nerve is enclosed by a fibrous sheath called the epineurium, which 
contains numerous nerve fascicles, blood vessels, epineurial fibroblasts and immune 
cells.  Each fascicle contains both myelinating and non-myelinating fibres as well as 
small blood vessels, fibroblasts and immune cells, of which all reside within an 
extracellular matrix called the endoneurium.  The fascicle is delimited by an outer 
perineurium that is composed of perineurial cells and collagenous extracellular 
matrix (ECM), which together with the endothelium of endoneurial blood vessels 
forms a protective blood-nerve barrier (BNB).    
 
 
The PNS is composed of two functional classes of nerve fibre, referred to as afferent 
(sensory) and efferent (motor) fibres that convey electrical impulses to and from the 
CNS, respectively.  In the case of spinal nerves, afferent nerve fibres enter the spinal 
cord through the dorsal horn, while efferent nerve fibres leave via the ventral horn; 
however, both types of nerve fibre merge a short distance from the spinal cord to 
form a single mixed spinal nerve.  The cranial nerves have a slightly different 
arrangement, for example the olfactory nerve is composed exclusively of afferent 
fibres; however, in the interests of brevity they are not reviewed here.  There are also 
important differences between the structure of afferent and efferent neurons.  For 
instance, the cell bodies (ganglia) of afferent nerve fibres are found outside the CNS 
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in capsular structures called dorsal-root ganglia (DRG), which are discreetly paired 
bilaterally along the dorsal aspect of the vertebrae, residing between the spinal cord 
and the confluence of afferent and efferent neurons (Figure 1.2).   
 
 
 
 
Figure 1.2 Schematic showing a cross-section through the spinal cord and 
depicting the dorsal root ganglion and spinal nerves.  The afferent (sensory) nerve 
fibres (shown in blue) enter via the dorsal horn, while the efferent (motor) nerve 
fibres (shown in red) leave via the ventral horn.  Both afferent and efferent fibres 
combine distal to the dorsal-root ganglion (DRG) to form a mixed peripheral (spinal) 
nerve (image by G. Mandl, 2012)1. 
 
 
Afferent neurons are pseudo-bipolar, projecting a single process that diverges a short 
distance from the ganglion into the peripheral branch, which innervates the target 
organ, and the central branch, which enters the spinal cord via the dorsal horn in 
order to synapse with CNS neurons (Mai & Paxinos, 2011).  The term ‘pseudo’, in 
this context, refers to the fact that these neurons are derived from bipolar neuroblasts 
in which both axons have later fused.  This arrangement allows for action potentials 
to effectively by-pass the cell-body, and therefore allows for sensory information to 
be transmitted directly from peripheral sensors to the CNS.  Anatomically, both the 
                                                 
1 http://people.eku.edu/ritchisong/342notes11.html 
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peripheral (myelinated and non-myelinated) and the central processes of the afferent 
neuron are considered to be axons rather than dendrites (Chen et al., 2007). 
 
The situation for efferent (motor) neurons is more complicated as this branch of the 
PNS can be divided into the somatic nervous system (SNS) or the autonomic nervous 
system (ANS).  Neurons of the SNS have their cell bodies embedded within the CNS 
and directly innervate striated skeletal muscle under voluntary control of the 
conscious brain.  In contrast, while primary neurons of the ANS also have their cell 
bodies encapsulated within the CNS, the projecting axon (the preganglionic fibre) 
synapses with the ganglion of a second neuron, which then recapitulates and 
transmits the signal on to the target effector via a second axonal fibre (the 
postganglionic fibre).  The ANS differs functionally from the SNS in that the ANS is 
largely involuntary, i.e. signals are generated without awareness from the conscious 
brain.  Furthermore, the ANS innervates smooth and cardiac muscle as well as glands 
and neurons of the gastrointestinal tract in order to regulate many vital functions of 
the body (Vander et al., 2001).   
 
The ANS is itself further subdivided into the sympathetic, parasympathetic and 
enteric subdivisions.  The sympathetic and parasympathetic subdivisions often 
innervate the same organ (duel-innervation) and tend to exhibit functional 
antagonism, for example, while activity through sympathetic fibres causes an 
acceleration in heart contractions, constriction of pupils and stimulation of exocrine 
secretion, the reverse is elicited by parasympathetic fibres, i.e. a reduction in heart 
rate, relaxation of pupils and the inhibition of exocrine secretion.  In addition, they 
perform separate functions, for instance sympathetic fibres innervate the adrenal 
medulla, which functions in an endocrine manner by releasing hormones into the 
blood.  The arrangement of the nerves, the location of the connecting ganglion of the 
secondary neuron and the exit points of the nerve from the CNS, vary considerably 
between the sympathetic and parasympathetic nervous systems.  Anatomically, 
sympathetic fibres leave the spinal cord from the thoracic and lumbar regions of the 
vertebrae, while parasympathetic nerve fibres leave from the sacral and cranial 
regions. The autonomic ganglia of parasympatheic nerve fibres lie within or near the 
target organ with little interconnectivity, while the autonomic ganglia of sympathetic 
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nerve fibres lie close to the spinal cord, and are extensively inter-connected by two 
parallel sympathetic trunk nerves that run either side of the spinal cord.   
 
The third ANS subdivision is the enteric nervous system, which defines a neural 
network within the connective tissue of the gastro-intestinal (GI) tract, comprising  
two layers of nervous tissues, the myenteric plexus and the submucous plexus, 
separated by a band of circular smooth muscle.  Enteric neurons form synapses 
extensively within and between the two nerve plexuses, as well as with both the 
parasympathetic and sympathetic subdivisions of the ANS and thus, indirectly with 
the CNS.  However, most activity is coordinated through neural reflexes that are 
independent of the CNS (short reflexes) and contained within the GI-tract.  Enteric 
nerve fibres innervate smooth muscle and gut epithelium, often generating waves of 
electrical activity that are capable of spreading rapidly throughout the GI system and 
beyond, i.e. to the CNS via afferent nerve fibres. 
 
Glia 
 
Glial cells (or neuroglia) are the accompanying cell to the neuron in both the CNS 
and the PNS (Vander et al., 2001).  Originally named from the Greek for ‘glue’, due 
to their perceived function in providing the physical matrix that support neurons, 
they are now also understood to be essential metabolic and cellular partners to 
neurons, and are vital to the function and injury response of the nervous system.   
The CNS and PNS have mutually exclusive glia, for instance CNS neurons are 
ensheathed by oligodendrocytes and supported by astrocytes, while the PNS nerve 
fibre is ensheathed predominantly by Schwann cells (Chen et al., 2007; Corfas et al., 
2004; Jessen & Mirsky, 2005).  This defining difference between the glial 
components of the CNS verses the PNS has profound consequences for regeneration 
as discussed later.  In addition to Schwann cells, the PNS is also supported by a 
minority of specialised glia.  These include olfactory ensheathing cells (OECs) 
supporting olfactory neurons; terminal glia (teloglia), which encase axons at the 
neuromuscular junction; enteric glia, which envelop neurons of the complex ganglia, 
and satellite glia that surround the soma of dorsal-root, sympathetic and 
parasympathetic ganglia (Jessen, 2004; Jessen & Mirsky, 2005; Murphy et al., 1996).  
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In this review I will focus on the Schwann cell, which is the major supporting glia of 
the PNS.  
 
Schwann cells were first identified by Theodore Schwann in 1839, following on from 
observations made by Remak the year before, who identified and distinguished the 
presence of both opaque and transparent fibres in the PNS (Rosenbluth, 1999).  
These phenomena can now be explained by the existence of two highly-specialised 
adult Schwann cell fates: myelinating or non-myelinating Schwann cells (Figure 
1.3).   
 
 
 
Figure 1.3 Schematic showing the two fates of mature Schwann cells.  Adult 
Schwann cells exist as either myelinating Schwann cells, which synthesise myelin 
and ensheath a single axon in concentric multi-lamella sheets of membrane, or as 
non-myelinating Schwann cells, which do not synthesise myelin and individually 
ensheath multiple axons into Schwann cell/axonal families termed Remak bundles 
(Adapted from Jessen & Mirsky, 1999; Salzer, 2008). 
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Myelinating Schwann cells, which have historically been the most studied, are 
responsible for Remak’s opaque fibres.  In cross-section, myelinating Schwann cells 
ensheath large axons (greater than 1µm in diameter) in a one to one ratio, through 
concentric multilamellar wrapping of their plasma-membrane around the axon 
(Hartline & Colman, 2007; Sherman & Brophy, 2005).  In addition, they synthesise 
large amounts of myelin protein and lipids, which are used to generate the two major 
regions of the myelin sheath: compact myelin, in which the exchange of metabolites 
including ion transfer is impeded, and non-compact myelin, which provide essential 
aqueous conduits within the sheath for metabolic exchange, both within the Schwann 
cell and between the Schwann cell and the axon it surrounds (Nave, 2010a; Poliak & 
Peles, 2003).  The primary function of myelinating Schwann cells is to electrically 
insulate the axon that they ensheath, in order to permit significantly greater signal 
conduction velocities.   In contrast, non-myelinating Schwann cells do not synthesise 
myelin but instead envelop multiple, small-calibre axons (generally less than 1µm in 
diameter), within invaginations of their membrane, called Remak bundles 
(Denisenko et al., 2008; Jessen & Mirsky, 2005; Nave & Salzer, 2006; Sherman & 
Brophy, 2005).   
 
Fibroblasts 
 
Fibroblasts are ‘non-vascular, non-epithelial and non-inflammatory' cells, which 
primarily function to construct the connective tissues that ensure the integrity of 
multiple organ systems within the body (Aboussekhra, 2011).  They achieve this by 
synthesising procollagen, as well as other ECM components, which they secrete into 
the external milieu.  In the case of collagen, which accounts for 30% of all protein 
synthesis in humans, extracellular collagen peptidases convert fibroblast-secreted 
procollagen into tropocollagen while lysyl oxidase and other extracellular enzymes 
generate the functional collagen fibrils (Di Lullo et al., 2002).  In contrast to 
epithelial cells, fibroblasts are not usually tethered to a basement membrane and thus, 
are generally not immobilised within the connective tissues they create.  In healthy 
adult homeostatic tissue, fibroblasts that exhibit low-rates of basal proliferation, are 
found dispersed throughout the stroma of all connective tissues in the body.  Upon 
tissue wounding or in fibroblast-associated cancers, fibroblasts generate large 
intracellular contractile fibres (stress-fibres) and revert to a more metabolically active 
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state, indicated by an abundance of rough endoplasmic reticulum (Aboussekhra, 
2011).  They synthesise and secrete ECM components, including collagen Type-1 
fibres that will often result in tissue scarring (Polyak & Kalluri, 2010).   
 
In the adult peripheral nerve, inactivated nerve fibroblasts are found within all three 
compartments of the nerve, i.e. the epineurium, perineurium, and endoneurium 
(Dreesmann et al., 2009) at about one fibroblast to every nine Schwann cells (Jessen 
& Mirsky, 2005).  The different compartments of the nerve contain fibroblasts that 
are specialised to perform specific functions.  One example are perineurial cells, 
which are a highly-specialised fibroblast-like cell that comprises the perineurium that 
surrounds the nerve fascicle, and which forms a selectively-permeable barrier 
between the endoneurium and the epineurium and is part of the blood-nerve barrier 
(BNB) (Alanne et al., 2009; Pina-Oviedo & Ortiz-Hidalgo, 2008).  These flattened 
cells are held together by tight-junctions composed of zonula occludens (ZO)-1, 
occludin, claudin-1, and claudin-3 (Pummi et al., 2004).  The development of the 
perineurium is initiated relatively late in the Schwann cell lineage and is discussed 
later.   
 
In terms of ECM and collagen synthesis, the standard injury response elicited by 
fibroblasts in PNS nerve appears tailored to reduce tissue scarring, which is 
beneficial to PNS nerve regeneration because scarring from excessive collagen Type-
1 synthesis, as observed following CNS injury, presents a barrier to successful 
regeneration.  Instead, and in contrast to fibroblast-related astrocytes in the CNS, 
nerve fibroblasts play a unique, conducive role in PNS regeneration.  For instance, 
Morris et al. (1972) observed that perineurial fibroblasts reorganised the architecture 
of the regenerating nerve to generate ‘mini-fascicles’, absent from the pre-injured 
nerve, which provide a protective environment for regenerating axons (Hall, 2005).  
In addition, fibroblasts present in the injured nerve secrete neuregulin (NRG)-1, 
which has a pro-migratory affect on recently de-myelinated Schwann cells, and thus 
encourages the migration of Schwann cells from the proximal stump into the injury 
site (Dreesmann et al., 2009), while ephrin-B/EphB2 signalling between Schwann 
cells and fibroblasts enhances homotypic Schwann cell/Schwann cell adhesional 
interactions and promotes directed, collective migration of Schwann cells by a Sox2-
N-cadherin dependent mechanism (Parrinello et al., 2010). 
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Inflammatory cells 
 
The endoneurium of peripheral nerves, containing the nerve fibres, is an immune-
privileged environment.  This is maintained by the perineurium, that surrounds the 
endoneurium, and specialised endothelial cells that form the endoneurial blood 
vessels - both of which generate the BNB that prevents immune cells and harmful 
metabolites from accessing the endoneurium.  However, certain restricted immune 
cells, termed resident immune cells, are present and are dispersed throughout the 
endoneurium.  These include macrophages, which account for 4% of the cellular 
composition of the endoneurium, and a smaller number of mast cells, both of which 
remain inactive in normal nerve physiology (Hall, 2005).  Together with Schwann 
cells, the resident immune cells provide a rapid response to nerve injury and are 
essential mediators in Wallerian degeneration (WD), i.e. the controlled disintegration 
of distal axons following nerve injury (refer to section 1.5.1 for a detailed analysis of 
WD and the injury response).  Resident immune cells are primed to respond to nerve 
injury, where they perform different functions.  In addition to recently 
dedifferentiated  (denervated) Schwann cells, activated macrophages begin the 
process of phagocytising myelin debris, or ‘myeloids’, which are a by-product of the 
myelin sheath left following Schwann cell dissociation from axons (Hall, 2005).  
This is an essential part of the repair process, as myelin components, for example 
myelin-associated glycoprotein (MAG), are inhibitive to regeneration (reviewed by 
Filbin, 2003; Tang et al., 1997).  Activation of resident macrophages and mast cells 
is thought to be mediated by Schwann cells, through secretion of cytokines, 
including interleukin (IL)-1-α and tumour necrosis factor alpha (TNF-α), which build 
up at the nerve stump (site of injury) (Hall, 2005).  Although less is known about 
mast cells, they are thought to be involved in mediating the breakdown of the BNB, 
which occurs within 48-hours after injury, through the secretion of vasoactive agents; 
although, endothelial cells and macrophages are also thought to play substantial roles 
in this through secretion of metalloproteinases and TNF-α, IL-1, respectively  (Hall, 
2005).  The increased permeability of the BNB, together with proliferation of 
resident cells, results in a substantial increase in the number of macrophages, mast 
cells, neutrophils, and T-cells within the endoneurium (Napoli et al., 2012).    
Infiltrating immune cells provide a secondary response to nerve injury, continuing to 
clear myelin debris and promote regeneration.  Schwann cells are thought to play a 
 31  
   
key role in the chemoattraction of infiltrating macrophages via the secretion of 
macrophage chemoattractant protein-1 (MCP-1) and leukaemia inhibitory factor 
(LIF) (Napoli et al., 2012; Tofaris et al., 2002).  The authors also suggest that an 
autocrine-signalling cascade involving IL-6, LIF, and MCP-1 may explain the 
gradual accumulation of macrophage chemoattractants; thus accounting for the 
delayed entry of macrophages into the nerve.  Following the repair of the nerve, 
lipid-rich macrophages remain in the epineurium for several weeks before numbers 
drop either by apoptosis or drainage into the lymph system (Hall, 2005).   
 
Blood vessels 
 
In addition to their central role in supplying oxygen and exchanging metabolites with 
tissues, the endothelium of the nerve, creates a protective, immune-privileged BNB, 
which together with the perineurium, prevents infiltration of inflammatory cells and 
selectively restricts the exchange of metabolites between blood and the endoneurium 
(Choi & Kim, 2008).  The major blood vessels of the nerve run within the connective 
matrix of the epineurium and along the outer epineurial sheath.  The immune-
privileged milieu of the endoneurium, is serviced by small blood vessels composed 
of single-cell thickness endothelia held together by inter-locking tight-junctions 
(responsible for maintaining the BNB), that are themselves surrounded by pericytes 
(Joseph et al., 2004).  The properties of the endoneural vasculature is critical for 
maintaining cellular and metabolic homeostasis within the endoneurium; however, 
following nerve injury, the BNB must be overcome in order for immune cells, 
required for the phagocytosis of myelin debris, to enter the injury site and contribute 
to the generation of a permissive milieu for regeneration (Napoli et al., 2012).  
Important questions remain as to the role of Schwann cells in the breakdown of BNB 
following injury (Napoli et al., 2012).  
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1.4 The biology of Schwann cells 
 
1.4.1 Schwann cell development 
 
Schwann cell development is tightly coupled to the axons that they associate with 
(Jessen et al., 2008a).  The two adult Schwann cell phenotypes, myelinating and non-
myelinating Schwann cells, are derived in a step-wise manner, from three transient 
cell populations: neural crest (NC) cells, Schwann cell precursors (SCPs) and 
immature Schwann cells (ISCs), each of which can be identified by a signature set of 
partially overlapping molecular differentiation markers (Jessen & Mirsky, 2005).  In 
addition, ISCs differentiate to myelinating Schwann cells via a ‘pro-myelinating’ 
intermediate state that is dependent on Krox20 expression for further progression to 
the myelinated state (Jessen & Mirsky, 2005) (Figure 1.4).   
 
 
 
 
 
Figure 1.4  Schematic showing the Schwann cell lineage. Mature adult Schwann 
cells exist as either myelinating or non-myelinating Schwann cells.  Their 
development follows a step-wise differentiation programme that encompasses a 
number of transient Schwann cell progenitors, comprising the multi-potent migrating 
neural crest (NC) cells, Schwann cell precursors (SCPs) and immature Schwann cell 
(ISCs).  The developmental profile is remarkably plastic, with only the SCP to ISC 
transition considered irreversible, while differentiated adult Schwann cells remain 
able to readily dedifferentiate upon injury (indicated by the dashed-line)  (Jessen & 
Mirsky, 2005). 
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Neural crest cells 
 
Neural crest cells (NCCs) have been identified as the origin of nearly all Schwann 
cells (Jessen & Mirsky, 2005).  They are formed towards the end of neurulation, a 
process that compartmentalises the PNS from the CNS, and are specified from the 
dorsal aspect of the neural tube.  Following closure of the neural tube, NCCs undergo 
a form of epithelial-mesenchymal transition (EMT) in which they are extruded from 
the neural epithelium (a process known as delamination), to form a highly motile, 
transient population of undifferentiated cells (Jessen & Mirsky, 2005).  A subset of 
the neural crest – neural crest stem cells (NCSC) – remains capable of extraordinary 
multi-potency, forming a diverse range of tissues (Joseph et al., 2008; Morrison et 
al., 1999).  For instance, in addition to the glia, neural crest derivatives form the vast 
majority of the PNS, including ganglia and neuroendocrine tissue as well as 
mesectoderm (smooth muscle and bone), melanoctyes and the connective tissues of 
the head (Garratt et al., 2000; Morrison et al., 1999).  Importantly, neural crest do not 
appear to be the cell-of-origin for perineurial cells, a fibroblast-like cell that forms 
the perineurium, nor are they endothelial cells that form the blood vessels or 
pericytes that surround the endothelium (Joseph et al., 2004).  At this stage, all NCCs 
express the specification factor Sox10 as well as Activating protein (AP)-2, Ets-1, 
ErbB3 and the low-affinity neurotrophin receptor p75(NTR) (Garratt et al., 2000).  
NCCs migrate laterally to form various structures with many down-regulating Sox10, 
for example derivatives of facial-cranio mesenchyme; however, all glial cells and 
glial progenitors of the CNS and PNS continue to express Sox10 throughout 
embryonic development and throughout life (Jessen & Mirsky, 2005; Kuhlbrodt et 
al., 1998).  Loss of Sox10 results in the absence of Schwann cells from the nerve and 
conditional loss of Sox10 in immature Schwann cells prevents myelination even in 
the presence of the potent myelination drivers Krox20 and Oct-6 (Finzsch et al., 
2010).  NCCs destined to form Schwann cells of the spinal nerves migrate and 
concentrate in regions just distal to the DRGs that line either side of the vertebrae, 
where they associate with the extending PNS axons of both afferent and efferent 
neurons.  From this point onwards, all further stages in the Schwann cell lineage 
remain in close proximity with axons, which is essential for many aspects of PNS 
biology, for instance Schwann cell survival, proliferation, differentiation (Jessen & 
Mirsky, 2005) and also neuronal survival and function (Lemke, 2001).  
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Schwann cell precursors 
 
Schwann cell-committed NCCs have generally completed their transition to SCPs by 
E14-E15 in the rat (E12-13 in the mouse) (Jessen & Mirsky, 2005), and can be 
identified by their expression of differentiation markers absent from NCCs, including 
F-spondin and GAP43, as well as basal expression of myelin protein zero (MPZ)/P0  
(Dong et al., 1995; Jessen & Mirsky, 2005; Stewart et al., 2001). It is still unclear 
which transcriptional regulators orchestrate this transition, although as in all stages of 
the lineage, continued expression of Sox10 is required (as discussed earlier). At this 
stage, the primordial ‘nerve’ consists of tightly packed columns of axons and SCPs 
which are not serviced by a blood supply and have no basement membrane for 
protection (Court et al., 2006; Jessen & Mirsky, 2005).  PNS neurons continue to 
extend out axons to innervate targets, a process not complete until birth, while SCPs 
proliferate but remain closely associated with axons; although at this stage they do 
not ensheath axons (Jessen & Mirsky, 2005).  During this process, SCPs appear to 
mantle and thus protect the axonal growth cone, as it navigates through mesenchymal 
tissues to locate targets for innervation, which is especially evident when neurones 
make growth decisions (Wanner et al., 2006b).  A defining feature of SCPs, distinct 
from later Schwann cell-types, is their essential, cell-contact dependent reliance on 
axons for their survival and proliferation, which is mediated through NRG1 Type III 
expressed on the cell-surface of the axons (Birchmeier & Nave, 2008; Dong et al., 
1995). 
 
Immature Schwann cells 
 
The majority of SCPs have differentiated to immature Schwann cells (ISCs) by E15-
E17 in the rat (E13-E15 in mouse), where they start to express the differentiation 
markers S100β (calcium binding protein-100), GFAP (glial fibrillary acidic protein)  
and O4 (lipid antigen), while down-regulating N-cadherin and cadherin-19 (Corfas et 
al., 2004; Jessen & Mirsky, 2005).  The transition from SCP to immature Schwann 
cells is thought to be irreversible, and ISCs are generally committed to form either 
myelinating or non-myelinating adult Schwann cells (although this later transition is 
reversible), which is achieved shortly after birth (E22-23 in rat and E20-21 in mouse) 
(Jessen & Mirsky, 2005).  The factors regulating SCP to ISC transition are thought to 
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include NRG-1 Type 1 (Dong et al., 1995) and Notch (Woodhoo et al., 2009), both 
of which have been shown to control the generation of ISCs from SCPs in vitro and 
in vivo respectively.  However, NRG1 Type I and Type II knockout mice still 
develop ISCs normally (Meyer et al., 1997), while inactivation of Notch delays 
myelination and hyper-activation of Notch causes the early generation of Schwann 
cells in vivo; strongly suggesting that Notch signalling is responsible for regulating 
this transition (Woodhoo et al., 2009). 
 
This transition also marks a profound change in the structure of the embryonic 
primordial nerve, which becomes increasingly established as mesenchymal cells are 
recruited from the surrounding milieu to form a loosely-connected sheath enclosing 
large collections of axons and their associated glia (Parmantier et al., 1999).  These 
rudimentary perineurial cells later undergo a mesenchyme to epithelial transition and, 
over the proceeding weeks, the perineurium develops into a tight multi-layered 
sheath, secured by tight junctions, which functions as a BNB (Parmantier et al., 
1999).  Interestingly, ISCs have been implicated in the correct formation of the 
mature perineurium via the secretion of desert hedgehog (Dhh).  Knockout mice 
lacking the Dhh gene (Dhh-/-) exhibit nerves in which the perineurium is malformed 
and immature, i.e. not a tight, multilayered sheath (Parmantier et al., 1999).  The first 
nerve fibroblasts are also observed following SCP to ISC transition, which raises 
intriguing questions as to their origins in the nerve.  A study by Joseph et al. (2004), 
using cre-recombinase fate mapping, suggests that endoneurial fibroblasts might be 
derived from early glial progenitors.  The study showed that progenitor cells, which 
expressed p75NTR, S100β and Dhh, i.e. an identical profile to that of SCPs, had the 
potential to differentiate to fibroblast rather than Schwann cell progenitors, i.e. that 
expressed Thy1 but not Dhh and p75NTR (Figure 1.5).    However, it remains to be 
determined if SCPs are the cell of origin for endoneurial fibroblasts or if fibroblasts 
are derived instead from a progenitor cell committed to form fibroblasts but which 
also happen to express SCP differentiation markers.  Importantly, endoneurial 
fibroblasts are only found after SCPs have differentiated to ISCs, which strongly 
supports the theory that SCPs are able to differentiate to both glial and fibroblast 
progenitors (Jessen & Mirsky, 2005; Joseph et al., 2004).  
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Figure 1.5  Proposed model for multi-lineage peripheral nerve development.  In 
this model, fibroblasts share a common progenitor with Schwann cells.  The 
progenitor expresses similar surface markers to Schwann cell precursors (SCPs), i.e. 
p75NTR (neurotrophin receptor), S100β and Dhh (Desert hedgehog) and can generate 
both Schwann cell and fibroblast progenitors, where fibroblast progenitors down-
regulate S100β and p75NTR, while up-regulating the fibroblast marker Thy1 (Joseph 
et al., 2004). 
 
The transition from SCP to ISC marks a significant change in glial cell morphology, 
with ISCs assuming a bi- or tri- polar morphology in contrast to the flattened 
morphology exhibited by SCP clusters (Jessen & Mirsky, 2005; Woodhoo & 
Sommer, 2008).  This alteration in cell morphology is advantageous because it 
improves Schwann cell function in terms of axonal searching, interaction and 
manipulation, which are required at this stage in development.  In addition, there is a 
dramatic change in the regulation of cellular survival (Jessen & Mirsky, 2005).  The 
critical survival dependency, exhibited by SCPs for axonal NRG-1, is replaced in 
ISCs by cell-autonomous survival circuits mediated by autocrine signalling loops, in 
which ISCs secrete a range of self-acting survival factors including platelet-derived 
growth factor (PDGF)-β, insulin-like growth factor (IGF)-2 and neurotrophin (NT)-3 
(Meier et al., 1999) as well as leukaemia inhibitory factor (LIF) (Dowsing et al., 
1999) and lysophosphatidic acid (LPA) (Li et al., 2003).  The requirement for 
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survival autonomy in ISCs and, more importantly, mature Schwann cells, reflects the 
essential role played by Schwann cells in the repair process, where denervated 
Schwann cells must survive in the absence of axons (Jessen & Mirsky, 2005) (refer 
to section 1.5.1 for the role of Schwann cells in the nerve repair process).  
 
Radial sorting and the generation of adult Schwann cells 
 
Prior to their final differentiation to mature Schwann cells, ISCs undergo a process 
referred to as radial sorting, in which ISCs refine large collections of multi-sized 
calibre axons to either large single axons that later give rise to myelinated fibres or to 
clusters of small-calibre axons that later give rise to non-myelinating fibres (Jessen & 
Mirsky, 2005; Kuhlbrodt et al., 1998).  Thus, the mature Schwann cell fate is not 
predetermined within the lineage but instead depends on the random assortment of 
Schwann cells with axons.  Radial sorting is a highly physical process, involving 
manipulation of axonal bundles by Schwann cell protrusions to segregate and sub-
divide axons (Kuhlbrodt et al., 1998).  It is characterised by Schwann cell 
proliferation, process extensions and a morphological transition towards a spindle-
like shape (Chernousov et al., 2008).  Radial sorting is highly reliant on the 
interactions between ISCs and the ECM (Court et al., 2006), which is underlined by 
the essential requirement for laminins and integrins in this process.  For instance, 
Schwann cells deficient in laminin had substantially reduced active forms of Rac1 (a 
Rho GTPase important for process extension) and cdc42 (required for cell 
proliferation), which greatly hindered their ability to sort axons (Chernousov et al., 
2008).  Proliferation is an essential component of radial sorting, as the number of 
Schwann cells must increase to match the number of newly segregated axons which 
prior to de-fasciculation existed as large axonal bundles (Court et al., 2006; Martin & 
Webster, 1973).  A study by Yang et al. (2005), showed that combined loss of both 
laminin-2 and laminin-8 from ISCs resulted in the inhibition of Schwann cell 
proliferation and subsequent disruption to the radial sorting process.  Equally, Feltri 
et al. (2002) demonstrated the importance of integrin signals to radial sorting.  They 
used a conditional β1-integrin Schwann cell knockout mouse and observed the 
presence of unsorted axonal bundles in sciatic nerves, indicating that radial sorting 
had been severely disrupted.  NRG1 is also important for radial sorting, for example 
the nerves of NRG1(+/-) mice exhibited large unsorted bundles (Taveggia et al., 
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2005).  Interestingly, some parts of the PNS, for example the sympathetic nerve 
fibres, are never myelinated either in vivo or in vitro and are thus, always ensheathed 
by non-myelinated Schwann cells (Birchmeier & Nave, 2008). 
 
As radial sorting proceeds, the mixed bundles of unsorted, multi-sized axons are 
gradually sorted into either single large calibre axons (greater than 1µm in diameter), 
ensheathed by a single Schwann cell (in cross-section) or multiple small calibre 
axons that are ensheathed by a single Schwann cell and form Schwann cell-axonal 
families, termed Remak bundles (Figure 1.6).   At this stage, the adult fate of the 
ensheathing Schwann cell has been predetermined by the axon (Jessen & Mirsky, 
2005; Woodhoo & Sommer, 2008).  For instance, Schwann cells that ensheath 
multiple small-calibre axons later differentiate to form non-myelinating Schwann 
cells, which do not generate myelin or undergo compaction of their 
plasmamembrane.  In contrast, Schwann cells that ensheath single large-calibre 
axons begin a complex series of processes that differentiate the Schwann cell to the 
myelinated state.  In terms of myelinating Schwann cells, the first stage in this 
process is the generation of the pro-myelinating Schwann cell, in which the Schwann 
cell wraps the axon at least one and a half times with its plasmamembrane  (Jessen & 
Mirsky, 2005; Topilko et al., 1994).  The pro-myelinating state is only readily 
observed in mouse models where further progression to myelination has been 
blocked, for instance as occurs in the nerves of the Krox20-/- mouse (Topilko et al., 
1994).  Importantly, while the ensheathing pro-myelin Schwann cells are committed 
to myelination, at this stage they have yet to initiate myelination, i.e. undergo the 
biosynthetic process of generating myelin and the necessary myelin proteins required 
for compaction of their plasmamembrane. 
 
Myelination 
 
The myelination programme is a highly complex process, involving significant 
changes to cellular biosynthesis and cell morphology as well as cell-cycle exit 
(Srinivasan et al., 2012), and is accomplished only following an intricate, co-
ordinated programme of Schwann cell/axonal interactions.  For instance, the 
myelinating Schwann cell must synthesise large amounts of lipid-rich plasma-
membrane, interlaced with an abundance of specialised myelin proteins, that is 
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sufficient to wrap around the axon more than a 100 times and longitudinally extend 
to cover in some cases 1 mm of axon.  To achieve this, the Schwann cell increases its 
surface area by 'several thousand-fold' over a 48-hour period (Birchmeier & Nave, 
2008).  Concurrent with wrapping the axon, the Schwann cell plasma-membrane 
must also be compacted to generate compact myelin, in which both the extracellular 
and intracellular regions are tightly restricted.  This process of compaction is 
achieved by specialised myelin-specific proteins, for example MPZ, myelin basic 
 
Figure 1.6  Schematic showing the role of the axon in the determination of 
Schwann cell fate during radial sorting.  Schwann cells that randomly associate 
with large-calibre axons are induced to myelinate, while Schwann cells that associate 
with multiple small-calibre axons differentiate to non-myelinating Schwann cells.  
Cell-surface expressed neuregulin (NRG)-1 on the axon, which binds ErbB2/B3 
receptors in Schwann cells, has been implicated in the regulation of this process 
(adapted from Lemke, 2006). 
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protein (MBP) and peripheral myelin protein-22 (PMP22), which are under the 
regulatory control of the master regulator of myelination, Krox20.  The essential role 
of these proteins, and that of Krox20, are discussed in later sections.  In addition, the 
myelinating Schwann cell must establish radial and longitudinal polarity (Simons & 
Trotter, 2007), for instance the radially asymmetric composition of glial CAMs 
expressed on the outer (ECM-facing) and inner (axonal-facing) aspects and the 
longitudinal specification of the axo-glial domains, i.e. the Node of Ranvier, 
paranode and juxtaparanode), which are essential for saltatory conduction.  In 
addition, non-compact myelin channels must be incorporated into the myelin sheath 
so that the Schwann cell and the axon can be appropriately nourished (Nave, 2010a).  
Understanding the molecular machinery that coordinates and regulates these 
disparate processes to generate the functional myelinating fibre has been a matter of 
intense research.   
 
The regulation of myelination 
 
The regulation of myelination is multifaceted; consisting of a number of components 
that collectively switch the Schwann cell from the unmyelinated to the myelinated 
state. 
 
A)  Extracellular environment 
 
Myelination requires a permissive extracellular environment, for instance the correct 
ECM attachments/signals and crucially, the establishment of a basal lamina around 
the ensheathing Schwann cell/axonal unit (Bunge et al., 1986; Chernousov et al., 
2008; Court et al., 2006).  While the basal lamina undoubtedly provides structural 
protection for the fibre, its requirement for myelination is probably due to its role in 
the establishment of Schwann cell polarity (Simons & Trotter, 2007).  In terms of 
Schwann cell-ECM attachments, the binding of Schwann cell expressed integrins 
with ECM fibronectin and laminin has been shown to be required for myelination 
(Chernousov et al., 2008; Podratz et al., 2001).  Specifically, the binding of laminin-
2, laminin-8, and laminin-10 with Schwann cell expressed integrins have all been 
implicated in myelination (Yu et al., 2007).  Furthermore, loss of intergin-β1, known 
to bind various ECM components, also inhibits myelination (Feltri et al., 2002).  In 
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addition to laminins, attachment to collagens in the ECM is also required, for 
instance binding between alpha-4 (V) collagen (within the ECM) and Schwann cell 
expressed glypican-1 (a proteoglycan) is required for myelination in vitro, with loss 
of either leading to inhibition of myelination (Chernousov et al., 2006). 
 
B)  Extrinsic factors and cognate receptors 
 
Myelination requires instructive signals from the axon, one of which is known to be 
mediated in a juxtacrine manner via NRG-1 Type III-β1a, which signals 
intracellularly through the ErbB2/B3 heterodimeric receptor-tyrosine kinase (RTK) 
receptor (Nave & Salzer, 2006).  However, recently a second, and arguably as 
important, instructive signal has been reported, which is mediated through the G-
protein coupled receptor (GPR)-126, which is coupled to cyclic adenosine 
monophosphate (cAMP); a signal known to be important for myelination.  In this 
section, I will discuss the role played by both signals in determining the myelinated 
fate of Schwann cells. 
 
 
Neuregulin (NRG)-1 
 
Over the last twenty years, there has been mounting evidence for the critical role 
played by NRG-1 in almost all aspects of Schwann cell biology, including migration, 
proliferation, survival, differentiation and myelin thickness (Birchmeier & Nave, 
2008; Nave & Salzer, 2006; Quintes et al., 2010; Taveggia et al., 2005).  NRG1 
formerly known as glial growth factor (GGF) was originally identified as a potent 
Schwann cell mitogen (Lemke & Brockes, 1984) but was also separately identified 
as neu differentiation factor (NDF), heregulin, acetylcholine receptor inducing 
activity (ARIA) and sensory and motor neuron-derived factor (SMDF) (Davies, 
1998).  The NRG-1 gene encodes three major classes of NRG1 isoforms: the Type I 
class, including heregulin, NDF and ARIA; the Type II class, including GGF; and 
the Type III class, including the β1a and the β3 (SMDF) variants, of which all share 
the epidermal growth factor (EGF) domain, necessary and sufficient for ErbB 
binding (Garratt et al., 2000; Nave & Salzer, 2006).   
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The NRG1 gene encodes at least 15 different isoforms from multiple transcription 
sites and by alternative RNA splicing.  All isoforms are initially expressed on the cell 
surface but are post-translationally modified in situ by various extracellular  
metalloproteinases, including BACE1 (β-site APP cleaving enzyme-1) and 
membrane-anchored ADAM (a disintegrin and metalloprotease) proteins, which 
extracellularly cleave NRG1 molecules near their C-terminals just distal to the 
membrane, rendering Type I and Type II classes of NRG1 as soluble paracrine 
signals (Birchmeier & Nave, 2008; Hu et al., 2006).  NRG1 Type III is also cleaved, 
however, the isoform possesses an additional hydrophobic cysteine-rich domain 
(CRD) towards its N-terminus that forms a second transmembrane region resistant to 
cleavage - giving the isoform a looped extracellular conformation. Thus, while 
cleavage of Type III NRG1 isoforms (proximal to the EGF domain) sterically frees 
the EGF domain for signalling, the CRD domain ensures that the activated isoform 
remains tethered to the membrane (Nave & Salzer, 2006) (Figure 1.7). 
 
 
 
Figure 1.7  Schematic showing the three major classes of Neuregulin-1.  All 
NRG1 isoforms are initially expressed on the axonal cell-surface and are later post-
translationally cleaved by metalloprotease, for example BACE-1 (see black arrow).  
Cleavage releases NRG-1 Type I and Type II molecules as soluble factors that signal 
in a paracrine manner; however, cleavage of Type III, which is looped back on itself, 
results in the exposure of the EGF domain for signalling in a juxtacrine manner  
(Jessen & Mirsky, 2005). 
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Over the last decade, NRG-1 Type III β1a has emerged as the predominant 
functional isoform expressed by sensory and motor neurons of the PNS (Lemke, 
2001; Michailov et al., 2004; Taveggia et al., 2005), and is thought to be the axonal 
signal responsible for regulating neural crest migration, SCP survival, nerve 
fasciculation and Schwann cell differentiation (Jessen & Mirsky, 2005; Wolpowitz et 
al., 2000).  NRG1 Type III appears to be instrumental in the binary decision that 
results in the myelination of larger axons and the non-myelination of smaller axons.  
For some time, the mechanism that allowed Schwann cells to 'sense' the axonal 
diameter in order to make this decision was unknown and to date is still not 
completely understood.  One suggestion is that the amount of axonal-expressed 
NRG1 Type III is correlated with the axonal diameter so that larger calibre axons 
with greater surface-areas will provide a correspondingly greater NRG1 stimulus to 
the ensheathed Schwann cell.  In this hypothesis, the NRG1 Type III signal acts in 
both a threshold and dose-dependent manner (Figure 1.8).   
 
The threshold component is binary, i.e. Schwann cells require a specific 
concentration of NRG1 (as provided by axons of 1µm or greater in diameter) to 
initiate myelination, without which the myelination programme is not initiated and 
the Schwann cell differentiates to the non-myelinating state.  This theory is supported 
by Taveggia et al. (2005) and Michailov et al. (2004), who investigated the effect on 
myelination in various NRG1 mouse models.  In these studies, the NRG1(-/-) animals 
failed to myelinate and were characterised by malformed Remak bundles containing 
both large and small axons, indicative of a failure in radial-sorting, and were 
invariably lethal with animals not surviving post-birth.  The NRG1(+/-) nerves 
manifested a less severe phenotype; however, myelinated nerves were hypo-
myelinated and Remak bundles were still poorly sorted.  In addition, when NRG1 
Type III was over expressed by axons, the resulting myelinating fibre was hyper-
myelinated suggesting that the concentration of NRG1 was correlated with myelin 
sheath thickness.  Finally, Taveggia et al. (2005) showed that sympathetic nerve 
fibres, which normally never myelinate, could be induced to myelinate by NRG1 
Type III over-expression in these neurons.  Taken together, these findings are 
consistent with NRG1 Type III acting in a dose-dependent manner in the regulation 
of myelin sheath thickness and lends credence to the idea of NRG1 Type III, as the 
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axon derived ‘rate-limiting factor for myelination’ (Corfas et al., 2004; Michailov et 
al., 2004; Nave & Salzer, 2006).  In addition, studies have also determined the 
critical importance of the juxtacrine (cell-cell contact dependent) mode of NRG1 
Type III signalling as soluble NRG1 failed to elicit the same effect and may even 
inhibit myelination (Zanazzi et al., 2001). 
 
The Neuregulin receptor 
 
The NRG1 signal is conveyed through a heterodimeric RTK receptor composed of 
ErbB2 and ErbB3, which binds the EGF domain of NRG molecules (Davies, 1998; 
Lemke, 2001; Nave, 2010a).  A third ErbB protein, ErbB4, also exists although it is 
minimally expressed in Schwann cells (Nave & Salzer, 2006).  The ErbB2/B3 
 
 
Figure 1.8 Axonal neuregulin-1 type III operates in a binary (threshold) and 
dose-dependent manner to regulate Schwann cell differentiation. (A) Immature 
Schwann cells ensheath larger axons in 1:1 ratios while ensheathing multiple smaller 
axons into Remak bundles in a process called radial sorting.  Larger axons provide a 
greater NRG1 signal, which after a threshold amount commits the Schwann cell to 
the myelinated state.  (B)  The amount of NRG1 Type III above the threshold 
determines the extent of myelination with the NRG1(-/-) failing to myelinate, the 
NRG1(+/-) nerves hypomyelinated and the NRG1 Type III over-expressing mice 
having hyper-myelinated nerves (Nave & Salzer, 2006). 
 
A) 
B) 
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receptor is the predominant NRG-1 receptor in Schwann cells.  The receptor is 
composed of the high-affinity (but kinase inactive) ErbB3, which recognises and 
binds axonal NRG1 Type III that is tethered to the axolemma.  This interaction is 
necessary before the low-affinity (but kinase active) ErbB2 molecule can bind in cis 
with the ErbB3-NRG1 complex in order to generate the active receptor (Davies, 
1998; Lemke, 2001).  Heterodimerisation of ErbB2/B3 causes transphosphorylation, 
recruitment of SH3 adaptors and associated downstream signalling (Nave & Salzer, 
2006).  All components of this pathway are required for viability as NRG1, ErbB2 
and ErbB3 knockout mice are all embryonic lethal, with death in NRG1 and ErbB2 
null animals occurring prior to SCP generation, i.e. before E10, as a result of defects 
in cardiogenesis (Nave & Salzer, 2006).  However, ErbB3 animals survived longer 
mostly because ErbB3 is not expressed in cardiac tissue and thus mutants survive 
until late gestation.  Temporal analysis of embryonic ErbB3 null nerves revealed that 
by E10.5 the nerves are devoid of Schwann cell progenitors and exist as bare axons 
which degenerate at E18-E19 (Nave, 2010b; Riethmacher et al., 1997).  Importantly, 
while DRG neurons initially survive without Schwann cells, by E18.5 approximately 
90% have died in the absence of Schwann cells (Davies, 1998), thus underlining the 
critical co-dependency between Schwann cells and axons.  
 
Intracellular signalling through the ErbB2/B3 receptor 
 
Activation of the ErB2/B3 receptor results in the intracellular activation of known 
signalling cascades including the mitogen activated protein kinase (MAPK) cascade 
and the phosphatidylinositol-3 kinase (PI3K) cascade (Birchmeier & Nave, 2008).  
Understanding how Schwann cells responds to signalling through these different 
pathways may hold the key as to how one signal, i.e. NRG1, appears to drive 
seemingly opposing cellular processes and behaviours at different developmental 
stages (Corfas et al., 2004; Nave & Salzer, 2006; Ogata et al., 2004).  For instance, 
nearly all aspects of normal Schwann cell development has been shown to require 
axonal NRG1 Type III and ErbB2/ErbB3 signalling through the PI3K pathway 
leading to activation of a number of downstream effectors including the serine-
threonine kinase AKT (also known as Protein Kinase B) (Nave & Salzer, 2006) 
(Figure 1.9).  Although activated to a degree, the ERK pathway is not thought to be 
required for axon-mediated Schwann cell survival as indicated by MEK and ERK 
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inhibitor studies (Maurel & Salzer, 2000).  In contrast to PI3K, the ERK downstream 
signal can be inhibitive to myelination, where sustained ERK activation leads to 
down-regulation of myelin specific genes (Harrisingh et al., 2004), causing de-
myelination, dissociation from axons and Schwann cell proliferation (Ogata et al., 
2004; Parrinello et al., 2008).  Thus, signalling through the ERK pathway takes 
precedence over the PI3K pathway during the injury response. 
 
 
 
Figure 1.9  Membrane tethered axonal neuregulin (NRG)-1 Type III regulates 
Schwann cell differentiation and myelin thickness.  The NRG1 signal is 
transduced through the ErbB2/B3 heterodimeric receptor-tyrosine kinase (RTK) 
receptor, which predominantly activates the AKT-mTOR pathway.  Signalling via 
intergrins (from the extracellular matrix) and insulin-like growth factor (IGF)-1 are 
also important modulators of myelination (Nave, 2010b).   
 
 
G-protein coupled receptor (GPR)-126 
 
While NRG1 has been shown to be required, it is not sufficient to instruct 
myelination, for instance heterologous expression of NRG1 Type III does not result 
in myelination in vitro, despite retaining its activity as a mitogen (Taveggia et al., 
2005).  Moreover, it is still far from clear how NRG1 is exerting its downstream 
effects particularly in relation to a direct transcriptional link between the NRG1 
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signal and transcriptional activation of myelin genes (Birchmeier & Nave, 2008).  
Experimental elevation of intracellular cAMP in cultured Schwann cells, often by 
addition of the cAMP analogue forskolin, has been adopted in vitro for quite some 
time in order to mimic the axonal signal in driving Schwann cell differentiation and 
myelination (Monuki et al., 1989; Morgan et al., 1991; Scherer et al., 1994).  In 
addition, Howe & McCarthy (2000) showed that in vivo inhibition of PKA (protein 
kinase A), which is a major target of intracellular cAMP and is independent of 
NRG1, using a dominant negative PKA, resulted in an 80% reduction in myelinated 
Schwann cells (Howe & McCarthy, 2000).  
 
The in vivo physiological signal that elevates cAMP during Schwann cell 
differentiation has until recently remained elusive.  The identification of GRP-126 
appears to provide an answer (Monk et al., 2009).  GRP-126 is expressed on the 
Schwann cell and has been shown to directly and transiently elevate intracellular 
cAMP, thus providing a second instructive signal for myelination, with importantly, 
a well-documented link to the transcriptional apparatus involved in the initiation of 
myelination (Monk et al., 2009).  For instance, cAMP is known to activate PKA 
(discussed above), which activates a number of downstream transcription factors 
important for Schwann cell differentiation, including nuclear factor (NF)-κB and 
cAMP response element binding protein (CREB) (Arthur-Farraj et al., 2011; Monk 
et al., 2009; Monuki et al., 1989).  These act collectively to induce Oct-6 
transcription, which together with Brn2 and Sox10 is required for the initiation of 
Krox20 expression and thus, myelin gene expression.  The central importance of 
GRP-126 was initially demonstrated by GRP-126 mutant zebrafish models and later 
by mouse models, in which myelination in GRP-126 mutants was blocked and 
Schwann cell development arrested at the pro-myelinating stage (Monk et al., 2009).  
Moreover, the addition of forskolin is sufficient to restore myelination in the 
zebrafish mutants, confirming that cAMP is the deficient pathway downstream of 
GRP-126 required for myelination.  Furthermore, expression of GRP-126 was shown 
to be independent of NRG1, thus the authors suggest that GRP-126 signalling is 
required after NRG1 to initiate myelination.  Further work is needed to determine the 
axonal ligand for GRP-126.  Interestingly, a recent study by Arthur-Farraj et al. 
(2011), showed that the concentration of cAMP was important for modulating the 
NRG1 Type III signal, such that low cAMP favoured NRG1 as a mitogen, while high 
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levels of cAMP favoured NRG1 as a pro-myelinating differentiator.  Importantly, 
loss of either the cAMP or NRG1 signal prohibits myelination, while combined 
cAMP and NRG1 signalling in mouse Schwann cells leads to robust myelin gene 
expression, for example Krox20 and MPZ, confirming the essential importance of 
both signals in the instruction of Schwann cell myelination (Arthur-Farraj et al., 
2011). 
 
C)  Extrinsic modulators 
 
Positive modulators 
Correct and timely progression to myelination requires a number of additional 
extrinsic factors that modulate the primary instructive signals of NRG1 and cAMP.  
These include, progesterone, brain derived neurotrophic factor (BDNF), glial cell 
line derived neurotrophic factor (GDNF) and Insulin-like growth factor 1/2 (IGF1/2) 
(Jessen & Mirsky, 2008b).  BDNF is a neurotrophin that signals through the low-
affinity p75 neurotrophin receptor (p75NTR) (Chan et al., 2001).  Loss of either the 
ligand (BDNF) or receptor (p75NTR) impedes myelination and results in a reduction 
in myelin sheath thickness and the number of myelinated fibres (Chan et al., 2001; 
Chen et al., 2006).  The IGF1 signal, which is conveyed through the IGF receptor, 
has been implicated in modulating the cAMP signal during activation of the PI3K 
pathway, and thus plays a role in myelination (Ogata et al., 2004).  Another 
modulator is BACE1, involved in the cleavage and activation of the NRG1 signal 
(previously discussed on page 42), in which BACE1 null mice exhibit hypo-
myelinated nerves and radial-sorting defects (Hu et al., 2006). 
 
Negative modulators 
Many of the negative regulators act to inhibit myelination by promoting the 
dedifferentiation of Schwann cells and in addition, commonly function as Schwann 
cell mitogens.  Negative extrinsic factors include neurotrophin (NT)-3 and Jagged.  
The NT-3 receptor is the high-affinity neurotrophin receptor TrkC, whose activation 
inhibits myelination and stimulates Schwann cell proliferation (Chan et al., 2001).  
Axonal expressed jagged signals via its Notch receptor expressed on the Schwann 
cell.  Autotypic binding between Jagged and Notch, leads to Notch activation, 
resulting in the cleavage of the C-terminal Notch intracellular domain (NICD), which 
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translocates to the nucleus and functions to directly regulate transcription  (Jessen & 
Mirsky, 2008b; Taveggia et al., 2010; Woodhoo et al., 2009).  Recent work has shed 
new light on the complexities of Notch signalling in Schwann cell development, 
including lineage transition, repression of myelination and the stimulation of 
Schwann cell proliferation following PNS injury (Woodhoo et al., 2009). 
 
D)  Transcriptional regulators 
 
Myelination is ultimately governed by the co-ordinated action of positive and 
negative transcriptional regulators, where the prevailing net balance of these 
activities determines whether Schwann cells differentiate to myelinated Schwann 
cells or, in the case of adult nerve injury, dedifferentiate back to a non-myelinated 
state.  Positive transcriptional regulators include Sox10, NFκB, Brn2, Oct-6 (also 
known as SCIP (suppressed cAMP inducible POU), Tst1 and Pou3f1) and Krox20 
(Egr2) (Jessen & Mirsky, 2005; Quintes et al., 2010).  Negative transcription factors 
include c-Jun, Sox2, Pax3, Krox24 (Egr1) and NICD (Jessen & Mirsky, 2008b). 
 
Positive transcriptional regulation 
The first of these transcription factors to be expressed is Sox10, often described as 
the Schwann cell specification factor, which is expressed in NCCs and continues to 
be expressed throughout the Schwann cell lineage and indeed by all glial cells of the 
PNS (Britsch et al., 2001; Schreiner et al., 2007).  Sox10 is an HMG (High Mobility 
Group)-box transcription factor and is a Class-E member of the Sox family (Svaren 
& Meijer, 2008).  As previously discussed, the loss of Sox10 (in mouse models) 
results in the ablation of the Schwann cell lineage, demonstrating the importance of 
this transcription factor to Schwann cell biology (Britsch et al., 2001).  In terms of 
myelination, Sox10 is thought to function with NFκB to govern the initiation of 
myelination (Svaren & Meijer, 2008).  However, progression to the pro-myelinating 
state, i.e. where the Schwann cell wraps the axon one and half times, is dependent on 
the expression of Oct-6 and the closely related Brn2 (both of which are POU domain 
III transcription factors) as well as Sox10 (Salzer et al., 2008).  Interestingly, the 
expression of both Oct-6 and Brn2 are increased markedly following axonal contact, 
which is known to elevate cAMP.  Evidence has emerged to suggest that these 
intracellular pathways converge onto a 4.3kb conserved region that resides 
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downstream of the Oct-6 gene called the Schwann cell specific enhancer (SCE) 
(Mandemakers et al., 2000; Svaren & Meijer, 2008).    Deletion studies have shown 
that 500bp of this region are critical for Schwann cell differentiation and 
furthermore, numerous Sox binding sites have been identified in this sequence, 
highly suggestive of a role for Sox proteins in the regulation of Oct-6 (Svaren & 
Meijer, 2008).  A distinct role for Sox10 in the generation of myelinating Schwann 
cells is supported by the finding that a hypomorphic allele of Sox10, in which Sox10 
expression is driven at substantially lower rates than wild-type animals, was 
sufficient to specify Schwann cells, but  was not sufficient to differentiate Schwann 
cells (Schreiner et al., 2007). 
 
Both Oct-6 and Brn2, in combination with Sox10, are important for initiating 
myelination at the correct developmental time, for instance loss of Oct-6 delays 
myelination by several weeks in mouse and combined loss of Oct-6 and Brn2 further 
delays myelination with pro-myelinating Schwann cells persisting in adult nerves  
(Bermingham et al., 1996; Jaegle et al., 2003; Svaren & Meijer, 2008).  These 
findings suggest that Oct-6 and Brn2 can functionally compensate for one another.  
Oct-6 and Brn2 exert their pro-myelination activity through binding at multiple sites 
on the cis-acting Krox20 enhancer element - the myelin Schwann cell enhancer 
(MSE) - located 35kb downstream of the Krox20/Egr2 gene (Ghislain et al., 2002).  
The binding of Oct-6 and Brn2 at the MSE activates Krox20 expression.  Recently, it 
has been shown that Sox10 cooperates with Oct-6 to synergistically promote Krox20 
expression and thus, myelination (Ghislain & Charnay, 2006).  Interestingly, Krox20 
activity depends on the down-regulation of Oct-6 and Brn2, for instance a study by 
Ryu et al. (2007) showed, using a conditional Oct-6 mouse (condPou3f1:MPZ) in 
which Oct-6 expression was driven by MPZ, that if Oct-6 expression persisted, then 
Krox20-dependent myelin gene expression was inhibited, leading to severe 
hypomyelination of adult nerves.   
 
Krox20 is a member of the early-growth response (EGR) genes and is often cited as 
the master transcriptional regulator of myelination because of its sufficiency to 
induce myelination (Decker et al., 2006; Parkinson et al., 2004; Topilko et al., 1994).  
Krox20 is necessary for myelination (in addition to Sox10) and controls an array of 
myelin specific gene expression including genes encoding the myelin specific 
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proteins, for example MBP, MPZ, MAG and periaxin (Pxn), as well as genes 
involved in lipid biogenesis, for instance HMG CoA reductase (Leblanc et al., 2005).  
Krox20(-/-) animals exhibit normal radial sorting and progress to the pro-myelinating 
state but are blocked from differentiating further (Topilko et al., 1994).  Expression 
of Krox20 is thus essential for progression past the pro-myelinating stage in the 
Schwann cell lineage and for the entirety of myelination including maintenance of 
myelin gene expression throughout adult life (Decker et al., 2006).  Krox20 is a zinc-
finger transcription factor, where the zinc finger domain is essential for its function, 
i.e. loss of the domain results in the failure of the myelination programme (Topilko et 
al., 1994). The activity of Krox20 is modulated by a number of proteins, of which the 
NGF1/Krox20-A-binding (Nab) proteins (Nab1 and Nab2) are best characterised.  
The Nab proteins share two homologous domains, NCD1 and NCD2, where NCD1 
is known to interact with the R1 domain on Krox20 (Le et al., 2005b) and NCD2 is 
important for transcriptional regulation (Swirnoff et al., 1998).  Importantly, the 
interaction of Nab with Krox20, through binding of the NCD1 domain of the former 
with the R1 domain of the later, is essential for Krox20 function and myelination (Le 
et al., 2005b). 
 
Negative transcriptional regulation 
The negative transcriptional regulators of the myelination programme have 
historically received less attention; however, in recent years significant progress has 
been in understanding their role in the myelination programme and following injury.  
For instance, negative transcription regulators act to repress the myelination 
programme in development in order to regulate the initiation of myelination and to 
drive Schwann cell dedifferentiation following nerve injury.  Importantly, they are 
usually associated with stimulating Schwann cell proliferation as opposed to positive 
transcription factors, which are associated with cell-cycle exit and differentiation. 
 
The best characterised negative transcription factor is c-Jun, a basic leucine zipper 
transcription factor, which is expressed in Schwann cell prior to myelination and is 
down-regulated following the initiation of myelination, while being up-regulated 
upon nerve injury (Parkinson et al., 2008; Salzer et al., 2008).  The activation of c-
Jun is carried out by Jun N-terminal kinases (JNKs), which phosphorylates c-Jun on 
its N-terminal.  c-Jun, together with JunB and JunD, form part of the AP-1 
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transcription complex, where the activated c-Jun signal exerts a dominant inhibitory 
affect on myelination, for instance Schwann cells with forced c-Jun expression do 
not myelinate even in the presence of Krox20 or cAMP signal (Parkinson et al., 
2008).  c-Jun is down-regulated by Krox20 activity, thus, the onset of myelination is 
dependent on Krox20 expression (Parkinson et al., 2004).  Another transcription 
factor that closely mirrors c-Jun expression is Sox2, indeed there is some evidence to 
suggest that Sox2 expression is directly induced by c-Jun, although it is still unclear 
if both molecules interact (Parkinson et al., 2008).  Similar to c-Jun, Sox2 is 
expressed by Schwann cell progenitors (during development) prior to myelination 
and in nerve injury.  Sox2 is also down-regulated by Krox20, which is required for 
progression to myelination (Le et al., 2005a).   
 
Pax3 is a member of the paired box gene family of transcription factors and is 
expressed by ISCs and non-myelinating Schwann cells in vivo (Kioussi et al., 1995).  
Levels of Pax3 have been directly shown to decrease as cAMP levels increase in 
vitro (Kioussi et al., 1995).  Furthermore, enforced expression of Pax3 prevents 
either Krox20 or cAMP induced myelin gene expression.  However, while Pax3 
expression appears similar to c-Jun and Sox2, its activity is less well characterised 
and it remains to be determined if it is involved in Schwann cell dedifferentiation 
(Jessen & Mirsky, 2008b).  Another less-well characterised transcription factor is Id-
2, a member of the helix-loop-helix (HLH) family of transcription factors, which also 
inhibits myelination but its effects appear more subtle.  Basal expression levels of Id-
2 in Schwann cell development is relatively low; however, levels increase following 
the initiation of myelination and are later reduced as myelination progresses (Stewart 
et al., 1997).  Levels of Id-2 are also increased following nerve injury, in-line with 
other transcription factors, for example c-Jun, Sox2 and Pax3, although it is unclear 
how Id-2 antagonises myelination following injury (Jessen & Mirsky, 2008b). 
 
In addition to Krox20, a number of other EGR transcription factors, for example 
Krox24 and EGR3 are involved in the myelination programme.  These factors 
antagonise Krox20 activity and act to repress myelination, although their activity in 
the myelination programme is poorly understood (Jessen & Mirsky, 2008b).  
However, Krox24 is expressed in non-myelinating adult Schwann cells and 
furthermore, it is up-regulated (with EGR3) in denervated Schwann cells following 
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nerve injury, concomitant with a fall in Krox20 expression, although Krox24 null 
mice are still able to regenerate nerve following injury (Topilko et al., 1994). 
 
Recent work has implicated Notch and specifically, its Notch intracellular domain 
(NICD) cleaved subunit, which is the component responsible for its transcriptional 
regulatory activity, in the negative repression of myelination, as well as in lineage 
progression (as discussed earlier).  Notch expression is down-regulated during 
myelination and has been shown to be repressed by Krox20 in vitro (Woodhoo et al., 
2009).  In addition, enforced NICD expression blocks cAMP induced myelination in 
vitro and transient elevation of NICD at the onset of myelination has been shown to 
delay myelination (Woodhoo et al., 2009).  Furthermore, in the same paper, the 
authors showed that the distal stump of sciatic nerve cuts are strongly positive for 
NICD. 
 
 
Figure 1.10   Schematic of a pro-myelinating Schwann cell, showing the balance 
of factors required to initiate myelination.  Axon to Schwann cell signalling 
includes NRG1 Type III/ErbB2-B3 and Jagged/Notch, while axo-glial adhesion is 
mediated through Necl1/Necl4 interaction.  Other extrinsic factors include signalling 
via GPR-126 (adaxonal face) and ECM signalling though laminins. Progression to 
the myelinated state is dependent on a shift in the balance between positive and 
negative factors (adapted from Taveggia et al., 2010). 
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1.4.2 Nerve homeostasis and myelination 
 
 
The evolution and function of myelin 
 
The evolution of myelin is thought to have occurred in placoderms (hinge-jawed 
fish) at a similar time to neural crest evolution (Hartline & Colman, 2007; Zalc et al., 
2008), some 300 million years ago (Nave, 2010b).  Myelin is a common feature of 
all vertebrate nervous systems, although other non-vertebrate species have separately 
evolved their own form of electrical insulation (Zalc et al., 2008).  Myelin is thought 
to have evolved following selective pressure to achieve rapid and reliable 
transmission of action potentials without the need for excessively large calibre axons, 
which would be unacceptable in bony organisms where cranial space is a premium 
(Nave, 2010b; Poliak & Peles, 2003; Zalc et al., 2008).  In fact, it is thought that the 
advent of myelination allowed the placoderm oculomotor nerve to achieve a length 
ten-fold greater than that of their immediate ancestors, while maintaining the same 
nerve diameter (Zalc et al., 2008).  
 
The primary function of myelin, which can be observed in electron micrographs 
(EM) as electron-dense concentric rings around the axon, is to electrically insulate 
the axon by reducing the capacitance of the axolemma (axonal plasma-membrane) 
and increasing transverse resistance (Hartline & Colman, 2007; Poliak & Peles, 
2003).  This provides two major benefits over equivalent non-myelinating fibres.  
First, myelinated fibres are more energy efficient, using less ATP, which is required 
by Na+ and K+ ATPase ion pumps, by reducing the area of ion exchange to a 
fraction (0.5%) of the surface area of the axolemma (Nave, 2010b).  Second, the 
insulating properties of myelin coupled with regularly-spaced interruptions in the 
sheath at the Node of Ranvier, allow for saltatory (Latin for saltair or 
‘leaping/jumping’) conduction of action potentials down the fibre.  This method of 
nerve conduction provides for up to 100-fold increases in the conduction velocity of 
the myelinated fibre compared to non-myelinating equivalents (Nave, 2010b; Zalc et 
al., 2008).   Thus, while a relatively large non-myelinated fibre of 10µm diameter 
could achieve an nerve conduction velocity (NCV) of 1ms/s, the equivalent 
myelinated fibre could theoretically achieve an NCV of 100ms/s.  In addition, while 
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the signal along non-myelinated fibres is subject to cable properties, i.e. the original 
electrical signal decays at a rate equal to the inverse square of the length, the action 
potentials propagated by saltatory conduction along myelinated fibres, is continually 
regenerated at each Node of Ranvier, in a chain of membrane depolarisation and re-
polarisations events (Hartline & Colman, 2007). 
 
The NCV in myelinating fibres is determined by two main parameters.  The first 
parameter is determined by the axonal diameter and myelin sheath thickness, 
represented by the ‘g-ratio’.  The g-ratio is calculated by dividing the axonal 
diameter by the diameter of the myelinated fibre as a whole, where 0.68 is an optimal 
value (Court et al., 2004; Nave & Salzer, 2006; Quintes et al., 2010; Sherman & 
Brophy, 2005).  In healthy nerves, the ratio is maintained between 0.6 and 0.7, thus 
myelin sheath thickness is proportional to axonal diameter (Nave & Salzer, 2006; 
Sherman & Brophy, 2005). A reduction in the thickness of the myelin sheath, for 
example, as observed in nerves of NRG1(+/-) mice, causes a proportional reduction in 
NCV (Nave & Salzer, 2006).  Additionally, injured nerves, in which Schwann cells 
have dedifferentiated and then re-myelinated, often have larger g-ratios indicative of 
a reduced sheath thickness.  This suggests that the NRG1 dose response is no longer 
perfectly coupled to myelin biosynthesis following nerve injury (Sherman & Brophy, 
2005).  The second parameter is the internode length, which dictates the frequency of 
Nodes of Ranvier along the axon.  Although largely theoretical, the importance of 
this parameter is apparent in the periaxin null mouse, in which the lateral growth of 
the Schwann cell plasma-membrane is truncated.  These mice exhibit a greater 
frequency of Schwann cells along the axon and a reduction in the average internode 
length, which subsequently results in a reduction in NCV concordant with the 
increased frequency of Nodes of Ranvier per unit length (Court et al., 2004).  During 
development, both the g-ratio and the internode length are carefully regulated to 
ensure maximum efficiency of nerve impulses, i.e. to achieve the desired NCV for 
the least axonal diameter and least energy expenditure.  
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Cell adhesion molecules as mediators of Schwann cell/axonal interactions 
 
Cell adhesion molecules (CAMs) mediate interactions between Schwann cells and 
axons and are a central theme to this thesis.  In addition, cell-cell adhesion is 
fundamental to the development and maintenance of the three-dimensional 
architecture of the nervous system (Haney et al., 1999).  In this section I will first 
give a brief overview of cell-cell interactions and adhesion molecules.  I will then 
discuss in more detail the role of specific CAMs that mediate Schwann cell/axonal 
interactions and which collectively generate and maintain the structure of myelinated 
peripheral nerve fibres. 
 
General principles of cell-cell interactions 
 
When cells contact each other they may meet the same cell type (homotypic 
interaction) or a different cell type (heterotypic interaction).  The encounter can elicit 
different responses which largely depend on the repertoire of cell surface expressed 
signalling molecules presented by each cell.  They either elicit (a) no reaction, (b) 
repulsion, where the cell cytoskeleton is remobilised to move the cell in the opposite 
direction (or is extruded if in a monolayer) or (c) adhesion, where both cells form an 
attachment to each other.  The latter two behaviours, i.e. repulsion and attraction, are 
initiated following recognition of the encountered cell through surveillance of the 
cell's surface expressed molecules.  Thus, repulsion and attraction are often utilised 
for the purposes of cell-sorting events.  If the encounter results in attraction then the 
force and duration of the attraction are important, as both variables have implications 
for generating and maintaining cell-cell junctions.  Importantly, although initial 
forces may be weak, the collective force of a junction may strengthen over time with 
recruitment of additional subunits into a larger junctional complex. 
 
Vertebrate cell-cell junctions can be of a number of different types but these mainly 
fall into four functional categories: (a) anchoring junctions, for example adherens 
junctions (abutting the actin cytoskeleton) and desmosome (abutting with 
intermediate filaments); (b) occluding junctions, for instance, tight junctions that 
form  seals between cells;  (c) channel-forming junctions, for instance, gap junctions, 
that permit the intercellular  transport of diffusible solutes; and (d) signal-relaying 
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junctions, with highly specialised signal transduction roles (Alberts et al., 2008, 
p1132).  Importantly, the structural role of cell-cell adhesion cannot be uncoupled 
from cell-cell signalling, which occurs in all of these types of adhesion junctions.   
 
Attraction between cells is mediated by cell adhesion molecules (CAMs).  Typically, 
the structure of a CAM incorporates a transmembrane domain, an extracellular 
domain (for recognition and binding to the ligand expressed on an adjacent cell), and 
a cytoplasmic domain, which is often tethered to the cytoskeleton (Hansen et al., 
2008).  CAMs mediate cell-cell adhesion by trans-interaction either by recognising 
an identical CAM, referred to as a homophilic interaction, or by recognising a 
different CAM, referred to as a heterophilic interaction.  Hansen et al. (2008) 
classifies CAMs based on structure as (i) cadherin superfamily (ii) integrin 
superfamily (iii) selectins and (iv) immunoglobulin superfamily of CAMs.  In this 
review I will focus on selected members of the cadherin and immunoglobulin 
superfamily, as these CAM groups are most relevant to this thesis. 
 
Cell adhesion molecules of peripheral nerve 
 
A study by Spiegel et al. (2006) identified three main groups of Schwann cell 
expressed adhesion molecules.  These are: (1) early mediators of Schwann 
cell/axonal interaction, for example Neural cadherin (N-cadherin), L1-cell adhesion 
molecule (L1-CAM), neural cell adhesion molecule (NCAM) and semaphorin-4F 
(Sema4F); (2) structural adhesion molecules, for example Epithelial cadherin (E-
cadherin), MPZ, PMP22 and claudin-19; (3) mediators of stable interactions between 
myelinated Schwann cells and their ensheathed axons including those involved in the 
specialisation and compartmentalisation of the Schwann cell/axonal membrane, for 
example Tag-1/contactin-2, neurofascin (NF)-155, gliomedin and Necls.  These, 
together with the mediators of Schwann cell/ECM attachment, orchestrate various 
processes of myelinating Schwann cells, including cell attachment, process 
extension, axon ensheathment, spiral enwrapping, compaction and the formation of 
the Nodes of Ranvier (Spiegel et al., 2006).  The adhesion molecules involved in 
Schwann cell/axonal interactions and myelination, discussed in the following 
sections, are summarised in Table 1.1. 
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Cell adhesion molecules of early Schwann cell/axonal interactions 
 
N-cadherin 
 
The cell adhesion molecule N-cadherin/cadherin-2 will be discussed in detail 
because of its central relevance to this thesis.  N-cadherin is expressed early in the 
Schwann cell lineage at the neural crest stage but appears to be down-regulated 
following transition to mature Schwann cells (refer to Chapter Three for more 
details).  The cadherin or ‘calcium-dependent adherent protein’ family are defined by 
their dependence on soluble calcium ions for their adhesive function (Patel et al., 
2003).  The cadherin superfamily consists of a diverse collection of CAMs that can 
be subdivided into five main structural and functional groups with different ligand-
binding preferences.  These are the classical cadherins, desmosomal cadherins, 
atypical cadherins, proto-cadherins and cadherin-related signalling proteins 
(Gumbiner, 2005).  In addition to their dependency on calcium, all cadherins share a 
conserved region of approximately 110 residues in their extracellular domain, which 
are often repeated (Patel et al., 2003).   Cadherins function not only in cell adhesion 
but are also central to processes of cell-cell recognition, cell and tissue polarity, cell 
migration and cell-sorting (Halbleib & Nelson, 2006).   
 
N-cadherin is a member of the classical cadherins, which are the most studied 
cadherin subdivision and are best known for their structural role in forming adherens 
junctions that hold cells together in tissues, for example epithelial tissue.  Members 
of this group have historically been named according to their predominant site of 
expression.  They include E-cadherin (the founding member), N-cadherin, placental 
(P)-cadherin, retinal (R)-cadherin, and (type II) vascular endothelial (VE)-cadherin 
(Gates & Peifer, 2005; Gumbiner, 2005).  However, this nomenclature is confusing 
as the type of cadherin expressed is not restricted to the tissues as implied in their 
nomenclature, moreover (as in Schwann cells) different cadherins can be expressed 
in the same cell at different developmental times (Crawford et al., 2008).  Thus, the 
official nomenclature now defines the cadherins by a numerical suffix so that the 
previous list starting with E-cadherin is thus, cadherin-1 (CDH1) through to 
cadherin-5 (CDH5), respectively. Historically, N-cadherin was first identified in the 
brain and is often cited as the predominant cadherin of the developing nervous 
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system (Fairless et al., 2005; Ranscht, 2000).  In the CNS, N-cadherin plays an 
important role in synaptic function, synaptogenesis and dendrtic spine morphology 
(Bard et al., 2008; Benson & Tanaka, 1998).  In the PNS, N-cadherin had been 
shown to play a central role in growth-cone path-finding (Bard et al., 2008), and 
furthermore, has been implicated as an early mediator of Schwann cell/axonal 
interactions (Wanner et al., 2006a; Wanner & Wood, 2002), although its exact role 
has yet to be determined and is the subject of this thesis. 
 
The structure and downstream components of N-cadherin 
 
Similar to other members of the classical cadherins, the N-cadherin molecule is 
structurally composed of five extracellular  domains (ECD 1-5), a single-spanning 
transmembrane domain and a C-terminal cytoplasmic domain (Gumbiner, 2005).  
The ECDs are arranged in linear tandem repeats with ECD-5 juxtaposing the plasma-
membrane while ECD1 is the most outer domain and is thought to be the active 
domain for mediating adhesion.  Each ECD is composed of 110 conserved residues 
that form autonomous β-pleated sheets arranged in structures that resembles a ‘Greek 
key’ design and are linked together by flexible hinges containing three calcium-
binding sites (Patel et al., 2003) (see Figure 1.11).   
 
In addition to calcium, the core cadherin structure requires homodimerisation, while 
large assemblages of cadherin homodimers are required to generate the mature 
adherens junction.  Intracellularly, the cadherin dimer interacts with the actin 
cytoskeleton via a number of adapters that includes β-catenin and α-catenin, although 
the exact relationship and dynamics of this interaction is still unclear (Gates & 
Peifer, 2005).  Nethertheless, the internal attachment of the adherens junction to the 
cell cytoskeleton is important for cadherin function as it provides the necessary 
tensile strength and intracellular anchorage for the junction.  Interestingly, previous 
notions of a static interface between cadherin and actin have been challenged by 
Drees et al. (2005) and Yamada et al. (2005) who both show that α-catenin, rather 
than being a static link, is more likely to function as a regulator of actin dynamics, 
suggesting that the link between cadherin and the cell cytoskeleton is more transient 
than was first thought (Gates & Peifer, 2005). 
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Figure 1.11  Schematic showing the classical view of cadherin structure.  The 
molecule has five extracellular domains linked by flexible joins, a transmembrane 
domain and cytoplasmic domain that interacts with the actin cytoskeleton via a 
number of adapters including β-catenin and α-catenin (Gumbiner, 2005). 
 
The classical cadherins mediates cell-cell adhesion  
 
The majority of classical cadherins, including N-cadherin and E-cadherin, mediate 
intercellular adhesion by binding to one another in a homophilic manner, i.e.  an N-
cadherin dimer present on the plasma-membrane of one cell will bind (ligate) with an 
N-cadherin dimer expressed on the opposing plasma-membrane of a second adjacent 
contacting cell.  To achieve this, both cells must express the same cadherin type to 
allow homophilic binding, which is also important for the process of cell sorting.  
Homophilic N-cadherin-N-cadherin trans-ligation is dependent on calcium ions, 
which ensure the rigidity of the rod-like ECD domains and is essential for adhesive 
function.  Many studies investigating cadherin function and cell-cell interaction 
exploit this central requirement by altering the calcium ion concentration of the cell 
media in order to functionally perturb cadherin adhesion (see  Figure 1.12). 
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Despite extensive biochemical and biophysical studies, including the use of X-ray 
crystallography, NMR spectroscopy, electron microscopy and electron tomography, 
it is still unclear how the opposing cadherins sterically arrange themselves to form 
the adhesive bond (Gumbiner, 2005; Kiryushko et al., 2004).  An emerging view is 
that a number of different arrangements are possible - an idea which has been 
described as the multi-state nature of cadherin binding (Bayas et al., 2006).  
However, the linear-zipper model is often employed to describe the molecular 
binding conformation of classical cadherins and was devised from the crystal 
structure of the ECD1 domain of N-cadherin (Shapiro et al., 1995).  In this model, 
adhesive function is reliant on both cis and trans homophilic interactions mediated 
by different regions of the ECD1 domain.  Homophilic cis-interactions occur 
between W-moieties on ECD1, which mediate homodimerisation of N-cadherin 
molecules within the plane of the membrane, while homophilic trans-ligation occurs 
 
Figure 1.12  Schematic illustration showing the central role of calcium ions in 
generating the functional structure of the classical cadherins. Calcium ions 
interact with cadherin at binding sites nested within the linkage regions between the 
five extracellular domains (ECDs), where they generate rigidity in the molecule.  
Extracellular calcium ion depletion is commonly adopted as a tool to study the 
cadherin function and adhesion (based on Alberts et al., 2008). 
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2+ 
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at separate sites on ECD1 adjacent to the first three amino acids (conserved across all 
the classical cadherins) called the HAV sequence (histidine-alanine-valine) and is 
responsible for cell-cell ligation (Noe et al., 1999).  In terms of trans-ligation of N-
cadherin at the HAV region, the molecular bond is thought to be mediated between a 
protruding tryptophan residue (Trp2) on the first cadherin ECD1 with the 
hydrophobic pocket on a second opposing cadherin ECD1 (see Figure 1.13).   
 
 
 
 
 
 
Figure 1.13  Schematic showing the proposed linear-zipper model of cadherin 
homophilc adhesion.  (A) The ECD1 domain contains ‘W’ regions that are proposed 
to mediate cis-homodimerisation of cadherins, i.e. laterally within the membrane, 
and conserved histidine-alanine-valine (HAV) sequences that are thought to mediate 
homophilic trans-ligation of cadherins, i.e. between cells (Gumbiner, 2005).  (B) 
Extracellular domain structure of non-dimerised cadherin (Patel et al., 2003). 
 
A) B) 
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This adhesive interaction generates the ‘cadherin strand-dimer’ interface, which has 
been proposed to be responsible for the adhesive force in cadherin-mediated cell-cell 
adhesion (Patel et al., 2003).   Kinetic studies have revealed that the adhesive force 
of N-cadherin-N-cadherin trans-ligation is relatively weak and transient - lasting less 
than two seconds on average (Bayas et al., 2006).  Thus, the strength of adhesion 
mediated by cadherin interactions is only likely to be effective when multiple 
cadherin homodimers are combined together to form larger, multi-cadherin 
complexes.  This process of junctional maturation is likely to explain the 'zipper-like' 
pattern of cadherin at cell-cell junctions, where additional cadherin homodimers are 
recruited to bolster the initial 'pioneer' N-cadherin-N-cadherin ligation event.  In this 
way, the junction is thought to strengthen and mature over time as multiple cadherin 
dimers are recruited and trans-ligate across juxtaposed cell membranes to adhere 
cells together (Derycke & Bracke, 2004; Patel et al., 2003) (Figure 1.14).   
 
 
 
Figure 1.14  A theoretical model for adherens junction maturation.  Cadherin 
homodimers diffuse laterally in the plane of the membrane.  Following cell-cell 
contact, a homophilic cadherin-cadherin trans-ligation event occurs that weakly and 
transiently adhere the cells together.  This interaction impedes the lateral diffusion of 
cadherin within the membrane of both cells, resulting in the cis-recruitment of further 
cadherin molecules to the 'junction', which gradually matures and strengthens as the 
number of cadherins increases (Adapted from Bayas et al., 2006). 
Cadherins 
membrane 
outer-leaflet 
fast slow slow 
Initial N-cadherin 
trans-ligation 
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The regulation of cadherin activity 
 
The surface expression of cadherin is tightly regulated at multiple levels including 
transcription, trafficking (Kawauchi, 2011) and membrane organisation (Halbleib & 
Nelson, 2006) as well as post-translational modification, for instance by ADAM10 
and PS1/γ-secretase, which cleave the C-terminal end of N-cadherin (Uemura et al., 
2006).  In addition, the cadherin molecules are synthesised and transported to the 
membrane as inactive pro-proteins, with N-terminal pre-domains that sterically 
hinder the active ECD1 domain.  The half-life of cell-surface expressed E-cadherin 
in epithelial cells is approximately 5-10 hours (Gumbiner, 2000), which suggests that 
post-translational modification and/or internalisation of cadherin rather than 
transcriptional regulation, would be preferable in order for the cell to effect dynamic 
responses where the speed of response was important.  Another form of cadherin 
regulation is through alterations in catenin function.  Catenins perform three main 
roles: they provide the physical link to the actin cytoskeleton, regulate actin 
dynamics and modulate the adhesive properties of the cadherin ECD (Gumbiner, 
2005).  Interestingly, studies have shown that cadherins interact with a number of 
RTK receptors (Doherty et al., 2000), for example N-cadherin has been shown to 
interact with the EGF receptor through β-catenin (Hoschuetzky et al., 1994) and 
directly with the fibroblast growth factor (FGF) receptor (Williams et al., 1994). 
 
Semaphorin-4F 
 
Semaphorin-4F (Sema4F) is a member of the semaphorin family, which is broadly 
divided into transmembrane or secreted glycoproteins and are subdivided into eight 
classes, where only classes 3 to 7 are expressed by vertebrates (Kruger et al., 2005).  
Semaphorins are expressed throughout the nervous system where they are best 
characterised in axonal guidance, notably through the regulation of cell migration 
and attachment.  In addition, they are also important for immune cell regulation and 
heart development and are implicated in a number of cancers (Kruger et al., 2005).  
Sema4F is a member of the class-4 semaphorins, which are the largest group of 
membrane-associated semaphorins (Kruger et al., 2005). There are at least twenty 
semaphorins that all share a conserved Sema domain of approximately 400 residues, 
located near to the N-terminus (Kiryushko et al., 2004).  The structure of semaphorin 
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incorporates a seven-bladed, folded-β-propeller Sema domain, a PSI (plexins, 
semaphorins and integrins) domain, and, in the case of classes 2, 3, 4 and 7, a 
common immunoglobulin (Ig)-like domain (Kruger et al., 2005) (Figure 1.15).  
 
 
The semaphorins signal through multimeric receptors composed of neuropilins or 
plexins, which also incorporate the Sema domain in their structures (Kiryushko et al., 
2004).  The binding of semaphorin with plexins is mediated between the Sema 
domains of both molecules.  Interestingly, regions of the plexin molecule share 
homology with Ras GAPs, suggesting that plexin has intrinsic Ras GAP activity 
(Kruger et al., 2005).  Furthermore, Ras has since been shown to interact with plexin 
(Oinuma et al., 2004), while plexins have been shown to interact and modulate Rho-
family GTPases (Kruger et al., 2005).  These interactions might provide some clues 
as to explaining the diverse roles of semaphorin.  In contrast to plexins, semaphorins 
have not classically been thought of as adhesion molecules, but are instead best 
characterised as axonal guidance molecules (Kruger et al., 2005).  However, a study 
Figure 1.15  The domain structure of class-4 semaphorins.  The molecular 
structure incorporates a cytoplasmic domain, transmembrane domain and an 
extracellular domain consisting of an immunoglobulin (Ig)-like stalk, abutting a 
small plexin/semaphorin/integrin (PSI) domain that connects to the conserved Sema 
domain that mediates adhesive interactions with plexins and neuropillins. 
Semaphorin-4F 
Sema domain 
PSI domain 
Ig-like domain 
Cytoplasmic domain 
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by our laboratory has demonstrated a novel role for Sema4F in mediating Schwann 
cell/axonal interaction in vitro (Parrinello et al., 2008).  Furthermore, we showed that 
Sema4F was required for stable Schwann cell/axonal interactions and that Sema4F 
was downregulated following activation of the Ras/Raf/ERK signalling pathway, 
which subsequently resulted in the dissociation of Schwann cells from axons.  
Importantly, hyperactivation of the Ras/Raf/ERK pathway is central to the aetiology 
of Neurofibromatosis Type I, which implicates Sema4F in the generation of 
neurofibromas.  Furthermore, we showed that Sema4F was important for maintaining 
the quiescent state of associated Schwann cells, either by keeping the Schwann cell 
in close proximity to the inhibitory signalling milieu of the axon, or through an as yet 
undefined reverse signalling mechanism. 
 
L1-CAM 
 
L1-CAM is expressed by developing axons at growth-cones as well as by SCPs, 
ISCs and by mature non-myelinating Schwann cells (Haney et al., 1999; Jessen & 
Mirsky, 2005); however, it is down-regulated in myelinating Schwann cells 
(Seilheimer et al., 1989).  L1-CAM is a member of the IgCAMs and is structurally 
composed of six Ig-like domains, five repeated fibronectin Type III domains, a 
single-spanning transmembrane region and a cytoplasmic C-terminal domain (see 
Figure 1.16) (Kiryushko et al., 2004).  Its structure is highly conserved in mammals 
with orthologs found in chick (NgCAM), zebrafish (L1.1-L1.2) and drosophila 
(neuroglian) (Haney et al., 1999).  L1-CAM can bind in a homophilic or heterophilic 
manner, both of which are implicated in multiple processes, for instance homophilic 
ligation has been implicated in neurite out-growth, axonal-axonal and Schwann 
cell/axonal adhesion, while heterophilic interactions have been implicated in neurite 
extension and migration.  The binding partners for heterophilic L1-CAM interaction 
include Tag-1 (which is similar in structure to L1-CAM and discussed later) and 
integrin αvβ3, although the downstream effects of these interactions remain to be 
determined (Haney et al., 1999).  In terms of homophilic binding, the functional 
interaction appears to be mediated by a trimer of L1-CAM molecules on the plasma-
membrane of both contacting cells.  The extracellular Ig-like domains of all three L1-
CAM molecules bend to form an active 'horse-shoe' configuration (Hall et al., 2000).  
At its cytoplasmic domain, L1-CAM interacts with axonal ankyrin, which is 
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important for the functionality of L1-CAM (Crossin & Krushel, 2000).  L1-CAM 
deficient mice myelinate normally, suggesting that L1-CAM is not essential for 
myelination (Carenini et al., 1997).  However, these mice exhibit malformed Remak 
bundles, resulting from the loss of axonal ensheathment, leading to progressive cell-
death of non-myelinated sensory axons in the adult (Haney et al., 1999).  It has been 
suggested that the requirement for L1-CAM in non-myelinating Schwann cell/axonal 
interactions, stems from its binding with axonal ankyrin, which might be required to 
stabilise axonal microfilaments (Haney et al., 1999). 
 
 
 
 
 
Figure 1.16  Domain structure of L1-CAM and NCAM.  Both adhesion molecules 
are transmembrane proteins structurally composed of repeating fibronectin (FN) 
domains (comprising the stalk) and a repeating number of immunoglobulin (Ig)-like 
domains, in which the two most distal Ig-domains are linked to the rest of the 
molecule by a flexible hinge.  Adhesion is mediated through the Ig domains; 
although, the exact binding conformation of both CAMs is not known.  L1-CAM and 
NCAM interact intracellularly, via their cytoplasmic domains, with Ankyrin and 
Spectrin respectively.  
 
L1-CAM NCAM180/140 
Ankyrin Spectrin/Fyn-FAK 
FN-III 
repeats 
Ig-CAM 
repeats 
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Neural Cell Adhesion Molecule (NCAM) 
 
NCAM is expressed by Schwann cells during development but later down-regulated 
along with L1-CAM and N-cadherin at myelination (Kiryushko et al., 2004).  
NCAM is a member of the immunoglobulin superfamily of CAMs (IgCAMs) and is 
structurally composed of five Ig-like domains and two fibronectin (FN-III) binding 
domains (Figure 1.16).  NCAM binds heterophillically with a number of binding 
partners including L1-CAM and Tag-1 (Brummendorf & Rathjen, 1995) as well as 
the FGF receptor (Kiselyov et al., 1997).  In terms of L1-CAM binding, NCAM 
appears to assist homophilic trans-binding of L1-CAM-L1-CAM (Kiryushko et al., 
2004).  The adhesive interactions exhibited by NCAM is typically weaker then that 
mediated by calcium-dependent cadherins (Alberts et al., 2008, p1146).  
Interestingly, alternative splicing from the NCAM gene results in NCAM isoforms 
that exhibit variable levels of sialic acid.  This greatly affects the ability of NCAM to 
mediate adhesion, where high concentrations of sialic acid can switch NCAM from 
adhesion to repulsion.  Interestingly, N-cadherin, L1-CAM and NCAM have all been 
shown to interact with the FGF receptor and moreover, they have all separately been 
implicated with activating the MAPK signalling pathway through association with 
RTKs (Perron & Bixby, 1999; Schmid et al., 1999; Schmid et al., 2000). 
 
Structural cell adhesion molecules of myelinated nerve 
 
Both the Schwann cell and the axon are specialised into distinct domains.  The 
myelin sheath of the Schwann cell is specialised into two major compartments, 
compact myelin and non-compact myelin, which have distinct structural and 
functional properties (Garbay et al., 2000; Kursula, 2008).  For example, the 
extracellular space between opposing membranes in compact myelin is typically less 
than 2nm, while for non-compact myelin this can be as much as 12-14nm (Kursula, 
2008).  Thus, while the former can present an impenetrable barrier to ion flux, the 
latter permits sufficient space for metabolic exchange between the interior and 
exterior of the Schwann cell.  Axonal specialisation was first alluded by Ranvier 
(1871), who observed, in longitudinal sections of teased myelinated nerve fibres, the 
presence of regularly spaced regions (intervals) that were devoid of myelin, which 
have subsequently been termed Nodes of Ranvier (Rosenbluth, 1999).  Thus, the two 
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major compartments of the axon comprise the region between Nodes of Ranvier, 
termed the internode and the Node of Ranvier itself.  The axonal internode comprises 
the majority of the myelinated axon and is surrounded by compact myelin, while the 
Node of Ranvier and the paranode are surrounded by non-compact myelin (Poliak & 
Peles, 2003) (Figure 1.17).   
 
 
 
Figure 1.17  Schematic showing the structure and domains of a myelinated 
nerve fibre. The Schwann cell sheath is composed of compact and non-compact 
myelin.  Compact myelin surrounds the internode and is punctuated by non-compact 
cytoplasmic channels called Schmidt-Lanterman Incisures (SLI), which descend 
radially through the sheath, and Cajal bands, which run longitudinally within the 
outer-collar.  In addition, non-compact myelin surrounds the Node of Ranvier and its 
associated domains (the paranode and juxtaparanode), which allows ion-exchange 
essential for saltatory impulse conduction (Nave, 2010a).  
 
 
In the following sections, I will discuss the internode by first considering the glial 
components that form the sheath and also the glial and axonal CAMs that mediate 
interactions at the Schwann cell/axonal interface.  I will then describe the Node of 
Ranvier and associated domains and discuss the CAMs involved in their formation, 
stabilisation and function before lastly addressing the non-compact regions of the 
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Schwann cell, extra to the nodal domains, which form the cytoplasmic channels 
responsible for metabolic transport within the myelinated Schwann cell and between 
the Schwann cell and its ensheathed axon  (Nave, 2010a; Tricaud et al., 2005). 
 
The Internode 
 
The axonal internode is the longest domain compartment of the axon residing 
between two consecutive Nodes of Ranvier, and has the greatest internal cross-
sectional area of all the domains.  With the exception of the inner-most, axonal-
facing (adaxonal) membrane of the Schwann cell and various cytoplasmic channels 
(discussed later), the majority of the myelin sheath that surrounds the axonal 
internode is composed of compact myelin.   
 
The compact myelin sheath 
 
Compact myelin is characterised by multiple, concentrically-wrapped tight layers of 
Schwann cell plasma-membrane, which excludes cytoplasm and forms a dielectric 
insulating barrier, or sheath, around the axonal internode.  The major non-protein 
component of compact myelin is cholesterol, whose availability is generally 
considered the rate-limiting step for myelin biosynthesis (Nave, 2010b; Saher et al., 
2005).  The major protein components of compact myelin are MPZ, MBP and 
PMP22 (see Figure 1.18).   
 
MPZ is a member of the Ig-CAM superfamily of proteins and is structurally 
composed of a large glycosylated extracellular domain, a single helical 
transmembrane domain and a small basic cytoplasmic domain (Kursula, 2008; 
Lemke et al., 1988).  MPZ is a 30 kilodalton (kDa) protein and is the most abundant 
myelin protein accounting for over 50% of proteins found in peripheral myelin; 
furthermore, it is considered to be the predominant CAM involved in the compaction 
of the myelin sheath (Kursula, 2008).   MPZ forms a tetramer, in which the 
extracellular domains (ECDs) of one tetramer binds homophillically with the 
juxtaposed ECDs of an adjacent MPZ tetramer, to form autotypic junctions between 
opposing sheets of myelin membrane (Kursula, 2008; Martini & Schachner, 1997; 
Menichella et al., 2001) (Figure 1.18). 
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Figure 1.18  The structural components of compact myelin sheath.  Molecules 
involved in compaction include myelin protein zero (MPZ/P0), myelin basic protein 
(MBP) and peripheral myelin protein-22 (PMP22) (printed with permission from 
Sara Ribeiro). 
 
 
MPZ not only facilitates compaction across the extracellular space, but also 
compacts the intracellular cytosolic space via its cytoplasmic domain, which interacts 
with phospholipids on the internal opposing plasma-membrane of the Schwann cell 
(Wong & Filbin, 1996).  MPZ is the largest component by mass of the sheath, 
accounting for 50-60% of peripheral myelin proteins (Kursula, 2008).  MPZ null 
mouse models have hypomyelinated nerves with poor myelin compaction (Giese et 
al., 1992).  Interestingly, MPZ appears to be required for the correct localisation of 
E-cadherin (discussed later), with MPZ null mice displaying severely disrupted 
autotypic junctions (Menichella et al., 2001).   
 
MBP is expressed in both CNS and PNS myelin in a variety of different isoforms, 
which are generated through post-translational modification and alternative splicing 
of the MBP gene (Kursula, 2008).  MBP is a small, highly basic protein which is 
localised to the cytosolic leaflet of the membrane where it assumes a curved 
conformation.  While MBP is not strictly a CAM it is nonetheless thought to aid 
compaction and mediate adhesion by offsetting the negative charge of the 
phospholipid-rich outer leaflet, and thus neutralise electrostatic repulsion that would 
otherwise prevent compaction (Min et al., 2009). 
 
PMP22 is a small 22 kDa molecule, which is highly hydrophobic and is thought to be 
structurally composed of four transmembrane domains and an HNK-1 epitope  
(Martini & Schachner, 1997).  The core PMP22 molecule is thought to dimerise to 
extracellular 
intracellular 
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generate a multimeric complex (Adlkofer et al., 1995), which binds the cytosolic 
face of the inner-membrane leaflet and contains important lipid binding sites 
suggestive of a role in specialising the lipid composition of the myelin membrane 
(Kursula, 2008).  
 
Schwann cell/axonal cell adhesion molecules of the internode 
 
The region of the Schwann cell that interfaces with the axon along the internode is 
called the adaxonal membrane and is composed of non-compact myelin.  The 
internode is characterised by a number of glial expressed CAMs including MAG and 
Necl (nectin-like)-4, while Necl-1 is expressed on the axonal membrane (axolemma) 
(Perlin & Talbot, 2007; Yin et al., 1998) (Figure 1.19).   
 
 
 
 
Figure 1.19 The cell adhesion molecules of the internode.  Glial cell adhesion 
molecules (CAMs) include nectin-like (Necl)-4 and myelin-associated glycoprotein 
(MAG).  The internode is stabilised by autotypic Necl4-Necl1 interactions, while 
MAG has been implicated in the stabilisation of axonal actin filaments (adapted from 
Nave, 2010b). 
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MAG is expressed in both CNS and PNS myelin.  It is a transmembrane CAM 
composed of five highly glycosylated immunoglobulin (Ig)-like extracellular 
domains, with a molecular weight of 100 kDa (Martini & Schachner, 1997).  MAG is 
localised predominantly to the periaxonal collar as well as other non-compact myelin 
regions (discussed later). It is expressed as two isoforms, S-MAG and L-MAG, 
which differ in their C-terminal domains and putative functions as structural and 
signalling molecules respectively (Kursula, 2008).  Research into the functional role 
of MAG has historically been focused on its enrichment at the periaxonal membrane, 
suggesting a role for MAG in axo/glial interactions (Owens et al., 1990; Owens & 
Bunge, 1991). The functional relevance of MAG is unclear; however, Yin et al. 
(1998) suggests that homophilic binding between axonal-expressed MAG and 
Schwann cell expressed MAG, enhances the stability of axonal cytoskeletal filaments 
and thus, the viability of the myelinated axon.  Interestingly, this is similar to the 
suggested role for L1-CAM in non-myelinated axons (discussed earlier).  Despite 
this, MAG knockout mice exhibited normal myelination (Li et al., 1994; Montag et 
al., 1994), although this might be explained by functional compensation,  For 
instance, Carenini et al. (1997) showed that NCAM was able to partially compensate 
for MAG function in the MAG knockout mice, at least during development. 
  
The Necl (also known as SynCam or 'cell adhesion molecules') proteins are members 
of the Ig-CAM superfamily that have recently been implicated in maintaining the 
stability of the myelinated nerve.  There are four members expressed in humans and 
rodents, Necl-1 (SynCAM3), Necl-2 (SynCAM1), Necl-3 (SynCAM2) and Necl-4 
(SynCAM4).  Necls are single-spanning CAMs with three extracellular Ig-domains 
and a short cytoplasmic domain that contains both a PDZ moiety and a binding site 
for protein 4.1 members (Spiegel et al., 2007).  The Necls bind both homophilically 
and heterophilically with other Necls or closely-related nectins.  Necl-4 expression 
occurs exclusively in Schwann cells, and was discovered by Spiegel et al. (2006), 
who conducted a screen of cell-surface expressed and secreted molecules in 
myelinated Schwann cells and axons, in which Necl-1, Necl-2 and Necl-3 was also 
identified.  In contrast to Necl-4, Necl-1 is expressed exclusively on the axonal 
internodal membrane (Perlin & Talbot, 2007; Yin et al., 1998).  Two independent 
studies have separately found that Schwann cell expressed Necl-4 and axonal 
expressed Necl-1 bind in a heterophilic manner, which appears to be critical for 
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myelination (Maurel et al., 2007; Spiegel et al., 2007).  Spiegel et al. (2007) showed 
this using a dominant-negative Necl-4, which blocked myelination in vitro, while 
Maurel et al. (2007) used an siRNA approach to knockdown Necl-4, which 
prevented Schwann cell differentiation and myelination in DRG/Schwann cell 
cocultures. 
 
The Node of Ranvier and associated domains 
 
Since its discovery, the Node of Ranvier has been intensely studied.  Previous 
notions that Schwann cells were multi-nucleated cells stretching the length of the 
axon have long been dispelled in favour of autonomous cells with definite cellular 
boundaries between one Schwann cell and the next all encased within a protective 
and continuous basal lamina (Bunge et al., 1986).  Apart from forming the interface 
between two ensheathed Schwann cells, the function of the Node of Ranvier and its 
associated domains is to generate and propagate action potentials from Node to Node 
along the nerve fibre by fast saltatory conduction (Hartline & Colman, 2007).  In 
normal physiology, the spacing of the Node of Ranvier, and thus the internode 
distance, is tightly coupled with the diameter of the fibre; a parameter that impacts 
upon nerve conduction efficiency and optimal NCVs (as discussed previously) 
(Hartline & Colman, 2007).  Thus, as a rule-of-thumb, the inter-nodal distance is 
generally regarded as being 100 times the diameter of the myelinated fibre (Corfas et 
al., 2004; Poliak & Peles, 2003).  The formation of the Node of Ranvier and the 
specification of associated domains is critically dependent on Schwann cell/axonal 
interactions.  Importantly, in contrast to the axonal NRG1 signal, the Schwann cell 
appears to dictate the underlining domain specialisation of the axon (Poliak & Peles, 
2003; Salzer, 2003; Sherman & Brophy, 2005).  The Node of Ranvier is flanked by 
the Paranode and Juxtaparanode (Figure 1.20).  
 
The Node of Ranvier 
 
The Node of Ranvier is approximately 1µm in length and is the first axonal domain 
to be specified.  It is located at the interface between two adjacent ensheathing 
Schwann cells (Poliak & Peles, 2003).  The overlying glial component of the Node is 
highly-ruffled, forming a so-called microvilli fringe.  Importantly, homotypic 
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Figure  1.20 The structure of the Node of Ranvier and its associated domains 
in a myelinated nerve fibre.  (A) The myelinated nerve fibre is enwrapped by 
multiple Schwann cells, which coverer the length of the axon, and is protected by an 
outer and continuous basal laminar.  (B) The Node of Ranvier is flanked by the 
Paranode and Juxtaparanode, where paranodal junctions (PNJs) at the Paranode, seal 
the axolemma to the Schwann cell.  The PNJ prevents lateral diffusion of ion-
channels between the Node (containing sodium ion channels - shown in red) and the 
Juxtaparanode (containing potassium ion channels - shown in green).  Non-compact 
myelin surrounds the Node of Ranvier and the Paranode, while compact myelin 
surrounds the internode and juxtaparanode.  Adapted from Poliak & Peles, 2003. 
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Schwann cell-cell interactions are not observed in this region. In support of this, 
neither E-cadherin or tight junctional components, for example claudin-1, claudin-2, 
claudin-3 and ZO-1 have been detected between adjacent Schwann cells at the Node 
of Ranvier (Alanne et al., 2009).  However, unlike the equivalent CNS Node, the 
basal lamina is continuous from one Schwann cell to the next (Alanne et al., 2009; 
Bunge et al., 1986; Schafer & Rasband, 2006).  The overlying myelin sheath is 
composed of non-compact myelin and is characterised by an expanded extracellular 
space which is in contrast to the periaxonal space where the opposition between 
Schwann cells and axons is significantly tighter.  The axolemma at the Node is 
highly enriched in sodium ion channels, with concentrations typically 25-fold that of 
the internode (Salzer et al., 2008).  The enrichment of sodium ion channels in the 
axolemma of the Node, together with a reduction in the transverse resistance of the 
Schwann cell plasma-membrane and the expansion in extracellular space, are all 
essentially important for generating and propagating impulses by saltatory 
conduction (Hartline & Colman, 2007; Sherman & Brophy, 2005).     
 
In addition to sodium channels, the axolemma at the Node also expresses a number 
of CAMs and associated adaptors including neurofascin (NF)-186, neuronal cell 
adhesion molecule (nrCAM), ankyrin G and βIV-spectrin (Salzer, 2003; Sherman et 
al., 2001; Sherman et al., 2005).  Interestingly, Lustig et al. (2001) showed that both 
NF-186 and nrCAM directly interact in cis with sodium ion channels, suggesting a 
role for these CAMs in the regulation of sodium ion channel localisation.  A study by 
Eshed et al. (2005) later identified gliomedin as a Schwann cell expressed single-
spanning, transmembrane CAM, which binds axonal-expressed neurofascin-186 and 
NrCAM.  The gliomedin protein incorporates an extracellular olfactomedin and 
collagen domain, which permits binding with ECM components, notably 
proteoglycans via its collagen domain.  Importantly, gliomedin is asymmetrically 
localised to the region of the plasma-membrane that forms the microvilli fringe, i.e. 
the outer flanks of the Schwann cell (Eshed et al., 2005); thus, providing a plausible 
mechanism for the Schwann cell directed recruitment of axonal sodium ion channels 
to the prospective site of the Node of Ranvier (Eshed et al., 2005) (Figure 1.21).   
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Figure 1.21 Schwann cell/axonal CAM interactions at the Node of Ranvier.  
Positioning of the Node of Ranvier appears to be determined by the asymmetric 
localisation of Schwann cell expressed gliomedin to the microvilli (extremity of the 
Schwann cell).  The axonal expressed binding partner of gliomedin is neurofascin 
(NF)-186 and neuronal cell adhesion molecule (nrCAM), whose cytoplasmic 
domains interact in cis with Node specific sodium ion channels via ankyrin-G to 
specialise the underlying axonal domain (Schafer & Rasband, 2006). 
 
In support of this, the gliomedin gene is under the regulatory control of Oct-6 and 
Krox20, in which expression is induced at the onset of myelination (Eshed et al., 
2005).  Moreover, functional blocking of both NF-186 and nrCAM in myelinating 
DRG cocultures resulted in the disruption of sodium ion channels and the 
malformation of the Node of Ranvier (Lustig et al., 2001).  However, there is 
evidence that the positioning of the Node of Ranvier occurs prior to sodium ion 
clustering.  A study by Melendez-Vasquez et al. (2001) has suggested that the 
location of the Node of Ranvier is specified prior to gliomedin-mediated sodium ion 
clustering.  In this work, they show that ezrin, an ezrin-radixin-moesin (ERM) family 
member, is asymmetrically localised to the adaxonal Schwann cell plasma-
membrane at the Schwann cell's outer-flanks, i.e. at prospective microvilli regions.  
Ezrin is known to interact with ankyrin-G and βV-IV spectrin, both of which are 
expressed by the axon, therefore this axo/glial interaction could provide a 
mechanism, preceding sodium ion clustering, responsible for the initial specification 
of the Node of Ranvier. 
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The Paranode 
 
The paranode is characterised by a tight ring of Schwann cell/axonal paranodal 
junctions (PNJs), which bridge the gap between the axolemma and the paranodal 
loops (helical wraps of non-compact Schwann cell membrane).  The PNJ borders the 
Node of Ranvier and is a large multimeric junction that is often considered to be 
orthologous to the insect septate junction (Salzer, 2003).  It has been described as 
one of the largest intercellular adhesion complexes in vertebrate biology (Schafer & 
Rasband, 2006; Sherman & Brophy, 2005).  The PNJ appears to performs two main 
functions.  First, it provides structural support, anchoring the flanks of Schwann cell 
plasma-membrane to the axon and second, it functions as a diffusion barrier.  In 
terms of the latter, the PNJ seals the extracellular space at the Node of Ranvier from 
the periaxonal space surrounding the internode and juxtaparanode - reducing the gap 
between Schwann cell sheath and the axon from ca. 15nm (at the internode) to less 
than 5nm (Salzer, 2003; Salzer et al., 2008).  This is important, as the PNJ restricts 
ion-flux between compartments, thereby ensuring the integrity of the charge 
separation required for efficient saltatory conduction.  Second, the PNJ prevents 
lateral diffusion of domain-specific membrane proteins, notably ion channels, 
between the internode/juxtaparanode and the Node of Ranvier (Poliak & Peles, 
2003).  Thus, in mouse models where the PNJ is defective, potassium ion channels 
that are normally restricted to the internode/juxtaparanode, are found aberrantly 
mixed with Nodal sodium ion channels.  Interestingly, sodium ion channels are still 
specifically retained at the Node of Ranvier despite the absence of the PNJ (Dupree 
et al., 1999), presumably because these channels are anchored by interactions 
between gliomedin, NF-186 and nrCAM (as previously discussed).  
 
The PNJ is formed between Schwann cell-expressed neurofascin (NF)-155 and an 
axonal expressed heterodimer composed of Caspr (contactin associated protein) (also 
known as paranodin) bound to contactin (Figure 1.22) (Schafer & Rasband, 2006) 
(Charles et al. 2002).  Contactin lacks a transmembrane domain and is tethered to the 
axonal membrane via a glycosylphosphatidylinosito (GPI) moiety, where it interacts 
with Caspr and NF-155 via its Ig-domain.  Schwann cell expressed NF-155 is a 
member of the IgCAM G superfamily and is one of two NF isoforms encoded by 
alternative splicing of the NF gene.  NF-155 has been implicated in neurite out-
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growth, axonal fasciculation and axon-axon adhesion (Tait et al., 2000).  Both 
isoforms are single transmembrane proteins structurally similar to L1-CAM and like 
L1-CAM (and NrCAM), they are able to bind ankyrin via their cytoplasmic domains.  
Their extracellular domains are structurally composed of six tandem Ig-domains and 
three or four fibronectin (FN) Type III domains.  The main difference between them 
is that the NF-155 isoform contains an additional FN-III domain while lacking the 
mucin-like domain of NF-186 (Davis et al., 1996).   
 
 
 
Figure 1.22  Cell adhesion molecules of the paranodal junction.  The paranodal 
junction is composed of Schwann cell expressed Neurofascin (NF)-155 bound to 
axonal expressed Caspr and contactin.  Caspr is anchored to the axonal actin 
cytoskeleton by protein 4.1b/ankyrinB interactions (Schafer & Rasband, 2006). 
 
 
All three CAMs (NF-155, contactin and caspr) are essential components of the PNJ, 
with loss of any one component resulting in the failure of the PNJ (Bhat et al., 2001; 
Boyle et al., 2001; Sherman et al., 2005).  Interestingly, despite the absence of the 
PNJ, Schwann cell/axonal interactions were often maintained at the paranode, 
although the space between the axon and the Schwann cell was markedly increased.  
This suggested that other CAMs were able to partially compensate for the loss of the 
PNJ in order to ensure the continuity of stable axo/glial interactions (Poliak & Peles, 
2003). 
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Cell adhesion molecules of the paranodal loops 
 
The paranodal loops (PNLs) are held together by autotypic adherens junctions 
between multilamella sheets of non-compact myelin membrane, which collectively 
act to stabilise the extremities of the sheath.  The principal mediator of these 
interactions, as well as in other non-compact myelin regions, for example the outer-
mesaxon and SLIs (discussed later), is E-cadherin (Fannon et al., 1995; Hasegawa et 
al., 1996).  E-cadherin is a classical cadherin, whose homophilic trans-ligation 
mediates greater adhesive strength than equivalent N-cadherin and thus mediates 
long-term stable interactions in tissues (Gumbiner, 2005).  Consistent with this, E-
cadherin, which is best characterised for generating tissue sheets in epithelial cells, 
predominates over N-cadherin expression in adult myelinating Schwann cells, while 
N-cadherin is down-regulated during differentiation concomitant with the generation 
of an increasingly stable nerve architecture during development (Crawford et al., 
2008).  Importantly, E-cadherin function in myelinated Schwann cells appears to be 
dependent on the interaction between E-cadherin and p120-catenin (discussed in 
detail later).  Cadherin-switching is a recurring theme in Schwann cell development, 
and occurs during neural crest delamination and following Schwann cell/axonal 
association, where Schwann cells and their progenitors need to modulate the 
adhesive strength of their interactions in order to generate tissues.  Importantly, 
cadherin switching also occurs following nerve injury concomitant with Schwann 
cell dedifferentiation (Zelano et al., 2006), where N-cadherin mediates transient 
interactions, which are important for repair. 
 
The Juxtaparanode 
 
The juxtaparanode is the most distal of the associated domains of the Node of 
Ranvier and interfaces with the internode.  This domain is characterised by the 
enrichment of shaker-like (delayed-rectifier) potassium ion channels (Kv1.1 & 
Kv1.2) on the axolemma (Poliak & Peles, 2003) (Figure 1.23).   
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Figure 1.23  The cell adhesion molecules of the Node of Ranvier and associated 
domains of myelinated fibres.  The juxtaparanode is stabilised by homotypic Tag1 - 
Tag1 interactions assisted by axonal Caspr2.  The paranode is stabilised by the 
interaction between glial neurofascin (NF)-155 and axonal Caspr/contactin 
heterodimer, while the Node of Ranvier is stabilised by interactions between 
gliomedin and axonal NF-186, which clusters axonal sodium ion channels (adapted 
from Nave 2010). 
 
 
Importantly (as previously discussed), the PNJ acts to prevent potassium ion 
channels from laterally diffusing into the Node of Ranvier and thus, mixing with 
sodium ion channels (Schafer & Rasband, 2006).  The exact function of potassium 
ion channels in this compartment is still unclear; however, they are thought to be 
required for stabilising the internode resting potential (Poliak & Peles, 2003).  A 
major CAM of the juxtaparanode is Tag-1/contactin-2, which is specifically 
expressed in this compartment by both myelinating Schwann cells and the axon 
(Traka et al., 2002).  Tag-1 is a member of the IgCAM superfamily and is a GPI 
membrane-tethered protein, although it can be expressed in a secreted form (Traka et 
al., 2002).  Tag-1 binds homophillically in trans to mediate Schwann cell/axonal 
interaction and has been shown to recruit Caspr2, which is a member of the neurexin 
superfamily (Poliak et al., 1999; Poliak et al., 2003).  Interestingly, Caspr2 is found 
colocalised with potassium ion channels (Kv1.1), in which a direct interaction has 
Tag1 
Tag1 
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been shown; thus, a Tag-1-Caspr2-Potassium ion channel complex provides a 
plausible mechanism for Schwann cell-directed potassium ion channel clustering at 
the juxtaparanode (Poliak et al., 2003).  Furthermore, Tag-1 deficient mice have 
indistinct juxtaparanodal regions, with mis-localised Caspr2 and potassium ion 
channels (Traka et al., 2002). 
 
Non-compact myelin extra to the Node of Ranvier 
 
In addition to aforementioned non-compact myelin regions surrounding the Node of 
Ranvier, the myelinated Schwann cell and, indirectly, the underlying axon, is 
‘serviced’ by an elaborate system of interconnected cytoplasmic channels, which 
form non-compact myelin conduits through otherwise intractable regions of compact 
myelin (Nave, 2010b; Sherman & Brophy, 2005).  The importance of these aqueous 
corridors have only come to light in the last twenty years or so, and are reinforcing 
the notion that Schwann cells and axons are not only physically integrated but are 
also metabolically coupled (Nave, 2010a).  For instance, the ensheathed glia are 
thought to provide regions of the axon far from the neuronal cell body (in some cases 
greater than 1m), with metabolites and trophic support (Nave, 2010a).  The two main 
types of cytoplasmic channel that exist in myelinated Schwann cells, are Cajal bands 
and SLIs, which permit the flow of metabolites in a longitudinal and radial direction 
respectively.   
 
Schmidt-Lanterman Incisures (SLIs) 
 
SLIs are aqueous channels of non-compact myelin that penetrate radially through 
successive sheets of enwrapped Schwann cell plasma-membrane to connect regions 
of non-compact myelin in the outer-collar (containing the nucleus) with regions of 
non-compact myelin of the inner-collar (interfacing the periaxonal space) (Denisenko 
et al., 2008; Nave, 2010b) (see Figure 1.17).  Thus, SLI channels permit the 
translocation of metabolites between the inner and outer layers of the Schwann cell 
sheath, which is necessary for myelin maintenance, and between the Schwann cell 
and the axon via diffusion over the adaxonal membrane.  In terms of the latter, the 
SLI channels effectively reduce the distance for metabolites to translocate, from the 
nucleus to the axon, by approximately 1000-fold (Nave, 2010a).   
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The formation and structural stability of SLI channels is dependent on the assembly 
of a number of interconnecting gap-junctions, predominantly composed of connexin-
32 (Cx32) and stabilised with E-cadherin/p120-catenin (Perrin-Tricaud et al., 2007).  
Cx32 is a tetraspan transmembrane protein, which also forms channels between 
paranodal loops (Suter & Scherer, 2003).  The SLI channel spans between two layers 
of myelin sheath in order to form a funnel-shaped aqueous-filled lumen, which is 
continuous with the cytoplasm on either side.  They are composed of six connexin 
molecules, which interact to form a connexon, where two connexons interact in trans 
to form the SLI channel (Suter & Scherer, 2003).  While Cx32 is the predominant 
connexin responsible for generating SLIs, diffusion experiments using aqueous dyes 
have shown that functional SLI channels are still present in the Cx32 null mouse 
(GjB1-/-) (Balice-Gordon et al., 1998).  One explanation for this, is that the connexin 
family is numerous, with at least twenty mammalian members, which are highly 
homologous; thus, functional redundancy between this group is likely to compensate 
for loss of Cx32 in the formation of SLIs in these mice (Suter & Scherer, 2003).  
Interestingly, loss of Cx32 appears only to be tolerated during development and not 
during later maintenance of the sheath (Martini & Schachner, 1997).   
 
In addition to connexins, the assembly of SLI channels is also dependent on E-
cadherin and, critically, the interaction between E-cadherin and its intracellular 
modulator p120-catenin; for instance, Perrin-Tricaud et al. (2007) used mutant E-
cadherin proteins that lacked p120-catenin binding-sites, and found that SLI channel 
formation was ablated by the failure of this interaction in vivo.  It is not fully 
understood how p120-catenin functions in this regard, although Davis et al. (2003) 
show that this interaction is important in the regulation of E-cadherin turnover.  The 
study by Perrin-Tricaud et al. (2007), also found that the thickness of the myelin 
sheath was reduced following E-cadherin-p120-catenin disruption.  This finding 
appears contradictory to an earlier study by Young et al. (2002), who questioned the 
essential importance of E-cadherin in myelinated nerve.  The authors used an E-
cadherin knockout mouse and found that E-cadherin ablation had no effect on 
myelination in terms of the generation, integrity and function of the myelinated nerve 
nor did it affect the post-injury regeneration and function recovery of re-myelinated 
nerve.  However, they did find some disruption to nerve architecture shown by a 
measurable loss of compaction in the perinodal outer mesaxon. 
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Cajal bands 
 
Cajal bands run in parallel with the axon (longitudinally), along the outer-collar of 
the myelin sheath (see Figure 1.24).  They were first described by Cajal in 1933 as 
‘longitudinal bands embedded in a meshwork of protoplasmic trabeculae’.  Cajal 
postulated that these channels were likely to be important for the ‘nutritional 
requirements’ of the Schwann cell by allowing Schwann cells to elongate to cover 
relatively large distances between neighbouring myelinating Schwann cells on the 
axon (cited in Sherman & Brophy, 2005).  Since then, there has been much interest 
in elucidating the structure and function of Cajal bands.   
 
The formation of Cajal bands is dependent on the non-compact myelin protein 
periaxin (Pxn), which is expressed in Schwann cells as two isoforms, L-periaxin and 
S-periaxin, generated as alternative splice variants from the Pxn gene.  While both 
isoforms share a PDZ domain for generic protein interactions, L-periaxin contains 
additional non-PDZ domains in the form of a basic domain and an acidic domain 
(Kursula, 2008) and is the active isoform required for Cajal band formation.  The 
channel is formed following the assembly of a heterotrimeric complex composed of 
L-periaxin, Dystrophin-related protein 2 (DRP2) and the transmembrane laminin 
receptor Dystroglycan, which is localised to the abaxonal (outer) membrane of the 
myelinated Schwann cell (Sherman & Brophy, 2005) (see Figure 1.24).  The 
heterotrimeric complex mediates interactions with the Schwann cell basal lamina and 
ECM, for example laminin, which is important for Cajal band formation (Sherman et 
al., 2001).   
 
A study by Court et al. (2004) using a Pxn-/- mouse has demonstrated the importance 
of Pxn in the formation of Cajal bands, which were absent from these mice.  In 
addition, myelinating Schwann cells from Pxn-/- mice were longitudinally truncated 
relative to controls and displayed a greater frequency of Nodes (Court et al., 2004).  
Intriguingly, these findings support Cajal’s original assertion that the channels were 
required as a means to transport nutrients to the growing extremities of the cell 
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(Sherman & Brophy, 2005).  However, Pxn does not appear to be required for 
myelination as Schwann cells from Pxn-/- mice still enwrap axons and myelinate 
normally with g-ratios indistinguishable from controls (Gillespie et al., 2000); 
although, the efficiency of conduction and the NCV are likely to be affected by the 
reduction in internode length.  These findings show how myelin sheath thickness and 
longitudinal hypertrophy are regulated by distinct mechanisms and do not appear to 
be coupled.  For instance, myelin sheath thickness is determined by trophic factors 
expressed by the axon, e.g. NRG1 Type III (as previously discussed), while the 
 
 
 
Figure 1.24  Schematic depicting the Cajal bands in myelinated fibre.  The Cajal 
bands are cytoplasmic corridors of non-compact myelin, which extend longitudinally 
along the outer-collar of the Schwann cell to connect the outer-flanks with the cell 
nucleus.  Cajal bands are dependent on the assembly of the L-periaxin-Dystrophin-
related protein 2 (DPR2)-dystrophinglycan complex.  Cajal bands are important for 
transporting mRNA, e.g. myelin basic protein (MBP), from the nucleus to the outer-
flanks of the Schwann cell for localised translation (adapted from Sherman & 
Brophy, 2005). 
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supply of nutrients to the growing edge of the Schwann cell (via Cajal bands), 
appears to be limiting in terms of longitudinal hypertrophy (Sherman & Brophy, 
2005).  However, in terms of the latter, it is still unclear how longitudinal 
hypertrophy is regulated and whether, for instance Node formation is involved in the 
cessation of growth. 
 
In addition to their role in transporting metabolites and proteins, Cajal bands have 
also been implicated in the translocation of mRNA transcripts encoding myelin genes 
from the nucleus to the outer-flanks of the Schwann cell (Court et al., 2004).  This 
remarkable discovery in 1982 (unprecedented at the time), showed that MBP was 
being synthesised at the growing edge of the Schwann cell from mRNA that had 
been transported from the nucleus (Sherman & Brophy, 2005).  In support of this, 
Court et al. (2004) showed in Pxn-/- mice, in which Schwann cells are devoid of 
Cajal bands, that anterograde microtubule transport was disrupted in these cells and 
moreover, MBP mRNA and MBP protein were absent from the leading (growing) 
edge of the Schwann cell. 
 
 
Table 1.1 Adhesion molecules relevant to this thesis 
 
Molecule Symbol  Function/proposed function 
    
Contactin  Cntn A Component of the paranodal junction.  Binds 
heterotypically to glial NF-155 and in cis with Caspr. 
Contactin associated 
protein 
Caspr A Component of the paranodal junction.  Stabilises 
interactions between Contactin and NF-155.  
Contactin associated 
protein-2 
Caspr-2 A Component of the juxtaparanode.  Stabilises Tag1-Tag1 
interactions. 
Contactin-2 Tag1 B Component of the juxtaparanode.  Tag1 binds 
homotypically to mediate axo/glial adhesion and is 
stabilised by axonal Caspr-2. 
Dystroglycan Dag-1 S Expressed in the outer-collar of the Schwann cell, where 
it binds extracellularly to laminins in the ECM and 
intracellularly to periaxin via dystrophin-related protein-
2.   Required for Cajal band formation. 
Epithelial cadherin E-cad S Component of non-compact myelin.  Required with 
p120-catenin to form autotypic junctions between sheets 
of Schwann cell lamella at the paranodal loop. 
Gliomedin Gliomedin S Expressed in the region of the Schwann cell microvilli.  
Interacts with NF-186 and nrCAM - it is important for 
positioning the prospective Node of Ranvier. 
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L1-cell adhesion 
molecule 
L1-CAM B Implicated in Schwann cell/axonal interactions; thought 
to be required for structural stability of non-myelinated 
fibres. 
Myelin protein zero MPZ/P0 S Facilitates compaction of myelin.  MPZ exists as a 
tetramer; binding homotypically with MPZ on 
juxtaposed membrane. It also facilitates intracellular 
compaction and is the most abundant myelin protein. 
Myelin-associated 
glycoprotein 
MAG S Expressed on the adaxonal membrane.  MAG has been 
implicated in Schwann cell/axonal interactions and has 
also been implicated in the stabilisation of axonal actin 
filaments. 
Nectin-like protein-1 Necl-1 A Binds to Necl-4 to stabilise Schwann cell/axonal 
interactions at myelination.  Required for myelination. 
Nectin-like protein-4 Necl-4 S Binds Necl-1 to stabilise Schwann cell/axonal 
interactions at myelination.  Required for myelination. 
Neural Cadherin N-cad B Implicated in Schwann cell/axonal interactions. 
Neural cell adhesion 
molecule 
NCAM B Facilitates homotypic L1-CAM binding.  May 
functionally compensate for L1-CAM loss.  
Neurofascin-155 NF-155 S Component of the paranodal junction; forms an 
adhesive bond with contactin. 
Neurofascin-186 NF-186 A Expressed at the Node of Ranvier.  Interacts in trans 
with gliomedin and in cis with sodium ion channels. 
Neuronal cell adhesion 
molecule 
nrCAM A Expressed at the Node of Ranvier.  Interacts with 
gliomedin and binds in cis with sodium ion channels. 
Semaphorin-4F Sema4F S Schwann cell/axonal interactions; implicated in 
Ras/Raf/ERK mediated Schwann cell dissociation. 
A, expressed by axons; S, expressed by Schwann cells; B, expressed by Schwann cells and 
axons.  
 
 
1.5 Nerve injury and pathology 
 
1.5.1 Injury 
 
In contrast to the CNS, peripheral nerves are capable of remarkable regeneration 
following injury.  The processes involved are complex and multifaceted.  They 
require an extraordinary degree of tissue engineering, orchestrated predominantly by 
Schwann cells, but also involve a myriad of other cell-types, and are critically 
dependent on an environment permissive for regeneration (Chen et al., 2007; 
McDonald et al., 2006; Stoll et al., 2002; Webber & Zochodne, 2010). The absence 
of Schwann cells or an equivalent in the CNS is often cited as being one of the most 
significant obstacles to CNS regeneration (Filbin, 2003).  Pioneering experiments 
demonstrated essential differences in regenerative capacity between the two tissues.  
For instance, when an excised section of CNS tissue was juxtaposed to the proximal 
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stump of a peripheral nerve lesion, normal axonal outgrowth from the PNS tissue 
was inhibited by the microenvironment of the CNS tissue (Waller, cited by Stoll et 
al., 2002).  However, when transected CNS neuronal processes were juxtaposed with 
a section of peripheral nerve, the opposite was observed, i.e. CNS processes 
regenerated into PNS tissue (Benfey & Aguayo, 1982).  It is now thought that myelin 
components, especially MAG, are the principle inhibitive factor for nerve 
regeneration (Chen et al., 2007; Filbin, 2003).   
 
Wallerian degeneration 
 
The series of the events that takes place following axonal damage were first observed 
by Waller (1850) in the nerves of frogs where the ensuing processes of axonal 
degeneration, Schwann cell dedifferentiation, dissociation and proliferation as well 
as immune cell invasion, all of which are required for later regeneration of the nerve, 
have subsequently been called Wallerian degeneration (WD) (Dyck & Hopkins, 
1972; Stoll et al., 2002).  Importantly, WD is a regulated set of processes that occur 
distal to the site of axonal injury and which ultimately provides the correct 
environment for later regeneration.  Furthermore, WD is exclusive to peripheral 
nerve and is centrally reliant on the reversibility of the Schwann cell differentiated 
state, in which differentiated Schwann cells are instructed to dedifferentiate and re-
form a proliferative pool of Schwann cell progenitor-like cells.  These Schwann 
cells, often referred to as ‘injury’ or ‘denervated’ Schwann cells (to distinguish these 
cells from their developmental progenitors), rapidly engage in the clearance of 
myelin debris (myeloids), promote the invasion of immune cells through the BNB 
(discussed in section 1.3.1) and later provide structural and trophic support for the re-
growth of axons (Webber & Zochodne, 2010).  In cut nerve, newly emerging axons 
leave the proximal nerve stump and are guided across the injury site (nerve bridge) 
by Schwann cells, which migrate in a coordinated wave of migration across the nerve 
bridge (Parrinello et al., 2010).  Dedifferentiated, dissociated Schwann cells in the 
distal (degenerated) portion of the nerve also play a central role.  They are found 
aligned with the basal laminar to generate tracts, known as Bands of Bunger, which 
guide re-growing axons back to their target tissues (McDonald et al 2006).  
Following axonal regeneration, Schwann cells re-associate with axons and re-
differentiate to mature myelinating Schwann cells to complete the regeneration of the 
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functional nerve (Chen et al., 2007; McDonald et al., 2006; Stoll et al., 2002; 
Webber & Zochodne, 2010) (see Figure 1.25).   
 
 
 
Figure 1.25  Schematic illustration of the events following nerve transection.  
Wallerian degeneration occurs distal to the site of injury, whereby the axon 
undergoes controlled disintegration concomitant with Schwann cell dedifferentiation, 
proliferation and myelin debris clearance.  Denervated Schwann cells attract 
inflammatory cells, e.g. macrophages to the distal stump.   This process creates a 
permissive environment for axonal re-growth into distal tissue for re-innervation.  
The repair process is completed following Schwann cell/axonal reassociation and 
recommencement of the myelination programme. 
 
 
The axonal response 
 
The events of WD are triggered by axonal damage; however, the exact ‘damage 
signal’ from the distal section of the injured axon to the surrounding Schwann cells 
remains to be determined (Chen et al., 2007; Hall, 2005).  The controlled process of 
axonal degeneration begins rapidly in the section of the axon that is distal to the site 
of injury, with the cytoskeletal disintegration of small and large calibre axons usually 
completed within 24-hours and 48-hours respectively (Stoll et al., 2002).  The 
emergence of the ‘Wallerian degeneration slow’ (Wlds) mouse model, in which 
axonal disintegration is delayed by up to three weeks following nerve crush, has 
provided valuable insights into the mechanism of WD (Hall, 2005; Lunn et al., 
1989).  This work confirmed that axonal disintegration after injury was not a passive 
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decay of the severed axon, i.e. occurring through lack of metabolites and contact 
with the nucleus, but rather, axonal disintegration during WD was an active, 
regulated process.  Recent work to elucidate the mechanism for WD has focused on 
characterising the Wlds mutant protein responsible for delaying the normal process of 
axonal degradation.  The Wlds protein has been identified as a mutant chimeric 
protein composed of full-length nicotinamide mononucleotide adenylyl transferase 1 
(Nmnat-1) fused with 18 amino acids derived during the fusion event (termed W18) 
and the first 70 amino acid residues of Ubiquitination factor e4b (Ube4b) (termed 
N70) (Avery et al., 2009; Mack et al., 2001).  It was initially thought that the active 
component of the Ube4b/Nmnat chimeric responsible for the delayed response was 
Nmnat-1, as this protein appeared to be sufficient alone to suppress axonal 
degradation in vitro (Araki et al., 2004).  However, it has since been reported that 
both components are probably required to protect the axons of Wlds mice from 
disintegration during WD (Coleman & Freeman, 2010). 
 
The Schwann cell response 
 
Upon nerve injury, Schwann cells initiate a programme of dedifferentiation that 
results in the ‘shedding’ of the myelin sheath and the dissociation of Schwann cells 
from axons.  The first detectable cellular response following injury in myelinating 
Schwann cells, is the activation of the ErbB2/B3 receptor, which occurs at the Node 
of Ranvier within 10 minutes following injury (Guertin et al., 2005).  This is 
followed by robust and sustained ERK1/2 activation (Harrisingh et al., 2004), which 
precedes the down-regulation of Krox20 and up-regulation of c-Jun and Sox2, and is 
followed, within 48-hours, by the down-regulation of myelin specific genes 
including MPZ, MBP, Pxn and PMP-22 (Chandross et al., 1996; Gupta et al., 1988; 
Kuhn et al., 1993) and the up-regulation of ISC-surface expressed markers, L1-
CAM, p75NTR and GFAP (Hall, 2005; Jessen & Mirsky, 2008b), as well as N-
cadherin, NCAM, Necl-1 and Necl-3 (Shibuya et al., 1995; Thornton et al., 2005; 
Zelano et al., 2006).  In addition, dedifferentiated  Schwann cells up-regulate cyclin-
D1 and re-enter the cell cycle (Jessen & Mirsky, 2008b).  As previously discussed, 
the nature and/or identity of the axonal damage signal is unknown (Lunn et al., 
1989).  Proliferating denervated Schwann cells become phagocytic and, in addition 
 91  
   
to resident and infiltrating immune cells, for example macrophages and neutrophils, 
are highly active in clearing myelin debris from the site of injury and distal regions.  
 
The repaired nerve 
 
Nerve regeneration is remarkably effective, for instance we have shown that in 
rodent sciatic nerve, the majority of transected nerves had spontaneously re-
established connections with distal targets by 48-hours following transection 
(Parrinello et al., 2010).    Nethertheless, clinical outcomes do vary according to the 
type of the injury, for example nerve transection is more severe than crush injuries, 
and between species, for example PNS regeneration in rodents is superior to that in 
humans.  In addition, although functionality often returns following nerve 
regeneration, the structure of the repaired nerve can differ, which is most often 
evident by the presence of so-called mini-fascicles.  Another difference is an increase 
in the frequency of the Nodes of Ranvier and decrease in internode length along 
myelinated fibres distal to the site of injury.  This is because Schwann cells re-enter 
the cell-cycle following dissociation from axons and thus, during later re-association, 
the number of Schwann cells is greater than before (Poliak & Peles, 2003).  These 
differences in nerve architecture underline the fact that the processes involved in 
PNS regeneration, which involve de novo post-developmental tissue reformation, are 
distinctly different from the equivalent development stages (Parrinello et al., 2010).  
 
 
1.5.2 Demyelinating neuropathies 
 
In the previous section, I discussed the reversible nature of the Schwann cell 
differentiation programme.  However, a number of disorders result in a more 
permanent impairment of Schwann cell/axonal interactions and/or myelin 
composition, structure and function.  In this section, I briefly outline the various 
types of human  PNS neuropathy and show that underpinning all these disorders is a 
common breakdown in Schwann cell/axonal communications (Juarez & Palau, 
2012).  Heritable mutations occur in genes of all major components of the 
myelination programme, from structural components to transcription factors, and 
together account for the majority of inherited neurological diseases (Suter & Scherer, 
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2003), accounting for dysregulation in some 40 genes (Juarez & Palau, 2012).  The 
inherited neuropathies predominantly affect myelinated nerves of the PNS and were 
extensively studied and characterised by the 19th century pioneers in the field; 
Charcot, Marie, Tooth and Herringham.  Thus, these disorders are often collectively 
known as Charcot-Marie-Tooth (CMT) diseases, but may also be known as 
hereditary motor and sensory neuropathies (HMSN) (Suter & Scherer, 2003).   
 
CMT Type-1 disorders are the most common form of neuropathy and are caused by 
autosomal or X-linked dominant mutations.  Additional clinical symptoms include 
swellings in trunk nerves that resemble ‘onion bulbs’, which are caused by multiple 
cycles of Schwann cell de-myelination and re-myelination.  They often manifest at 
an early age and result in axonal length-dependent muscle weakness (Suter & 
Scherer, 2003).  CMT Type-1 is subdivided according to the genes affected.  These 
include mutations or duplications in PMP22 (CMT1A), MPZ (CMT1B) in which 80 
mutations have been identified, Cx32 (GjB1) (CMTX or X-Linked CMT), in which 
240 mutations have been identified (Nave, 2010b; Nave & Salzer, 2006; Suter & 
Scherer, 2003).  By far the largest contribution of all PNS neuropathies occurs 
following duplication of the PMP22 allele (Suter & Scherer, 2003).  Interestingly, 
this disorder highlights the importance of maintaining the correct stoichiometric 
ratios of myelin genes, for instance the ratios between PMP22 and MPZ are finely 
balanced; thus, duplication of PMP22 significantly destabilises the myelin sheath 
resulting in the de-myelinating phenotype.  
 
The other types of CMT are less common and include Type-2 disorders, caused by 
dominant autosomal inheritance of mutations in axonal genes, which cause axonal 
degeneration followed by de-myelination - usually by the second decade of life.  
CMT Type-3 disorders, which are severe de-myelinating disorders inherited in a 
dominant or recessive manner and fall into two main groups referred to as Congenital 
Hypomyelinating Neuropathy (CHN) and Dejerine-Sottas (DSS), where the latter 
manifests in later infancy.  And CMT Type-4 disorders, which encompass a number 
of rare autosomal recessive neuropathies (Suter & Scherer, 2003).  
 
The de-myelinating neuropathies rarely manifest total loss of myelin but rather, they 
exhibit varying degrees of de-myelination or Schwann cell dysfunction, all of which 
 93  
   
impact negatively on the efficiency of the nerve to carry impulses.  However, this 
inefficiency does not appear to generate significant clinical symptoms; moreover, the 
most dehabilitating aspects of these disorders, result from axonal degeneration, often 
affecting the longest axons first, which causes progressive length-dependent muscle 
weakness (Nave, 2010b; Suter & Scherer, 2003).  This further underlines the 
importance of tight, stable Schwann cell/axonal interactions for the viability of 
axons.  
 
1.5.3 Neurofibromatosis type I 
 
Neurofibromatosis type 1 (NF1) is an autosomal-dominant disorder, with an 
incidence of 1 in 3500 live births, which predominantly effects neural crest-derived 
tissues (Brannan et al., 1994; Parrinello & Lloyd, 2009).  NF1 is 100% penetrant, i.e. 
affected individuals are always symptomatic, although the disorder is complex and 
the age of onset and symptoms varies from patient to patient (Carroll & Ratner, 
2008; Riccardi & Lewis, 1988).  NF1 patients manifestations a range of symptoms 
including pigmentation disorders of the skin (café-au-lait macules and freckling) and 
the eye (Lisch nodules), but it is most characterised by the life-long propensity of 
these patients to develop sporadic benign tumours called neurofibromas (Bader, 
1986; Evans et al., 2002).  Neurofibromas are heterogeneous tumours composed of 
dissociated Schwann cells, neural processes, perineural cells, fibroblasts and 
infiltrating mast cells all encased within an enlarged collagenous matrix (Corfas et 
al., 2004; Zhu & Parada, 2002) (Figure 1.26).   
 
Neurofibromas occur as two main types, defined according to their location and the 
types of nerves affected, which are either dermal neurofibromas (DNFs) or plexiform 
neurofibromas (PNFs).  DNFs, which are the most common form, are superficial 
cutaneous or subcutaneous tumours with defined edges that derive from small dermal 
peripheral nerves and normally manifest during adolescence.  Although they can 
cause significant disfigurement, these tumours are benign and typically, do not 
progress to malignancy (Zhu & Parada, 2002).  In contrast, PNFs reside deep within 
tissues, forming irregularly defined tumours that derive from spinal and cranial nerve 
trunks.  Although benign, PNFs are World Health Organisation (WHO) grade-1 
tumours with a 5-10% lifetime risk of progression to malignant peripheral nerve 
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sheath tumours (MPNST), which are WHO grade-4 highly-malignant tumours with 
very poor clinical outcomes (Evans et al., 2002; Reilly, 2009; Zhu & Parada, 2002).   
 
 
 
Figure 1.26 Schematic showing a cross-section through a normal nerve 
fascicle compared to a nerve fascicle in the early stages of neurofibroma 
formation. (A) The normal fascicle, in which Schwann cells are tightly associated 
with axons.  (B) The neurofibroma fascicle, as found in NF1 patients, in which 
Schwann cells have dissociated from axons and proliferated along with fibroblasts.  
The perineurium is also disrupted, which permits immune cells to invade the 
epineurium and enhance the hyper-proliferative state of cells in the milieu (Parrinello 
& Lloyd, 2009). 
 
 
Neurofibomin function and Ras signalling 
 
For some time the cell of origin responsible for generating neurofibromas was 
unknown, which was largely due to the heterogeneity and complexity of 
neurofibromas and the Neurofibromatosis type 1 disorder as a whole (Riccardi & 
Lewis, 1988).  However, it is now well-established that the neoplastic cell-of-origin 
of neurofibroma is the Schwann cell (Zhu et al., 2002), while the lesion responsible 
occurs in the NF1 gene, which encodes the neurofibromin tumour suppressor protein.  
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Individuals with NF1 syndrome are NF1 heterozygotes, where neurofibromas are 
initiated in Schwann cells that have undergone loss of heterozygosity (LOH) in their 
remaining second NF1 allele.  Importantly, the correct microenvironment appears to 
be important, for instance tumours do not tend to form when NF1 is specifically 
ablated in Schwann cells and the surrounded tissue is NF1+/+; however, they are able 
to arise from NF1+/-tissue environments (Yang et al., 2008).   
 
Neurofibromin encodes a GTPase activating protein (GAP) domain, which acts to 
negatively regulate Ras-signalling by favouring the hydrolysis of active Ras-GTP to 
inactive Ras-GDP (Ballester et al., 1990).  Ras is a small GTPase, localised to the 
inner-face of the plasma-membrane, which functions as a molecular binary switch 
and is important for many cellular processes and additionally, is implicated in a 
number of cancer aetiologies.  The best characterised route for Ras-activation is via 
RTK receptor activation following ligand-binding of extracellular growth-factors 
(Ogata et al., 2004).  Growth-factor binding to RTK receptors results in RTK 
dimerisation and autophosphorylation, which activates the receptor.  Cytoplasmic 
adaptor molecules, for example Src Homology-2 (SHC) and growth factor receptor-
bound protein-2 (GBR2), bind to active RTKs and further recruit guanine nucleotide 
exchange factors (GEFs), for example Son of Sevenloss (SOS), which, in contrast to 
GAPs, act to promote the conversion of inactive Ras-GDP to active Ras-GTP.  
Activated Ras-GTP lies at the apex of a number of intracellular signalling cascades 
including the MAPK pathway comprising of Raf, MEK and ERK1/2, the PI3K 
pathway (PI3K and AKT1), which is important for cell growth and the Cdc42-RAC-
RHO pathway, which is important for cytoskeletal mobilisation (Zhu & Parada, 
2002) (See Figure 1.27). 
 
NF1: Ras activation and tumour formation 
 
Dysregulation of Ras signaling has been implicated in a number of different cancers 
including neurofibromas in patients with Neurofibromatosis type 1 (Harrisingh & 
Lloyd, 2004).  We previously showed that oncogenic Ras signaling, that occurs 
following loss of neurofibromin function, acts through the Raf/MEK/ERK pathway 
to drive Schwann cell dedifferentiation (Harrisingh et al., 2004).  However, an 
important early stage in the aetiology of neurofibroma formation is the irreversible 
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dissociation of Schwann cells from axons, which must be effected via alterations in 
Schwann cell/axonal adhesion (Joseph et al., 2008; Wu et al., 2008; Zheng et al., 
2008).  Indeed, we later identified the Schwann cell expressed axonal guidence 
molecule, semaphorin-4F (Sema4F), which is  downregulated by oncogenic 
Ras/Raf/ERK signalling, as the Schwann cell/axonal mediator responsible for 
maintaing stable interactions (Parrinello et al., 2008) (Figure 1.28). 
 
 
Figure 1.27 Receptor tyrosine kinase (RTK) activation of Ras and its 
downstream affects.  Activation of RTKs, for example platelet-derived growth 
factor receptor (PDGF-R) and epidermal growth factor receptor (EGF-R), leads to 
RTK dimerisation and autophosphorylation, which in turn permits SHC and GBR2 to 
bind the cytoplasmic domain of the activated RTK.  These adaptors recruit the 
guanine nucleotide exchange factor (GEF) son of sevenless (SOS), which activates 
Ras by favouring the conversion of Ras-GDP to Ras-GTP.  Neurofibromin (NF1) is a 
GTPase activating protein (GAP) that inactivates Ras by hydrolysing Ras-GTP to 
Ras-GDP.  Ras activates a number of downstream signalling cascades including the 
Raf/Mek/Erk (mitogen activated protein kinase, MAPK) pathway, implicated in 
Schwann cell dedifferentiation as well as the phosphatidylinositol 3-kinase (PI3K) 
pathway, implicated in growth and survival, and the Cdc42-Rac-Rho pathway, 
known to regulate the cytoskeleton as well as gene expression (Zhu & Parada, 2002). 
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Figure 1.28 Ras function and dysregulation in Neurofibromatosis type I 
(NF1).  Ras is a small GTPase that acts as a molecular switch between an inactive 
(Ras-GDP) and active (Ras-GTP) state.  Ras signalling is inactivated by GTPase 
activating proteins (GAPs), for example neurofibromin (NF1), which favour the 
conversion of Ras-GTP to inactive Ras-GDP, and is activated by guanine nucleotide 
exchange factors (GEFs), for example son of sevenless (SOS), which favour the 
conversion of Ras-GDP to active Ras-GTP.  Loss of NF1 in the presence of 
mitogens, results in oncogenic hyper-activation of the Ras/Raf/ERK pathway, which 
leads to the down-regulation of Semaphorin-4F (Sema4F) and subsequent loss of 
Schwann cell/axonal interactions, i.e. the first stages in the generation of 
neurofibromas. 
 
 
 
 
1.5.4 Neurofibromatosis type II 
 
Neurofibromatosis type II (NF2) is an autosomal dominant disorder with an 
incidence of 1:33,000-40,000 live births (Baser et al., 2002).  The disease clinically 
manifests as sporadic schwannommas, which are homogeneous tumours, composed 
exclusively of Schwann cells, which bulge out from the nerve sheath. These slow-
growing, benign tumours are generated following an inactivating mutation in the 
NF2 gene, in which affected individuals are already heterozygous for NF2, resulting 
in the functional loss of the tumour suppressor Merlin/schwannomin (the NF2 gene 
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product) in affected Schwann cells.  Schwannomas are thus, large clonal expansions 
of Schwann cells that are all NF2-/- and are derived from the same founding 
neoplastic Schwann cell.  Various mouse models have been developed in an attempt 
to understand the aetiology of NF2, including the NF2 null homozygous mouse 
(NF2-/-), which was found to be embryonic lethal and the heterozygous mouse  
(NF2+/-), which failed to develop Schwannomas, although surprisingly, these mice 
did develop osteosarcoma and fibrosarcoma (Ramesh, 2004).   Interestingly, 
conditional loss of NF2 in Schwann cells (NF2-/-) does causes hyperplasia and 
generates Schwannomas in cranial nerves, suggesting that the loss of the second 
allele is the limiting event in mouse models (Giovannini et al., 2000). 
 
Merlin, is highly related to the ERM (Ezrin-radixin-moesin) family of proteins which 
share a Four-point-one (F)-ERM domain know to mediate membrane-cytoskeletal 
interactions (Ramesh, 2004).  Consistent with other ERM proteins, Merlin activity is 
critically dependent on its membrane localisation (Curto & McClatchey, 2008), 
where it has been implicated, both physically and functionally, in the regulation of 
contact-dependent inhibition of proliferation (CIP) and as a suppressor of mitogenic 
signals (Curto & McClatchey, 2008).  However, the downstream action of Merlin is 
complex and multi-faceted.  For instance, Merlin-dependent CIP is thought to be 
directed by a number of pathways including negative regulation of the Ras and Rac 
GTPase signalling pathways (Morrison et al., 2007; Shaw et al., 2001) and by 
modulation of growth factors, receptors and their pathways, for example growth-
factor receptor degradation (Fraenzer et al., 2003), receptor internalisation (Maitra et 
al., 2006), receptor re-localisation (Fernandez-Valle et al., 2002) and in the 
disruption of downstream components of growth factor receptor signalling (Curto et 
al., 2007) (see Figure 1.29).   
 
1.6 Conclusions and thesis goals 
 
In this review, I have outlined the function, cellular components and structure of the 
peripheral nervous system, and I have described the biology of Schwann cells in 
terms of their development, tissue homeostasis, injury and nerve pathology. The 
central theme in all these processes, which underpin the behaviour of Schwann cells 
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and axons, is the absolute requirement for contact-dependent, bidirectional 
signalling.  This signalling regime is supported by a plethora of cell adhesion 
molecules, which play pivotal roles in mediating physical interactions between 
Schwann cells and axons.  For instance, they are required for creating and 
maintaining the well-ordered heterotypic and radially symmetrical nerve fibre.  This 
 
 
Figure 1.29 A model for the activity of Merlin in the regulation of cell-contact 
dependent inhibition of proliferation.  Merlin coordinates and links intercellular 
adhesion with downstream receptor signalling.  The schematic shows the interactions 
between Merlin/NF2, cadherin and the mitogenic receptor tyrosine kinase (RTK) 
epidermal growth factor receptor (EGF-R).  At low cell-density (minimal cell-cell 
contacts), proliferation signals from activated RTKs are dominant, Rac activity is 
increased, the actin cytoskeleton is highly dynamic and Merlin is inactive.  As cell-
density increases, the number of cell-cell contacts increases, mediated through  
cadherin trans-ligation events.  Cadherins interact with EGF-R in cis and Merlin 
binds their cytoplasmic domains to stabilises this interaction, while in addition, 
Merlin inhibits Rac activity and stabilises the actin cytoskeleton.  As a result, 
mitogenic RTKs are increasingly restricted to non-signalling adhesional domains, 
cemented by stabilised actin, and prevented from further signalling resulting in an 
attenuation of cell proliferation (Curto & McClatchey, 2008). 
 
 100  
   
relationship allows for an optimally adapted functional nerve; both in terms of the 
nerve impulse, i.e. the efficiently at which electrical impulses are conveyed, and in 
terms of the readiness of the nerve to respond favourably to injury.  
 
I also discussed two very different outcomes epitomised by the loss of Schwann 
cell/axonal contact.  Firstly, in the case of nerve injury, where loss of Schwann 
cell/axonal contact is reversible; and secondly, in the case of tumourgensis, where 
Schwann cell/axonal dissociation is considered an irreversible progression of the 
disease.  The interaction state is important for both outcomes.  In terms nerve injury, 
Schwann cell dissociation from the damaged axon is essential for the repair and 
regeneration process.  In terms of the tumourgenesis, loss of contact between 
Schwann cells and the axon, allows for a neoplastic Schwann cells (in a pro-
tumourgenic environment) to proliferate free from the inhibitive environment of the 
axon. 
 
Identifying and characterising the key molecular mediators governing heterotypic 
Schwann cell/axonal interactions will be important, if we are to fully understand the 
processes involved in the regulation of Schwann cell/axonal dissociation and re-
association.  In this thesis, I aim to identify and define a role for key adhesional 
mediators of Schwann cell/axonal interactions. 
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Chapter Two: Materials & Methods 
 
2.1 Reference tables 
 
 
2.1.1 Cell culture media 
 
 
Table 2.1 Cell-culture media 
Media Component Source Cells 
3% NS 
growth 
media 
DMEM (with phenol red, Glucose 1g/L) Cambrex NS 
LTNS 
LTD 3% 
Charcoal-stripped Foetal calf 
serum (FCS)  Sigma 
4mM Glutamine Gibco 
100µg/ml Kanomycin Sigma 
2µg/ml Gentamycin  Sigma 
1µM Forskolin Calbiochem 
~1000x Glial Growth Factor (GGF)* in-house 
3% NR 
growth 
media 
DMEM (without phenol red, Glucose 1g/L) Gibco Raf1:ER 
 Supplements as for 3% NS growth 
media (above) 
 
 400µg/ml G418 (optional selection drug) Calbiochem  
10% 
growth 
media 
DMEM (without phenol red, Glucose  
               4.5g/L) Gibco 
Fibroblast 
Phoenix 
AD293 10% Foetal Bovine Serum (FBS) Sigma 
4mM Glutamine Gibco 
100µg/ml Kanomycin Sigma 
2µg/ml Gentamycin Sigma 
Basal 
media 
F-12:DMEM 1:1 (without phenol red) Gibco DRG  
 100ng/ml Nerve Growth Factor (NGF) Alamone 
20µg/ml Insulin (human) Lonza 
 Penicillin/Streptomycin Gibco 
100µg/ml Transferrin Calbiochem 
100µg/ml Bovine serum albumin (BSA) Fraction V Invitrogen 
60ng/ml Progesterone Sigma 
16µg/ml Putrescine Sigma 
40ng/ml Selenium Sigma 
50ng/ml Thyroxine Sigma 
50ng/ml Tri-Iodo-thyrine Sigma 
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Differ-
entiation 
media** 
 Basal media   
1:100 Matrigel (growth Factor reduced) BD Biosciences 
 
50µg/ml Ascorbic acid Sigma  
10% Charcoal-stripped Foetal calf serum (FCS)  Sigma 
 
* Concentration of GGF is titred on a batch-by-batch basis. ** media stored in the dark 
(Ascorbic acid is light- sensitive) 
 
 
2.1.2 siRNA oligonucleotides 
 
Table 2.2 siRNA oligonucleotides 
Gene Entrez Oligo Target sequence NS RafER 
[ ] [ ] 
Scram   AATTCTCCGAACGTGTCACGT 1nM 3nM 
Ncad 83501 
#1 
#3* 
#4 
AACGGGCATCTTCATCATCAA 
TCCCAACATGTTTACAATCAA 
CAGTATACGTTAATAATTCAA 
1nM 3nM 
Sema4F 29745 #5 #6* 
AGCGTCTCATACGTACAATTA 
CCGCGGGATGGTTCAAGATAT 1nM  
Sox2 84046 #1 #2 
AACAGTTACGTTTCCAACTTA 
AACCGTGATGCCGACTAGAAA 1nM  
* Double transfections: 0.75nM + 0.75nM 
 
 
 
2.1.3 shRNA oligonucleotides 
 
Table 2.3 shRNA oligonucleotides 
Construct Target Sequence 
shScram* TGCGTTGCTAGTACCAACT 
shNcad-1 CGGGCATCTTCATCATCAA 
5’-atccGCGGGCATCTTCATCATCAATTCAAGAGATTGATGATGAAGATGCCCGTTTTTTACGCGTg- 
5’-aattcACGCGTAAAAAACGGGCATCTTCATCATCAATCTCTTGAATTGATGATGAAGATGCCCGCg- 
 103  
   
shNcad-3 CCCAACATGTTTACAATCA 
5’-gatccGCCCAACATGTTTACAATCATTCAAGAGATGATTGTAAACATGTTGGGTTTTTTACGCGTg- 
5’-aattcACGCGTAAAAAACCCAACATGTTTACAATCATCTCTTGAATGATTGTAAACATGTTGGGCg- 
shNcad-10 TCTGCACCAGGTTTGGAAT 
5’-gatccGTCTGCACCAGGTTTGGAATTTCAAGAGAATTCCAAACCTGGTGCAGATTTTTTACGCGTg- 
5’-aattcACGCGTAAAAAATCTGCACCAGGTTTGGAATTCTCTTGAAATTCCAAACCTGGTGCAGACg- 
 
Shown, is the 19bp target sequence and the upper and lower strands of the 66bp oligos that 
form the hairpin.  *Negative control shRNA (Clontech) 
 
2.1.4 Primers for qRT-PCR 
 
Table 2.4 Primers for qRT-PCR 
 
Gene Sequence Product 
GAPDH Fwd:  TGCACCACCAACTGCTTAG Rev:  GGATGCAGGGATGATGTTC 177 bp 
N-cadherin Fwd:  CAGAGAGTCGCCAAATGTCA Rev:  TTCACAAGTCTCGGCCTCTT 163 bp 
Sema3B Fwd:  GCTGTCTTCTCCACCTCCAG Rev:  ACATGCCAGGTCTTGGGTAG 166 bp 
Sema4F Fwd:  CTCCTATCTCACCCGGTTTG Rev:  TTGACAATGGCGAGAATCTG 246 bp 
MBP Fwd:  CACAAGAACTACCCACTACGG Rev:  GGGTGTACGAGGTGTCACAA 106 bp 
MPZ Fwd:  CTGGTCCAGTGAATGGGTCT Rev:  CATGTGAAAGTGCCGTTGTC 225 bp 
Ephrin-R 4A Fwd:  CACCATCATCCATTGCTTTG Rev:  AAAGGGTTCAGGCCTTTGAT 199 bp 
Sema, semaphorin; MBP, myelin basic protein, MPZ, myelin protein zero, GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; Fwd, forward; Rev, reverse, bp, base-pair  
 
2.1.5 Antibodies and fluorescent dyes 
 
Table 2.5 Antibodies and fluorescent markers 
Primary 
antibody Species [ ] Conditions Source 
Immunofluorescence    
BrdU Mouse 1:300 0.5% Triton X-100 and 2M HCL Roche (BMC 9318) 
Fibronectin Mouse 1:500  Sigma 
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GFP Rabbit 1:6000 0.5% Triton X-100 AbCam (ab290-50) 
GFP Mouse 1:100 0.5% Triton X-100 Sigma (G6589) 
Myelin Protein 
Zero Mouse 1:1000 Methanol Astex clone 18 
N-cadherin Mouse 1:400 0.5% Triton X-100 BD Transduction Labs (#610920) 
Neurofilament Rabbit 1:6000 0.1% Trion X-100 Millipore (ab1987) 
p75NGFR Rabbit 1:350 No permeabilisation Millipore (07-476) 
RT97 Mouse 1:500 Triton X-100 Gift of J. Woods 
S100β Rabbit  0.1% Trion X-100 DAKO (Z0311) 
SV40 Mouse 1:50 0.5% Triton X-100 Fitzgerald Industries Int. (pAb4190 
Thy1.1 Mouse 1:50 No Permeabilisation  
Western blotting    
N-cadherin Mouse 1:10,000 TBST, milk BD Transduction Labs 
E-cadherin Mouse 1:10,000 TBST, milk BD Transduction Labs 
Β-Tubulin Mouse 1:20,000 TBST, milk Sigma (V9131) 
     
Secondary 
antibody Target [ ] Conditions  
Immunofluorescence    
Alexa-Fluro 594 Mouse 1:400  Invitrogen-Molecular probes (A11032) 
Alexa-Fluro 594 Rabbit 1:400  Invitrogen-Molecular probes (A11012) 
Alexa-Fluro 488 Mouse 1:400  Invitrogen-Molecular probes (A1029) 
Alexa-Fluro 488 Rabbit 1:400  Invitrogen-Molecular probes (A11034) 
Biotin Rabbit 1:250  Sigma 
Streptavidin-FITC Biotin 1:500  Invitrogen-Molecular probes (S32354) 
Western blotting     
Anti-horse radish 
peroxidase (HRP) Mouse 1:5000 TBST Milk GE Healthcare (NA9310) 
Anti-horse radish 
peroxidase (HRP) Rabbit 1:5000 TBST Milk GE Healthcare (NA9340) 
Fluorescent dyes Target [ ]   
Phalloidin-FITC F-Actin 1:1000  Sigma 
Hoechst DNA 1:6000   
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2.1.6 Solutions used for molecular techniques 
 
Table 2.6 Solutions used for molecular techniques 
Solutions Components 
 
L-Broth agar 
 
10g tryptone, 5g yeast extract, 5g NaCl, 1ml 1N NaOH, 15g agar 
or agarose, to a final volume of 1 liter in water 
  
L-Broth 10g tryptone, 5g yeast extract, 5g NaCl, 1ml 1N NaOH, to a final 
volume of 1 litre in water 
  
TE Buffer 10mM Tris-Cl (pH 7.5-8), 1mM EDTA (pH8) 
 
TAE Buffer 
 
40mM Tris, 20mM glacial acetic acid, and 1mM EDTA (pH 8.0) 
 
 
2.1.7 Solutions and buffers for Western blotting 
 
Table 2.7 Solutions and buffers for Western blotting 
Solutions Components 
RIPA lysis buffer 1% Triton X-100, 0.5% sodium deoxycholate, 50mM Tris pH7.5, 
100mM NaCL, 1mM EGTA pH8, 20mM NaF, 100µg/ml PMSF, 
15µg/ml aprotonin, 1mM Na3VO4. 
 
Discontinuous 
polyacrylamide gel 
  
Resolving gel (Acrylamide/Bis 30%/0.8% solution to required 
final polyacrylamide concentration (5-15%): 
 
373mM Tris (pH 8.8), 0.1% sodium dodecyl sulphate (SDS), 
0.04% tetramethylethylenediamine (TEMED), 0.04% ammonium 
persulphate (APS). 
 
Stacking gel (5% acrylamide/bis): 
 
125mM Tris (pH 6.8), 0.5% SDS, 0.12% TEMED, 0.06% APS 
 
4x Sample buffer 200mM Tris pH 6.8, 8% SDS (BioRad), 40% glycerol, 400mM 
DTT, 0.25% bromophenol blue. 
 
10x Running buffer 2.5M glycine (BDH), 250mM Tris, 1% SDS. 
 
10x Transfer buffer 200mM Tris, 1.5M glycine, 20% methanol (BDH) 
 
Blocking solution 5% milk, 0.05% Tween-20 (BioRad) in PBSA 
 
Stripping buffer 200mM glycine, pH2.5, 0.4% SDS. 
 
1x PBSA Tween 0.05% Tween-20 in PBSA 
 
20x TBS Tween 200mM Tris pH8, 3M NaCl, 1% Tween-20 
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PBSA 137mM NaCL, 2.7mM KCL, 1.47mM KH2PO4, 8.1mM 
NA2HPO4 
 
20X TBS 200mM Tris pH8, 3M NaCl 
 
 
 
2.2 Cell culture 
 
Cell culture was conducted on plastic dishes and multi-well plates, which were pre-
treated for adherent cell culture (Nunclon coated plates from Nunc/Thermo-
Scientific).  Culture-ware and glass coverslips were coated with 2.4µg/ml poly-L-
lysine (PLL, Sigma) for at least one hour, washed twice in purified water and 
allowed to dry before use.  PLL-coated glass coverslips were further coated with 
20µg/ml laminin (Engelbreth-Holm-Swarm (EHS), Sigma) in minimal essential 
media (MEM)-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Gibco) 
for at least one hour, which was removed immediately prior to seeding cells.  
Adherent cells were re-suspended as follows; culture plates were washed twice with 
PBS to remove traces of serum and pre-warmed (37°C) Trypsin-EDTA was added to 
plates in order to degrade cell-substratum contacts.  Cell rounding was observed 
using an Olympus inverted light-microscope, and further trypsinisation was inhibited 
by the addition of DMEM supplemented with 10% foetal-calf serum (FCS). 
Schwann cell suspensions were counted using a Beckman Coulter counter with cell 
size limits of between 9 to 27µm diameter.   
 
2.2.1 Schwann cells 
 
Primary rat Schwann cells were obtained from the sciatic nerves of postnatal day-7 
Sprague-Dawley rats, as described by Cheng et al. (1995) and subjected to sequential 
immunopanning with Thy1.1 antibody, in order to removed fibroblasts and other 
contaminating cells.  Following purification, 99.9% homogenous Schwann cell 
cultures - referred to as NS cells in this thesis - were obtained.  NS cells were seeded 
onto 10cm PLL-coated dishes (5.8x105 cells) and incubated at 37˚C, 95% humidity 
and 10% CO2 in 3% serum growth medium (refer to Table 2.1).  After three days, 
when the cells were approximately 80% confluent, the plates were trypsinised and 
5.8x105 cells were seeded onto new 10cm culture plates.  NS cells were maintained 
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in a continual state of proliferation and expanded by serial passages, which we 
previously showed, could be achieved indefinitely and without adverse culture 
affects (Mathon et al., 2001). 
 
2.2.2 Fibroblasts 
 
Primary fibroblast were obtained from sciatic nerve preps as described for Schwann 
cells by immunopanning.  Purified fibroblasts were seeded onto non-PLL coated 
plates and incubated in 10% CO2, 3% (low) oxygen at 37˚C and 95% humidity in 
10% serum growth media (see Table 2.1).  
 
2.2.3 Raf-1:ER Schwann cells 
 
The inducible (estrodial-dependent) Raf-1/estogen-receptor fusion protein (Raf-
1:ER) (Samuels et al., 1993) was stably integrated into Schwann cells by retroviral 
infection of the Raf-1:ER construct.  Schwann cells were cocultured (1:2) with 
retroviral producer cells during the infection phase and then drug-selected with 
400µg/ml of G418 (Lloyd et al., 1997).  Surviving homogenous Raf-1:ER Schwann 
cells were pooled and expanded under incubation conditions of 37˚C, 95% humidity 
and 10% CO2.   The estrogen analogue 5-hydroxy-tamoxifen (Tmx) was used at 
100nM in order to bind the estrogen receptor (ER) domain permitting reversible 
activation of Raf1 kinase (Harrisingh et al., 2004).  
 
2.2.4 SV40 Large-T antigen (LT) expressing Schwann cells (LTNS 
& LTD) 
 
LTNS cells, which stably express the Large-T antigen, were generated by retroviral 
infection of NS cells with the pBabe-puro-SV40 vector (James DeCaprio, Dana-
Farber Cancer Institute, Boston) (Figure 2.1).   
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Figure 2.1 Vector map of the pBabe-puromyclin vector.  The vector 
incorporates the coding sequence for SV40, which inactivates signalling from P53 
and Rb family members. 
 
 
SV40 Large-T antigen positive Normal Schwann (LTNS) cells were expanded on 
PLL-coated plates under puromycin selection (0.5µg/ml).    LT cells were seeded 
onto PLL-coated plates and incubated at 37°C, 95% humidity, 10% C02 in 3% serum 
NS growth media (Table 2.1).  LT derived (LTD) cells were isolated from a 
population of LTNS cells and maintained under identical culture conditions. 
 
2.2.5 Viral Packaging/Producer Cells 
 
Adenovirus was produced using Ad293 cells (Stratagene, #240085), while retrovirus 
was produced using the packaging cell-line, 393T Phoenix cells (Nolan Labs, 
Stanford University).  For both cell-types, the cells were seeded at high-density onto 
non-PLL coated 15cm plates (5x106 cells) and incubated at 37˚C, 95% humidity and 
5% CO2 in 10% serum growth media (see Table 2.1).  The cells were media-
changed on the first day and passaged every 3 days for expansion and were syringed 
through an 18G needle to reduce cell clumping and ensure an even distribution of 
cells in successive plates.  
 
 
 109  
   
2.2.6 Rat dorsal-root ganglion (DRG) explants 
 
DRGs were obtained from the vertebrae of postnatal day 0/1 Sprague Dawley rats.  
The vertebrae was opened, in an anterior-to-posterior direction, using surgical 
scissors and the spinal cord was removed to expose DRG capsules, which are paired 
either side of the vertebra.  DRGs were extracted using fine forceps, transferred to 
ice cold L-15 media (Gibco, #21041-025) and further manipulated to remove 
contaminating tissue.  DRG capsules were then explanted onto the centre of either 
PLL, laminin-coated (25µg/ml) 13mm glass coverslips in 4-well plates (for analysis 
by immunohistochemistry) or onto the central six wells of PLL, laminin-coated 
(25µg/ml) 12-well plates (for analysis by time-lapse microscopy).  The DRG 
explants were incubated at 37˚C at 95% humidity and 5% CO2 in basal media (see 
Table 2.1), where 200µl of basal media/well was added to 4-well plates and 400µl of 
basal media/well was added for 12-well plates.  After 18 hours, the media was 
supplemented with the S-phase inhibiter cytosine β-D-arabinofuranoside (AraC) at a 
concentration of 105M for a 24 hour period in order to remove endogenous mitotic 
Schwann cells and fibroblasts.  The cell media was then changed with fresh basal 
media and subjected to further media changes every two to three days for a minimum 
of 6 days up until the cultures were used in experiments.  Invariably, after 6 to 7 
days, the DRG explants have extended neural processes to form extensive radial 
networks, free from contaminating cells, that widely cover the coverslips.  In vivo, 
DRG neurones are known to project a single axon that diverges into two branches, 
the peripheral and central branches, and are marked by the absence of dendrites 
(Chen et al., 2007) (refer to page 24 of the introduction for further details).  Thus, for 
the purposes of this thesis, I shall assume and describe these neural processes are 
axons.   
 
2.3 Cell culture assays 
 
2.3.1 siRNA transfection 
 
Schwann cells or Raf-1:ER cells were seeded onto 6-well plates (1x105 cells per 
well) 24-hours prior to transfection so that cells were 70-80% confluent prior to 
transfection.  The cell medium was then changed with 2.3ml of fresh 3% NS growth 
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media at least one hour prior to transfection.  HP Genome-wide rat siRNAs oligo 
duplexes (Qiagen) were re-suspended to generate 20µM stock aliquots (see Table 
2.2 for a list of siRNAs used).  Stock aliquots were diluted to form 0.2µM working 
stocks, of which 12µl of siRNA (36µl of siRNA for Raf-1:ER transfections) was 
made up in 100µl of DMEM with glutamine and mixed before addition of 6µl 
HiPerfect reagent.  The transfectant was further mixed and incubated at room 
temperature for 15 minutes after which it was administered drop-wise to cells for a 
final concentration of 1nM (for NS cells) and 3nM (for Raf-1:ER cells).  Plates were 
incubated for 18-hours with transfectant (overnight), after which they were washed 
twice with 3% growth media (to remove transfectant) and returned for a further 24-
hours incubation.  Assays were performed 48-hours after initial transfection where 
possible. 
 
2.3.2 Adenovirus 
 
Production 
Batch production of adenovirus was achieved by infection and viral amplification 
within Ad293 producer cells.  Ad293 cells were seeded 2-3 days prior to infection 
and allowed to reach 80% confluence.  The cell media was then changed with fresh 
10% serum growth media and  between 5 to 10 µl of adenovirus was added to plates, 
which were gently swirled to ensure even distribution of virus.  The green 
fluorescent protein (GFP)-only expressing adenovirus (AdGFP) and the Sox2-GFP 
expressing adenovirus (AdSox2) were a gift from David Parkinson (University of 
Plymouth), while the N-cadherin expressing adenovirus (AdNcad) was a gift from 
Mark Rosenthal (Wistar Institute, USA).  Plates were incubated (as previously 
described) for 3 to 4 days, and continually monitored for signs of cell-rounding 
(indicative of  viral lytic activity).  Adenovirus was obtained from the cell-
suspension (from 'rounded' plates) following successive freeze-thaw cycles as 
follows:  the cell suspension was collected and centrifuged at 2000rpm for 5 minutes.  
The supernatant was then discarded and the pellet re-suspended in 1ml PBS and 
subjected to three rounds of freeze-thaw-vortex cycles to release virus from cells.  
The resulting suspension was then centrifuged at 1200rpm for 5 minutes and the 
supernatant was passed through 0.45µm filters, with aliquots stored at -80˚C and 
discarded after each thaw.  The first aliquot was thawed and used to derive an 
 111  
   
optimal infection concentration for the batch.  Briefly,  NS cells were infected using 
serial dilutions 1:100, 1:200, 1:400, 1:800 of virus and infection rate was gauged by 
GFP fluorescence to achieve 90-100% infection, with minimal cytotoxic effects.  
 
Adenoviral infection for over-expression studies 
Schwann cells or fibroblasts were seeded onto 6-well plates the day before infection 
and maintained in culture until cells were 80% confluent, after which the cell media 
was changed to ensure a total plate volume of 3ml.  Adenovirus was added directly 
to media in wells and gently mixed by swirling to ensure even distribution of virus.  
The plates were then returned to the incubator for 18-hours, after which the plates 
were washed twice with either 3% serum NS growth media or 10% serum growth 
media in order to remove excess virus from Schwann cells and fibroblasts 
respectively. 
 
2.3.3 Retrovirus and the generation of shRNA Schwann cells 
 
Production 
The pSIREN-RetroQ-ZsGreen RNAi system (Clonetech, #631526) was used to 
generate retrovirus in order to introduce shRNA constructs into Schwann cells to 
generate stable shRNA cell lines, which express the shRNA under the human U6 
Promoter and coexpress the Zoanthus sp. GFP marker.  Three independent, non-
overlapping short hairpin (sh)RNA oligonucleotides were algorithmically designed 
using the on-line Clontech RNAi designer2, which identifies a 19bp sequence that 
targets the gene of interest.  This is then incorporated into a longer 66bp oligo, which 
contains BamHI and EcoRI overhangs that allows directional insertion of the oligo 
into the pSIREN vector.  In addition, an Mlu1 restriction site was also included so 
that the insert could be identified.  The target sequences and the shRNA duplexes 
generated are shown in Table 2.3.  ShRNA duplexes were obtained from Sigma and 
cloned into the RNAi-Ready pSRIEN-RetroQ retroviral expression Vector (Clontech 
631526).  These steps are covered in detail in the Knockout RNAi Systems User 
Manual (Clontech Laboratories, protocol #PT3739-1) and are summarised here: 
 
                                                 
2 http://bioinfo.clontech.com/rnaidesigner/sirnaSequenceDesign.do 
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(1) shRNA duplexes were annealed by mixing 100μM of each shRNA oligo (reverse 
and forward) in a 1:1 ratio and heating to 95ºC for 30 seconds, followed by gradual 
cooling over 6 minutes.  (2) Annealed shRNAs were diluted to 0.5μM concentration 
(1:100 dilution) in TE buffer and then ligated to the linearized vector by incubating 
the following mixture (Table 2.8) at room temperature for 3 hours: 
 
Table 2.8 Reaction mixture for shRNA insert / vector ligation 
  
 
Vol    [ ] Component 
2μl 25ng/μL pSIREN-RetroZ Vector 
1μl 0.5μM shRNA oligos 
1.5μl 10x T4 DNA ligase buffer 
0.5μl 10 mg/ml BSA 
9.5μl  nuclease-free water 
0.5μl 400 U/ml T4 DNA ligase enzyme 
 
 
A ligation reaction was set up as above for each of the N-cadherin target 
oligonucleotides (shNcad-1, shNcad-3 and shNcad-10), scrambled shRNA and a 
vector-only control.  (3) Each ligation reaction was transformed into competent 
JM109 bacteria (Progmega) by adding 2μL ligation mixture to 50μL of bacterial cell 
suspension, incubating on ice for 5 minutes and then heat shocking at 42ºC for 30 
seconds in a water bath before replacing on ice.  (4) Transformed bacteria were 
grown in 250μL of Super Optimal Broth (SOC) medium, shaking for 1 hour at 37ºC. 
30μL of each transformation was then spread onto agar plates containing the 
selection antibiotic ampicilin and incubated at 37ºC over-night.  (5) Eight separated 
colonies were picked from each plate and grown up in small starter cultures of LB 
medium supplemented with ampicilin for 8 hours.  (6) Plasmids were then isolated 
and purified from the bacteria using the Mini-Prep kit (Qiagen) and digested with the 
Mlu1 restriction endonuclease to check for the presence of the Mlu1-containing 
shRNA insert (see restriction digestion and analytic gels).  (7) 0.5mls of starter 
culture from positive clones was inoculated into 250mL of LB medium and  
supplemented with ampicilin.  Cultures were incubated overnight at 37ºC and 
subjected to vigorous shacking.  Plasmids were purified from these bacterial cultures 
by Maxi-Prep (Qiagen) and kept as a stock dissolved in TE and frozen at -20ºC.  The 
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shRNA plasmids were also verified by sequencing (MWG-Biotech), in which all 
three shRNA plasmids had 100% homology for their intended sequence. 
 
Phoenix transfection and retroviral infection of cells 
The Phoenix retrovioral packaging cell line was used to generate viral supernatant in 
order to infect low-passage Schwann cells.  The protocol was as follows: (1) 5x106 
Phoenix cells were seeded onto 10cm plates (one plate for each transfection) and left 
to settle overnight.  (2) 5μg of plasmid DNA was mixed with 500μl of serum free 
medium (DMEM + Glutamine), followed by 17.5μl of PLUS™ reagent (Invitrogen 
18324-012), and incubated at room temperature for 15 minutes.  A separate tube was 
prepared for each of the constructs.  (3) In new tubes, 25μl of Lipofectamine™ 
reagent (Invitrogen, 11514-015) was mixed with 500μl of serum free medium for 
each transfection, and the DNA/PLUS™ mix from step 2 added. The transfection 
mixture was incubated for a further 15 minutes at room temperature to allow 
DNA/lipid complexes to form.  (4) The cell medium on Phoenix cells was replaced 
with 4mls of serum-free medium per plate and washed once with serum-free 
medium. (5) The DNA/lipid complexes from step 3 were carefully added drop-wise 
to the Phoenix plates, rocked gently to mix, and incubated under standard culture 
conditions for 3-4 hours in order to transfect the shRNA encoding DNA into 
Schwann cells.  (6) The transfection medium was removed and replaced by fresh  
10% serum media.  The cell media was replaced after 24 hours with 6ml fresh 
medium and the cells were left overnight to produce virus.  (7) 4ml of viral 
supernatant was collected from each plate and Polybrene (hexadimethrine bromide, 
Sigma H9268) was added at a final concentration of 8μg/ml.  The solution was 
filtered to remove cell debris before been added to subconfluent Schwann cells.  
Phoenix plates were topped up with an extra 4ml medium to continue virus 
production.  (8) Schwann cells were incubated for 2 hours with the viral supernatant, 
then left to recover for 2 hours in normal medium and left to recover overnight.  The 
following day, Schwann cells were subjected to a second round of infection for 2 
hours, before final recovery in normal 3% serum growth medium.  (9) Infected 
Schwann cells were left to recover for two days in normal 3% growth medium, 
passaged and analysed by immunofluorescence for N-cadherin knockdown. 
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2.3.4 DRG cocultures for association assays 
 
Cells were typsinised and immediately centrifuged (Sorvall TC) at 1500rpm for 5 
minutes.  The cell pellets were re-suspended in basal media and cell counts were 
determined using a Beckman Coulter Counter.  The corresponding seeding 
concentrations for each cell-type in 4-well plate format (as adopted for fixed 
cocultures) and 12-well plate format (as adopted for time-lapse microscopy) are 
listed in Table 2.9.  Cells were seeded onto day-6 or 7 DRG explants.  The well-
volume was topped-up to 500µl per well (for 4-well plates used for fixed cultures) 
and 700µl per well (for 12-well plates used for time-lapse microscopy).  DRG 
cocultures were either fixed after 8-hours or time-lapse microscopy was performed 
over 20 hours.   
 
Table 2.9 Cell plating densities for DRG cocultures 
 
Cell Type 4-well plate 12-well plate 
NS 1.5x104 2.0x104 
Fbs 1.1x104 1.5x104 
LTNS 1.2x104 1.6x104 
LTD 1.0x104 1.3x104 
 Cell densities determined by titration 
 
2.3.5 Myelination assay 
 
Scrambled and N-cadherin shRNA Schwann cell lines were generated for each 
myelination assay and expanded to healthy mitotic plates.  shRNA cells were 
trypisinised, re-suspended in basal media and counted using a Beckman Coulter 
Counter.  4x104 cells were seeded per DRG explant and cocultures were incubated in 
basal media for one week, during which time Schwann cells were allowed to 
proliferate.  Myelination was then induced using differentiation media (see Table 
2.1).  The media contains matrigel (to mimic ECM signals) and Ascorbic acid (a 
potent differentiator).  Cocultures were incubated in the dark for approximately two 
weeks, with cell media changes every two days.  The extent of myelination was 
gauged by the presence of thick translucent 'myelin tubes' observed by phase-contrast 
microscopy in live-cells.   
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2.3.6 Proliferation assays 
 
BrdU incorporation 
Schwann cells were seeded at low density (2x104 cells) and high density (3.5x104 
cells) in 4-well plates and transfected with siRNA 24-hours later for 16 hours.  The 
cell media was then changed and four hours later, the media was supplemented with  
5-bromo-2-deoxyuridine (BrdU) for 7 hours.  The plates were fixed with 4% PFA 
and immunostained for BrdU, which labels cells in S-phase nuclei.  Quantification of 
Schwann cell proliferation was achieved by blind-counting immunostained glass 
coverslips (by epifluorescence) to determine the proportion of BrdU positive cells. 
 
Growth-curve assay 
Schwann cells were seeded onto 10cm plates and transfected 24-hours later with 
scrambled and N-cadherin siRNA for 16-hours.  The cell media was then changed 
and 8-hours later, the knockdown cells were seeded onto 6-well plates as 4 sets of 
triplicates, i.e. each siRNA condition was conducted in 12 well format (2x6 WP), 
allowing for 4 time-points at approximate 24-hour intervals (0, 24, 48, 72 and 96hrs).  
At each time-point, cell counts were obtained in triplicate, by analysing the cell-
suspension (following trypsinisation) using a Beckman Coulter Counter, and the 
average count was plotted against time in culture.       
 
2.4 Molecular techniques 
 
2.4.1 Bacterial transformation 
 
Agar plates were prepared by melting L-broth agar and once cooled sufficiently, 
adding the correct antibiotic selection prior to pouring. Ampicillin was used at a final 
concentration of 0.1 mg/ml, while Kanamycin was used at a final concentration of 
30µg/ml.  To transform bacteria, 10µl of ligation mixture or 20ng of purified plasmid 
was added to 100µl of competent bacteria (DH5α) and incubated on ice for 45 
minutes prior to 2 minutes heat-shock at 42°C. After less than 5 minutes on ice, 1ml 
of L-broth without antibiotics was added to each reaction and incubated at 37°C for 
45 minutes. The bacteria mixture was subsequently collected by centrifugation at 
6000rpm for 2 minutes in a microfuge (sigma) and about 75% of the supernatant 
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removed. The bacteria was then re-suspended in the remaining L-broth and spread 
over agar plates containing the relevant antibiotic selection.  Plates were incubated at 
37°C overnight and single colonies were extracted from the agar and used to 
inoculate L-broth (with antibiotics) to obtain cultures for plasmid extraction.   
 
2.4.2 Plasmid DNA extraction 
 
Either 4mls (mini) or 100mls (maxi) of L-broth containing 5µg/ml ampicillin was 
inoculated with a single colony of transformed bacteria and grown overnight, 
shaking at 37ºC.  The culture was centrifuged at 4000rpm for 20 minutes to pellet the 
bacteria and plasmid DNA was extracted by alkaline lysis using the Qiagen mini- 
and endotoxin free maxi-prep kits according to the manufacturers guidelines.  
Briefly, the bacterial pellet was re-suspended and lysed in the lysis buffer supplied. 
The lysates were then passed through columns containing Qiagen Anion-Exchange 
Resin in a low salt buffer.  After a series of washes the bound plasmid was eluted and 
pelleted by centrifugation.  DNA pellets were re-suspended in TE buffer  or water. 
 
2.4.3 Determination of quantity and quality of nucleotide  
 
Duplex DNA and RNA was quantified using either spectrophotometry (Nanodrop-
1000) or agarose gel electrophoresis.  For spectrophotometry, in addition to 
quantification, an absorbance  A260/A280 ratio was calculated to determine purity of 
the product - where a value of 1.8 were desirable for dsDNA and a value of 2 was 
desirable for RNA. 
 
2.4.4 Restriction digestion & analytic gels 
 
Restriction endonucleases and buffers were sourced from Promega and correct 
enzyme/buffer combinations and conditions were determined using the on-line guide 
at the Promega website3.  Restriction digests were used for plasmid diagnostics, in 
which NEB cutter V24 was used to discover unique restriction sites and determine 
corresponding band-signatures. 
 
                                                 
3 http://www.promega.com/guides/re_guide 
4 http://tools.neb.com/NEBcutter2 
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Table 2.10 Standard reaction mixture for restriction digests  
 
Vol    [ ] Component 
16.3µl  Water 
0.2µl  Bovine serum 
albumin 
2µl 10x Restriction buffer 
0.5µl 5U Enzyme 
0.5µl  DNA template 
*0.5µl for double enzyme combinations 
 
The mixture was incubated at 37˚C for 2 hours as per manufactures protocol.  The 
restriction pattern was analysed following agarose gels electrophoresis to resolve 
DNA by size.  Agarose gels (typically 0.8%) were set in 50ml tris-acetate-EDTA 
(TAE) supplemented with 0.5µl ethidium bromide (EtBr) in TAE and 1µl of DNA 
digest was run and developed using a Flash Gene UV illuminator (Syngene Bio-
Imaging).  
 
2.4.5 Polymerase chain reaction (PCR) 
 
Table 2.11 Standard PCR reaction mix and thermal-cycler programme 
 
 
Vol    [ ] Component  # Program  
2.0µl 25mM MgCl2  1 95˚C 3’  
0.5µl 10mM dNTP  2 95˚C 30s Denaturation 
5.0µl  5xFlexibuffer  3 55˚C 30s Annealing 
0.5µl 10mM Forward Primer  4 72˚C 30s  
0.5µl 10mM Reverse Primer  5 Goto # 2 29x  
15.37µl  Water  6 72˚C 5’ Elongation  
0.125µl  GoTaq Polymerase  7 4˚C End  
1µl  DNA Template      
 
 
Reactions were conducted on the PTC-200 (Peltier) thermos cycler and used 1-2 μl 
cDNA as template in a final volume of 25μl.  Primers amplified fragments ranging in 
size from 200–400bp and PCR conditions were determined empirically for the 
different primer pairs. 
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2.4.6 RNA extraction & purification 
 
Standard RNA extraction protocol: Confluent cell cultures in 6-well plates were 
aspirated to remove the cell media, after which the cells were lysed (in wells) with 
400µl of Tri-reagent (Ambion) for 5 minutes at room temperature.  The lysate was 
then transferred to tubes and vigorously shaken with 80µl of chloroform and left to 
phase-partition at room temperature for 15 minutes.  RNA was then isolated from the 
aqueous upper phase and precipitated with 200µl Isopropanol and vortexed.  The 
mixture was centrifuged and washed in 75% ethanol, and then centrifuged after 
which the pellet was re-suspended in 10µl RNase-free water. 
 
RNA extraction for sensitive assays (microarray): Total RNA was extracted from 
cultured cells using the RNAeasy Plus Minikit (Qiagen).  Briefly, the cell media was 
removed, the plates were washed twice with Ice-cold PBS and the cells were lysed 
and homogenized in a highly denaturing guanidine-isothiocyanate–containing buffer 
(Buffer RLT).  The lysate was then  transferred to a Qiashredder homogeniser 
column (Qiagen) and homogenised lysates were subsequently passed through a 
gDNA eliminator spin column to remove genomic DNA. Ethanol was added to the 
flow-through to provide appropriate conditions for RNA binding to the RNAeasy 
spin column.  Following centrifugation of the sample through the RNAeasy column, 
salts and contaminants were washed away with 70% ethanol and RNA was eluted in 
20μl RNAse free H20.  
 
2.4.7 First-strand cDNA synthesis 
 
The SuperScriptTM II Reverse First-Strand Synthesis System (Invitrogen) was used 
with random hexamers to reverse transcribe 500ng-1μg of RNA to produce cDNA 
for quantitative RT-PCR reactions.  Template RNA was mixed with 1µl of random 
hexamers [50ng/µl] and 1µl dNTP [10mM] up to a final volume of 10µl with DEPC 
treated RNase-free water (RNA template mix).  This mixture was incubated at 65˚C 
for 5 minutes prior to addition to the reaction mixture (Table 2.12, part A) to make a 
final volume of 20µl and thermo-cycled (Table 2.12, part B): 
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Table 2.12 First-strand cDNA synthesis  
 
 
 (A) Reaction mixture     (B) Program 
Vol    [ ] Component  # Temp 
2µl 10x RT Buffer  1 25˚C 10 min 
4µl 25mM Magnesium chloride  2 42˚C 50 min 
2µl 0.1mM DTT  3 70˚C 15 min 
1µl 40u/µl RNase Out  4 4˚C ICE 
1µl 50u/µl Super-Script II     
10 µl  RNA template mix     
 
 
Finally, 1µl of RNase H [2U/µl] was added to the mixture, which was then at 37˚C 
for 20 minutes in order to degrade residual RNA. 
 
2.4.8 Quantitative RT-PCR (qRT-PCR) 
 
Quantitative PCR was performed using the DyNAmo SYBR Green qPCR Kit 
(Finnzymes, NEB) and the Opticon 2 DNA engine (MJ Research).  PCR reactions 
(25μl) contained 12.5μl of PCR Sybr Green mix and 0.3 mM primers.  All reactions 
were performed in duplicate and each experiment included a standard curve and a 
no-template control.  Standard templates consisted of gel purified PCR product and 
each standard curve consisted of 5 serial dilutions of template.  The threshold cycle 
for each standard sample was plotted against an arbitrary number to obtain a standard 
curve.  This was then used to extrapolate the amount of template in the unknown 
“test” samples.  Relative expression was calculated by normalizing to GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase).  Intron-spanning gene-specific primer 
pairs were designed using the Primer3 algorithm (Rozen & Skaletsky, 2000). 
Conditions for each primer pair and template were determined empirically.  At the 
end of 40 cycles of amplification a dissociation curve analysis was performed in 
which SYBR green fluorescence was measured at 1ºC intervals between 55ºC and 
95ºC. 
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2.4.9 Microarray 
 
RNA was extracted from confluent, duplicate 10cm culture plates as described in 
section 2.4.7 and subjected to enhanced purification using an QIA RNA purified kit 
(Qiagen).  Purified RNA was quantified by spectrophotometry and a test sample run 
through a 1% agarose electrophoretic gel using RNase-free TAE, in order to assess 
RNA quality.  Five micrograms per duplicate plate for both test and reference 
conditions, was submitted to the Cancer Research UK Gene chip service (Paterson 
Institute) for gene expression analysis using Affymetrix GeneChip Rat 230_2 
expression arrays (cDNA).  The microarray experiment was performed according to 
MBCF protocols:- labelling: PICR one-cycle target labelling v1; reaction mixture: 
PICR cocktail v2.0 (DMSO); hybridisation: PICR one-cycle 11µM feature; scanning: 
PICR Scanner 3000.  The experiment was controlled using Affymetrix GeneChip 
Operating Software (GCOS) ver 1.1.1.  The data output was held in compliance with 
the Minimum Information About a Microarray Experiment (MIAME) database 
standard.   
 
Data analysis: data pre-processing was conducted using using Bioconductor5, which 
is a set of life-science specific packages that work within the statistical programming 
language "R"6.  Differential gene expression was assessed between replicate groups 
using an empirical Bayes' t-test as implemented in the 'limma' package. 
 
Quality control: The Rat 230-2 GeneChip incorporates a number of internal 
controls.  These include  the hybridisation controls: bioB [1.5pM], bioC [5pM], bioD 
[25pM] and cre [100pM] (GeneChip Eukaryotic Poly-A RNA); (2) poly-A controls: 
dap, lys, phe and thr; (3) normalisation controls: 100 test probes and (4) house-
keeping/control genes: GAPDH, β-actin, hexokinase-1. 
  
                                                 
5 http://www.bioconductor.org/ 
6 http://www.r-project.org/ 
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2.5 Biochemistry 
 
2.5.1 Protein extraction & quantification 
 
The cell media was aspirated from plates, which were washed twice with ice cold 
PBS.  The culture plates were then scraped to detach cells and the resulting cell 
debris was transferred to tubes and centrifuged at 8000rpm for 5 minutes at 4˚C.  The 
pellet was re-suspended with 80-100µl of lysis RIPA buffer and vortexed in order to 
lyse cells and the mixture further centrifuged at 13,000rpm for 15 minutes.  The cell 
debris (pellet) was discarded and protein quantified against a BSA standard-curve 
using the colorimetric bicinchoninic acid assay (BCA, Thermo-Scientific), with extra 
RIPA added as needed to equalise protein concentration across samples.  Samples 
were then emulsified in 4x sample buffer, heated to 95˚C for 5 minutes to facilitate 
denaturation. 
 
2.5.2 Western blotting 
 
Western blotting was performed using the Bio-Rad Laboratories Western blot 
running kit.  The apparatus was setup using a discontinuous polyacrylamide gel (see 
Table 2.7 for gel recipe), where 10 to 15µg of protein was loaded per well and 5µl of 
Rainbow RPN756v (GE Health Care) was used as a size reference.  Samples were 
resolved by sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-
PAGE), and transferred to nitrocellulose membranes (Millipore Immobilon-P). 
Membranes were blocked for 1 hour at room-temperature in 5% milk powder/TBST. 
Blocked membranes were incubated overnight in primary antibody diluted in block 
solution, with rolling agitation, before washing in TBST and incubating for one hour 
in horseradish peroxidase-conjugated secondary antibody diluted in block. 
Membranes were then washed 4 times in TBST and once in TBS before 
chemiluminescent detection using ECL Plus™ reagent (GE Healthcare).  Blots were 
developed following exposure to light sensitive film (Kodak). 
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2.6 Microscopy & image processing 
 
2.6.1 Live-cell images 
 
Phase-contrast images of live cells were routinely captured using a QICAM camera 
connected to an inverted Olympus CK40 microscope.  Images were processed using 
OpenLab software and encoded using TIFF (loss-less) format. 
 
2.6.2 Immunofluorescence 
 
Immunohistochemistry was routinely carried out on adherent cells fixed onto  13mm 
glass coverslips.  The incubation steps were conducted in the dark using within 
sealed humidity chambers.  Cell monocultures were fixed in 4% Paraformaldehyde 
(PFA) for 10 minutes and washed 4 times by serial PBS washing.  DRG cocultures 
were fixed in 4% PFA for 15-20 minutes and washed 4 times in serial PBS washes.  
In most cases, cells were first permeabilised using either detergent (Triton X-100 
(BDH) in PBS) or Methanol (Refer to Table 2.5 for the list of primary and secondary 
antibodies and their conditions).  Detergent permeabilisation was achieved following 
immersion in the reagent for 10-15 minutes, following by a series of 4 PBS washed.  
Coverslips were transferred to droplets of 3% BSA in PBS (non-specific block) and 
incubated for at least 1 hour at room-temperature.  Methanol permeablisation was 
achieved by immersion of the coverslips in ice-cold methanol for 10 minutes at 
minus 20˚C.  Cells were then rehydrated by washing 6 times by serial PBS washing 
and blocked in 10% goat serum (Sigma) for at least 1 hour at room-temperature.  
Cells were incubated with primary antibody for 1-hour at room-temperature (or 
overnight at 4ºC) and afterwards washed 6 times by serial PBS washing.  Cells were 
incubated with secondary antibody (including fluorescent dyes, e.g. Hoechst, where 
appropriate) for a further 1 hour at room-temperature, after which the coverslips were 
washed 6 times and PBS, once in purified water prior to mounting on glass slides 
using ProLong Gold (Invitrogen) and cured for 18-24  hours before being sealed with 
nail varnish.  Slides were viewed by epifluorescence using an Axioplan (Zeiss) 
fluorescence microscope and images taken with a Hamamatsu (C4742-95) camera, 
processed in Openlab software and encoded into TIFF format. 
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S100β immunostaining: the primary signal was amplified using anti-rabbit biotin 
step, in which cells were incubated for 1hr at room temperature, washed (as 
previously) and then subjected to a final 1hr incubation with fluorescent tagged 
steptavidin, which has a high affinity for biotin. 
 
BrdU immunostaining: fixed cells were permeabilised for 30 minutes at room 
temperature in 0.5% TritonX100 + 2M HCl, in order to denature DNA prior to 
blocking with 3% BSA and antibody staining as previously described. 
 
2.6.3 Time-lapse microscopy 
 
Time-lapse videos of DRG cocultures were performed using the central six wells of 
12-well plates.  The cells were seeded (in duplicate or triplicate) onto DRG explants 
cultured within 12-well plates (see Table 2.9) and allowed to settle for 15 minutes on 
a flat-surface.  The plate was transferred to the time-lapse apparatus and installed on 
an automatic microscope stage within a controlled humidity chamber (95% humidity, 
37˚C and 5% CO2).  The cocultures were observed using an inverted Zeiss Axiovert 
200M microscope with an objective magnification of 16x.  Three to four XY 
positions were selected for each DRG at locations where added cells (rounded at this 
stage) were judged to be in close proximity to axons.  Multi-well time-lapse image 
sequences were captured using a Hamamatsu (ORCA-ER) camera at 2x binning 
using autofocus at intervals of 3 minutes for approximately 20 hours.  Time-lapse 
analysis was computed using Velocity 5 software.  Time-lapse videos were encoded 
as Sorenson Quick-time movies at 0.7 frames per second. 
 
2.6.4 Extracellular area measurements 
 
Schwann cell monocultures were coimmunostained for p75NTR and N-cadherin, 
while cell-nuclei were labelled with Hoechst.  Images were captured using a 
Hamamatsu (C4742-95) camera connected to an Axioplan (Zeiss) inverted 
fluorescent microscope.  At least twenty independent fields of view were analysed 
per coverslip, from triplicate coverslips for each condition.  For each field of view 
analysed, a greyscale TIFF encoded composite was created containing three images 
(1) cell nuclei (Hoechst staining), used to determine cell number; (2) N-cadherin 
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immunofluorescence, used to check N-cadherin knockdown and (3) p75 
immunofluorescence, used to calculate extracellular area.  Image analysis was 
conducted using Image-J software (v1.37).  The p75 immunofluorescent images were 
imported to Image-J as 8-bit grayscale (1280x1022) and transformed as follows:  The 
image and look-up table (LUT) was first inverted and a region of interest (ROI) of 
1100 x 900 dimensions was positioned over the centre of the image where intensity 
is most uniform.  The image was cropped in order to mitigate the edge effect (an 
artefact of microscopy).  A background subtraction of 100 was performed, contrast 
was enhanced by 0.5 and thresholds were set to 0-15 limits.  This creates an image in 
which contrast is maximal and allows for algorithmic identification of extracellular 
areas.  The number and area of these regions were measured and outlines below a 
threshold area of 2.5x105 (arbitrary units) were discounted as they were more likely 
to be small intracellular regions rather than extracellular gaps. 
 
2.6.5 Scoring Schwann cell/axonal association 
 
Fixed DRG cocultures were quantified for Schwann cell/axonal interaction by 
scoring three distinct states as described in Parrinello et al. (2008) and out-lined in 
Chapter Three of this thesis.  These are not associated, associated, not aligned or c) 
associated and aligned (see Figure 3.2B for examples).  Cocultures were fixed and 
immunostained with an axonal marker (e.g. neurofilament (NF) or RT97) and a 
Schwann cell marker (S100β), while cell nuclei were labelled with Hoechst.  
Quantification was performed on triplicate coverslips and scored blind using an red-
green-blue (RGB) Triple-band pass filter on an inverted Axioskop (Zeiss) 
microscope at 40x magnification, in order to view all three light channels 
simultaneous, i.e. axons, Schwann cells and cell nuclei nucleus.  Fields of view were 
selected from less-dense, peripheral regions of the DRG-axonal radiation.  The first 
scoring area was selected one field-of-view in from the extremity of the axonal 
radiation.  All visible Schwann cell/axonal interactions were scored, after which the 
field-of-view was adjusted in order to score sequential,  adjacent fields-of-view, in a 
clock-wise direction around the DRG, until at least 200 interactions per coverslip had 
been scored. 
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2.7 Statistics 
 
Statistics were computed using GraphPad (Prism) software.  Unless otherwise stated, 
the results were analysed by the student's two-tailed T-test.  Results in which p-
values are below 0.05 or 5% are denoted * (significant) and below 0.01 or 1% are 
denoted ** (very significant). 
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Chapter Three: A screen for mediators of Schwann cell/axonal 
interactions 
 
3.1 Chapter introduction 
 
Schwann cells are found in close proximity to axons from an early developmental 
stage (Armati, 2007; Woodhoo & Sommer, 2008).  This intimate relationship begins 
shortly after NCCs have delaminated from the dorsal horn of the neural tube, 
migrated to the nerve roots (Corfas et al., 2004; Kuriyama & Mayor, 2008; Le 
Douarin & Kalcheim, 1999) and have differentiated to SCPs (Jessen & Mirsky, 
2005; Woodhoo & Sommer, 2008).  SCPs exist in multi-Schwann cell/axonal 
clusters that are dependent on close axonal contact for their survival, proliferation 
and later differentiation to mature Schwann cells (Corfas et al., 2004; Woodhoo & 
Sommer, 2008).  These coordinated and complex processes are not only important in 
early development and for maturation of the nerve, but are also integral to the 
regeneration process that occurs following adult peripheral nerve injury (Chen et al., 
2007).  Additionally, the loss of Schwann cell/axonal interactions is a common 
feature in many glial tumours, from neurofibromas (that occur in Neurofibromatosis 
type 1 (NF1)) to highly malignant peripheral nerve sheath tumours (MPNSTs), and 
appears to be one of the earliest observable events (Carroll & Ratner, 2008; 
Parrinello et al., 2008; Zhu et al., 2002).  Thus, given the importance of Schwann 
cells in nerve development, injury and neuropathology there is a strong case for 
expanding our existing knowledge of Schwann cell/axonal interactions. 
 
3.2 Characterising Schwann cell/axonal interactions 
 
To study Schwann cell/axonal interactions, I used an in vitro primary DRG/Schwann 
cell coculture system.  Sciatic nerves were extracted from postnatal day-7 rats and 
Schwann cells purified to at least 98% homogenous populations by removing 
contaminating cells, for example fibroblasts and immune cells, through sequential 
immunopanning as described in Mathon et al. (2001).  By doing this, we exploited 
the remarkable regenerative capacity of Schwann cells to dedifferentiate and reform 
a proliferative population after nerve injury (Harrisingh et al., 2004).  In previous 
work undertaken by our laboratory, we showed that Schwann cells isolated in this 
manner could be cultured indefinitely in 3% serum while retaining normal 
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checkpoints and character, and without evidence of adverse culture effects (Mathon 
et al., 2001).  Schwann cells cultured in this way - referred to in this thesis as normal 
Schwann (NS) cells - are amenable to expansion for a range of cell interaction assays 
in vitro.  Importantly, Schwann cells derived from postnatal myelinating Schwann 
cells have, following extraction from the animal, dedifferentiated (de-myelinated) 
and dissociated from axons to form a proliferating pool of Schwann cells and as such 
closely resemble the post-injury Schwann cells found in vivo.  For instance, they 
express a similar set of cell-surface expressed molecules to ISCs including GFAP, 
p75NTR, L1-CAM and NCAM (Jessen & Mirsky, 2008b; Woodhoo & Sommer, 
2008).  Furthermore, as in vivo, dedifferentiated Schwann cells continue to 
demonstrate notable plasticity by retaining the ability to reassociate and remyelinate 
axons, a process that is essential for in vivo peripheral nerve repair following 
Wallerian degeneration (Chen et al., 2007; Hall, 2005; Stoll et al., 2002).  However, 
there are differences between injury Schwann cells and ISCs, for instance the former 
strongly express N-cadherin as well as integrin α1β1 (Jessen & Mirsky, 2008b).  It is 
important, therefore, to stress that cultured NS cells are used to study post-injury 
reassociation rather than developmental processes per se, although insights from the 
former may still provide useful clues as to the developmental program of Schwann 
cell/axonal interaction.  
 
Normal Schwann cell/axonal interactions 
 
I first wanted to examine in detail the normal processes involved in Schwann 
cell/axonal interactions.  In particular, I wanted to understand the various stages of 
the interactions and how they are regulated temporally.  To study this, I decided to 
analyse the interactions using time-lapse microscopy.  DRGs from day-0 or day-1 
postnatal rats were extracted and explanted separately onto the central region of 
multi-well plates.  After 24-hours, the culture medium was supplemented with the 
mitotic toxin cytosine β-D-arabinofuranoside (AraC) for a period of 48 hours, in 
order to remove contaminating cells, for example endogenous Schwann cells and 
fibroblasts, while leaving axons intact.  The DRG-axonal cultures were incubated for 
an additional three to four days, after which they were generally free of 
contaminating cells.  At this stage, the axonal networks typically covered 
approximately two-thirds of the surface area of the wells.  I next seeded Schwann 
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cells onto axons at low-density and performed multi-well time-lapse microscopy 
over an eight hour period (Video 3.1).  As represented by the image sequence shown 
in Figure 3.1A, I was able to observe several key stages involved in the early 
interactions between Schwann cells and axons.  In this sequence, a representative 
Schwann cell was observed as it recognised, associated and aligned with an axon 
(see white arrow).  The first image shows the Schwann cell as it appears to search its 
immediate vicinity for an axonal target.  This process is aided by the morphology of 
the Schwann cell, which forms two or three large cytoplasmic protrusions that extend 
out bi- or tri-laterally from the cell - morphology reminiscent of ISCs (3.1Ai).  In this 
example, the Schwann cell first makes contact with an axon using the extremity of 
one of these cytoplasmic protrusions (3.1Aiii), which defines the point of Schwann 
cell/axonal recognition.  Importantly, the axon was observed to inflect slightly at the 
point of contact suggesting that the Schwann cell had firmly attached itself as part of 
the recognition process.  Remarkably, as shown in the next image, the Schwann cell 
then appeared to contract its cytoplasm and pull itself up onto the axon (3.1Aiv).  
Once associated, the Schwann cell was observed to extend and align its cytoplasm 
along the axon (3.1Avi) and, importantly, remained fully associated with the axon for 
the duration of the analysis, despite exhibiting considerable lateral movement.  In a 
few cases (not shown), associated Schwann cells were observed to contact multiple 
axons, which is similar behaviour to axonal bundling seen during radial sorting 
(Chernousov et al., 2008). These initial observations of Schwann cell/axonal 
interactions, drawn from the time-lapse analysis, are summarised in a schematic 
model (Figure 3.1B), in which I describe the interaction programme as occurring via 
a number of step-wise interactions and processes: 
 
(1) Recognition: the Schwann cell extends long bipolar cytoplasmic processes, 
which may allow for the maximal chance of locating targets.  Following an 
encounter, the Schwann cell positively identifies its target as an axon by a, as yet, 
poorly understood cell-cell contact-dependent mechanism.  
 
 (2) Association: the Schwann cell cytoplasm contracts, while the heterotypic 
Schwann cell/axonal contact region, which initially mediated recognition, is 
maintained, resulting in the Schwann cell being pulled up towards the axon.  Finally, 
the Schwann cell is assembled onto the axon. 
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Figure 3.1 Analysis of Schwann cell/axonal interactions. (A)  One-day old, rat 
DRGs were explanted, treated with AraC for 24hrs (to remove endogenous cells) and 
incubated for 6-7 days to generate axonal cultures. NS cells were seeded onto axons 
at 2x104cells/DRG and time-lapse analysis performed over 20hrs.  Shown is an 
image sequence from Video 3.1, illustrating the early interactions between Schwann 
cells and axons.  The white arrows show a representative Schwann cell/axonal 
encounter, while Schwann cell alignment and elongation with axons is indicated by 
the white double-arrows.  (B) Schematic model of NS/axonal interactions, where 
stages i to iii are evidenced from part A, and include: (i) axonal recognition, (ii) 
association, and (iii) alignment; while later processes, which become evident as the 
interaction matures, include (iv) polarisation (Chan et al., 2006) and (v) 
differentiation. 
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(3) Alignment:  the Schwann cell elongates its cytoplasm along the length of the 
axon and aligns its nucleus with the axon.  The majority of the Schwann cell then 
remains associated with the axon, although it is free to move laterally and 
lamellipodia-like protrusions continue to extrude from the axon.   
 
In addition to these early Schwann cell/axonal interactions, the model also includes 
later interactions, not evident from the above time-lapse analysis, but which are 
inferred from previous studies.  These include: 
 
(4) Polarisation: the cytoplasm and plasma-membrane of the Schwann cell becomes 
asymmetrically specialised in relation to the axonal membrane.  Schwann cell/axonal 
polarisation was studied by (Chan et al., 2006), who showed that the Schwann cell 
membrane contacting the axonal membrane becomes polarised through the 
asymmetric recruitment of partitioning defective (Par)-3.  The authors showed that 
Par-3 mediated polarisation was important for the correct localisation of p75NTR 
receptors at the Schwann cell/axonal interface and disruption blocked further 
progression to myelination.   
 
(5) Myelination:  the Schwann cell differentiates to its final adult phenotype by 
successively wrapping the axon in a lipid-rich membrane and initiating a program of 
protein and lipid myelin biosynthesis.  In the interests of simplicity, the 
differentiation to non-myelinated Schwann cells is not discussed in this model.  
Progression to myelination is highly complex with multiple requirements, which are 
discussed in detail within the introductory chapter (refer to page 40). 
 
(6) Mature interactions: In the absence of nerve trauma or disease, it is highly 
likely that once the Schwann cell has associated and myelinated an axon, that this 
partnership is maintained in a stable manner throughout life. 
 
3.3 Schwann cell/axonal recognition 
 
Encounters between cells, either between the same cell-type (homotypic) or between 
different cell-types (heterotypic), can elicit different responses in both contacting 
cells.  For example, Schwann cell/fibroblast interactions result in mutual repulsion 
 131  
   
that leads to their segregation (Dreesmann et al., 2009; Parrinello et al., 2010), while 
Schwann cell/Schwann cell encounters are typically repulsive, although they become 
attractive in the presence of fibroblasts (Parrinello et al., 2010).  In terms of the 
complexity of the interaction, encounters between Schwann cells and axons are 
unusual in that, in addition to exerting an attractive effect, the Schwann cell 
behaviour, morphology and differentiation are all fundamentally changed by the 
interaction, ultimately leading to the generation of a complex three-dimensional 
architecture.  This programme of interactions (illustrated in Figure 3.1B) is only 
initiated when a Schwann cell encounters an axon, i.e. other cell-types, for example 
fibroblasts, will not elicit this response.  Therefore, a key question to address is how 
Schwann cells recognise axons.  Recognition is the theoretical first-step in the 
interaction program.  We would expect the failure of this event to have profound 
consequences for further maturity of the interaction and ultimately in myelination.  
Despite the likely importance of this step, the mediator(s) of axonal recognition are 
still unclear.   
 
Evidence from time-lapse microscopy suggests that it is the Schwann cell, rather than 
the axon, that initiates the interaction programme (Video 3.1).  However, it is still 
unclear how Schwann cells locate axons, for instance, whether Schwann cells are 
directed towards axons by molecular cues/gradients (chemotaxis) or whether they 
locate axons in a stochastic fashion.  In terms of the latter, this could either be 
achieved passively or by stimulation (to increase cell movement) via molecular 
factors in the milieu (chemokinesis).  A study by Cornejo et al. (2010) demonstrated 
that both GDNF and NRG1 exhibit a chemotactic and chemokinetic effect on the 
migration of Spl201 cells (an SCP cell-line), while NGF was shown to mediate a 
chemokinetic affect.  In our in vitro coculture assays, in which primary adult 
Schwann cells were seeded in close proximity to axons, the time-lapse video 
appeared to show non-associated Schwann cells that were migrating in a random, 
rather than directed, manner (Video 3.1).  Interestingly, as previously described, 
Schwann cells often assumed bi- or tri-polar morphologies that resulted from the 
presence of multiple large cytoplasmic lamellipodia-like protrusions, projecting some 
distance from the Schwann cell.  These structures appeared to be fairly dynamic, 
capable of extending and collapsing as well as making lateral ’sweeping’ 
movements, thus it is tempting to speculate that these protrusions provide Schwann 
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cells with a means to maximise the chance of an axonal encounter.  Together, these 
observations suggest that Schwann cells are likely to acquire axons stochastically, 
although a chemotactic component cannot be dismissed. While the Schwann cell 
acquires axons for association, the axon grows and elongates, making directional 
decisions with transient distal structures called growth-cones, in order to migrate 
through tissue and locate targets for innervation (Doherty et al., 2000; Shi et al., 
2010).  The directionality of the growth-cone is determined by the interplay between 
repulsive and attractive molecular-gradients and axonal guidance molecules (Kruger 
et al., 2005; Rosoff et al., 2004).  Interestingly, a study by Seggio et al. (2010) 
showed, in the absence of secondary guidance cues, that DRG-axons would 
preferentially extend and orientate themselves in alignment with underlying Schwann 
cells in vitro.  This is consistent with a post-injury role for Schwann cells as a 
cellular scaffold that is permissive for axonal regeneration (Parrinello et al., 2010).   
 
3.4 Large-T Schwann cell/axonal interactions 
 
To understand how Schwann cells interact with axons, I initially studied axonal 
interaction behaviour in the context of a Schwann cell-like clone, in which normal 
axonal interactions have been lost.  The genetic lesion in these cells - referred to as 
LT derived (LTD) cells – is currently unknown; although they are thought to have 
arisen, as a sub-population, from otherwise stably expressing LT (the large-T antigen 
from the SV40 virus) Schwann cells – referred to as LT normal Schwann (LTNS) 
cells. Furthermore, LTD cells appeared to be morphologically distinct from LTNS 
and to exhibit an apparent proliferative advantage over LTNS, which may explain 
how LTD could have become an established monoculture over successive culture 
passages.  In contrast to LTD cells, the genetic component of LTNS cells is well 
defined.  The expression of SV40 LT antigen has been used previously to study p53 
and retinoblastoma (Rb) family signalling, as the viral protein specifically inhibits 
these signalling pathways (Doherty & Freund, 1997; Lloyd et al., 1997).  Therefore, 
LTNS cells are a partially transformed Schwann cell-type, which, in-line with 
Todaro et al. (1964)’s original observations show elevated proliferation compared to 
normal Schwann cells (Cremona & Lloyd, 2009).  Importantly, in contrast to LTD 
cells, LTNS appeared to interact normally with axons.   
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In order to quantify the ability of LTD to interact with axons, I decided to compare 
these cells to NS and LTNS cells in an association assay.  To do this, I used the 
primary in vitro Schwann cell/DRG coculture system described previously.  DRG-
axons were explanted, AraC treated and incubated over 7-days to generate bare 
axonal cultures.  NS, LTNS and LTD cells were then seeded onto DRG-axons at 
low-density and allowed to interact for eight hours before fixation.  Fixed NS/DRG, 
LTNS/DRG and LTD/DRG cocultures were then coimmunostained with the S100β 
Schwann cell marker and the RT97 axonal marker, while nuclei were stained with 
Hoechst DNA dye (Figure 3.2Ai-iii, respectively).  These images qualitatively 
showed that both NS and LTNS strongly interacted and associated with axons.  In the 
NS and LTNS cocultures, the majority of Schwann cells had aligned their cytoplasm 
with axons and, in many cases, their nuclei were similarly aligned (3.2Ai-ii; see 
white arrows).  This was in stark contrast to LTD/DRG cocultures where interaction 
and association was poor to non-existent even when LTD cells were in close 
proximity to axons (3.2Aiii; see white arrow-heads).  Indeed, in many instances 
where LTD cells contacted axons, the orientation of the cell was out of alignment 
with the axon, and in some cases perpendicular to the axon, with the cytoplasm often 
extending over or under axons.   
 
To quantify the extent of the impairment in Schwann cell/axonal interactions we 
devised an experimental approach and systematic scoring system referred to as a 
DRG association assay (Parrinello et al., 2008).  The assay was designed to reduce 
experimental bias, ensure fields-of-view were representative and allow for the range 
of interactions present to be quantified (refer to materials and methods for full 
details).  Fields-of-view were chosen in a systematic manner.  The scoring regions 
were selected one field-of-view in from the periphery of the axonal radiation and 
subsequent adjacent fields of view were counted, in a clockwise manner, in an arc 
around the coverslip until approximately 200 interactions per coverslip were scored.  
This method restricted scoring to regions of low axonal density, where scoring was 
more reliable, while also providing a high sampling coverage.     
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Figure 3.2 LTD/axonal interaction are severely impaired relative to NS and 
LTNS DRG cocultures.  DRGs were incubated as previously, in order to generate 
axonal cultures, after which NS, LTNS or LTD cells were seeded onto axons and 
incubated for 8hrs before fixation.  (Ai-iii) Epifluorescence of cocultures, 
coimmunostained for the Schwann maker S100β (green) and the axonal marker 
RT97 (red), with cell nuclei labelled by Hoechst (blue).  The white arrows show 
representative examples of tight Schwann cell/axonal interaction, while the white 
arrow-heads show representative examples of axonal non-interaction. 
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(B) Quantification of Schwann cell/axonal interactions shown in part Ai-iii. (i) 
Typical examples of three types of cell interaction found in cocultures: Associated, 
the Schwann cell associates and aligns with the axon; Associated, not aligned, the 
Schwann cell partly associates but fails to align its cytoplasm with the axon; Non-
associated, the Schwann cell does not interact with the axon.  (ii)  The bar-chart 
shows the percentage of cells that either associated but failed to align with axons 
(grey), or that failed to associate entirely with axons (black), where bars shows S.D. 
of triplicates (n>200).  Statistics given by the two-tailed T-test (***P<0.001; n.s., 
not-significant).  The dataset represents one of three independent experiments that 
gave similar results. 
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The scoring criteria used in the assay are illustrated in Figure 3.2Bi, which shows 
the common states of interaction observed:  
 
(i) Associated and aligned: the Schwann cell nucleus is in line with the axon 
and cytoplasmic protrusions are tightly aligned with the axon (or in some 
cases multiple axons).   
 
(ii) Associated, not aligned: Schwann cells show indications of axonal 
recognition with part of the cytoplasm making contact and aligning but the 
majority of the cell is not aligned.  
 
(iii) Non-associated: Schwann cells display no recognition and either make no 
axonal contact (even when an axon is in-reach) or the cytoplasm bisects the 
axon with no evidence of interaction.   
 
The immunofluorescence was scored using a tri-band epifluorescent microscope so 
that axons (red), Schwann cell cytoplasm (green) and cell nuclei (blue) could be 
viewed simultaneously.  The association data revealed that over 90% of NS and 
LTNS Schwann cells were associated and aligned with axons, with both cell-types 
showing comparable levels of association and alignment with axons (Figure 3.2Bii).  
This was in stark contrast to LTD cells, in which less than 10% of cells were 
associated with axons and of those that had associated, the majority had failed to 
align with axons.  Two important inferences can be drawn from this data.  First, 
LTNS and NS are similarly capable of interacting with axons, thus, the loss of p53 
and Rb activity from Schwann cells does not impair Schwann cell/axonal 
interactions.  Second, these results confirmed that LTD, a population derived from 
LTNS, had acquired a severe axonal interaction deficiency. 
 
3.5 LTD cells are a non-interacting Schwann cell type 
 
To visualise, dynamically, the encounters between LTD cells and axons, I employed 
time-lapse microscopy, where LTD cells were seeded onto axons at low-density and 
the cocultures incubated for 20 hours (Video 3.2).  The analysis showed that LTD 
cells had completely lost the ability to recognise axons (Figure 3.3).  LTD cells 
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Figure 3.3 Time-lapse analysis confirmed that LTD cells were severely 
impaired in all aspects of axonal interaction.  DRGs were explanted and incubated 
for 7 days, after which LTD cells were seeded onto axons and time-lapse analysis 
was performed for 20hrs.  (A) Shown is an image sequence, selected from Video 3.2, 
which shows encounters between LTD cells and axons.  The white arrows show a 
representative LTD cell that failed to recognise axons or to initiate classical 
‘grabbing/pulling’-behaviour evident from NS/axonal cocultures (Figure 3.1A). 
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elicited no adhesion to axons and failed to display typical Schwann cell-like 
behaviours, for instance, the ‘pulling’ and ‘grabbing’ of axons, that normally follow-
on from an encounter with an axon.  Moreover, LTD cells made multiple 
transgressions over axons with minimal disruption to the conformation of the axonal 
network.  Evidence from this work strongly suggests that LTD cells are lacking 
either the molecules which mediate Schwann cell/axonal interactions or part of the 
cellular machinery that responds to this recognition signal.  
 
As LTD cells are a non-interacting Schwann cell clone, they have the potential to 
provide us with a powerful tool to identify molecules that are important in mediating 
Schwann cell/axonal interactions.  However, it was important to ensure that LTD 
cells were derived from LTNS and also that they shared a common Schwann cell 
origin, and had not originated from a rare contaminating ‘non-Schwann’ cell-type, 
for example, a transformed fibroblast.  With this in mind, NS, LTNS and LTD cells 
as well as perineural fibroblasts were analysed both in terms of their gross 
morphology and in the expression of key cell-type specific molecular markers.  I 
initially examined the cell-types by phase-contrast microscopy and observed that the 
morphology of NS, LTNS and LTD cells were all classically bipolar, which is typical 
of Schwann cells, while conversely, perineural fibroblasts were larger, flattened cells 
with a distinctly different morphology (Figure 3.4A).  I next fixed and 
immunostained confluent monocultures of NS, LTNS, LTD and fibroblasts for the 
Schwann cell markers, S100β and P75NTR (Figure 3.4B), the fibroblast markers 
Thy1 and fibronectin (Figure 3.4C), and for Large-T SV40 antigen (Figure 3.4D).  
The immunofluorescence confirmed that LTD cells expressed the Schwann cell 
markers S100β and p75NTR, while LTD cells did not express the fibroblast markers 
Thy1 or fibronectin.  Importantly, both LTNS and LTD cells expressed the LT SV40 
antigen, supporting the assertion that LTD are derived from LTNS.  Together, these 
results suggest that LTD cells do not originate from fibroblasts but instead, most 
likely originate from Schwann cells. 
 
3.6 Expression analysis between LTNS cells and LTD cells 
 
The evidence I have presented so far suggests firstly, that LTD cells are derived from 
LTNS and thus share a common Schwann cell origin, and secondly, that they have 
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Figure 3.4 Characterisation of cell-types examined in this thesis: - NS, 
Normal Schwann; LTNS, Large-T Normal Schwann; LTD, Large-T derived and 
Perineural fibroblasts. (A) Representative phase-contrast images of live sub-
confluent monocultures showing (i) axonal interacting cell-types and (ii) axonal non-
interacting cell-types. 
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(B) Representative epifluorescence of fixed NS, LTNS, LTD and perineural 
Fibroblast monocultures immunostained for the Schwann cell markers (i), S100β 
(green) and (ii) p75NTR (green), with cell nuclei labelled by Hoechst (blue). 
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(C) Representative epifluorescence of fixed NS, LTNS, LTD and Fibroblast 
monocultures immunostained for the fibroblast markers, (i) Thy1 (red) and (ii) 
fibronectin (green), with cell nuclei labelled by Hoechst (blue). 
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(D) Representative epifluorescence of fixed NS, LTNS, LTD and perineural 
Fibroblast (Fb) monocultures immunostained for the Large-T SV40 antigen (red), 
with cell nuclei labelled by Hoechst (blue). 
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undergone a change which has resulted in their inability to recognise axons.  I 
therefore wanted to determine the nature of the genetic change that had resulted in a 
loss of axonal interactions.   
 
 I reasoned that by identifying the changes in gene expression between LTNS and 
LTD, we could identify putative mediators of Schwann cell/axonal interactions.  We 
envisaged two possible scenarios:  (1) the loss of axonal interactions had resulted 
from a mutation in a single critical gene for interaction or alternatively, (2) a 
mutation in a key transcriptional regulator had resulted in global changes in 
transcription that had altered the cell state and compromised the interaction program.  
In order to test these two different hypothesises I conducted a cDNA differential 
expression microarray between LTNS cells and LTD cells.  We decided to use an 
Affymetrix Rat 230-2 GeneChip array because this platform was considered to 
provide the most comprehensive coverage of the rat genome at the time7.  In 
addition, we had previously used this format successfully in our laboratory 
(Parrinello et al., 2008). 
 
3.6.1 Array specification 
 
The Affymetrix Rat 230-2 GeneChip is a genome-wide rat transcription (cDNA) 
array.  It has 31,042 probesets designed against 30,000 sequences (28,000 of which 
were reported by the manufacture to be well-substantiated genes).  According to the 
manufacture’s protocol, probesets were designed from sequence data held by various 
bioinformatics depositories, which included the NIH genetic sequence database 
(GenBank)8, the Expressed Sequence Tagged database (dbEST) and the Reference 
Sequence (RefSeq) database. Sequences were further refined following cross-
reference to the publically available draft rat genome sequence9 (Gibbs et al., 2004).  
The 230-2 array combines probesets from two previous affymetrix GeneChip arrays 
(Rat Expression 230A and 230B) to generate a single high density oligonucleotides 
array with a concentration (detection) sensitivity of 1:100,000, which corresponds to 
approximately 1.5pM or a few transcripts per cell (Göhlmann & Talloen, 2009, 
p.40). 
                                                 
7 Affymetrix, Datasheet #701611 Rev. 1, 2004 
8 National Center for Biotechnology Information ; http://www.ncbi.nlm.nih.gov 
9 Baylor College of Medicine Human Genome Sequencing Center, June 2002 
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3.6.2 LTNS verses LTD expression microarray 
 
The microarray analysis is summarised in Figure 3.5A.  Total RNA was collected 
from sub-confluent plates of low-passage, proliferating LTNS and LTD Schwann 
cell monocultures and replicate samples were collected three days later.  Total RNA 
was purified and a sample subjected to agarose electrophoretic analysis and 
spectrophotometry to determine the quality of RNA.  As shown in Figure 3.5B, the 
presence of two distinct bands (representing the 18S and 28S ribosomal RNA) is 
indicative of low RNA degradation and the absence of further bands indicated that 
the RNA samples were free from DNA contamination, while the 260/280 absorbance 
was within the range of 1.8-2.0 (data not shown), indicative of low-protein 
contamination.  Five micrograms of RNA from each condition were then sent to the 
Paterson Institute Microarray Service10 for GeneChip analysis in collaboration with 
Gill Newton.  The raw data output was visualised in Figure 3.5C, which showed 
qualitative similarities between the four GeneChips analysed.  This showed that there 
were no gross differences in the manufacturing process between the GeneChip 
arrays.  Importantly, although vertical striations can be observed, this was mirrored 
across all GeneChips.   
 
3.6.3 Analysis of quality control metrics 
 
Prior to conducting further analysis, I examined a number of quality control metrics 
in order to confirm the quality of the GeneChips and quantify the variation attributed 
to technical rather than biological factors.  The Affymetrix Rat 230-2 array structure 
incorporates a number of internal controls.  These include: (1) hybridisation controls, 
(2) house-keeping/control genes, (3) poly-A controls and (4) normalisation controls.  
In addition, each probeset is composed of multiple probe-pairs that independently 
measure the same transcript.  The quality control metrics were calculated 
automatically using Affymetrix Microarray Suite (MAS) 5.0 software, and are 
summarised in Figure 3.6 (refer to Affymetrix manual11 and glossary12 for further 
details of these metrics).   
                                                 
10 The Patterson Institute for Cancer Research, Manchester 
11 GeneChip Expression Analysis: Data Analysis Fundamentals (www.affymetrix.com) 
12 Affymetrix report file glossary: MAS 5.0 Documentation (www.afymetrix.com) 
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Figure 3.5 Schematic illustration showing the stages involved in microarray 
processing.  (A) Summary of the experimental procedures of RNA processing and 
microarray analysis. FDR; false discovery rate (B) Electrophoretic analysis of RNA 
samples.  (C)  Graphical representations of the raw expression data from replicate 
GeneChips of LTNS and LTD. 
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The raw fluorescence intensity, as shown for each GeneChip in Figure 3.6A, is a 
measure of the background noise.  It is calculated by subtracting the mean central 
intensity from the mean peripheral intensity for each locus (spot) on the array, giving 
the pixel-to-pixel variation.  Figure 3.6B quantifies the average background  
intensity, which measures auto-fluorescence within the GeneChip and is derived 
from the mis-match (MM) probe data.  Both these metrics can be heavily influenced 
by technical discrepancies in sample preparation and/or scanner electronics. The data 
showed that all four GeneChips had similar levels of auto-fluorescence and pixel 
variation, suggesting that they had been processed in a similar and comparable way. 
 
The hybridisation efficiency of probes (irrespective of sample RNA) was examined 
using hybridisation control transcripts.  Figure 3.6C charts the signal intensities 
obtained after addition, into the hybridisation mixture, of known, graduated 
concentrations of BioB, BioC, BioD and cre (at concentrations of 1.5pM, 5pM, 25pM 
and 100pM respectively).  The data was plotted on a relative scale with BioB set to 
the array resolution (1:100,000) with the remaining controls plotted relative to this.  
The data, as shown in Figure 3.6C, accurately reflected the intensities expected 
given the initial concentrations of ‘spiked’ controls.  Another metric used to evaluate 
the technical procedure (especially the efficacy of reverse transcription to generate 
cDNA and the process of biotin labelling to generate cRNA), are the use of control 
genes.  The rat 230-2 array incorporates pairs of control probesets for β-actin and 
GAPDH that are specifically designed to independently target the 3-prime and 5-
prime ends of the two ‘housekeeping’ genes.  Due to an inherent three-prime bias in 
cDNA arrays (Cui & Loraine, 2009), the expected signal intensity ratio of the three 
prime probeset to the five-prime probeset should, as shown in our data (Figure 
3.6D), be greater than one but not exceed three.    
 
I next examined the scaling and normalisation process, which allow comparisons to 
be made between the four separate GeneChips.  In this analysis, the data was 
subjected to normalisation (scaling) using the default Affymetrix MAS 5.0 
algorithm.  The graph shows, for each GeneChip, the scaling factor that would be 
required to achieve equality of total intensity means.  For our data, the maximum 
scaling factor required to achieve normalisation was 1.5, which compares favourably 
against the accepted upper-limit threshold of three-fold (Figure 3.6E).  Similarly, 
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Figure 3.6 Affymetrix quality control metrics. (A)  Raw intensity (RawQ); a 
measure of pixel-to-pixel variation used to quantify the signal attributed to ‘noise’ in 
the GeneChip.  This is calculated by subtracting the mean central intensity from the 
mean peripheral intensity for each locus (spot) on the array.  (B)  Average 
background; a measure of non-specific fluorescence. This is calculated from the mis-
match probes.  (C) Hybridisation controls; a measure of hybridisation efficiency.  
Four test RNAs of known concentration (BioB, BioC, BioD and Cre) are ‘spiked’ 
into the hybridisation mix and their detection is analysed to determine if the ratio of 
intensities reflects the initial ‘spiked’ concentration. (D) Control genes; a measure of 
RNA and assay quality.  The graph shows a ratio of intensities for two housekeeping 
genes (Actin and GAPDH), where the three-prime hybridisation intensity and the 
five-prime hybridisation intensity are plotted as a ratio.  
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(E) Percentage present; a measure of the ability of the array to detect significant 
probe hybridisation events. (F) Scaling Factor; a measure of the variance in the mean 
intensities between GeneChips.  The graph shows the magnitude of the adjustment 
(scaling) factor required to normalise the GeneChip data to allow direct comparisons 
between GeneChips.  (G) Relative log expression (RLE) plot; a measure of the 
deviation in gene expression from the median expression value for all genes across 
all arrays. (H) Normalised Unscaled Standard Error (NUSE); a measure of the 
variance in standard error estimates from expression intensities across all arrays.  The 
values are standardised so that the average SE estimate for a gene is one. 
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(I) mRNA degradation plot; measures the mRNA degradation as an average across 
all probesets.  This was calculated by plotting the signal intensity against the rank 
order at which the probes hybridised along the DNA, with the most five-prime probe 
assigned a zero rank.  Because mRNA is degraded from the five-prime end first, the 
slope of the line at this end is used to gauge degradation rates.  (J) Hierarchical 
cluster dendrogrogram; measures relatedness between samples (clusters) based on a 
defined similarity matrix.  Clusters in the same branch are considered more similar 
than clusters derived nearer the root of the tree. 
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the ‘percentage present’ metric is a useful indicator of the specificity of probe 
hybridisation.  The graph in Figure 3.6F shows the total percentage of perfect match 
(PM) probe hybridisations that are considered statistically significant when compared 
with their mis-match (MM) probe pair.  This metric should be comparable across 
arrays, as observed in our data, in which the percentage present is about 60%.   
  
The hybridisation quality can also be measured by the Relative Log Expression 
(RLE) and the Normalised Unscaled Standard Error (NUSE).  The RLE plot was 
calculated by determining the deviation in gene expression for a gene from the 
median expression value for that gene across all arrays for each gene in the array.  
The values are shown in log scale and should, as shown by our data in Figure 3.6G, 
be approximately zero with equal chip-wise distribution.  The NUSE plot is a similar 
metric, which shows the distribution of standard error (SE) estimates calculated for 
each gene across all arrays.  The data is ‘standardised’ so that the median standard 
error of a gene across all arrays is set to one, with the box showing the mean, upper 
and lower quartiles and the bars showing the range.  In our data, this metric was 
comparable across arrays, with values close to one (Figure 3.6H). 
 
I next assessed the quality of sample mRNA by analysing the RNA degradation plot, 
which can be derived from the fact that RNA degradation preferentially occurs at the 
5-prime end of mRNA transcripts.  Because there are a number of probes for each 
target gene, the target sequences can be ranked from the five-prime end of the 
transcript to the three-prime end.  Thus, if five-prime mRNA degradation occurs, the 
extent of this can be measure by plotting the relative mean intensities (on the y-axis) 
against the relative position of probes for a probeset (on the x-axis).  The gradient of 
the line towards the five-prime end of the graph indicates the degree of mRNA 
degradation.  The acceptable range is considered to be between 0.5 and 1.7.  Our data 
showed some degree of five-prime mRNA degradation but importantly, this was 
comparable across all four GeneChips (Figure 3.6I). 
 
Finally, Figure 3.6J, shows a hierarchical clustering dendrogram, which measures 
the relatedness of samples (clusters) based on a defined similarity matrix.  Clusters in 
the same branch are considered more similar than clusters derived from branches 
nearer the root of the tree.  As expected, experimental replicates of both LTNS and 
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LTD were observed to cluster together, while replicate pairs were delineated to 
different branches of the tree.  As expected, this implies that the biological variation 
between test samples of LTD and LTNS was significantly greater than that within 
replicates. 
 
In conclusion, the quality control metrics revealed no significant issues in relation to 
the technical procedures or RNA sample quality.  I therefore proceeded to pre-
process the raw intensity data so that differential expression could be determined. 
 
3.6.4 Pre-processing of microarray data 
 
The initial data processing was conducted in collaboration with Richard Mitter13.  
The raw Affymetrix data was first pre-processed in order to generate an expression 
matrix using the Robust Multi-array Average (RMA) algorithm (Irizarry et al., 
2003a) as implemented in the Bioconductor R package.  The RMA method, which 
exclusively uses the perfect-match (PM) probe data, was chosen because it was 
shown to have an advantage over competitors, i.e. Affymetrix MAS 5.014 or dChip 
(Li & Wong, 2001), in terms of specificity, consistency and sensitivity (Irizarry et 
al., 2003b).  The raw intensity values were background corrected, to remove the 
signal attributed to non-specific binding of fluorophore, and log2 transformed to 
ensure the continuous distribution of data, which was required for later statistical 
steps.  The data was quantile normalized in order to correct for systemic technical 
differences and importantly, to allow for meaningful chip-wise comparisons of 
expression data.  A scaling factor was calculated and the global intensities were 
adjusted so that all GeneChips had a similar mean intensity.  A linear model, derived 
by the ‘median polish’ algorithm (Irizarry et al., 2003a), was then transposed over 
the normalised data in order to summarise the probe level data into a single 
expression measure for each probeset on each GeneChip array. 
  
  
                                                 
13 London Research Institute (LRI) Bioinformatics & Biostatistics group 
14 Affymetrix (2001) Microarray Suite User Guide, V5.; 
www.affymetrix.com/support/technical/manuals.affx. 
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3.6.5 Calculating differential gene expression  
 
Differential gene expression was assessed between replicate groups by calculating 
the expression ratio, which was represented as a Log2 fold-change.  Each expression 
ratio was attributed a p-value, as calculated by the empirical Bayes T-test, which 
describes the statistical confidence in that given expression ratio.  An FDR (false 
discovery rate) was then calculated for each expression ratio.  This is an adjustment 
to the p-value necessary to control the family-wise error rate caused by multiple 
simultaneous statistical testing that would otherwise lead to unacceptably high type 1 
errors (Chen et al., 2010).  The FDR is the proportion of false positives among all the 
probesets where the null-hypothesis was initially rejected, i.e. genes identified as 
being differentially expressed.  This statistic provided a good overall compromise 
between false positive and false negative error rates (Cui & Churchill, 2003).   
 
3.6.6 Gene annotation, analysis and secondary processing 
 
The probeset-level summarisation was processed using Affymetrix NetAffx15 
software in conjunction with the March 2009 Rat 230-2 Affymetrix GeneChip 
definition file (CDF), in order to assign the summarised intensity values for probesets 
to their corresponding gene targets on the rat genome.  The full dataset (Dataset A 
on the CD-ROM), which contained 31,099 probesets, was then subjected to 
secondary processing, outlined in Figure 3.7, which illustrates the steps taken to 
refine the dataset from the full redundant probeset-level dataset to a final dataset of 
unique genes with significant and meaningful expression fold-change (described in 
detail below).  As shown in Figure 3.7, the dataset for each stage of this process is 
depicted in the central column of boxes, which correspond to the datasets held on the 
accompanying CD-ROM.  Initial analysis of the full dataset revealed that 20,220 
probesets, approximately 65% of the total list, could be annotated and assigned to 
known rat genes, while 35% of the probes had no gene assignments (Table 3.1).   
 
 
 
 
                                                 
15 www.affymetrix/analysis/netaffx 
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Figure 3.7 Schematic of analysis involved in secondary data processing. The 
left column shows processes, the middle column shows outcome and the right 
column shows analysis. Refer to CD-ROM for the Datasets, which are denoted by 
letters in the small-boxes (middle-column). 
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Table 3.1 Gross analysis of probesets comprising the Rat 230-2 microarray 
 
 
 
 
 
 
 
 
 
I next examined the Rat 230-2 probesets in more detail because I wanted to fully 
understand the source information used by Affymetrix in their design, and also to 
establish the relationship between probesets and the genes they represent.  As 
discussed previously, the Rat 230-2 probesets were designed using submissions from 
multiple data depositaries/sources, i.e. RefSeq, GenBank, EMBL & DDBJ 
submissions, which, for example can include data derived from validated unique 
gene entries, expression-sequence tags (EST)s or journal submissions.  The list is 
degenerate as more than one probeset (that could be designed from different sources) 
can target the same gene.  In order to analyse this information in my data, I cross-
referenced the accession numbers returned for each probeset from the annotation, 
with a list of accession prefix definitions published on the NCBI website16, to 
identify the data source used in the design of probesets (Table 3.2; see also 
Appendix Table B for the full list).  This information shows that the design of the 
probesets for the Rat 230-2 array was derived predominantly from EST databases 
with just over 10% of probesets designed from validated RefSeq entries.  
Unsurprisingly, nearly 100% of the non-annotated list was derived from EST 
databases.  The annotated portion of the dataset was composed of 16% validated 
RefSeq entries with 77% composed from EST databases.  Although, the importance 
of the non-annotated list should not be underestimated, i.e. as a potential means to 
reveal novel but uncharacterised candidates, the constraints of this project would not 
allow sufficient time for the detailed investigation required. On this basis, I decided 
to exclusively focus all further analysis on the annotated portion of the list (Dataset 
B).   
 
                                                 
16 www.ncbi.nlm.nih.gov/Sequin/acc.html, accessed: 2011 
Component Value 
Sequences with annotation 20,220 (65%) 
Sequences without annotation 10,822 (35%) 
AFFX- Control probesets 57 
Total Probe Sets 31,099 
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Table 3.2 Summary of the types of source data used in the design of 
probesets for the Rat 230-2 GeneChip 
 
 
 
Resource Entire Dataset 
Non-annotated 
dataset only 
Annotated 
dataset only 
  %  %  % 
RefSeq 3170 10.21 5* 0.05 3165 15.61 
EST 26287 84.68 10728 99.60 15559 76.75 
Direct subs 1580 5.09 37 0.34 1543 7.61 
Journal scanning 5 0.02 1 0.01 4 0.02 
Total 31042 100 10711 100 20271 100 
RefSeq, referenced sequences; EST, expressed sequence-tags; Direct subs, direct 
submissions.  *ReqSeq were investigated and subsequently found to have 
redundant/erroneous accession numbers.  (see Appendix Table B for full list). 
 
 
Table 3.3 highlights some important additional parameters for the annotated dataset.   
It shows that there are 6246 more probesets than unique gene targets.  This 
redundancy is either due to multiple probesets for a single gene designed from the 
same source, i.e. the probeset IDs share a common accession number (310 cases), or 
from different sources, i.e. the probeset IDs have different accession numbers but 
target the same gene (5936 cases).  Nearly half the genes on the array were detected 
with just one probeset, with just over 2000 of these detected with probesets designed 
using validated, reference sequences (RefSeq).  
 
Table 3.3 Analysis of data from the annotated gene list 
 
 
Parameter Value % 
Total number of annotated probesets 20,271  
Number of probesets designed from 
unique sources, i.e. the number of 
different GenBank accession numbers) 
19,961  
Number of unique gene targets 14,025  
Number of non-redundant probesets (one 
probeset to one gene relationships)  9,707* 47.8 
* Includes 2,212 genes represented by RefSeq designed probesets 
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At this stage in the data processing, I decided to reduce redundancy from the dataset 
by preferentially removing duplicated probesets designed from ESTs in cases where 
a RefSeq designed probeset was already available.  I did this because RefSeq 
designed probesets are derived from intact mRNA that have been validated to a 
unique gene, whereas ESTs are derived from mRNA fragments in which, by 
definition, their origin is less reliable compared to the former (Nagaraj et al., 2007). 
Thus, in this way I gave precedence to RefSeq designed probesets over EST 
designed probesets.  Importantly, duplicate probesets were not removed in cases 
where there were no RefSeq designed probesets available for a gene.  Following this 
analysis, the refined Dataset C contained 19,029 probesets.     
 
I next examined the data using a volcano plot, in order to examine the distribution 
and magnitude of significant expression changes.  The negative Log10 of the FDR 
(on the Y-axis) was plotted against the Log2 fold-change (on the X-axis) (Figure 
3.8).  I selected a fold-change cut-off threshold of two and a nominal FDR cut-off of 
less than or equal to 0.1, shown by the red markers.  This graphical view of the 
significant expression change showed that surprisingly large numbers of genes were 
transcriptionally dysregulated in LTD cells, which was symmetrically distributed in 
terms of genes that were up or down regulated in LTD cells.  I next devised a list 
with just the significant probesets with expression differentials that were greater than 
two-fold, i.e. the probesets marked in red (Dataset D).  At this point I masked 
duplication by considering only probesets with the lowest FDR in order to generate a 
final list of uniquely dysregulated genes (Dataset E), of which 547 were 
significantly down-regulated and 365 were significantly up-regulated compared to 
LTNS (the top 120 dysregulated genes are summarised in Appendix Table A, parts i 
and ii respectively; refer to the accompanying CD-ROM for the full list).  
 
3.6.7 Functional gene annotation, cluster and enrichment analysis 
 
The final gene-list (Dataset E) contains 912 genes whose expression had become 
significantly altered (greater than two-fold) between LTNS (interacting) and LTD 
(non-interacting) cells.  Thus, the scope of genetic change was large with no single 
obvious candidate identified.  In order to uncover biologically meaningful trends in 
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Figure 3.8 LTD cells have globally dysregulated gene expression.  (A) The 
volcano (scatter) graph shows the relationship between the negative Log10 of false 
discovery rate (FDR) and the Log2 of the fold-change, thus illustrating the magnitude 
of expression differences that are significant.  The red markers show the probesets 
where FDR is less than 0.01 and fold-change is greater than 2 (up or down), while 
the black markers show the non-significant and/or below 2-fold probesets that, for 
the purposes of further analysis, were excluded from the dataset. 
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this data, which might explain the overall transition from LTNS to an LTD 
phenotype, I conducted functional enrichment analysis.  The finalised, non-redundant 
gene list was functionally annotated using DAVID17, a web-based tool for functional 
gene annotation and enrichment analysis (Huang et al., 2009).  Functional annotation 
was derived from at least 11 different gene ontology resources including the Gene 
Ontology (GO) project18 (specifically: biological pathway, BP; cellular component, 
CC & molecular function, MF) as well as KEGG19 terms (see Appendix Table B for 
the full list).  The annotated gene-list contained multiple annotation terms for each 
gene, which reflects their multiple functions and the myriad ways in which they can 
be functionally classified.  Enrichment analysis is a bioinformatics tool for providing 
statistical confidence in the discovery of functional patterns in microarray data.  The 
gene-list (Dataset E) was submitted to DAVID for functional annotation enrichment 
analysis, which statistically highlights the most over-represented biological 
annotation in the dataset.  The data output (Dataset F) from this analysis is 
statistically organised into clusters which are ranked by an enrichment score, 
reflecting the biological relevance of each cluster within the submitted gene list.  The 
analysis was conducted using default DAVID parameters for statistical enrichment; it 
showed that 261 clusters of functionally related ontology terms were statistically 
enriched within the gene list when compared to the Rattus norvegicus background.  
The first five most enriched annotation clusters are shown in Table 3.4 (the first 12 
clusters are shown in Appendix Table D, while the full list is included in Dataset F 
of the CD-ROM).  
 
Table 3.4 Functional annotation enrichment analysis (clusters 1 to 5) 
 
 
 
Category Term No. % P-value BG Fold 
       
Annotation Cluster 1 Enrichment Score: 14.5      
GOTERM_BP_FAT GO:0022610~biological adhesion 71 7.81 3.53E-18 463 3.18 
GOTERM_BP_FAT GO:0007155~cell adhesion 71 7.81 3.53E-18 463 3.18 
SP_PIR_KEYWORDS cell adhesion 35 3.85 1.67E-09 180 3.23 
       
     
                                                 
17 Database for Annotation, Visualization and Integrated Discovery; http://david.abcc.ncifcrf.gov/ 
18 Gene Ontology Project; http://www.geneontology.org/ 
19 Kyoto Encyclopedia of Genes and Genomes; http://www.genome.jp/kegg/ 
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Annotation Cluster 2 Enrichment Score: 13.48      
GOTERM_CC_FAT GO:0031012~extracellular matrix 55 6.05 2.96E-20 252 4.31 
GOTERM_CC_FAT GO:0005578~proteinaceous extracellular matrix 48 5.28 1.05E-17 220 4.31 
GOTERM_CC_FAT GO:0044420~extracellular matrix part 30 3.30 2.15E-15 97 6.10 
GOTERM_CC_FAT GO:0044421~extracellular region part 83 9.13 1.76E-13 693 2.36 
GOTERM_CC_FAT GO:0005604~basement membrane 24 2.64 3.74E-13 72 6.58 
GOTERM_CC_FAT GO:0005576~extracellular region 123 13.53 9.53E-13 1281 1.90 
SP_PIR_KEYWORDS extracellular matrix 20 2.20 1.01E-06 89 3.73 
       
Annotation Cluster 3 Enrichment Score: 7.14      
GOTERM_BP_FAT GO:0032989~cellular component morphogenesis 49 5.39 5.00E-10 376 2.70 
GOTERM_BP_FAT GO:0048666~neuron development 45 4.95 3.32E-09 347 2.69 
GOTERM_BP_FAT GO:0030182~neuron differentiation 53 5.83 5.63E-09 457 2.41 
GOTERM_BP_FAT GO:0031175~neuron projection development 38 4.18 1.04E-08 273 2.89 
GOTERM_BP_FAT GO:0048812~neuron projection morphogenesis 33 3.63 1.09E-08 215 3.18 
GOTERM_BP_FAT GO:0030030~cell projection organization 45 4.95 1.14E-08 361 2.59 
GOTERM_BP_FAT GO:0000902~cell morphogenesis 43 4.73 1.68E-08 340 2.62 
GOTERM_BP_FAT GO:0032990~cell part morphogenesis 35 3.85 3.13E-08 248 2.93 
GOTERM_BP_FAT GO:0048858~cell projection morphogenesis 34 3.74 3.80E-08 238 2.96 
GOTERM_BP_FAT GO:0000904~cell morphogenesis involved in differentiation 32 3.52 5.92E-07 242 2.74 
GOTERM_BP_FAT GO:0048667~cell morphogenesis involved in neuron differentiation 27 2.97 6.90E-06 207 2.71 
GOTERM_BP_FAT GO:0007409~axonogenesis 25 2.75 9.78E-06 186 2.79 
GOTERM_BP_FAT GO:0007411~axon guidance 16 1.76 1.44E-04 105 3.16 
       
Annotation Cluster 4 Enrichment Score: 6.62      
GOTERM_BP_FAT GO:0007517~muscle organ development 28 3.08 3.43E-08 169 3.44 
GOTERM_BP_FAT GO:0060537~muscle tissue development 24 2.64 1.62E-07 138 3.61 
GOTERM_BP_FAT GO:0014706~striated muscle tissue development 23 2.53 2.62E-07 131 3.64 
GOTERM_BP_FAT GO:0060538~skeletal muscle organ development 17 1.87 7.20E-07 78 4.52 
GOTERM_BP_FAT GO:0007519~skeletal muscle tissue development 17 1.87 7.20E-07 78 4.52 
       
Annotation Cluster 5 Enrichment Score: 5.64      
GOTERM_MF_FAT GO:0005539~glycosaminoglycan binding 22 2.42 7.65E-09 102 4.60 
GOTERM_MF_FAT GO:0030247~polysaccharide binding 23 2.53 1.66E-08 116 4.23 
GOTERM_MF_FAT GO:0001871~pattern binding 23 2.53 1.66E-08 116 4.23 
GOTERM_MF_FAT GO:0008201~heparin binding 15 1.65 5.00E-06 72 4.44 
GOTERM_MF_FAT GO:0030246~carbohydrate binding 29 3.19 0.0023379 337 1.84 
SP_PIR_KEYWORDS heparin-binding 8 0.88 0.00581103 37 3.59 
 
The table shows the five most enriched clusters ranked by enrichment score, where ‘No.’ is 
the number of genes involved with the term; ‘p-value’ is the Modified 1-tailed Fisher Exact 
p-value; ‘BG’ is the number of genes in the rat genome that map to that same term; ‘Fold’ is 
the enrichment-fold change, which is the percentage overlap of the gene list with the term 
over the same term in the background list (rat genome). 
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The first (most-enriched) cluster (14.56) contained terms exclusively related to cell-
adhesion (highlighted in yellow), while the second cluster (13.48) contained terms 
that were either related to ECM or were more generally of a function related to 
extracellular localisation.  This analysis showed that cell adhesion was the most 
statistically significant and enriched functionally altered annotation between 
interacting (LTNS) and non-interacting (LTD) cells.  These findings are consistent 
with the severity of the interaction impairment shown by LTD cells, as CAMs 
mediate interaction between cells and so any alteration in their expression would be 
expected to have implications for cellular interactions.  Moreover, the change in 
adhesion profile is indicative of a switch in Schwann cell identity, implicating the 
role of transcriptional master regulators in the impairment.  Analysis of genes with 
shared functional annotation (gene functional annotation) was also conducted and is 
included in Appendix Table E (Dataset G).  This table includes an enriched cluster 
of adhesion genes (fifth-ranking) and an enriched cluster of transcriptional regulators 
(eighth-ranking).  Transcription factors have the capability of regulating multiple, 
often related genes and therefore are possible candidates for study.  
 
To address all these findings in more detail, I selected three functionally-related 
groups of genes with  relevance to this thesis, for further analysis: (1) cell adhesion 
molecules because of their structural role in mediating cellular interactions; (2) 
semaphorins because we have previously showed a role for Sema4F in mediating 
Schwann cell/axonal interactions (Parrinello et al., 2008); (3) transcription factors 
because of their ability to alter the expression of multiple genes, which might have 
implications for Schwann cell identity.  
 
Cell adhesion molecules 
 
As discussed, CAMs provide the physical connections for cellular interactions. 
Cluster one of Table 3.4 highlighted three adhesion-related functional annotations.  
The genes represented by these functional groups in this cluster, together with their 
corresponding expression fold-change values, are listed in Table 3.5.   
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Table 3.5 List genes from functional-annotation cluster one of Table 3.4, 
which share common adhesion related functions 
 
 
Accession ID Gene Fold-change 
AI412746 tweety homolog 1 (Drosophila) -117.93 
BM389026 periostin, osteoblast specific factor -87.60 
NM_019153 fibulin 5 -74.16 
AI599143 collagen, type XIV, alpha 1 -73.18 
NM_031069 NEL-like 1 (chicken) -36.69 
AI598833 LIM domain 7 -28.81 
BM389302 nidogen 2; similar to nidogen 2 protein -25.71 
AI235948 nidogen 1 -22.91 
BE108345 collagen, type XII, alpha 1 -20.83 
BM388456 collagen, type XI, alpha 1 -18.73 
AB035507 melanoma cell adhesion molecule -17.21 
NM_021760 collagen, type V, alpha 3 -15.88 
AI233246 insulin-like growth factor binding protein 7 -15.34 
AF159103 tumor necrosis factor alpha induced protein 6 -15.04 
BE116590 adherens junction associated protein 1 -14.57 
NM_130429 lymphoid enhancer binding factor 1 -14.54 
NM_017345 L1 cell adhesion molecule (L1-CAM) -14.00 
BG663483 protocadherin alpha 4 -12.80 
AA943034 cell adhesion molecule 4 (Necl-4) -10.69 
AI407898 immunoglobulin superfamily, member 11 -10.52 
NM_031333 cadherin 2 (N-cadherin) -9.13 
BI295776 sorbin and SH3 domain containing 1 -8.61 
AI101782 collagen, type XVIII, alpha 1 -7.38 
NM_134452 collagen, type V, alpha 1 -7.24 
AI408064 amyloid beta (A4) precursor protein -6.46 
AF016296 neuropilin 1 -6.18 
NM_013016 signal-regulatory protein alpha -5.69 
AW433901 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) -5.63 
NM_031521 neural cell adhesion molecule 1 (NCAM) -5.21 
BE103601 cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) -5.04 
BE126420 AE binding protein 1 -4.98 
AA956340 protocadherin 7 -4.55 
NM_012974 laminin, beta 2 -3.64 
AA997129 laminin, gamma 1 -3.45 
NM_031977 v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) -3.40 
BG380309 collagen, type XVI, alpha 1 -3.33 
NM_053931 glycoprotein Ib (platelet), beta polypeptide; septin 5 -3.15 
NM_017338 calcitonin/calcitonin-related polypeptide, alpha -2.98 
D25290 cadherin 6 -2.91 
AA891940 ras homolog gene family, member A; ras homolog gene family, member C -2.85 
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AI171799 ependymin related protein 1 (zebrafish) -2.62 
AI412938 G protein-coupled receptor 56 -2.53 
U72660 ninjurin 1 -2.53 
BF392901 collagen, type XXVII, alpha 1 -2.38 
NM_013180 integrin beta 4 -2.36 
BG380566 hyaluronan and proteoglycan link protein 4 -2.30 
BE115857 parvin, alpha -2.25 
AI227627 CD9 molecule -2.23 
NM_030863 Moesin -2.19 
AW527799 LIM domain containing preferred translocation partner in lipoma -2.17 
BF402765 cadherin 10 2.05 
AF065438 lectin, galactoside-binding, soluble, 3 binding protein 2.11 
NM_134459 CD99 molecule-like 2 2.26 
BF415817 neogenin homolog 1 (chicken) 2.34 
NM_053720 apoptosis antagonizing transcription factor 2.50 
U69109 PTK2B protein tyrosine kinase 2 beta 3.41 
NM_053481 phosphoinositide-3-kinase, catalytic, beta polypeptide 3.58 
NM_057118 contactin 1 3.59 
X74293 integrin alpha 7 4.19 
BF412784 Fras1 related extracellular matrix 1; tetratricopeptide repeat domain 39B 4.35 
BI292586 integrin alpha 3 4.64 
M37394 epidermal growth factor receptor 5.22 
NM_130419 discoidin, CUB and LCCL domain containing 2 5.27 
NM_133298 glycoprotein (transmembrane) nmb 6.07 
BI279663 desmocollin 2 6.19 
AW523000 cadherin 15 8.55 
NM_134455 chemokine (C-X3-C motif) ligand 1 8.92 
BF419320 WNT1 inducible signaling pathway protein 1 11.30 
NM_053572 protocadherin 21 24.81 
NM_030856 leucine rich repeat neuronal 3 28.15 
AB001382 secreted phosphoprotein 1 58.21 
This table lists genes with the adhesion-related GO-Terms stated in Cluster one of Table 3.4. 
and may not contain all adhesion genes.  The out-put was cross-referenced with the LT 
microarray to obtain fold-change values.   Genes of interest are highlighted in yellow. 
 
Many of the CAMs previously implicated as playing a role in Schwann cell/axonal 
interactions were found to be down-regulated in LTD cells, including L1-CAM (14-
fold), NCAM (5.2-fold) and N-cadherin/cadherin-2 (9.1-fold).  Importantly, while 
the majority of adhesion genes were down-regulated, a minority were up-regulated 
including several cadherins, for example cadherin-10, cadherin-15, and 
protocadherin-21.  While it was not surprising that adhesion genes were 
dysregulated, both the number of adhesion genes affected and the magnitude of the 
fold-change of affected genes was surprising.  These findings suggest that LTD cells 
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had undergone a change in cell-state that had radically altered the repertoire and 
levels of surface expressed CAMs, which had possibly compromised their cellular 
identity as Schwann cells.  This could reflect an adhesion profile, expressed in 
Schwann cells, which was under the regulatory control of the defective molecule 
found in LTD cells. 
 
Semaphorins 
 
In addition to classical adhesion molecules, I also examined gene expression changes 
in the semaphorin family of genes, as we had recently shown in our laboratory, that 
loss of Sema4F in Schwann cells caused Schwann cell/axonal disassociation and was 
implicated in the aetiology of Neurofibromatosis type I (Parrinello et al., 2008).  
Table 3.6 lists the significantly dysregulated semaphorin family genes and their 
receptors from Dataset E (CD-ROM).   
 
Table 3.6 Semaphorin family members and their receptors significantly 
changed in LTD cells 
 
Accession ID Gene Fold-change 
BM386525 Semaphorin 6D -26.71 
BI275485 Semaphorin 3B -8.49 
BE108859 Semaphorin 3G -3.11 
NM_019272 Semaphorin 4F -2.92 
BM387083 Semaphorin 6A -2.61 
BM390000 Semaphorin 3F 3.07* 
NM_017310 Semaphorin 3A 3.37 
AF016296 Neuropilin-1 -6.2 
AI102248 Plexin D1 -4.61 
Genes of special interest are highlighted in yellow (FDR < 0.01, FC > 2 up/down); 
*(0.01<FDR<0.1) 
 
Consistent with this work, Sema4F was shown to be down-regulated nearly three-
fold in LTD cells.  Interestingly, four other members of the family were also down-
regulated, with Sema6D levels down-regulated by nearly 27-fold.  It is still unclear 
whether other members of the semaphorin family function as adhesion molecules 
because their primary function described to date has centred on axonal guidance, 
attraction and repulsion (Kruger et al., 2005).  In addition to semaphorins, a number 
of semaphorin receptors (plexins) and co-receptors (neuropillins)  were also found to 
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be dysregulated, these include neuropillin-1 (down-regulated 6.2-fold) and Plexin D1 
(4.6-fold down-regulated), where Plexin-D1 is the receptor for class-3 semaphorins 
(Kruger et al., 2005). 
 
Transcriptional regulators 
 
Transcription factors regulate the expression of multiple genes and co-ordinate the 
level of expression to control many aspects of cell biology, particularly during 
differentiation where different programmes of gene expression are required.  In 
addition, they are often implicated in establishing a cellular identity or 'molecular 
signature', which is defined by the pattern of gene expression under their regulatory 
control.  Table 3.7 lists the genes from Dataset E that share the BP GO-Term 
'regulators of DNA transcription'. 
 
Table 3.7 List of genes involved in transcription 
 
Accession ID Gene Fold-change 
BF388057 hairy/enhancer-of-split related with YRPW motif 2 -30.28 
NM_019193 SRY (sex determining region Y)-box 10 (Sox10) -23.76 
NM_130429 lymphoid enhancer binding factor 1/LEF1 -14.54 
BG671865 necdin homolog (mouse) -10.85 
AI072336 naked cuticle homolog 2 (Drosophila) -9.24 
NM_022300 brain abundant, membrane attached signal protein 1 -8.29 
BI295741 homeo box A10 -7.66 
AI408064 amyloid beta (A4) precursor protein -6.46 
BI284495 transcription factor AP-2, gamma -5.35 
NM_013154 CCAAT/enhancer binding protein (C/EBP), delta -5.04 
BE126420 AE binding protein 1 -4.98 
AI013919 cyclin-dependent kinase inhibitor 1C (P57) -4.96 
BE107033 ecotropic viral integration site 1 -4.40 
BF416474 retinoic acid induced 14 -4.28 
NM_024364 Hairless -4.26 
BF415939 FBJ osteosarcoma oncogene -3.47 
NM_053369 transcription factor 4 -3.45 
AI411774 B-cell CLL/lymphoma 3 -3.37 
BF548737 SRY (sex determining region Y)-box 2 (Sox2) -3.19 
BM390477 cut-like homeobox 1 -3.06 
BI289559 SRY (sex determining region Y)-box 6 (Sox6) -2.98 
NM_139113 nuclear receptor subfamily 2, group F, member 6 -2.96 
AF140346 secreted frizzled-related protein 4 -2.93 
 165  
   
BE120513 TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor -2.64 
AI176779 hypothetical protein LOC654482 -2.46 
BF396205 homeo box C10 -2.42 
NM_053894 Jun dimerization protein 2 -2.39 
BM386654 SCAN domain-containing 1 -2.33 
AB062135 DnaJ (Hsp40) homolog, subfamily C, member 12 -2.32 
AI228548 S100 calcium binding protein A1 -2.20 
NM_031528 retinoic acid receptor, alpha -2.18 
BE113920 signal transducer and activator of transcription 3 -2.17 
AJ132046 metastasis associated 1 -2.16 
BE107303 homeo box A5 -2.12 
AW529031 zinc finger E-box binding homeobox 2 -2.06 
BG378709 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 2.00 
AI176506 necdin-like 2 2.16 
NM_031789 nuclear factor, erythroid derived 2, like 2 2.33 
NM_053412 interleukin enhancer binding factor 3 2.35 
BE102096 jumonji domain containing 1C 2.42 
BE099050 nuclear factor I/B 2.48 
NM_012576 nuclear receptor subfamily 3, group C, member 1 2.52 
AI713965 iroquois homeobox 3 2.53 
BF545627 ets variant 4 2.87 
BE108745 nucleosomal binding protein 1 2.90 
BF386078 eyes absent homolog 2 (Drosophila) 2.93 
NM_032462 Kv channel interacting protein 3, calsenilin 3.34 
NM_053349 SRY (sex determining region Y)-box 11 (Sox11) 4.36 
BE117444 teashirt zinc finger homeobox 1 5.34 
AF474979 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 5.36 
NM_053530 twist homolog 1 (Drosophila) 6.46 
NM_021693 SNF1-like kinase 7.17 
AI599177 teashirt zinc finger homeobox 3 10.82 
AI175048 SIX homeobox 1 25.73 
The main dataset was searched using GO-term “GO:0006355~regulation of cellular 
transcription, DNA-dependent”, in order to return genes involved in transcription 
(FDR<0.01, FC>2 up/down).  Total R. norvegicus genes in this category: 2707 (Feb 2012).  
Genes of special of interest are highlighted in yellow. 
 
This analysis showed that a substantial number of transcription factors had become 
dysregulated in LTD cells.  Importantly, this included members of the Sox/SRY 
family, of which, Sox2, Sox6 and Sox10 are down-regulated by 3.2-fold, 3-fold and 
24-fold respectively,  while Sox11 was up-regulated 4.5-fold.  Both Sox2 and Sox10 
are key transcription factors known to be important in Schwann cell biology.  Sox10 
expression begins in NCCs, continuing throughout the developmental lineage of 
Schwann cells and persists in mature adult Schwann cells, where it is thought to be 
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important for the specification of Schwann cells (Jessen & Mirsky, 2005).  Sox2 is 
similarly expressed in early Schwann cell development, however its expression 
declines with differentiation and transition to mature myelinating Schwann cells 
(Parkinson et al., 2008; Salzer et al., 2008).  Importantly, Sox2 expression is elevated 
in Schwann cells as they undergo dedifferentiation following nerve injury (Le et al., 
2005a).  Given  the importance of these transcription factors, notably Sox2 (as its 
expression is co-ordinated at times of early Schwann cell/axonal interaction), it is 
plausible that one of these master regulators are important for generating a Schwann 
cell adhesion profile or identity.  If this were the case, then loss of a transcription 
factor in LTD cells, responsible for cell-surface expression of CAMs, might explain 
the axonal interaction failure inherent in these cells.  In later experiments, I will 
explore the role of Sox2 as a possible candidate in this regard. 
 
3.7 Array validation by qRT-PCR 
 
In order to validate the expression ratios from the microarray analysis, the mRNA 
levels of key selected genes was analysed independently using real-time polymerase 
chain reaction (qRT-PCR).  The following down-regulated genes of interest were 
selected: N-cadherin, Sema4F, Sema3B, MPZ and Sox2, while ephrin-4A was 
selected as an example of an up-regulated gene.  Total RNA was obtained from the 
LTNS and LTD cells used in the original microarray, while GAPDH was selected as 
the normalising control because its expression levels are thought to remain constant 
between the two cell-types.  Although this approach does not represent a systematic 
validation of the microarray, it nonetheless confirmed the substantial down-
regulation of key genes of interest highlighted from the microarray, for example N-
cadherin, Sema4F and Sox2, while also confirming the up-regulation of ephrin-4A 
(Figure 3.9).  Interestingly, the magnitude of the fold-changes reported by qRT-PCR 
was invariably greater than that reported in the microarray, therefore it is likely that 
the fold-change reported in the microarray under-represents the true fold-change. 
 
3.8 Over-expression of Sox2 in Schwann cells 
 
Analysis from the microarray experiment showed that both N-cadherin and the 
transcription factor Sox2 were down-regulated in LTD cells by 9.1-fold and 3.2-fold 
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Figure 3.9 Validation of selected genes from the microarray analysis.  
Quantitative RT-PCR analysis, from original LTNS and LTD replicate microarray 
samples (#1 & #2), was performed to assay for relative levels of (i) N-cadherin; (ii) 
semaphorin-4F (Sema4F); (iii) semaphorin-3B (Sema3B); (iv) myelin protein zero 
(MPZ); (v) Sox2 and (vi) Ephrin-4A.  Expression levels were normalised to GAPDH 
levels with bars showing S.D. of duplicates.   
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respectively.  As previously discussed, Sox2, in addition to N-cadherin, is expressed 
in Schwann cells during early development and following nerve injury; both of 
which coincide to a time when Schwann cells are forming early interactions with 
axons, i.e. when they are recognising and associating with axons.  While N-cadherin 
is a putative candidate for mediating Schwann cell/axonal interactions, Sox2 might 
be involved in the transcriptional regulation of N-cadherin as well as a number of 
other CAMs, which collectively might form part of a profile of adhesion gene 
expression required for normal Schwann cell/axonal interactions.  I therefore wanted 
to determine if the loss of axonal interaction displayed by LTD cells was caused by 
the loss of Sox2 expression, therefore leading to dysregulation of downstream Sox2 
targets.  To test this, I adopted an adenoviral approach to drive Sox2 expression.  I 
obtained a GFP adenovirus (AdGFP), a Sox2-GFP adenovirus (AdSox2) and an N-
cadherin adenovirus (AdNcad) and optimised the concentration of virus by exposing 
NS cells to a serial-dilution of viral supernatant in order to obtain a batch titre.  I then 
seeded NS monocultures onto culture plates and infected the cells 24-hours later with 
AdGFP and AdSox2-GFP for 16-hours.  The medium was then changed and the 
infected cultures were incubated a further 24-hours before fixation.  The cultures 
were immunostained for N-cadherin while GFP was used to determine the infection 
rate, which for all adenoviruses, was nearly 100% in Schwann cells (Figure 3.10A).  
Interestingly, I observed a surprising result in that the localisation of N-cadherin 
within Schwann cells was dramatically different between Ad-GFP controls and 
AdSox2-GFP infected Schwann cells.  As shown by the white arrows, Sox2 
expression appeared to localise N-cadherin to Schwann cell homotypic cell-cell 
junctions.  This was striking to observe, with large strands of N-cadherin 
encroaching from the junction into or across the Schwann cell.  However, it was not 
clear if this pattern of N-cadherin immunofluorescence was as a result of increased 
N-cadherin expression, i.e. increased protein levels - which we expected, or was 
caused by the relocalisation or post-translational modification of existing N-cadherin 
in the cell.   
 
In order to investigate further, I infected NS cells with AdGFP, AdNcad and 
AdSox2-GFP and examined the expression of junctional N-cadherin (Figure 3.10B).  
This showed that the over-expression of N-cadherin (using AdNcad) only marginally 
increased N-cadherin levels at cell-cell junctions, while most of the additional N-
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Figure 3.10  Over-expression of Sox2 in Schwann cells strengthens N-cadherin 
junctions and promotes homotypic Schwann cell clustering.  Schwann cells were 
infected with either GFP or Sox2-GFP adenovirus for 16hrs, media-changed and 
fixed after a further 24hrs of incubation.  (A) Representative epifluorescent images 
from Schwann cell cultures immunostained for N-cadherin (red) with infected cells 
marked by GFP expression (green).  The white arrows show examples of extensive 
N-cadherin re-localisation. 
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(B)  Representative epifluorescence from (i) AdGFP, (ii) AdNcad and (iii) AdSox2-
GFP Schwann cell infected monocultures that were immunostained for N-cadherin 
(red) with cell nuclei labelled with Hoechst (blue).  (RHS) Enlargements from the 
regions outlined by the white boxes.  The white arrow-head shows perinuclear 
deposits of N-cadherin, while the white arrow shows long N-cadherin junctional 
strands. 
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(C)  Representative epifluorescence from low-density AdGFP and AdSox2-GFP 
monocultures that were fixed and immunostained for N-cadherin (red), with infection 
marked by GFP expression (green).  Scale-bars are 25µm.  (D) Quantification of the 
Sox2 induced clustering of Schwann cells.  Clustering was scored by counting the 
number of Schwann cells in groups of 1, 2-5, 6-10 and greater than 10.  Statistics by 
Fisher's exact test for rxq contingency tables (p<0.001). 
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cadherin protein appeared to accumulate in perinuclear regions.  Conversely, 
expression of Sox2 (using AdSox2-GFP) appeared to result in a targeted increase of 
N-cadherin localisation to cell-cell junctions, while non-junctional N-cadherin was 
comparable to AdGFP controls.  The altered pattern of N-cadherin at the cell-cell 
junctions, in which long-strands of N-cadherin are found perpendicular to the 
junctions, can be clearly observed in higher magnification images (3.10Biii, see 
white arrow).  The significance of longer N-cadherin strands at the junction is not 
clear although it may be indicative of stronger (mature) adherens junctions.  In terms 
of understanding the relationship between Sox2 and N-cadherin, this data suggested 
that Sox2 expression does not substantially increase N-cadherin levels but rather, its 
main role is to alter the localisation of N-cadherin at cell-cell junctions.   
 
3.8.1 Sox2 drives Schwann cell clustering by an N-cadherin-
dependent mechanism 
 
In order to investigate further, the role of Sox2-mediated N-cadherin at the cell-cell 
junctions, I worked collaboratively with Simona Parrinello, to determine if this 
observation had a functional role in Schwann cell biology. We were especially 
interested to discover if Sox2 had a role to play in nerve regeneration because Sox2 
has been shown to be up-regulated in dedifferentiated  Schwann cells upon nerve 
injury (Le et al., 2005a).  To study this, we adenovirally infected subconfluent 
Schwann cells with either AdGFP or AdSox2-GFP for 16-hours.  After which, the 
medium was changed and the monocultures were incubated for a further 24 hours.  
At this point, we viewed the live monocultures by phase-contrast microscopy.  
Remarkably, we observed that low-density AdSox2 infected Schwann cells were 
aggregating together in clusters, which was not observed in low-density AdGFP 
Schwann cell cultures.  We next fixed the cultures and immunostained for N-
cadherin.  Consistent with previous observations, Sox2 over-expressing Schwann 
cells, as indicated by endogenous GFP expression, were generally present in groups, 
with clustering mediated by robust N-cadherin at junctions between the cells (Figure 
3.10C).  We quantified this effect by scoring the frequency of Schwann cell clusters 
which contained either 1, 2-5, 6-10, or more than 10 Schwann cells.  Our results 
showed that Sox2 resulted in a shift from single cells to large clusters of cells, which 
we showed was the result of a switch in contact-behaviour from repulsion to cell 
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aggregation (Figure 3.10D).  Simona later showed that Sox2 expression, responsible 
for this altered response, was induced by heterotypic interactions between fibroblasts 
and Schwann cells mediated by contact-dependent signalling through Ephrin-B 
(expressed by the fibroblast) and EphB2 (expressed by the Schwann cell) (Parrinello 
et al., 2010).  Furthermore, ephrin-mediated Sox2 expression in Schwann cells was 
required for the coordinated migration of Schwann cells from the proximal stump in 
transected sciatic nerve in vivo (Parrinello et al., 2010).   
 
3.8.2 Re-expression of Sox2 in LTD cells 
 
Dysfunction of a master-regulator, for instance Sox2, in LTD cells might have 
resulted in an aberrant expression profile of adhesion genes required for interactions 
with axons.  To determine if establishing Sox2 expression in LTD cells could restore 
the ability of these cells to interact with axons, I initially examined the levels of 
selected CAMs, down-regulated in LTD cells, following Sox2 expression in LTD 
cells.  LTNS and LTD cells were infected for 16-hours with either AdGFP or 
AdSox2 and, after changing the cell media, the cultures were incubated for a further 
24-hours.  The plates were then either fixed or RNA was collected for RT-PCR.  In 
addition to Sox2, I chose to analyse the transcript levels N-cadherin and Sema3B 
because both CAMs were down-regulated in the LT microarray, by 9.1-fold and 8.5-
fold respectively, and therefore I wanted to determine if re-expression of Sox2 could 
induce their expression.  The RT-PCR analysis showed that Sox2 expression did not 
significantly affect the transcript levels of either N-cadherin or Sema3B (Figure 
3.11A).  I next examined low-density cultures of LTNS and LTD, infected with 
AdGFP and AdSox2, by phase-contrast microscopy in order to study the 
monocultures for evidence of clustering.  While Sox2 expressing LTNS cells showed 
evidence of clustering, the Sox2 expressing LTD cells appeared not to cluster 
(Figure 3.11B).  The cultures were then fixed and immunostained for N-cadherin, 
which showed that LTNS cells were clustering, consistent with previous Sox2 
expression studies in NS cells.  Interestingly, LTD cells infected with AdSox2-GFP 
did not restore N-cadherin levels and furthermore, these cells appeared not to cluster  
(Figure 3.11C).  These observations corroborate the RT-PCR data (Figure 3.11A) 
and immunofluorescence (Figure 3.11B), as well as our previous work (Parrinello et 
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Figure 3.11 Sox2 over-expression does not affect N-cadherin levels in LTNS 
and LTD.  LTNS and LTD cells were infected for 16hrs with either AdGFP or 
AdSox2 adenovirus, media-changed and incubated a further 24hrs.  (A) Quantitative 
RT-PCR to determine levels of Sox2 and N-cadherin, with levels normalised to 
GAPDH levels.  Statistics by Turkey-Kramer multiple comparison test (p>0.05: n.s., 
not-significant). Bars show S.D. of duplicates.   
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(B)  Phase-contrast images of low-density LTNS and LTD monocultures infected 
with GFP and Sox2-GFP adenovirus.  (C) Representative epifluorescent images 
showing N-cadherin immunostaining (red) and GFP expression (green) with cell 
nuclei labelled with Hoechst (blue).  
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al., 2008), which together suggest that Sox2 does not induce N-cadherin expression 
but rather alters the localisation of existing N-cadherin at cell-cell junctions.  Thus, 
LTD cells and fibroblasts, which do not express N-cadherin, do not exhibit N-
cadherin re-localisation following Sox2 expression and, consequently, do not exhibit 
cell clustering.  
 
3.9 Chapter summary and conclusions 
 
In this chapter, I have shown how normal encounters between Schwann cells and 
axons results, via a step-wise process of interactions, in Schwann cells that are stably 
associated and aligned with axons.  A key first step in this process is Schwann cell 
recognition for axons.  We found that while LT expression in Schwann cells does not 
affect Schwann cell/axonal interactions, a derivative LT population (LTD) had, 
through unknown genetic changes, entirely lost the inherent ability to recognise and 
interact with axons.  I used LTD in order to screen for possible mediators of these 
interactions and showed, by microarray analysis, that LTD cells had significantly 
altered global gene expression changes, notably in genes encoding cell adhesion 
molecules, for example N-cadherin, Sema4F, NCAM, L1-CAM and Necl-4 as well 
as in genes encoding important Schwann cell transcription factors, for example Sox2 
and Sox10.  I went on to confirm, by functional enrichment analysis, that cell 
adhesion was the most enriched functional gene ontology.   
  
Globally dysregulated gene expression suggested that a transcription factor 
controlling Schwann cell identity might explain the loss of axonal interaction elicited 
by LTD cells.   I therefore investigated Sox2, as this transcription factor is up-
regulated in Schwann cells following nerve damage and prior to Schwann cell/axonal 
re-association.  Surprisingly, I found that Sox2 had a distinct role in that it promotes 
Schwann cell clustering, by directing N-cadherin localisation to cell-cell junctions, 
but did not restore N-cadherin or Sema3B levels when expressed in LTD cells.  
Interestingly, Sox2 altered the morphology of the junction – generating long strands 
of N-cadherin that project into the cell from the cell-cell junction.  This was quite 
distinct from Schwann cells in which N-cadherin was over-expressed, suggesting that 
Sox2 played a more refined role in altering the cellular localisation of N-cadherin.  
The functional purpose of this remains to be clarified, although it is tempting to 
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speculate that the long strands of N-cadherin observed in Sox2 expressing Schwann 
cells might be involved in strengthening and stabilising homotypic junctions, in-line 
with an in vivo function for Schwann cell clustering in nerve repair. 
 
While the identity of the genetic lesion responsible for the LTD non-interaction 
phenotype still remains to be determined, a number of novel and previously 
identified CAMs were detected in the array.    In terms of the latter, a number of 
down-regulated CAMs including melanoma CAM (mCAM), NCAM, N-cadherin 
and Necl4 were also identified from a screen conducted by Spiegel et al.,  (2006) of 
Schwann cell expressed CAMs.  Thus, the fact that the current microarray 
methodology has independently identified CAMs, which have been previously 
discovered in an independent screen of Schwann cell CAMs, further validates our 
approach.  In terms of the former, a number of novel CAMs not previously 
implicated in Schwann cell/axonal interactions were identified, including cadherin-6, 
protocadherin-7, protocadherin alpha 4 and CD9, which are discussed more fully in 
the discussion.   
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Chapter Four:  N-cadherin mediates homotypic and heterotypic cell-
cell interactions 
 
4.1 Chapter introduction 
 
In Chapter Three, I set out a theoretical model to describe Schwann cell/axonal 
interactions, which emphasised the importance of direct, reciprocal cell-cell contact 
dependent communication throughout all stages of the interaction process.  Although 
previous research has largely focused on the study of heterotypic interactions, i.e. 
between Schwann cells and axons, the importance of homotypic Schwann cell-cell 
interactions to normal nerve physiology should not be underplayed.  Both homotypic 
and heterotypic cell interactions are important in the generation and maintenance of 
the mature functional architecture of the PNS.  While heterotypic interactions are 
clearly a defining property of Schwann cells, homotypic interactions also play 
important roles in Schwann cell biology.  For instance, they are required to generate 
SCP clusters during PNS development (Wanner et al., 2006b) and might also play a 
role in the homeostatic nerve between differentiated Schwann cells at the Node of 
Ranvier (Poliak & Peles, 2003; Salzer, 2003).  They also play central roles in the 
nerve repair process, where they facilitate the coordinated outgrowth of Schwann 
cells from the proximal stump, into and across the nerve bridge (injury site), and are 
important in the formation of cellular conduits in the degenerated distal nerve 
(known as Bands of Büngner), which create a favourable substratum for later axonal 
re-growth and regeneration (Chen et al., 2007; McDonald et al., 2006; Napoli et al., 
2012; Parrinello et al., 2010; Ribeiro-Resende et al., 2009; Webber & Zochodne, 
2010).  Both types of interactions are mediated through cell adhesion molecules 
(CAMs) which are pivotal to the ensuing interaction process (Patel et al., 2003; 
Spiegel et al., 2007), although the exact mediators involved remain poorly defined.  
In this chapter, I have addressed the role of N-cadherin, a calcium-dependent CAM, 
in the generation of homotypic Schwann cell-cell and heterotypic Schwann 
cell/axonal interactions.    
Research spanning several decades into Schwann cell/axonal interactions has led to 
the identification of a number of CAMs thought to play significant roles in the 
interaction process, for example L1-CAM (Haney et al., 1999; Seilheimer et al., 
1989; Wood et al., 1990), NCAM (Hansen et al., 2008), Necl4/cell adhesion 
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molecule-4  (Maurel et al., 2007; Perlin & Talbot, 2007; Spiegel et al., 2007) and N-
cadherin/cadherin-2 (Hansen et al., 2008; Letourneau et al., 1991; Wanner & Wood, 
2002).  The importance of some of these CAMs has since been questioned.  For 
instance, L1-CAM was thought to be an important mediator of axonal ensheathment 
(Seilheimer et al., 1989) and myelination (Wood et al., 1990).  Both authors used 
antibodies designed to block L1-CAM function; however, later work by Dahme et al. 
(1997) and Haney et al. (1999), who investigated the role of L1-CAM using mouse 
knockout models, have since found that Schwann cells devoid of L1-CAM interacted 
normally with axons.   
In this chapter, I investigated the role of N-cadherin, which I chose to study because 
N-cadherin, similar to L1-CAM, NCAM and a number of other CAMs, was down-
regulated in non-interacting LTD cells when compared to interacting LTNS controls 
(Chapter Three), and was therefore a potential candidate for mediating Schwann 
cell/axonal interactions.  In addition, evidence from the literature alluded to the 
importance of N-cadherin as a facilitator of both homotypic and heterotypic 
interactions.  A role for N-cadherin was first suggested by Letourneau et al. (1991) 
who showed that calcium ion depletion form the cell media of chicken Schwann 
cell/DRG cocultures was sufficient to perturb heterotypic interactions.  A later study 
by Wanner & Wood (2002), followed this by investigating Schwann cell-cell and 
Schwann cell/axonal interactions within an in vitro rat denervated Schwann cell 
culture system.  Here, the authors used a number of N-cadherin ‘function-blocking’ 
techniques and reagents, for example, calcium depletion, ligand blocking antibodies 
and inhibitory cyclic pentapeptides, in order to disrupt N-cadherin ligation and 
therefore function in Schwann cells.  Although the use of these techniques and 
reagents is subject to a number of caveats, for instance the risk of off-target effects, 
the work nonetheless suggested that N-cadherin was likely to be involved.  Follow 
up studies by the same group investigated the developmental expression of N-
cadherin in the Schwann cell lineage of the early developing PNS nerve (Wanner et 
al., 2006a; Wanner et al., 2006b).  In these studies, SCPs were found to express N-
cadherin; however, levels were later substantially reduced following their 
differentiation to mature Schwann cells, although a mechanism to explain this has yet 
to be defined (Wanner et al., 2006a).  This work also found that NRG-1 (NRG-1) 
was sufficient to drive the up-regulation of N-cadherin in Schwann cells in vitro.  
 180  
   
The physiological relevance of this, however, is unclear because NRG-1 is present 
throughout development, including at times when N-cadherin is normally down-
regulated.  Nevertheless, it has been shown that N-cadherin is strongly up-regulated 
in Schwann cells following sciatic nerve injury (Parrinello et al., 2010; Shibuya et 
al., 1995; Thornton et al., 2005; Zelano et al., 2006), which suggests that up-
regulated N-cadherin expression, in denervated ‘injury Schwann cells’ was likely to 
facilitate Schwann cell directed processes of nerve repair.  
To determine the role of N-cadherin in mediating homotypic Schwann cell-cell and 
heterotypic Schwann cell/axonal interactions I decided to use an siRNA approach to 
specifically deplete N-cadherin levels in primary Schwann cells.  This was done in 
preference to post-translational ‘functional blocking’ strategies described earlier as 
siRNA action is efficient and highly specific to the intended mRNA, with off-target 
effects further mitigated by using multiple independent and non-overlapping siRNAs 
for each gene targeted.  In contrast, inhibitory reagents used to block cadherin 
function are largely problematic in these respects, for example Fairless et al. (2005) 
reported that cyclic pentapeptide inhibiters were relatively inefficient at blocking N-
cadherin function in Schwann cells, while the specificity of these approaches remains 
unclear.  
 
4.2 Homotypic Schwann cell-cell junctions 
 
 
4.2.1 The expression and localisation of N-cadherin in Schwann 
cells 
 
 
In order to examine the role of N-cadherin in mediating Schwann cell-cell homotypic 
interactions, I first determined the sub-cellular expression and localisation of N-
cadherin in Schwann cell monocultures.  NS cells were plated at either low or high 
density and fixed three days later.  Immunofluorescence was then performed using an 
N-cadherin antibody that recognised the cytoplasmic C-terminal region of the N-
cadherin protein.  In addition, monocultures were coimmunostained with the 
Schwann cell specific, cytoplasmic marker S100β in order to clearly demark the 
extent of the cell.  As expected, low-density Schwann cell monocultures had fewer 
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Figure 4.1 Schwann cells express N-cadherin which is localised to homotypic 
Schwann cell-cell junctions.  (Ai-ii) NS cells were seeded at low (2x104 cells) and 
high (3.5x104 cells) density, and fixed after 72hrs.  Representative epifluorescent 
images of NS monocultures were coimmunostained for N-cadherin (red) and S100β 
(green), with cell nuclei labelled by Hoechst (blue).  The white arrows illustrate 
examples of N-cadherin localisation at cell-cell junctions, while the white arrow-
heads illustrate examples of N-cadherin localisation at ‘lamellipodia-like’ 
cytoplasmic processes not in contact with other cells.  The white boxes show  4x 
enlargements of selected regions from the main image. 
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(B-C) Representative high-magnification epifluorescent images of Schwann cell 
monocultures showing Schwann cell-cell homotypic junctions.  (B) Monocultures 
were coimmunostained for N-cadherin (red) and S100β (green), with white arrow-
heads indicating homotypic cell-cell junctions.  (C) Monocultures were 
immunostained with N-cadherin (red) and counterstained with phalloidin fluorescein 
(green) to show the actin cytoskeleton.  The white arrows indicate colocalisation of 
N-cadherin with F-actin filaments.  The cell nuclei are labelled with Hoechst (blue).  
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homotypic junctions than higher-density counterparts, with homotypic junctions 
clearly associated with the presence of robust accumulations of N-cadherin at the 
cell-cell interface, as shown by the white arrows in Figure 4.1. Diffuse low-level N-
cadherin staining was also observed throughout the cytoplasm of the cell, but was 
notably absent from the nucleus.  Importantly, N-cadherin was also observed at the 
surface of cytoplasmic, lamellipodia-like protrusions (indicated by the white arrow-
heads).  As discussed in Chapter Three, these structures are a morphological 
characteristic of non-associated Schwann cells.  In high-density Schwann cell 
monocultures (Figure 4.1Aii), and also more clearly defined in higher magnification 
images (Figure 4.1B; see white arrow-heads), Schwann cells were observed to form 
multiple N-cadherin-rich cell-cell junctions with multiple Schwann cells appearing to 
bind together to form a monolayer.  In many cases, N-cadherin immunostaining was 
extensive, with large ‘zipper-like’ accumulations of N-cadherin observed between 
contacting cells.  There were also examples of large N-cadherin assemblages at cell-
cell junctions that permeated deeper into the cytoplasm of neighbouring Schwann 
cells (Figure 4.1B).  These observations are consistent with the formation of mature 
N-cadherin junctions that strengthen overtime via the stepwise cis-recruitment of N-
cadherin dimers.  This was especially evident in high-density cultures where cell-cell 
encounters are more frequent and are presumably more stable.   
 
In order to further characterise Schwann cell homotypic cell-cell junctions, I 
visualised the actin cell cytoskeleton in conjunction with N-cadherin 
immunofluorescence.  This was important because cell-cell junctions require firm 
anchorage to the cell cytoskeleton to withstand the forces required, for example, to 
maintain Schwann cell clusters or facilitate association to axons. It is well established 
in epithelial cells that the classical cadherins interact with the actin cytoskeleton, and 
that this linkage is critical to generating the strength of the cadherin mediated cell-
cell junction  (Shewan et al., 2005). Thus, alignment between peripheral actin 
filaments and N-cadherin junctions would indicate that N-cadherin was more likely 
to be a functional CAM for Schwann cell-cell homotypic interactions.  Consistent 
with this view, Schwann cell monocultures counterstained with phalloidin 
fluorescein revealed that spurs from the peripheral (cortical) actin network taper 
towards, and appose with, N-cadherin junctions (Figure 4.1C; the white arrows 
indicate examples of colocalisation and coalignment).  This observation supported 
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the view that the actin cytoskeleton, important for cell movement and structure, is 
linked and responsive to the adherens junction that maintains the homotypic 
interactions with neighbouring cells. 
 
4.2.2 siRNA as a tool for N-cadherin knockdown in Schwann cells 
 
To specifically deplete N-cadherin mRNA transcripts from Schwann cells I used 
small interfering (si)RNAs.  I used three different siRNAs from Qiagen’s HiPerfect 
(HP) genome-wide range (siNcad-1, siNcad-3 & siNcad-4), which were designed to 
recognise non-overlapping short sequences within the three-prime region of the rat 
N-cadherin mRNA transcript, while scrambled siRNA was included as a control for 
all siRNA experiments.  As we had not previously used siRNA in Schwann cells – I 
first titrated the siRNA and lipid concentration and varied other parameters in order 
to determine the optimum conditions for transfection and knockdown.  Schwann cell 
monocultures were transfected 24-hours after plating with siRNA for 16-hours using 
a range of siRNA concentrations from 1nM to 10nM.  Following transfection, the 
culture plates were washed with fresh-media, in order to remove excess siRNA 
complexes, and further incubated for 32-hours before fixation, i.e. 48-hours post-
transfection.  The titration was then assessed by epifluorescence to determine the 
least amount of siRNA required to achieve the greatest silencing efficacy.  This was 
important, as increasing siRNA concentration is correlated with deteriorating cell 
health and an increased incidence of cell death (Qiagen manual).  Surprisingly, I 
found that a relatively low concentration of siRNA – 1nM N-cadherin siRNA – was 
sufficient to efficiently reduce N-cadherin levels in Schwann cells (Figure 4.2A).  
The immunofluorescence showed that while the majority of Schwann cells were 
depleted of N-cadherin, a small number still retained normal (control) levels of N-
cadherin protein (see white arrows); reflecting instances where transfection had not 
been successful.   
 
The proportion of non-transfected cells, as quantified from N-cadherin 
immunofluorescence, was determined for each siRNA (scrambled, siNcad-1, siNcad-
3, siNcad-4), with both siNcad-3 and siNcad-4 achieving the greatest proportion of 
Schwann cells knocked down for N-cadherin at over 90% (Figure 4.2B).  I next 
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Figure 4.2 siRNA mediated N-cadherin silencing is effective, specific and 
transient.  NS cells were transfected 24hrs after seeding for 16hrs with 1nM or 3nM 
siRNA of either scrambled or three N-cadherin siRNAs (siNcad-1, siNcad-3 & 
siNcad-4).  Cells were media-changed and further incubated for 32hrs, after which 
cells were fixed and RNA collected.  (A) siRNA transfected  monocultures were 
immunostained for N-cadherin (red), and cell nuclei were labelled with Hoechst 
(blue).  The white-arrows show examples of N-cadherin-positive, non-transfected 
cells.  (B) The proportion of Schwann cells expressing N-cadherin following siRNA 
treatment.  Counts in triplicate with 200+ cells scored per coverslip; bars represent 
S.D.  (C) Western blot: relative levels of N and E cadherin following N-cadherin 
knockdown.  (D) Quantification of Western analysis in part C by densitometry. 
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(E)  NS cells were transfected with 1nM of either scrambled, siNcad-1 or siNcad-3 
siRNA 24hrs after seeding for 16hrs.  Initial cell concentrations were adjusted to 
achieve confluent plates at respective time-points (48hrs, 72hrs, 96hrs and 120hrs 
following addition of transfectant), and cell lysates were obtained from plates for 
Western analysis to determine relative levels of N-cadherin across conditions with β-
tubulin used to control lane loading.  (F) Densitometric analysis of Western blot 
(part E) to quantify relative levels of N-Cadherin with time post-transfection.  The 
data was normalised against β-tubulin. 
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analysed N-cadherin protein levels by Western blot to quantify the level of 
knockdown.  Schwann cells were transfected with either 1nM or 3nM of scrambled, 
siNcad-1 or siNcad-3 and RNA was collected 48-hours after the start of transfection.  
Western blots were immunoprobed for N-cadherin and E-cadherin (Figure 4.2C) and 
normalised relative levels were quantified by densitometry analysis (Figure 4.2D).  
This work confirmed that 1nM of Ncad-1 siRNA was sufficient to achieve a good 
knockdown of N-cadherin (approximately 8-fold), while 1nM of Ncad-3 siRNA was 
sufficient to substantially deplete N-cadherin from Schwann cells (approximately 
200-fold), which was particularly impressive. Increasing the siRNA concentration to 
3nM did not reduce N-cadherin levels further for either siRNA.  This is consistent 
with previous findings, i.e. from the siRNA titration, which showed that 1nM of 
siRNA was optimal for N-cadherin knockdown.  The specificity of N-cadherin 
siRNA was confirmed by the finding that E-cadherin levels remained relatively 
constant.  I next wanted to determine the period of N-cadherin knockdown following 
a single transfection as this would be an important limiting parameter for subsequent 
siRNA experiments.  To do this, I assayed, by Western analysis, the relative change 
in N-cadherin protein levels over time after the start of transfection (Figure 4.2E; 
and quantified this result by densitometry in Figure 4.2F).  This data showed that the 
knockdown of N-cadherin lasted at least 72-hours, after which N-cadherin levels 
increased and were returned to basal levels by 96-hours – consistent with the time-
wise dependent degradation of siRNA.  Thus, on this basis I decided to take a 
conservative approach to future siRNA experiments, stipulating that the experiment 
be concluded 72-hours after the addition of transfectant, in order to guarantee N-
cadherin knockdown at the experimental endpoint. 
 
4.2.3 N-cadherin is the principal mediator of homotypic interactions 
 
Having optimised siRNA as an effective tool to deplete N-cadherin specifically from 
primary Schwann cells, I next assessed whether N-cadherin was required for 
homotypic Schwann cell-cell interactions.  NS cells were plated and transfected 24-
hours later with N-cadherin siRNA for 16-hours.  Culture plates were then washed 
with fresh medium and further incubated for 48-hours until the monocultures were 
confluent.  In contrast to non-transfected or scrambled controls, which showed 
characteristic ‘swirling’ patterns of Schwann cells typical of a confluent monolayer, 
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the N-cadherin-deficient monocultures were highly disorganised. These 
monocultures did not form Schwann cell ‘swirls’; instead, Schwann protrusions were 
often observed to encroach over the cytoplasm of adjacent Schwann cells (Figure 
4.3A; also see enlargement box).  These observations highlighted a general 
breakdown in the integrity of the Schwann cell monolayer.  To examine this further, 
I next fixed and immunostained the monocultures for N-cadherin and counter-stained 
with phalloidin in order to visualise the actin cytoskeleton.  While control cultures 
formed a tight monolayer, which was maintained by multiple homotypic interactions, 
monocultures depleted of N-cadherin formed very few homotypic junctions and 
consequently the monolayer was highly disrupted (Figure 4.3B).  The cell 
morphology and actin cytoskeleton are also substantially altered in these cultures.  In 
the scrambled (control) Schwann cells cultures, the cytoplasm of cells appeared to be 
stretched between neighbouring Schwann cells, while the phalloidin stain revealed 
large parallel and polarised arrangements of F-actin, which typically spanned the 
length of the cell and were often observed to link homotypic junctions from polar 
ends of the cell (see white arrow).  In contrast, N-cadherin-depleted Schwann cells 
had fewer cell-cell junctions and presented a rounded, less-polarised morphology.  
Moreover, the phalloidin stain revealed that the actin cytoskeleton predominantly 
formed concentric rings about the cortex of the cell rather than parallel stress fibres 
observed in controls (see white arrow-head).  It is highly likely that the different 
cellular phenotypes outlined above arise from the failure of N-cadherin mediated 
Schwann cell-cell interactions.  This is primarily because of the loss in the combined 
tensile force that would otherwise have been exerted by adjacent and contacting 
cells.  In addition, Gavard et al. (2004) showed, using another cell-culture system, 
that interactions between adherens junctions and the actin cytoskeleton was a key 
determinant to overall cell morphology.    
  
In order to quantify the loss of Schwann cell-cell homotypic interactions, I developed 
an algorithm, using Image-J software, to determine the extent to which N-cadherin-
loss affected the integrity of the Schwann cell monolayer.  I designed a systematic, 
non-biased assay to detect differences in the extracellular area within Schwann cell 
monocultures in which the cells had been transfected with either scrambled or N-
cadherin siRNA.  We hypothesised that, for a fixed number of cells per unit area, the 
extracellular area comprising the gaps between cells would be inversely correlated to 
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Figure 4.3 N-cadherin knockdown disrupts homotypic interactions in NS 
monocultures.  Schwann cells were transfected with 1nM of either scrambled or 
siNcad-3 siRNA.  The media was then changed and monocultures were further 
incubated for 32hrs. (A) Phase-contrast live images of cells 48hrs after transfection.  
The box inserts show representative enlargements from the main image. 
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(B) Representative epifluorescent images of Scrambled and N-cadherin-deficient 
Schwann cells.  Schwann cells were fixed 48hrs after transfection and 
immunostained for N-cadherin (red) and counter-stained with phalloidin fluorescein 
(green) to reveal the actin-cytoskeleton, while cell nuclei were labelled with Hoechst 
(blue).  The white arrow shows an example of stretched actin filaments observed in 
scrambled siRNA cultures, while the white arrow-heads show examples of cortical 
actin arrangements as often observed in N-cadherin depleted Schwann cells. 
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the density of homotypic junctions present.  Thus, an increase in extracellular area 
would imply a decline in homotypic interaction and junctions, reflecting a loss of 
integrity in the Schwann cell monolayer.  NS monocultures were transfected with 
either scrambled or N-cadherin siRNA for 16-hours and fixed 48-hours post-
transfection.  Monocultures were immunostained first for N-cadherin which 
confirmed that N-cadherin siRNA transfected cultures were depleted of N-cadherin 
relative to controls (Figure 4.4Ai), and second, for cell-surface expressed p75NTR, 
which was used in preference to S100β immunofluorescence, in order to highlight 
Schwann cells because this antibody provided improved contrast between intra- and 
extra- cellular regions, an essential requirement for the automation of this analysis 
(Figure 4.4Aii-iv).  Greyscale-images were captured from randomly selected fields-
of-view taken from p75NTR immunostained Schwann cell monocultures.  Images 
were processed using Image-J to identify the extracellular regions, shown in red 
(Figure 4.4Aiii-iv), which were then converted to an area map, depicting the 
boundary of the extracellular area, and overlaid against the original p75NTR 
immunofluorescence (Figure 4.4Aiv).  This enabled us to calculate the extracellular 
area in the monolayer which showed that loss of N-cadherin from Schwann cells 
resulted in a 2.5-fold increase in the extracellular area reflecting the loss of 
homotypic interactions (Figure 4.4B).  Together, this data indicates that N-cadherin 
is the principle mediator that forms and maintains homotypic adhesive interactions 
between Schwann cells. 
 
4.2.4 N-cadherin inhibit Schwann cell proliferation  
 
While investigating the effect of N-cadherin depletion on homotypic interactions, we 
noticed that there appeared to be an increase in cell number in monocultures where 
N-cadherin was depleted.  I decided to investigate this further by measuring the rate 
of proliferation in scrambled and N-cadherin knockdown monocultures.  To do this I 
initially used a 5-bromo-2-deoxyuridine (BrdU) incorporation assay.  NS 
monocultures were seeded at low and high density and transfected for 16-hours with 
either N-cadherin (siNcad-3 and siNcad-4) or scrambled siRNA, or they were left 
untransfected.  Monocultures were further incubated for 24-hours prior to the 
addition of BrdU for 7-hours, and then fixed and immunostained for BrdU to label 
nuclei in S-phase.  The proportion of cells in S-phase was used as a read-out for the 
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Figure 4.4 N-cadherin silencing disrupts homotypic Schwann cell-cell 
interactions. Scrambled or Ncad-3 siRNA transfected Schwann cells were 
immunostained for (i) N-cadherin and (ii) nuclei labelled with Hoechst. (iii) Cultures 
were immunostained for P75NTR, images were cropped and extracellular area was 
demarked in red using Image-J. (iv) Extracellular area was calculated using a pre-
optimised threshold particle area, to prevent erroneous counting of intracellular 
regions. 
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(B) Quantification of the extracellular area, as calculated in part A, was determined 
from multiple sets of immunofluorescent images captured in a randomised fashion 
from scrambled and N-cadherin siRNA Schwann cell monocultures with bars 
showing S.D. from triplicates.  The data was normalised by dividing the area fraction 
by the total number of cells.  Shown is one of three independent experiments 
showing similar results. Statistics: two-tailed T-test (T=9.004, ***p > 0.0001). 
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Figure 4.5 N-Cadherin reduces Schwann cell proliferation in a density 
dependent manner.  (A) Low and high density Schwann cells were transfected with 
scrambled or N-cadherin siRNA for 16hrs and further incubated for 24hrs prior to 
addition of BrdU for an 8hr pulse.  Representative epifluorescence from cultures 
immunostained for BrdU (red) with cell nuclei labelled with Hoechst (blue).  (B) 
Proportion of BrdU positive cell nuclei.  Counts conducted in triplicate with 200+ 
cells scored per coverslip; bars represent S.D. with statistics by T-test (***p<0.001)  
(C) Transfected Schwann cells were plated and trypsinised at 20, 45 and 70hrs post-
seeding in order to obtain cell counts; bars represent S.D. of triplicates.  Datasets 
from parts B & C are representative of three independent experiments. 
 195  
   
rate of cell proliferation.  The data confirmed that N-cadherin deficient Schwann 
cells exhibited elevated proliferation in higher density cultures, showing a two-fold 
increased rate of BrdU incorporation over relevant controls (Figure 4.5A-B).  This 
was consistently observed for both independent N-cadherin siRNAs (siNcad-3 and 
siNcad-4) confirming the specificity of the response.  In contrast, N-cadherin 
knockdown did not significantly alter the rate of proliferation in low-density cultures 
in which homophilic N-cadherin trans-ligation occurred less frequently.  Thus, the 
increased proliferation observed in N-cadherin depleted cells appeared to be density-
dependent, implicating N-cadherin signalling in the inhibition of cell proliferation as 
Schwann cells reached confluency.  To confirm these findings, I perfected a temporal 
proliferation assay by counting the total number of cells with time in culture.  To do 
this, NS cells were transfected with either scrambled, siNcad-3 or siNcad-4 for 16-
hours, the cell media was changed and the cells were trypsinised 4-hours later.  
Transfected cells were then seeded in triplicate onto culture plates (time 0) and 
incubated for 20, 45 and 70-hours after seeding.  At each time-point, the plates were 
trypsinised and the cell-suspension counted using a Coulter Counter to obtain cell 
counts (Figure 4.5C).  Consistent with previous results, the rate of cell proliferation 
at early time-points was not significantly different.  However, as the cell density 
increased, N-cadherin depleted Schwann cells continued to proliferate rapidly, while 
control cells proliferated at a markedly slower rate.  Together with the BrdU analysis, 
these findings suggest that N-cadherin trans-ligation between Schwann cells that 
mediate homotypic Schwann cell-cell junctions is inhibitive to proliferation and at 
least partially responsible for CIP observed in confluent Schwann cell monolayers. 
 
4.3 Heterotypic Schwann cell/axonal interactions 
 
I next wanted to determine the role of N-cadherin as a mediator of heterotypic 
Schwann cell/axonal interactions.  I initially focussed on the early events of Schwann 
cell/axonal interactions as modelled in Figure 3.1B.  In order to do this, I adapted the 
defined DRG/Schwann cell coculture system described in Chapter Three.  DRG 
capsules were explanted and exposed to AraC for 48-hours and then further 
incubated for five days in order to generate axonal cultures free from endogenous 
Schwann cells.  In parallel, Schwann cells were transfected with either scrambled or 
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N-cadherin siRNA for 16-hours and further incubated for 24-hours.  Cells were then 
trypsinised, counted with a Coulter counter and seeded at low-density onto DRG 
axonal explants.  Schwann cell/DRG cocultures were then incubated for 8-hours, 
fixed and coimmunostained for Schwann cell specific S100β and axonal specific 
RT97 in order to assess the state of heterotypic interaction. As expected, when 
scrambled (control) Schwann cells were incubated with DRGs, the majority of the 
cells were found to be strongly associated and aligned with axons (Figure 4.6A; see 
white arrows).  Interestingly, when N-cadherin-deficient Schwann cells were 
incubated with DRGs, there were many examples of deficiencies in both axonal 
association and alignment (see white arrow-heads).  In contrast to controls, the N-
cadherin-deficient Schwann cells that failed to associate properly with axons, were 
often observed either to fail entirely to contact an axon despite close proximity, or to 
extend their cytoplasmic protrusions over and/or under axons without making 
contact.  In other cases an indeterminate interaction was evident, in which the 
Schwann cell made contact but the cell cytoplasm was not aligned with the axon.  
Quantification of the interactions using the association scoring system (association 
assay) described previously (Figure 3.2D), i.e. associated and aligned, associated, 
not aligned or not associated, confirmed that heterotypic Schwann cell/axonal 
interactions were impaired in N-cadherin-deficient Schwann cells, to the extent that 
40% of cells either failed to associate with, or failed to align themselves with, axons 
as compared to around 10% deficiencies in relevant controls (NS, Scrambled or 
LTNS) (Figure 4.6B).   However, while depletion of N-cadherin from NS cells was 
sufficient to disrupt heterotypic interactions with axons, it did not account fully for 
the impairment observed in LTD/DRG cocultures, in which the vast majority of LTD 
cells (in excess of 95%) failed to associate or align with axons.  This implied that 
while N-cadherin is an important mediator of heterotypic interactions, it was not the 
only molecule involved, and thus, was likely to be acting in concert with other 
molecules to mediate these interactions. 
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Figure 4.6 N-Cadherin knockdown disrupts heterotypic Schwann cell/axonal 
association & alignment.  NS cells were transfected for 16hrs with either scrambled 
or N-cadherin siRNA, while DRG explants were incubated over 5 to 6 days to 
generate axonal networks.  Transfected Schwann cells were media-changed and 
further incubated for 24hrs, after which Schwann cells were seeded onto DRG axons 
and cocultures fixed after 8hrs. (A) Representative epifluorescent images from 
cultures coimmunostained for S100β (green) to show Schwann cells and RT97 (red) 
to show axons, with cell nuclei labelled with Hoechst (blue).  The white arrows show 
examples of Schwann cell association and alignment, while the white arrow-heads 
show examples of non-associated Schwann cells.   
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(B) Quantification of Schwann cell/axonal interactions.  Immunofluorescence from 
NS, scrambled (Scram), N-cadherin siRNA (siNcad-3 and siNcad-4), LTNS and 
LTD cell/DRG-axonal cocultures were scored.  The graph shows the proportion of 
non-associated cells (black bars) or associated but not aligned cells (grey bars) (refer 
to Figure 3.2D for scoring criteria).  Scoring was conducted blind from triplicate 
cocultures (200+ cells/DRG) with bars showing S.D.  Shown is a representative 
dataset from three independent experiments that gave similar results.  Statistical 
significance analysed by one-way ANOVA Tukey-Kramer Multiple Comparisons 
Test (*** p < 0.001, n.s. not significant). 
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4.3.1 N-cadherin localisation in Schwann cells, axons & heterotypic 
junctions 
 
To address how N-cadherin might be mediating heterotypic interactions, I next 
examined the localisation of N-cadherin within Schwann cells and axons.  To do this, 
Schwann cells were seeded onto established DRG-axonal cultures and cocultures 
were fixed after three, six or eight hours of incubation, after which they were 
coimmunostained for N-cadherin and neurofilament.  The immunofluorescence 
showed that N-cadherin was expressed by both Schwann cells and, to a lesser extent, 
axons (Figure 4.7).  Importantly, by eight hours, which was the incubation time 
selected as the end-point for the association assays, Schwann cells and axons were 
observed in close associated interactions (Figure 4.7Aiii).  Interestingly, I found that 
N-cadherin was strongly localised at the extremities of Schwann cell lamellipodia-
like protrusions, either robustly at sites of Schwann cell/axonal heterotypic 
interaction, as indicated by the while arrows, or in regions that had yet to make 
contact with an axon, as indicated by white arrow-heads.  In the case of the latter, 
this is consistent with earlier findings in Schwann cell monocultures (Figure 4.1A), 
in which I observed N-cadherin concentrated at the extremity of Schwann cell 
protrusions.  With this in mind, it is likely that N-cadherin, present in the protrusions 
of Schwann cells, might be functioning as an axonal sensor.  Positive recognition of 
axons by Schwann cell ‘lamellipodia-like’ processes, through homophilic trans-
ligation of N-cadherin, could then culminate in the later generation of N-cadherin-
rich heterotypic junctions between Schwann cells and axons.  These adherens 
junctions continue to mature so that by eight hours, strong N-cadherin staining can 
be observed - resulting in the stabilisation of the Schwann cell/axonal association 
(Figure 4.7Aiii). 
 
4.3.2 Schwann cells use cytoplasmic protrusions to locate, recognise 
and initiate association 
 
Immunofluorescence derived from fixed cocultures, revealed that N-cadherin was 
enriched in the tips of the Schwann cell cytoplasmic protrusions, which we 
hypothesised could be acting as an axonal sensor.  I therefore wanted to examine the 
importance of N-cadherin enrichment in these structures, which often make first 
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Figure 4.7 Temporal analysis of N-Cadherin localisation in Schwann cells 
interacting with axons.  Schwann cells were seeded onto day-7 explanted DRG 
axons and cocultures fixed after 3hrs, 6hrs and 8hrs incubation.  (A) Epifluorescence 
of cocultures coimmunostained for N-cadherin (white) and the axonal marker 
neurofilament (red), with cell nuclei labelled with Hoechst (blue).  White arrows 
show examples of N-cadherin localisation at sites of Schwann cell/axonal interaction 
and white arrow-heads show examples of N-cadherin localisation at Schwann cell 
lamellipodia-like protrusions prior to axonal contact. 
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contact with axons as observed in earlier time-lapse analysis (Figure 3.1).  To 
understand the role of N-cadherin in Schwann cell axonal-'grabbing’-behaviour, I 
performed time-lapse microscopy and analysed the behaviour of Schwann cells upon 
encountering axons.  DRG’s were explanted and axonal cultures were incubated for 7 
days.  Schwann cells were transfected with scrambled or N-cadherin siRNA for 16-
hours and seeded onto axons 24-hours later so that multi-point time-lapse analysis 
could be performed over 20-hours.  Three videos were captured for each condition, 
with fields-of-view selected so that recently seeded Schwann cells were in close 
proximity to axonal arbours.  The behaviour of scrambled Schwann cell/axonal 
encounters was indistinguishable from previously analysed NS/axonal interactions 
(see Figure 3.1 & Video 3.1), both of which exhibited classic ‘grabbing-like’ 
behaviour, making extensive use of cytoplasmic protrusions to search for and ‘pull’ 
on axons.  This behaviour often resulted in substantial remodelling of the axonal 
network as axons were ‘pulled’ by, and between, different Schwann cells.  In 
contrast, N-cadherin-deficient Schwann cells appeared to have lost the inherent 
ability to recognise and ‘grab’ axons (Figure 4.8A).  Consequently, the axonal 
network remained largely static as Schwann cell protrusions failed to pull or move 
axonal arbours.  Loss of N-cadherin, therefore, resulted in the failure of Schwann 
cells to elicit recognition and to trigger the process of association that would 
normally cause the Schwann cell to ‘swing-up’ onto the axon.  I next quantified the 
observed behaviour using a simple paradigm.  Each initial encounter between a 
cytoplasmic protrusion (from a Schwann cell) and an axon was coded as either a) 
grabbing or b) not grabbing. These criteria only take into account first contact events 
and do not measure the overall state of association and alignment as determined in 
fixed cultures.  This quantification provided striking evidence that loss of N-
cadherin, especially from Schwann cell cytoplasmic protrusions, significantly 
abrogated the Schwann cell’s ability to ‘grab’ axons, to the extent that there were less 
than half as many ‘grabbing’ behaviours scored in videos of N-cadherin depleted 
cells as compared to scrambled siRNA controls (Figure 4.8B).  These findings 
support the previous localisation studies and allowed us to propose a model of how 
N-cadherin functions to enable Schwann cell/axonal interactions.  Intriguingly 
however, many Schwann cells were still able to associate in some way with axons 
even if their cytoplasmic protrusions appeared to pass over or under the axon.  This 
appeared to be because the Schwann cell ‘body’ still makes an adhesive contact with 
 202  
   
Figure 4.8 N-cadherin deficient Schwann cells showed an impaired ability to 
recognise and ‘grab’ axons.  NS cells were transfected with either scrambled or N-
cadherin siRNA, seeded onto DRG axons and incubated for 20hrs in order that time-
lapse analysis could be performed (Video 4.1).  (A) An image sequence from Video 
4.1. where white arrows illustrate the course of a typical N-cadherin deficient 
Schwann cell as it encounters axons.  Note that the distal tips of the lamellipodia-like 
protrusions pass under or over axons but will invariably fail to ‘grab’, ‘pull’ or 
manipulate axons. 
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(B) Quantification of Schwann cell/axonal ‘grabbing’ behaviour.  The bar chart 
shows the percentage of Schwann cell/axonal encounters which resulted in the 
Schwann cells ‘grabbing’ the axon, specifically by using their ‘lamellipodia-like’ 
cytoplasmic projections.  At least three videos were quantified per experiment with 
typically 15-20 Schwann cells scored per video.  The dataset represents one of three 
independent experiments showing similar results with bars showing the S.D. of 
triplicates.  Statistical significance analysed by two-tailed T-test (T=7.609, 
***P<0.0016). 
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the axon and suggests that another adhesion molecule may be involved after N-
cadherin perhaps acting to stabilise the bulk of the cell onto the axon following 
association (a role for Sema4F in this regard is explored in Chapter Five). 
 
4.4 N-cadherin expression enables fibroblast/axonal interactions 
 
To determine if N-cadherin expression was sufficient to mediate axonal contact and 
recognition, I decided to express N-cadherin in a cell-type which does not normally 
interact with axons.  I decided to use fibroblasts because they are found within all 
three concentric layers of the nerve, i.e. epineurium, perineurium, and endoneurium 
(Dreesmann et al., 2009), yet these fibroblasts do not normally express N-cadherin 
and do not interact with axons. I used primary fibroblasts because preliminary 
immunofluorescence studies had indicated that immortalised fibroblasts, although 
more amenable to culture, occasionally expressed N-cadherin unlike primary 
fibroblasts.  In order to express N-cadherin in primary fibroblasts, I used an 
adenoviral expression system, as primary fibroblasts transfected poorly.  Primary 
fibroblasts were incubated in low-oxygen (3%) conditions in order to avoid cellular 
stress (Parrinello et al., 2003) and were infected with either adenovirus expressing 
GFP (control) or adenovirus expressing N-cadherin for 16-hours, after which the cell 
medium was changed and the cultures were further incubated for 24-hours, prior to 
seeding onto established DRG axonal cultures.  After 8-hours incubation, the GFP-
fibroblast/DRG and N-cadherin-fibroblast/DRG cocultures were fixed and 
coimmunostained for N-cadherin and neurofilament (axonal marker) in order to 
determine the state of interaction (Figure 4.9).  As expected, GFP-fibroblasts did not 
express N-cadherin, with only weak staining observed in axons.  Moreover, as shown 
by the white arrow-heads, GFP-fibroblasts did not interact or align themselves to 
axons.  In contrast, N-cadherin-fibroblasts were able to form multiple N-cadherin-
rich homotypic fibroblast cell-cell interactions, as shown by the short white arrows, 
in a similar fashion to Schwann cells (Figure 4.1).  Despite lacking the robustness of 
N-cadherin localisation observed in Schwann cell/axonal cocultures, there were still 
many examples, indicated by the long white-arrows, of N-cadherin-fibroblast/axonal 
alignment.  This suggested that fibroblasts expressing N-cadherin behave, at least 
partially, in a similar manner to Schwann cells when contacting axons (Figure 4.7A).  
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Figure 4.9 N-cadherin-expressing fibroblasts interact with axons.  Fibroblasts 
were seeded 24hrs prior to infection with either GFP (AdGFP) or N-cadherin 
(AdNcad) adenovirus for 16hrs.  Cells were media-changed and incubated a further 
24hrs before seeding onto DRG-axons and incubated for 8hrs prior to fixation. 
(LHS) DRG/GFP-fibroblasts were coimmunostained for N-cadherin (white) and 
neurofilament (red), while infected cells were labelled by GFP expression (green).  
The white arrow-head shows an example of non-interaction with axons.  (RHS) 
DRG/N-Cadherin-fibroblasts were coimmunostained for N-cadherin (white) and 
neurofilament (red).  The short-arrow shows an example of N-cadherin at homotypic 
fibroblast cell-cell junctions, while the long-arrow shows an example of alignment 
between the fibroblast cytoplasm and the axon. 
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Moreover, heterologous N-cadherin expression allowed fibroblast to recognise axons  
and to manipulate axons for association, even if full axonal association was not 
achieved. 
 
To study the dynamics of the interactions between N-cadherin expressing fibroblasts 
and axons, I performed time-lapse video analysis.  GFP-fibroblasts and N-cadherin-
fibroblasts were seeded onto established DRG-axonal cultures and videos were taken 
over 20-hours.  As expected, GFP-fibroblasts did not interact with axons.  In the 
majority of axonal encounters, fibroblasts protruded their cytoplasm under or over 
axons without interaction and without evidence of axons being ‘grabbed’ or 
associated with (Figure 4.10A and Video 4.2).  In marked contrast to controls, and 
somewhat to our surprise, we found that N-cadherin-fibroblasts interacted with axons 
in a similar manner to Schwann cells, displaying an axonal ‘grabbing’ and ‘pulling’ 
behaviour, on first contact with axons, typical of Schwann cell/axonal interactions 
(Figure 3.1A), and culminating in varying degrees of axonal interaction (Figure 
4.10B and Video 4.3).  I quantified this behaviour by scoring fibroblast/axonal 
encounters as either ‘grabbing’ or ‘non-grabbing’.  This analysis revealed that 60% 
of N-cadherin-fibroblasts interacted with axons through ‘grabbing’ events compared 
to less than 5% of controls (Figure 4.10C).  Therefore, heterologous N-cadherin 
expression in previously non-interacting fibroblasts showed that N-cadherin alone 
was sufficient to alter fibroblast behaviour (on encountering axons), allowing 
fibroblasts to recognise and manipulate axons.   
 
In order to confirm these findings, I analysed fibroblast/axonal interactions by a 
separate approach, in which the change in the axonal network was determined over 
the course of the video.  By this method, the extent to which the axonal network was 
remodelled was used as a read-out for the ‘pulling’ and ‘grabbing’ activity of 
fibroblasts for axons.  To analyse this, the shape of the axonal network, as shown in 
the first image of Figure 4.10A and Figure 4.10B, was represented by a green mask, 
while the last image was represented by a red mask.  Both the initial (green) and final 
(red) masks were then overlaid in order to gauge the change in the overall shape of 
the axonal network.   This qualitative analysis indicated that the axonal networks in 
GFP-fibroblast cocultures have minimally altered axonal networks, inferring a low 
incidence of interaction between fibroblasts and axons.  In contrast, N-cadherin-GFP 
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Figure 4.10 Fibroblasts that express N-cadherin can recognise, grab and 
partially associate with axons.  DRGs were explanted and incubated over 5-6 days 
prior to seeding either GFP-fibroblasts or N-cadherin-fibroblasts for time-lapse 
analysis over 20hrs.  (A) Representative phase-contrast image sequence of GFP-
fibroblasts/DRG interactions (Video 4.2).  The white arrows chart the progress of a 
typical GFP-fibroblast as it passes over or under axons but importantly, does not 
interact with axons. 
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(B) Representative phase-contrast image sequence of N-cadherin-fibroblast 
interactions with DRG axons (Video 4.3).  The white arrows chart the passage of a 
typical N-cadherin-fibroblast as it recognises, interacts and pulls on axons; a pattern 
that is repeatedly observed during the course of the analysis. 
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(C) Quantification of fibroblast/axonal ‘grabbing’.  The bar chart shows the 
percentage of fibroblast/axonal encounters which resulted in ‘grabbing’ by the 
fibroblast for the axon.  At least 3 videos were quantified per experiment with 
typically 10-15 fibroblasts scored per video.  The dataset represents one of three 
independent experiments showing similar results with bars showing the S.D. of 
triplicates.  Statistics by two-tailed T-test (T=6.667, ***P<0.0026). 
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(D)  The schematic illustrates the differing degrees to which the axonal network is 
remodelled over the course of the time-lapse analysis represented in part A (GFP-
fibroblasts) & part B (N-cadherin-fibroblasts).  The axonal pattern in the first image 
of the sequence is shown in green while the axonal pattern of the final image is 
shown in red.  Both green and red masks were overlaid to generate a composite, 
which qualitatively illustrates the shift in the axonal network and reflects the degree 
of manipulation exerted by fibroblasts on axons.  The white arrow shows an example 
of where axons had become twisted and pulled around an N-cadherin-fibroblast. 
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fibroblasts/DRG cocultures had dramatically altered axonal networks.  In some 
cases, as shown by the white arrow, the axonal network was completely distorted, for 
instance, as in this example, where the axons have been physically twisted around the 
N-cadherin expressing fibroblast.  This work is consistent with previous findings and 
taken together, further supports a distinct role for N-cadherin in Schwann cell/axonal 
‘grabbing/pulling’-behaviour and axonal recognition. 
 
4.5 Mature Schwann cell/axonal interactions 
 
4.5.1 N-cadherin expression in polarisation and myelination 
 
I next wanted to determine the pattern of N-cadherin expression in Schwann cells 
and axons following association, i.e. in mature interactions leading up to 
myelination.  To do this, I seeded NS cells at high density onto DRG-axonal explants 
and incubated the cocultures over 7 days to generate established cocultures.  At this 
point we would expect the Schwann cells to be polarised with respect to the axons 
(Chan et al., 2006).  Cocultures were then fixed and coimmunostained for N-
cadherin and neurofilament, which showed robust up-regulation of N-cadherin at the 
Schwann cell/axonal interface (Figure 4.11).  This work is consistent with previous 
observations made by Chan et al. (2006), who showed, while examining the 
importance of p75NTR in myelination, that Par-3, a well known component of the 
polarity machinery, was localised with N-cadherin along the axon, at the Schwann 
cell/axonal interface in established cocultures.  It was therefore tempting to speculate 
that N-cadherin may be functioning to facilitate polarisation of Schwann cells prior 
to myelination.   
 
4.5.2 shRNA as a tool for stable N-cadherin knockdown in Schwann 
cells  
 
The evidence I have presented thus far suggests that N-cadherin is a mediator of 
early Schwann cell/axonal interactions and is robustly expressed along the axon in 
more stable interactions: but does the disruption of these initial interactions, for 
instance, following loss of N-cadherin in pre-associated Schwann cells, present long-
term consequences for later Schwann cell function, i.e. the events of polarisation and 
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Figure 4.11 N-cadherin localises along axons in established Schwann 
cell/axonal cocultures.  DRG explants were incubated for 6-7 days, after which 
Schwann cells were seeded onto DRG-axons at high-density (4x104cells/DRG).  
Cocultures were incubated for 7 days before fixation with media-changes every 2 
days. The epifluorescence shows cocultures that were coimmunostained for N-
cadherin (white) and the axonal marker neurofilament (green), with cell nuclei 
labelled with Hoechst (blue).  The white arrow indicates an associated Schwann cell 
in which the N-cadherin expression pattern parallels axonal NF expression.  Note 
how the axon is forced to curve around the nucleus of the associated Schwann cell. 
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myelination?  In order to investigate this, it was necessary to use a different system 
for N-cadherin silencing, and switch from transient transfection to a stable system for 
effecting knockdown of N-cadherin expression.  This was essential because the 
protocol to induce myelination in vitro takes several weeks and therefore exceeds the 
time-frame for transient knockdown using siRNA.  To achieve stable, long-term 
knockdown of N-cadherin, I used the Clontech retroviral ‘Knockout RNAi’ system 
to deliver and stably integrate vectors encoding short-hairpin (sh)RNAs into the 
Schwann cell genome.  In addition to encoding shRNA, the integrated DNA also 
incorporated the green fluorescent protein (GFP) marker so that shRNA expressing 
cells can be identified.  We used the Clontech ‘RNAi designer’ to select three 
shRNA sequences referred to in this thesis as shNcad-1, shNcad-3, shNcad-10 (these 
sequences are not related to aforementioned siRNA sequences).  The 
oligonucleotides, including the manufacture's negative control (referred to as 
shScram), were then ligated into the pSiren (zsGreen) Retro-Q expression vector 
(Figure 4.12A).  Clones positive for the insert were identified by restriction enzyme 
analysis (Figure 4.12B) and subsequently sequenced to confirm the sequence was as 
designed.  Retroviral supernatant, from producer cells transfected with shScram, 
shNcad-1, shNcad-3 and shNcad-10 shRNAs, were then used to infect low-passage 
Schwann cells.  Infected shRNA monocultures were maintained in culture for two 
passages, to ensure sufficient time for recovery from infection, after which cells were 
assessed for N-cadherin expression, while GFP expression was analysed to determine 
the level of infection.  The immunofluorescence showed that while shScram 
monocultures strongly expressed N-cadherin in all cells (similarly to NS 
monocultures), the three shRNA N-cadherin cell-lines showed varying degrees of N-
cadherin knockdown (Figure 4.12C).  In these images, white arrows show examples 
of cells coexpressing N-cadherin and GFP, while white arrow-heads show examples 
of N-cadherin deficient cells expressing GFP.  Schwann cells infected with shNcad-1 
were most effective at reducing N-cadherin levels (see white arrow-heads).  In 
contrast, shNcad-3 and shNcad-10 were less efficient, only partially reducing N-
cadherin levels in some of the cells, while failing entirely to reduce N-cadherin levels 
in the majority of cases (see white arrow-heads).  To quantify this, I scored the 
proportion of GFP and N-cadherin expressing cells present in shScram, shNcad-1, 
shNcad-3 and shNcad-10 monocultures (Figure 4.12D).  Overall, the data showed 
that the rate of infection, as inferred from GFP expression, was consistently around 
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Figure 4.12 Generating stably integrated N-cadherin shRNA Schwann cells.  
Three shRNA sequences were designed to target N-cadherin mRNA and (A) ligated 
into the pSIREN-RetroQ vector.  (B) Mini-prep DNA derived from 6 clones were 
analysed by restriction analysis to identify positive clones that were later confirmed 
by sequencing (not shown).      
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(C)  shRNA-mediated N-cadherin knockdown was assayed by immunofluorescence.  
Low-passage Schwann cells were plated 24hrs prior to retroviral infection with 
shScram, shNcad-1, shNcad-3 and shNcad-10 for 2hrs.  Cells were then media-
changed and further incubated over several passages prior to fixation. Representative 
epifluorescence from cultures immunostained for N-Cadherin (red) with cell nuclei 
labelled by Hoechst (blue) & infected cells by GFP expression (green).  The white 
arrows show examples of N-cadherin positive shRNA cells, while the white arrow-
heads show examples of N-cadherin negative shRNA cells. 
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(D) Quantification of immunofluorescence from shRNA cell-lines.  The bar charts 
show the proportion of Schwann cells expressing N-cadherin and GFP (red), GFP 
alone (green) or negative for N-cadherin and GFP (white) for each of the shRNA cell 
types.  The data quantifies the reliability of the shRNA system by matching GFP 
expression with N-cadherin knockdown across N-cadherin shRNA lines.  Scoring 
was conducted in triplicate with at least 200 cells counted per DRG; bars represent 
S.D.  Shown is one of two independent datasets of similar results that reflect the 
shRNA lines later used in myelination assays depicted in Figure 4.13. 
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20%, which although low was still, in our view, acceptable for myelination assays.  
shNcad-1 scored highest for efficacy of knockdown, with 85% of shRNA infected 
(GFP) cells depleted for N-cadherin, which includes 5% of shNcad-1 cells that were 
knocked down for N-cadherin but failed to coexpress the GFP marker.  This 
contrasts with the findings from shNcad-3 and shNcad-10 shRNA lines, in which less 
than 20% and 30% of GFP-labelled cells were knocked down for N-cadherin 
respectively.  It was therefore decided to use only the shNcad-1 cells to determine the 
role of Schwann cell N-cadherin expression in myelination. 
 
4.5.3 Loss of N-cadherin from pre-associated Schwann cells 
impedes progression to myelination 
 
To examine if N-cadherin deficient Schwann cells were able to myelinate axons, I 
used an in vitro myelination model to mimic the myelination process.  DRGs were 
explanted and incubated over 5 days in order to obtain bare DRG-axonal networks.  
Low-passage, recently infected Schwann cells that expressed either shScram or 
shNcad-1 were seeded onto DRG-axonal cultures and cocultures were incubated over 
7 days.  After this, cocultures were incubated a further 2-3 weeks in pro-myelinating 
conditions, with medium supplemented with ascorbic acid and matrigel, and changed 
every two days.  This was independently repeated two further times, staggered to 
separate weeks, using newly generated shRNA cells for each experiment.   
 
Evidence of myelination was observed from phase-contrast microscopy of live 
cocultures, which was detected as thick semi-translucent tubes criss-crossing the 
cocultures.  Following sufficient myelination, the cocultures were fixed and 
immunostained for N-cadherin, to ensure that the effectiveness of the shRNA 
constructs had been maintained during the experiment.  As shown in Figure 4.13A, 
while GFP-shScram cells are positive for N-cadherin (see white arrows), the GFP-
shNcad-1 cells are largely devoid of N-cadherin (see white arrow-heads).  In both 
shScram and shNcad-1 myelinating cocultures, there is evidence of robust N-
cadherin localisation at sites of Schwann cell/axonal contact; however, in the case of 
the latter, this is restricted to the non-GFP background Schwann cell population.   
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Figure 4.13 N-cadherin shRNA cells show a reduced propensity to myelinate 
axons.  DRG explants were incubated for 5-6 days before addition of shRNA cells to 
DRG axons (4x104 cells/DRG).  Cocultures were incubated for 7-days in basal media 
and then switched to differentiation media (with matrigel and ascoribic acid), for an 
additional two weeks to stimulate myelination before fixation.  (A) Representative 
epifluorescence from cocultures immunostained for N-cadherin (white), with shRNA 
cells labelled by GFP (green) and cell nuclei labelled with Hoechst (blue).  The white 
arrows show examples of GFP cells that express N-cadherin, while the white arrow-
heads show examples of GFP cells depleted for N-cadherins. 
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(B) Scrambled and N-cadherin shRNA Schwann cell/DRG cocultures were 
immunostained with myelin protein zero (MPZ) to label myelinating Schwann cells 
(red), with cell nuclei labelled with Hoechst (blue) and shRNA expressing cells were 
marked by GFP (green).  The white arrows show representative examples of 
myelinating shScram-GFP cells and the white arrow-heads show representative 
examples of non-myelinating shNacd-1/GFP cells. 
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(C) Quantification of immunofluorescence as scored from myelinating shRNA/DRG 
cocultures (shown in Part B).  Six to 7 representative fields of view were analysed 
with typically 2000+ cells scored per coverslip.  In each field of view 100% of 
Schwann cells were scored in two ways.  First, as either GFP-positive or GFP-
negative and second, as either myelinating or non-myelinating.  Counts were 
obtained from triplicate coverslips with bars representing the S.D.  Shown is one of 
two independent datasets of similar results.  Statistics by two-tailed T-test (***p < 
0.0001; n.s., not significant). 
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In order to determine if myelination was affected by N-cadherin depletion in 
Schwann cells, I next immunostained the shRNA/DRG cocultures with MPZ, which 
is a marker of myelination. The immunofluorescence showed that both 
shScram/DRG and shNcad-1/DRG cocultures had similar levels of myelination, 
which is was not unexpected given the high proportion of non-infected background 
cells present in the cultures.  However, while there were many individual examples 
of GFP-shScram cells that had myelinated axons, i.e. where GFP expression 
colocalised with MPZ (see white arrows), there were few such examples in GFP-
Ncad1 cultures, with most GFP cells remaining unmyelinated despite close proximity 
to non-GFP myelinating cells (see white arrow-heads).  In order to quantify this 
result, I scored the proportion of GFP verses non-GFP Schwann cells that were 
myelinating, and then I scored the proportion of myelinating cells that either 
expressed GFP or did not express GFP (Figure 4.13C).  The overall proportion of 
cells in the cocultures that expressed GFP was approximately 14%, which 
represented a slight fall in shRNA numbers relative to uninfected Schwann cells after 
three weeks of incubation.  This may be explained in terms of a reduction in the 
proliferation of shRNA cells relative to the uninfected background population due to 
GFP related cellular stress.  The overall proportion of myelinating cells was 
approximately 10%, with slightly less myelination observed in N-cadherin shRNA 
cocultures, although this result was not significant.  However, when the proportion of 
myelinating to non-myelinating N-cadherin-shRNA cells were compared it was 
found that GFP-shScram (control) cells myelinated with, on average, three to four 
fold greater frequency then their N-cadherin-shRNA counterparts.  This trend was 
also observed when comparing the proportion of N-cadherin-shRNA myelinated 
cells to uninfected (non-GFP) myelinating cells.  Again, it was found that GFP-
shScram cells made up a greater proportion of the myelinating population, which was 
found to be three to four fold higher than equivalent N-cadherin shRNA cocultures.  
Thus, depletion of N-cadherin in Schwann cells, prior to interaction with axons, 
inhibits the ability of these cells to myelinate axons.   
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4.6 Chapter summary and conclusions 
 
In this chapter, I have shown that the cell adhesion molecule N-cadherin is localised 
at cell-cell junctions during both homotypic Schwann cell-cell and heterotypic 
Schwann cell/axonal interactions.  N-cadherin expression was found to be essential 
for the formation and maintenance of Schwann cell-cell junctions, with loss of N-
cadherin resulting in the disruption of CIP.  The automated assay I developed to 
detect homotypic Schwann cell-cell interactions is currently being adapted, in our 
laboratory, as a quantitative assay for scoring cell interactions in a non-biased RNAi 
screen to detect novel mediators of Schwann cell interactions. 
 
I have also identified an important role for N-cadherin, expressed by Schwann cells 
and axons, as a mediator of Schwann cell/axonal interactions.  I found that N-
cadherin was concentrated at the tips of Schwann cell lamellipodia-like protrusions, 
which was used by Schwann cells to locate axons through homophilic N-cadherin 
ligation with axonally expressed N-cadherin.  Loss of N-cadherin from Schwann 
cells impaired the ability of Schwann cells to locate axons, while introduction of N-
cadherin in otherwise non-interacting fibroblasts was sufficient to permit recognition 
and allow partial association with axons.  This confirmed the importance of N-
cadherin as the primary mediator of initial axonal interactions.  Finally, loss of N-
cadherin from Schwann cells was shown to significantly impair the ability of 
Schwann cells to later myelinate axons.  Together these findings confirm the 
importance of N-cadherin as a key mediator of cellular interactions within the PNS.  
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Chapter Five: N-cadherin and semaphorin-4F play separate but 
cooperative roles in heterotypic Schwann cell/axonal interactions 
 
5.1 Chapter introduction 
 
In Chapter Four, I showed that N-cadherin played an important role in early 
heterotypic Schwann cell/axonal interactions, while loss of N-cadherin in Schwann 
cells prior to reassociation disrupted re-myelination in vitro.  However, this work 
also showed that N-cadherin does not act alone to facilitate and maintain stable 
Schwann cell/axonal interactions.  For instance, Schwann cell association assays 
revealed that while 90% of LTD cells failed to interact normally with axons (Chapter 
Three), N-cadherin depletion alone only caused a 40% disruption of Schwann 
cell/axonal association and alignment (Chapter Four).  This difference in phenotypic 
severity suggested that loss of N-cadherin alone was unlikely to explain all of the 
LTD interaction defect.  In addition, evidence from time-lapse microscopy showed 
that N-cadherin-depleted Schwann cells were still partially capable of forming 
associations with axons; however, importantly, this interaction did not occur at cell 
protrusions but rather, the interaction was mediated through adhesion of the body of 
the Schwann cell with the axons, i.e. distinct from the cellular protrusions that 
usually elicit the axonal recognition response.  Together, these findings suggested 
that another adhesion molecule might be acting at a sub-cellular localisation distinct 
from cell protrusions, in concert with N-cadherin, to allow Schwann cells to establish 
stable heterotypic Schwann cell/axonal interactions.  In our laboratory, we previously 
identified a novel role for semaphorin-4F (Sema4F) as a Schwann cell expressed 
adhesion molecule that mediates heterotypic Schwann cell/axonal interactions 
(Parrinello et al., 2008).  Interestingly, in addition to N-cadherin and a number of 
other cell adhesion molecules, I showed in Chapter Three that Sema4F was 
significantly down-regulated approximately three-fold in non-interacting LTD cells.  
In this chapter, I set out to investigate whether Sema4F was acting with N-cadherin 
as a co-mediator of heterotypic Schwann cell/axonal interactions and whether both 
molecules together, might account for the LTD interaction defect. 
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5.2 Sema4F and the Ras/Raf/ERK signaling pathway 
 
Before directly testing a role for Sema4F, I first investigated the effect that 
oncogenic signalling through the Ras/Raf/ERK pathway in Schwann cells had on 
Schwann cell/axonal interactions.  We showed that the down-regulation of Sema4F 
was implicated in the aetiology of neurofibromatosis type I (NF1) (Parrinello et al., 
2008).  NF1 is an inherited cancer predisposition syndrome which manifests as 
multiple sporadic nerve tumours, heterogeneously composed of dissociated Schwann 
cells, fibroblasts and neurons (Carroll & Ratner, 2008; Evans et al., 2002; Gottfried 
et al., 2010; Parrinello & Lloyd, 2009).  The initiating stage in tumour progression is 
thought to be the spontaneous loss of heterozygosity (LOH) of the remaining NF1+/- 
allele in the neurofibromin gene in Schwann cells of affected individuals.  
Neurofibromin is a tumour suppressor and functions as a Ras-GAP that acts to 
attenuate the Ras signal, thus loss of NF1 results in the hyper-activation of Ras 
leading to oncogenic signalling through the Ras/Raf/ERK pathway.  Importantly, a 
key step in the generation of neurofibroma tumours is the dedifferentiation and 
irreversible dissociation of Schwann cells from axons (Harrisingh & Lloyd, 2004; 
Parrinello & Lloyd, 2009; Zheng et al., 2008).  We showed that oncogenic 
Ras/Raf/ERK was driving the down-regulation of Sema4F, which subsequently led 
to the dissociation of Schwann cells from axons (Parrinello et al., 2008).   
 
5.3 Oncogenic Ras signal disrupts Schwann cell/axonal 
interactions 
 
5.3.1 Ras activation disrupts Schwann cell/axonal interactions 
despite N-cadherin expression 
 
In order to expand upon our previous findings that Ras activation disrupted Schwann 
cell/axonal interactions, I used Schwann cells generated in our laboratory that 
expressed a constitutively active form of Ras, in which the glycine at residue 12 was 
substituted for valine (V12).  The Ras-V12 variant, referred to in this thesis as NS-
RasV12 cells, are insensitive to GAPs and thus, exhibit constitutively active 
Ras/Raf/ERK signalling.  In order to examine the affect of oncogenic Ras/Raf/ERK 
on Schwann cell/axonal interactions, I used our primary in vitro DRG coculture 
model described previously (Chapter Three).  DRG axons were explanted and 
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incubated over 7-days in order to generate established DRG-axonal cultures.  NS-
RasV12 cells were seeded onto axons and incubated for eight hours before fixation.  
Cocultures were coimmunostained for S100β and RT97, which appeared to show 
that Schwann cell/axonal interactions were at least partially disrupted in Ras-
activated Schwann cells (Figure 5.1A).  The immunofluorescence was scored for 
Schwann cell/axonal interaction, i.e. to determine the proportion of Schwann cells 
that were associated; associated, not aligned or non-associated.  These results 
confirmed that Ras-activation resulted in an approximate 50% impairment in 
heterotypic interactions, compared to a 15% background impairment in control 
cocultures (Figure 5.1B).  In order to examine whether N-cadherin was expressed in 
Ras-activated Schwann cells, I coimmunostained the cocultures for N-cadherin and 
neurofilament (to highlight axons) (Figure 5.1C).  Interestingly, the 
immunofluorescence showed that N-cadherin was still expressed by NS-RasV12 
cells.  Moreover, as shown by the white-arrows, N-cadherin localisation was similar 
to that observed in NS cells, where N-cadherin was localised at lamellipodia-like 
protrusions (see white arrows, Figure 5.1A).  Together, these results showed that 
Ras-activated (NS-RasV12) cells are impaired for axonal interaction, despite 
continued expression of N-cadherin and despite its correct localisation at cytoplasmic 
protrusions.  Therefore, the axonal-interaction impairment exhibited by NS-RasV12 
does not result from N-cadherin-loss but instead implicates additional co-mediators, 
for example Sema4F - known to be dysregulated upon Ras activation - that might 
function with N-cadherin to mediate interactions. 
 
5.4 Raf-ER cells: an inducible Raf for studying Schwann 
cell/axonal interactions 
 
In order to study Ras-activation and specifically the ERK pathway, I used Schwann 
cells generated in our laboratory, which  expressed an inducible form of Raf referred, 
in this thesis, as Raf-ER cells.  The inducible Raf kinase is a fusion protein consisting 
of Raf fused to the hormone binding domain of the estrogen receptor (ER), which 
can be reversibly activated by addition of tamoxifen (Tmx) - an estrogen analogue - 
to the cell media, while remaining inactive in the absence of ligand (Lloyd et al., 
1997).  We previously showed that activation of Raf-ER and subsequent sustained 
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Figure 5.1 Ras Schwann cells failed to remain associated with axons despite 
N-cadherin expression localised to cytoplasmic protrusions.  NS-RasV12 cells 
were seeded onto day-7 established DRG explants and fixed after 8hrs.  
Representative epifluorescence of cocultures coimmunostained for (A) S100β 
(green) and RT97 (red), with cell nuclei labelled with Hoechst (blue).  (B) 
Association assay: blind scoring conducted in triplicate with 200+ cells counted per 
DRG; bars represent S.D. Statistics by T-test (***p<0.0038).  (C) Cocultures were 
coimmunostained for N-cadherin (grey) and neurofilament (red), where the white-
arrows show examples of N-cadherin localisation at cell protrusions.    
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signalling through the Raf/ERK pathway, was sufficient to induce Schwann cell 
dedifferentiation and drive the dissociation of Schwann cells from axons (Harrisingh 
et al., 2004; Parrinello et al., 2008).  This work also showed that the signalling 
pathway downstream of Ras activation was via the Raf/ERK cascade rather than, for 
example the PI3 kinase pathway.  Thus, Raf-ER cells are a useful inducible model to 
study the effect of hyper-activation of Ras in Schwann cells in relation to Schwann 
cell/axonal dissociation. 
 
5.4.1 N-cadherin expression and knockdown in Raf-ER cells 
 
I first wanted to ensure that activated Raf-ER cells, like NS-RasV12 cells, expressed 
N-cadherin.  I also wanted to determine if Raf-ER cells were amenable to siRNA 
mediated N-cadherin silencing.  Low-passage Schwann cells that stably expressed 
the inducible Raf-ER kinase were transfected 24-hours after cell-plating with either 
scrambled or N-cadherin siRNA for 16-hours.  The cell media was changed and the 
monocultures were incubated for a further 4-hours, after which the media was 
supplemented with either Tmx to activate Raf or ethanol (EtOH) to act as a control.  
Raf-ER Schwann cell monocultures were fixed 28-hours later, as in previous 
experiments, and immunostained for N-cadherin (Figure 5.2A).  These results 
confirmed that N-cadherin is expressed by Raf-ER Schwann cells in both Raf 
inactive and activate states, with seemingly greater levels of N-cadherin expressed by 
Raf-activated cells.  Furthermore, there were multiple examples of homotypic cell-
cell interactions that were clearly mediated through trans-N-cadherin-N-cadherin 
ligation in either condition.  The results also showed that N-cadherin expression in 
Raf-ER Schwann cells could be silenced effectively by siRNA to a similar degree as 
achieved in NS cells, which is quantified in Figure 5.2B.  However, preliminary 
experiments (not shown) revealed that activated Raf-ER Schwann cells were 
resistant to siRNA transfection at the level previously used to knockdown N-cadherin 
in NS cells, i.e. 1nM.  I therefore titrated the siRNA concentrations from 1nM to 
10nM in order to determine the optimum concentration and discovered that 3nM was 
sufficient (as shown in Figure 5.2A-B) to achieve comparable transfection and 
depletion of N-cadherin in Raf-ER cells. 
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Figure 5.2 N-cadherin knockdown in Raf-ER cells is effective, but only at a 
higher concentration of siRNA.  Raf-ER cells were transfected with 3nM of 
scrambled or Ncad-4 siRNA for 16hrs, after which the cell media was changed and 
4hrs later, the cell media was supplemented with either tamoxifen (TMX) or ethanol 
(EtOH) for 28hrs prior to fixation.  (A) Representative epifluorescence of 
monocultures immunostained for N-cadherin (red) with cell nuclei labelled with 
Hoechst (blue).  (B) Quantification of the proportion of N-cadherin expressing cells.  
Counts were conducted in triplicate with 200+ cells counted per coverslips; bars 
represent S.D. 
 229  
   
5.5 Loss of N-cadherin and hyper-elevated Raf/ERK signalling 
severely disrupted heterotypic Schwann cell/axonal interactions 
 
I next wanted to address whether the loss of N-cadherin from Schwann cells in which 
Raf/ERK is constitutively activate would lead to an impairment in Schwann 
cell/axonal interactions that was greater than either state alone.  To test this, I used 
our in vitro DRG coculture system and association assay.  Raf-ER Schwann cells 
were transfected with either scrambled or N-cadherin siRNA for 16-hours.  The 
transfectant was removed and the cells further incubated for four hours prior to 
addition of either Tmx or EtOH.  Treated Raf-ER cells were then incubated for an 
additional 24-hours, after which they were seeded onto DRG axons and incubated for 
eight hours in media supplemented with Tmx or EtOH, fixed and coimmunostained 
for S100β and RT97.  As expected, the immunofluorescence showed that either loss 
of N-cadherin or activation of Raf/ERK  in Schwann cells, resulted in partial 
impairments in Schwann cell/axonal interactions, while the majority of scrambled, 
EtOH-treated (control) Raf-ER cells were observed to be associated and aligned with 
axons (as illustrated by the white arrows).  Interestingly, the depletion of N-cadherin 
from Raf-activated Schwann cells resulted in a substantially worse impairment of 
Schwann cell/axonal interactions as indicated by the white arrow-heads in Figure 
5.3A.  In order to quantify this effect, I scored Schwann cell/axonal interaction using 
the DRG association assay as described previously (Chapter Three) and found that 
Schwann cell/axonal association and alignment in N-cadherin-deficient, Raf-
activated Schwann cells, was impaired by as much as 75% (Figure 5.3B).  This 
accounted for a significantly greater impairment then the approximate 40% 
disruption to axonal interactions elicited by either N-cadherin knockdown or Raf-
activation alone.  Scrambled, Raf-inactive (EtOH-treated) Raf-ER cells were strongly 
associated and aligned with axons, and were indistinguishable from previously 
scored NS/DRG association scores, which typically had a 10% background 
impairment in interaction.  These results indicated that both N-cadherin and Raf-
activation were largely additive in terms of their contribution to Schwann cell/axonal 
interactions.  This is similar in terms of severity to the interaction defect exhibited by 
LTD cells, although there were still cells that interacted normally with axons.  In this 
regard, it is important to bear in mind that while all LTD cells carry the same genetic 
impairment for axonal-interaction,  the siRNA approach does not achieve a 100% 
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Figure 5.3 N-cadherin knockdown in Raf-activated Schwann cells severely 
disrupts interactions with axons.  Raf-ER cells were transfected and the cell media 
supplemented with either EtOH or TMX.  Monocultures were then incubated for 
24hrs, seeding onto day-7 established DRG-axons and fixed after 8hrs.  (A) 
Representative epifluorescence of cocultures coimmunostained for S100β (green) 
and RT97 (red), with nuclei labelled with Hoechst (blue).  The arrows show 
examples of Schwann cell/axonal interaction, while the arrow-heads show examples 
of non-association.  (B)  Association assay.  The bars represent S.D. of triplicates.  
Statistics by two-tailed T-test (***p<0.05; n.s., not significant). 
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transfection rate, which might explain the reduced phenotypic severity exhibited by 
N-cadherin siRNA Raf-ER (Tmx) cells.    
 
To study the loss of interactions dynamically, I used time-lapse microscopy.  The 
four different Raf-ER cell types were generated as previously described, i.e. 
scrambled Raf-ER Schwann cells (+/- Tmx) & N-cadherin knockdown Raf-ER 
Schwann cells (+/- Tmx).  The Raf-ER Schwann cells were then seeded separately 
onto axons and incubated for 20-hours so that time-lapse microscopy could be 
conducted.  Analysis from the time-lapse data showed that the majority of scrambled 
Raf-ER Schwann cells that were either Raf activated (Tmx) or inactivated (EtOH), 
were able to grasp, pull or otherwise manipulate axons using the distal tips of their 
cytoplasmic protrusions.  This behaviour can be observed in the image sequence 
shown in Figure 5.4A (Video 5.1), depicting scrambled, Tmx-treated Raf-ER 
Schwann cell/DRG cocultures, where the white arrows show the path of a typical 
Schwann cell that grasps and pulls upon axons it encounters.  However, while 
Schwann cells appeared to initially recognise and associate with axons, they often 
went on to form less-stable interactions when compared to Tmx-negative controls, 
for instance, Schwann cells would often spontaneously dissociate from axons.  In 
stark contrast to these observations, when N-cadherin-deficient, Raf-activated (Tmx-
positive) Schwann cell/DRG cocultures were studied, these cells invariably failed to 
recognise and grasp axons with their cytoplasmic protrusions (Figure 5.4B; Video 
5.2).  Instead, as shown by the white arrows, Schwann cells would often extend 
cytoplasmic protrusions across axons without a recognition response, which is 
similar in behaviour to NS cells transfected with the N-cadherin siRNA (Chapter 
Four).  However, unlike the latter, the Raf-activated, N-cadherin-deficient Schwann 
cells would often fail entirely to interact with axons in a manner similar to LTD cells 
and fibroblasts.   Thus, the combination of these interaction deficits, i.e. deficiencies 
in Schwann cell/axonal recognition at cytoplasmic protrusions (due to loss of N-
cadherin) and loss of interaction stability (due to Raf-activation), may explain the 
increased severity of the phenotype. 
 
In order to confirm this, I quantified the time-lapse videos to calculate the extent of 
Schwann cell-directed axonal grasping behaviour, where only initial axonal 
encounters mediated by the Schwann cell cytoplasmic protrusion were scored.  These 
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Figure 5.4 Schwann cell/axonal ‘grabbing’ behaviour is severely affected by 
loss of N-cadherin in a background of Raf/ERK activation.  DRGs were 
explanted and incubated to generate axonal cultures.  Inducible Raf-ER cells were 
transfected with scrambled or Ncad4 siRNA and subjected to treatment with EtOH or 
TMX (as previously described).  Monocultures were then incubated for 24hrs after 
which cells were seeded onto axons and time-lapse analysis conducted over 20hrs.  
(A) Representative phase-contrast image sequence from Video 5.1 of scrambled 
transfected, Raf-activated (TMX) Schwann cell/DRG cocultures.  The white arrows 
illustrate the course of a representative Raf-ER cell as it encounters axons. 
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(B) Representative phase-contrast image sequence from Video 5.2 of N-cadherin 
knockdown, Raf activated (TMX) Schwann cell/DRG cocultures.  The white arrows 
illustrate the course of a typical Raf-ER cell during encounters with axons.  Note the 
reduction in axonal ‘grabbing’ behaviour elicited by Schwann cells. 
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(C) Quantification of Schwann cell/axonal ‘grabbing’ events elicited by Schwann 
cells for axons at their cytoplasmic protrusions.  Three videos were scored per DRG 
from triplicate wells with typically 20-25 Schwann cells scored per video.  Bars 
represent S.D. with statistics by one-way ANOVA Tukey-Kramer Multiple 
Comparisons Test (***p<0.01; n.s., not significant).  Shown is one of three 
independent datasets of similar results. 
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(D) The schematic illustrates the differing degrees to which the axonal network is 
remodelled over the course of the time-lapse analysis represented in part A (Raf-ER 
scrambled/TMX) & Part B (Raf-ER siNcad-4/TMX).  The axonal pattern in the first 
image of the sequence is shown in green while the axonal pattern of the final image 
is shown in red.  Both green and red masks were overlaid to generate a composite, 
which qualitatively illustrates the shift in the axonal network and reflects the degree 
of physical manipulation exerted by Schwann cells on axons.   
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results showed that the loss of N-cadherin from Schwann cells resulted in a 
substantially less Schwann cell/axonal grasping events, which was independent of 
Raf activation (Figure 5.4C), thus, this suggested that N-cadherin, rather than 
Sema4F, functions primarily in cell protrusions to elicit the Schwann cell/axonal 
recognition response.  In addition, I qualitatively examined the extent to which 
Schwann cells were able to manipulate and remodel the axonal network during the 
course of the time-lapse.  The change in the axonal network was highlighted by 
overlaying the first frame with the last frame of the image sequence depicted in 
5.4A-B.  The skew in the pattern was then used to gauge the overall extent of 
Schwann cell/axonal interaction (Figure 5.4D).  Consistent with previous findings, 
the analysis showed that in the scrambled Raf-activated cocultures, the axonal 
network had become skewed, which was indicative of significant manipulation of 
axons by Schwann cells.  In contrast, the axonal network shape for the N-cadherin 
knockdown Raf-activated Schwann cells remained largely unchanged.  In 
conclusion, the Raf-activated (Tmx-positive) Schwann cells retained normal 
‘grabbing’ behaviour, consistent with their N-cadherin expression; however, they 
appear to lack the adhesive force necessary to maintain the association once the cell 
was ‘loaded’ onto the axon.   
 
5.6 Double knockdown of semaphorin-4F and N-cadherin in 
Schwann cells 
 
We found that the molecule downstream of the Raf signal responsible for the loss of 
Schwann cell/axonal interactions was Sema4F (Parrinello et al., 2008).  I therefore 
wanted to examine directly, the effect on Schwann cell/axonal interactions, of 
specifically depleting both N-cadherin and Sema4F from Schwann cells 
simultaneously.  In particular, I wanted to see if these experiments corroborated 
previous findings from Raf-ER, N-cadherin Schwann cell knockdown experiments.  
In order to test this, I obtained two non-overlapping, independent siRNAs targeted 
against Sema4F (siSema4F-5 and siSema4F-6).  The efficacy of Sema4F knockdown 
in Schwann cells was examined by RT-PCR because of the lack of a reliable Sema4F 
antibody.  NS cells were transfected for 16-hours with 1nM scrambled siRNA, N-
cadherin siRNA, two Sema4F siRNAs or a combination of N-cadherin and Sema4F 
siRNA (double knockdown).  After the cell medium was changed, the monocultures 
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were incubated for a further 32-hours and then viewed by phase-contrast microscopy.  
N-cadherin-depleted monocultures were clearly identifiable in both the single N-
cadherin knockdown and double N-cadherin/Sema4F knockdown by the distinctive 
nature of the cell monolayer, which in both cases was highly disorganised (Figure 
5.5A).  RT-PCR analysis was then performed using RNA extracted from culture 
plates.  As expected, this analysis confirmed that N-cadherin siRNA was highly 
effective at depleting N-cadherin, while Sema4F siRNA was effective at reducing 
Sema4F levels by at least two-fold in both the single Sema4F and double N-
cadherin/Sema4F siRNA knockdowns (Figure 5.5B).  I next investigated the effect 
on Schwann cell/axonal interactions of directly depleting both N-cadherin and 
Sema4F from Schwann cells.  To examine this, I repeated earlier association assays 
using primary DRG-axonal cultures.  NS cells were transfected with scrambled, N-
cadherin, Sema4F and N-cadherin/Sema4F siRNA for 16-hours.  The monocultures 
were then further incubated for 24-hours prior to seeding onto axons.  The cocultures 
were then incubated for eight hours, fixed and coimmunostained for S100β and 
RT97.  The immunofluorescence was quantified using the DRG association assay to 
assess the extent of Schwann cell/axonal association and alignment.  Consistent with 
previous findings from Raf-ER association studies, the quantification showed a 
similar trend, in that depletion of either N-cadherin or Sema4F alone resulted in 
approximately 40% impaired interactions, while depletion of both adhesion 
molecules simultaneously, resulted in approximately 80% disruption to association 
and alignment (Figure 5.6).  Similar to Raf-ER experiments, the majority (85%) of 
scrambled siRNA transfected Schwann cells were associated and aligned with axons. 
 
5.7 Chapter summary and conclusions 
 
In this chapter, I have shown that Schwann cell/axonal interactions are largely 
mediated by two independent cell adhesion molecules, N-cadherin and Sema4F, 
which both cooperate to mediate separate roles in the interaction process.  I showed 
that N-cadherin was operating mostly at the lamellipodia-like cytoplasmic 
protrusions, to initiate recognition and facilitate Schwann cell-mediated grasping for 
axons.  Sema4F is likely to have a more uniform distribution on the cell-surface, 
although lack of an effective antibody has hindered efforts to characterise its sub-
cellular localisation.   However, unlike N-cadherin, Sema4F is not required for 
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Figure 5.5 Simultaneous silencing of N-cadherin and Sema4F in NS cells 
after double siRNA transfection.  NS cells were transfected for 16hrs with either 
single siRNA (scram, Ncad-3, Sema4F-5 or Sema4F-6) at a concentration of 1nM or 
double siRNAs (Sema4F-5 & -6, Sema4F-6 & Ncad-3) at a combined concentration 
of 1.5nM.  Monocultures were then incubated a further 28hrs.  (A) Representative 
phase-contrast images of live cells displaying classic N-cadherin-deficient refractive 
phenotype.  (B) RT-PCR quantification of relative mRNA levels with GAPDH used 
to control lane-loading and levels standardised to scrambled.  Bars represent S.D. 
with statistics by two-tailed T-test (***p<0.001; n.s., not significant). 
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Figure 5.6 Combined loss of N-cadherin and Semaphorin-4F from Schwann 
cells severely impairs association and alignment.  DRGs were explanted and 
incubated for 7 days to generate axonal networks.  NS cells were transfected for 
16hrs with 1nM of either scrambled, siNcad-3 or siSema4F-6 siRNA, or with a 
combination of siNcad-3 [0.75nM] and sema4F-6 [0.75nM].  The cell medium was 
changed and monocultures incubated a further 24hrs, after which cells were seeded 
onto axons and fixed after a further 8hrs.  Cocultures were coimmunostained for 
S100β and RT97.  (A) Association assay: blind scoring conducted in triplicate with 
200+ cells counted per DRG; Bars represent S.D. from triplicate coverslips with 
statistics by T-test (***p<0.001; n.s., not significant).  Shown is one of three 
independent experiments of similar results. 
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Schwann cell/axonal recognition, rather its function appears to be in the stabilisation 
of Schwann cell/axonal associations following association.  The importance of 
Sema4F in this regard is underlined by its down-regulation in Neurofibromatosis 
type 1 caused by hyper-activation of Ras, which is ultimately sufficient to cause 
Schwann cell/axonal disassociation as a first step in neurofibroma formation.  This 
was particularly impressive  given that the Sema4F knockdown was not complete.  
Thus, together N-cadherin and Sema4F cooperate at different stages of the 
interaction to facilitate and maintain Schwann cell/axonal interactions.  
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Chapter Six: Discussion 
 
6.1 Chapter introduction 
 
The Schwann cell is a remarkably plastic cell.  It is capable of extraordinarily 
complex differentiation and specialisation, essential for the formation of the radial 
architecture and function of both myelinated and non-myelinated nerve fibres, while 
simultaneously remaining competent to respond to nerve injury - where the 
differentiation process is reversed to generate undifferentiated proliferating Schwann 
cells.  Underlying all Schwann cell behaviour is reciprocal signalling between 
Schwann cells and axons that is mediated in a cell-contact dependent manner, which 
by definition, is reliant on a close and physical relationship mediated through cell 
adhesion molecules.  In this thesis, I set out to investigate the interactions between 
Schwann cells and axons; in particular, to elucidate the molecular identity, and the 
localisation of action, of key mediators that facilitated these processes.   
 
6.2 Summary of main findings 
 
In Chapter Three, I described a model for early Schwann cell/axonal interactions 
which was based on time-lapse analysis.  I then studied a Schwann cell clone (LTD), 
where the normal interaction process with axons had become severely impaired.  In 
order to identify the genetic source of the LTD non-interaction phenotype, I 
conducted a differential expression microarray between axonal interacting (LTNS) 
and non-interacting (LTD) Schwann cells.  This work revealed a global shift in gene 
expression, which suggested that a master regulator of the Schwann cell interaction 
phenotype was mutated in this clone.  Interestingly, functional enrichment analysis 
showed that cell-adhesion was the most enriched functionally dysregulated group of 
genes in LTD cells.  This functional cluster included previously investigated N-
cadherin (Wanner et al., 2006a; Wanner et al., 2006b; Wanner & Wood, 2002), 
Sema4F (Parrinello et al., 2008), L1-CAM (Seilheimer et al., 1989) and NCAM 
(Hansen et al., 2008), as well as a number of other CAMs not previously cited in 
Schwann cell/axonal interactions, for example cadherin-6, protocadherin-7, ninjurin 
and melanoma CAM (mCAM), which are useful candidates for future interaction 
studies.   Interestingly, the transcription factors Sox2 and Sox10 were also found to 
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be down-regulated in LTD cells.  However, Sox2 was not found to be responsible for 
the genetic lesion in LTD cells responsible for the broad dysregulation of CAM-
related gene expression in LTD cells.  For instance, the transcript levels of N-
cadherin and Sema3B transcription were unaffected when Sox2 was over-expressed 
in Schwann cells and LTD cells.  Unexpectedly, I found that Sox2 over-expression in 
Schwann cells resulted in the relocalisation of N-cadherin to homotypic Schwann 
cell-cell junctions and induced changes in the morphology of the adherens junctions.  
Sox2 over-expression also changed the behaviour of Schwann cells during 
encounters with other Schwann cells, switching the response from one of repulsion to 
one of attraction, mediated through N-cadherin, which we found resulted in increased 
Schwann cell clustering (Parrinello et al., 2010). 
 
In Chapter Four, I developed and utilised an siRNA approach to investigate the role 
of N-cadherin in homotypic Schwann cell-cell interactions.  This work showed that 
N-cadherin was the functional cell adhesion molecule that bound Schwann cells 
together in groups.  I also presented evidence that suggests homotypic trans-ligation 
of N-cadherin, between Schwann cells, conveys a cell-cycle inhibitory effect on 
Schwann cells.  I next used a primary DRG/Schwann cell coculture system to 
investigate the functional role of N-cadherin in heterotypic Schwann cell/axonal 
interactions.  Here, I showed that N-cadherin was necessary but not sufficient to 
instigate normal Schwann cell/axonal interactions.  To determine how N-cadherin 
was functioning, and at which part of the interaction process, I studied N-cadherin 
immunofluorescence in conjunction with time-lapse analysis of normal Schwann 
cells and N-cadherin-depleted Schwann cells in coculture with DRG-axons.  The 
immunofluorescence showed that N-cadherin was localised to the cytoplasmic 
‘lamellipodia-like’ protrusions of the Schwann cells, even in Schwann cells that were 
not contacting axons.  Moreover, the time-lapse analysis showed that Schwann cells 
recognise and ‘grab’ axons using these cytoplasmic protrusions, which were 
significantly disrupted in N-cadherin depleted Schwann cells, consistent with a role 
for N-cadherin as a mediator of these interactions.  Importantly, work with perineural 
fibroblasts showed that this previously non-interacting cell-type could be driven to 
recognise and manipulate axons following heterologous N-cadherin expression.  
Together, these results showed that N-cadherin was necessary and sufficient for 
mediating Schwann cell/axonal recognition and early association with axons.  
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Previous studies have shown polarised N-cadherin expression along the adaxonal 
membrane interfacing the axonal axolemma in myelinating fibres (Chan et al., 2006), 
Therefore, I investigated N-cadherin in mature myelinating Schwann cell/DRG 
cocultures in order to clarify its role in mature interactions.   This work showed that 
loss of N-cadherin prior to initial Schwann cell/axonal interactions significantly 
impacted later myelination. 
 
In Chapter Five, I describe the distinct roles played by N-cadherin and Sema4F in 
mediating Schwann cell/axonal interactions and also the affect of Raf/ERK-
activation.  Constitutive activation of Ras/Raf/ERK in Schwann cells is known to 
reverse the differentiated state of Schwann cells (Harrisingh & Lloyd, 2004), while 
dysregulation of the pathway is central to the aetiology of neurofibromatosis type 1 
(Parrinello & Lloyd, 2009).  Moreover, the associated downstream loss of Sema4F 
causes Schwann cell/axonal dissociation and impairs Schwann cell/axonal re-
association and alignment in vitro (Parrinello et al., 2008).  Consistent with earlier 
work, sustained activation of Ras or Raf in Schwann cells impaired Schwann 
cell/axonal association and alignment despite strong expression of N-cadherin in 
these cells.  Moreover, time-lapse analysis showed that although Raf-activated 
Schwann cells recognised and ‘grabbed’ axons, the resulting Schwann cell/axonal 
associations were generally unstable and short-lived.  I advanced this finding by 
directly depleting Sema4F, a downstream target of the Ras/Raf/ERK pathway, from 
Schwann cells, which replicated the impairment displayed by either Ras or Raf 
activation.  Finally, I showed that combined loss of Sema4F and N-cadherin from 
Schwann cells significantly disrupted cell interactions.  These findings suggest that 
both N-cadherin and Sema4F are involved in normal Schwann cell/axonal 
interactions, but primarily function at different stages of the interaction: N-cadherin 
mediates recognition and initial association, while Sema4F facilitates the 
stabilisation of the association. 
 
6.3 Homotypic Schwann cell-cell interactions 
 
Homotypic Schwann cell-cell interactions play important roles in Schwann cell 
biology.  In early development, prior to association with axons, homotypic 
interactions between SCPs facilitate the formation of sheets of interconnected cells 
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that migrate with, and are found in close proximity to, the developing and extending 
peripheral nerves (Woodhoo & Sommer, 2008).  Homotypic interactions between 
SCPs are also important for capping and protecting sensitive axonal growth-cones as 
they traverse tissue to locate targets for innervation (Wanner et al., 2006b).  It has 
been suggested that homotypic interactions occur between juxtaposed Schwann cells 
along myelinated nerve fibres at the so-called microvilli fringe, i.e. in the region 
overlying the Node of Ranvier (Poliak et al., 2002).  However, Alanne et al. (2009) 
found no evidence for the involvement of E-cadherin, the most ideally placed CAM 
that could mediate this interaction, nor the presence of tight-junctional components, 
i.e. claudin family members, between Schwann cells.  Thus, homotypic interactions 
in myelinated nerve - if they occur at all - remain poorly understood and require 
further clarification.  In recent years, the role of homotypic interactions between 
denervated Schwann cells following nerve injury has been studied and their 
importance for nerve repair and regeneration has become clearer.  For instance, 
injuries to the nerve can be in the form of nerve crush or nerve transection, where the 
latter tend to have less favourable outcomes in terms of repair.  Despite this, a good 
proportion of sciatic nerve transections spontaneously reconnect with distal targets 
within 48-hours in rodents - importantly, homotypic Schwann cell-cell interactions 
have been shown to play a central role in facilitating the reconnection of the nerve 
(Parrinello et al., 2010).  In this study, we found that recently dissociated and 
dedifferentiated Schwann cells, at the proximal nerve stump (site of nerve injury), 
were clustering in a manner reminiscent of SCP-SCP sheets often observed during 
development, and which we showed, were important for guiding axons across 
otherwise intractable regions of the legion.   
 
6.3.1 A role for N-cadherin 
 
In the current thesis, I demonstrate a central role for N-cadherin in the mediation of 
homotypic Schwann cell-cell interactions between cultured denervated ‘injury’ 
Schwann cells in vitro.  This finding is consistent with earlier studies, which 
suggested that N-cadherin mediates homotypic Schwann cell-cell interactions in 
cultured denervated Schwann cells (Fairless et al., 2005; Wanner & Wood, 2002), as 
well as during development between SCPs (Wanner et al., 2006a).  Importantly, 
consistent with these studies and others, I confirmed that E-cadherin (an alternative 
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cadherin-type expressed by mature Schwann cells) was not expressed by denervated 
Schwann cells in vitro (Gess et al., 2008; Wanner & Wood, 2002) and was therefore 
unlikely to be a mediator of Schwann cell/Schwann cell interactions.   
 
During development, N-cadherin is expressed by Schwann cell progenitors, 
including NCCs and SCPs, while E-cadherin is not expressed in these progenitors, 
thus a role for N-cadherin in SCP clustering is highly plausible (Wanner et al., 
2006a; Wanner et al., 2006b).  Conversely, N-cadherin levels in peripheral nerve 
decline towards birth concordant with increasing levels of E-cadherin.  N-cadherin is 
minimal and E-cadherin is maximal at around a week after birth (Crawford et al., 
2008).  This is likely to reflect the changing requirement for stability in the nerve 
architecture that occurs during myelination and is initiated around birth (Jessen & 
Mirsky, 2005).  As previously discussed, E-cadherin performs two major roles in 
myelinated nerve: first, in the formation of autotypic junctions between membrane 
lamellae of the glial paranodal loops, and second, in the stability of SLI channels 
(Salzer et al., 2008).  Interestingly, E-cadherin expression is up-regulated at the same 
time as genes involved in the myelination programme, notably the cAMP responsive 
gene Oct6, and has itself been shown to be a target of cAMP dependent PKA 
activation (Crawford et al., 2008).  The signals that drive the simultaneous down-
regulation of N-cadherin remain to be elucidated.  Cadherin switching is therefore, 
an important part of Schwann cell biology, changing the adhesive properties of 
adherens junctions to reflect the differing functional requirements of Schwann cells 
at specific stages of development.  Cadherin-switching is observed in the early 
formation of NCCs, which undergo an EMT-like event that involves a switch in 
cadherin expression from E- to N-cadherin, thus allowing the delamination of fixed 
NCCs from the flanks of the neural tube to generates motile NCCs (Kuriyama & 
Mayor, 2008).  Later Schwann cell progenitors mediate transient interactions via N-
cadherin between themselves and axons, which is important for many processes, 
including neural crest migration and radial sorting.  As Schwann cells make more 
stable interactions with the axons, the need for transient interactions is reduced and 
the requirement for stable interactions, mediated by E-cadherin and other CAMs with 
greater adhesive strength (Gumbiner, 2000), is increased and is necessary to generate 
the stable three-dimensional microarchitecture of the functional homeostatic nerve.  
This cadherin switch (from N- back to E-cadherin) is effectively a reverse of the 
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earlier neural EMT-like process involved in neural crest de-lamination.  
Interestingly, as previously discussed, dedifferentiated Schwann cells from injured 
nerve undergo another round of cadherin-switches, as they re-express N-cadherin and 
(presumably) down-regulate E-cadherin, take part in nerve repair and then re-express 
E-cadherin and down-regulate N-cadherin during re-myelination of the repaired 
axons.  This is a further example of the versatility of Schwann cells. 
 
Future work should aim to clarify the downstream components required for N-
cadherin function in the mediation of homotypic interactions.  In terms of the former, 
while the adhesive interactions of cadherins are well documented, the intracellular 
signalling components of cadherin function are less clear.  Importantly, a number of 
cadherin binding partners can modulate the adhesive function of cadherins, for 
example p120-catenin (Perrin-Tricaud et al., 2007), Merlin (Curto & McClatchey, 
2008) as well as β-catenin (Davis et al., 2003).  Furthermore, cadherin function may 
be altered by binding in cis with other membrane proteins, for example RTKs 
(Doherty et al., 2000).  In Schwann cells, the role of these modulators of N-cadherin 
function is not well understood.  For instance, Lewallen et al. (2011) show that N-
cadherin and β-catenin colocalise, while immuno-precipitation (IP) experiments 
show a direct interaction between N-cadherin and β-catenin in Schwann cell/axonal 
cocultures.  Furthermore, they demonstrate that β-catenin is required for N-cadherin 
function in Schwann cells as its ablation results in a delay to myelination.  However, 
these findings are contradicted by Gess et al. (2008), who showed that β-catenin 
ablation in Schwann cells had no effect on the localisation of N-cadherin at cell-cell 
junctions and nor did it effect the morphology of Schwann cells, i.e. β-catenin was 
not required for mediating adhesive interactions between cells.  In light of these 
findings, it would be advantageous to clarify the role of accessory molecules 
involved in the adhesive function of N-cadherin in Schwann cell-cell interactions.  In 
order to address this, the Image-J quantification technique described in Chapter Four, 
could be adapted and employed as part of a RNAi screen to detect essential genes 
involved in all stages of homotypic Schwann cell-cell adhesion.  For instance, 
Schwann cells could be cultured in multi-well plates and subjected to siRNA-
mediated knockdown for an array of gene targets.  Confluent plates could then be 
analysed to calculate extracellular area as a readout for the integrity of homotypic 
interactions.  Implementation of such a screen would be relatively efficient as the 
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technique has been pre-optimised to permit rapid and reliable quantification of 
extracellular area in Schwann cell monocultures from fluorescent images. 
 
6.3.2 Sox2 relocalises N-cadherin to cell-cell junctions and promotes 
Schwann cell-cell clustering 
 
In the current thesis, I showed that Sox2 over-expression in Schwann cells resulted in 
substantially increased levels of N-cadherin at Schwann cell-cell junctions.  
Moreover, the gross morphology of the adherens junction (as viewed from 
immunofluorescence) was altered.  In normal Schwann homotypic interactions, the 
junction is composed of short 'zipper-like' strands of N-cadherin arranged 
perpendicular to the cell-cell interface.  In Sox2 over-expressing Schwann cells, this 
changed markedly, with substantially larger N-cadherin complexes residing at the 
cell junction where long-strands of N-cadherin appeared to project deep into the cell.  
Furthermore, we found that Sox2 was not acting to increase N-cadherin transcription, 
as mRNA levels remained unchanged between Sox2 and controls, indicating that N-
cadherin gene was not a direct Sox2 target.  Rather, Sox2 appeared to be directing 
the re-localisation of existing N-cadherin to Schwann cell-cell junctions (Parrinello 
et al., 2010).  Alternatively (or in addition), Sox2 effectors might be altering the 
stability of existing cell-surface expressed N-cadherin, i.e. by preventing degradation 
and/or internalisation of N-cadherin.  The question as to how Sox2 might be 
mediating these changes to N-cadherin and through which cellular effectors, remains 
to be elucidated (see future work for strategies to address this).  However, we 
recently showed that Sox2-dependent localisation of N-cadherin to cell-cell junctions 
was necessary for the formation and maintenance of Schwann cell-cell clusters in 
vitro and also following nerve transection in vivo (Parrinello et al., 2010).  In terms 
of the latter, we showed that fibroblasts present at the injury site play an important 
role by inducing the up-regulation of Sox2 expression in Schwann cells through 
heterotypic Fibroblast/Schwann cell interactions mediated by ephrin-B/EphB2 
signalling (see Figure 6.1).  
 
Importantly, Sox2 expression was found to promote Schwann cell-cell adhesion and 
furthermore, allowed directed and coordinated migration of Schwann cells from the 
proximal stump into and across the site of injury (nerve bridge) in injured nerve 
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(Parrinello et al., 2010) (see Figure 6.2).  Consistent with these findings, a study by 
Seggio et al. (2010) demonstrated, in the absence of other cues, that Schwann cell 
orientation alone was sufficient to direct axonal re-growth in vitro.  Thus, the 
collective migration of Schwann cells into the disorganised tissue milieu of the 
nerve-bridge (site of transection), which we showed occurs prior to axonal out-
growth,  is likely to aid regeneration by providing a favourable (guiding) substratum 
for axons to traverse the injury site in order to reconnect with distal targets, achieve 
re-innervation and complete the functional repair of the nerve (Parrinello et al., 2010; 
Scherer & Salzer, 2001). 
 
Sox2 is a transcription factor expressed early in the Schwann cell lineage, as well as 
after nerve injury, with a diverse range of transcriptional targets (Baer et al., 2007; 
Le et al., 2005a).  It is best characterised as playing a key role in maintaining the 
 
 
 
Figure 6.1 Schematic of the mechanism by which fibroblast/Schwann cell 
interactions promote Schwann cell-cell clustering after injury.  Heterotypic 
interactions occur between fibroblasts and Schwann cells mediated by Ephrin 
B/ephB2 signalling, which initiates repulsion between these cells and induces Sox2 
expression in Schwann cells.  Sox2 mediates the redistribution of N-cadherin to cell 
junctions and enhances homotypic Schwann cell-cell interactions leading to Schwann 
cell clustering, which is important for Schwann cell-directed re-growth of axons 
across the lesion following nerve transection. 
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pluripotency and self-renewal capabilities of embryonic stem cells (Chambers & 
Tomlinson, 2009), and has also been shown to reprogram somatic cells to generate 
pluripotent stem cells (Chambers & Tomlinson, 2009; Takahashi & Yamanaka, 
2006).  However, to our knowledge, this was the first time that Sox2 activity has 
been linked to the regulation of N-cadherin function to effect long-term changes in 
cell behaviour, notably the switching between repulsion and attraction, in order to   
coordinate the mass-movement of cells in response to positional cues provided by 
fibroblasts (Parrinello et al., 2010). 
 
Figure 6.2. Schematic illustrating the importance of Sox2 mediated Schwann 
cell-cell interactions during nerve regeneration.  Schwann cells present at the 
proximal stump up-regulate Sox2 following EphB2/EphrinB interactions with 
fibroblasts, which alters N-cadherin localisation at Schwann cell-cell junctions to 
promote clustering and drive a coordinated wave of Schwann cell migration across 
the nerve bridge.  Regenerating axons use these Schwann cell strands to traverse the 
nerve bridge and reconnect with distal portion of the nerve (Parrinello et al., 2010). 
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Future studies should aim to address the relationship between Sox2 and N-cadherin 
in Schwann cells.  In particular, it would be interesting to discover how Sox2 was 
directing and organising the sub-cellular localisation of N-cadherin at cell junctions.  
It is most plausible that Sox2 directs this process via transcriptional control of  target 
genes that are responsible redistributing N-cadherin.  Therefore, an analysis of Sox2 
binding sites would be a useful methodology for identifying Sox2 targets and thus, 
possible mediators in this process.  In addition, a useful tool to develop would be an 
N-cadherin-GFP fusion protein, which could be transfected into Schwann cells and 
visualised in live-cells by spinning-disc confocal microscopy to achieve high-
resolution video imaging of N-cadherin molecules in cells.  The sub-cellular 
localisation of N-cadherin could then be tracked following induction of Sox2 
expression, i.e. by using heterotypic Schwann cell/fibroblast cocultures, in order to 
discover how Sox2 remoulds N-cadherin junctions to enhance homotypic 
interactions.  In addition, this approach would also be useful for visualising the 
dynamics of N-cadherin at Schwann cell protrusions and in DRG cocultures, where it 
could provide further evidence for the involvement of  N-cadherin within these 
structures and also, in the dynamics of N-cadherin mediated Schwann cell/axonal 
recognition. 
 
6.4 Homophilic N-cadherin ligation between Schwann cells elicits 
an inhibitory effect on the cell-cycle 
 
The regulation of cell proliferation is of fundamental importance to Schwann cell 
biology throughout development and into adulthood.  In contrast to most 
differentiated mammalian cells, adult Schwann cells lack a defined stem-cell 
population.  They therefore retain an inherent capacity to dedifferentiate and re-enter 
the cell-cycle in order for Schwann cells to self-renew in response to nerve injury; 
however, this creates the potential for dysregulation and thus, Schwann cell 
proliferation is kept under tight regulatory control.  Additionally, during 
development, Schwann cell proliferation is required to match the number of 
Schwann cells with the number of axons, which is especially important during radial 
sorting (Court et al., 2006; Martin & Webster, 1973).  As Schwann cells prepare to 
myelinate, proliferation is attenuated and ensheathed Schwann cells assume a 
quiescent state, which is an essential pre-requisite for myelination.  The quiescent 
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state is maintained by close Schwann cell/axonal contact, in which the NRG1 signal 
is thought to play a role.  Intriguingly, this signal can elicit both mitotic and, albeit 
indirectly, inhibitory effects on Schwann cell proliferation depending on the 
developmental context.  In terms of the latter, this is mediated via NRG1 driving 
differentiation rather than inhibiting the cell-cycle per se.   For instance, in early 
development, NRG1 Type III-β1a acts as a potent mitogen for Schwann cell 
precursors and immature Schwann cells (Wolpowitz et al., 2000), while later in 
development, the same isoform of NRG1 drives Schwann cell differentiation 
(Michailov et al., 2004; Taveggia et al., 2005).  As discussed, the quiescent state of 
the myelinated Schwann cell is not permanent but rather is susceptible to reversal  -
as is observed in injured nerves, where dissociated Schwann cells are found in a 
proliferating state.  Consistent with this, we have shown that loss of axonal-contact, 
following down-regulation of Sema4F, leads to a relaxation of cell-cycle inhibition 
in Schwann cells, which allows cell proliferation in non-associated Schwann cells in 
the presence of exogenous mitogens (Parrinello et al., 2008).   
 
In the current work, I show that N-cadherin mediated Schwann cell-cell interactions 
elicited a cell-cycle inhibitory effect on Schwann cells in vitro.  In normal homotypic 
Schwann cell-cell interactions, as observed in cultured NS cells, the rate of 
proliferation attenuates as cultures reach confluence and importantly, the Schwann 
cell monolayer in these cultures is maintained despite increased cellular density.  
These observation can be explained in terms of a mechanism based on CIP (Tikoo et 
al., 2000).  Findings from the current work, in which N-cadherin was specifically 
depleted, showed that Schwann cell proliferation was not attenuated at confluence 
and furthermore, Schwann cells would often extend processes over one another 
rather than forming a tight monolayer, resulting in the appearance of disorganised 
Schwann cell monocultures in vitro.  Together, these findings suggest a role for N-
cadherin in Schwann cell CIP.  This is not an unprecedented finding as cadherin 
mediated CIP has previously been reported.  For instance, E-cadherin has been 
shown to mediate CIP in epithelial cells (Perrais et al., 2007).  In addition, a study by 
Levenberg et al. (1999), using Chinese Hamster Ovary (CHO) clones with 
incremental N-cadherin expression, showed that increasing N-cadherin expression 
resulted in a proportional decline in cell proliferation at confluence.  They found that 
this effect was mediated through p27, which arrested the cell-cycle in G1.  This work 
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appears to be contradictory to a study by Fairless et al. (2005), that found that 
Schwann cell proliferation, as measured by BrdU incorporation, was not affected in 
siRNA mediated N-cadherin knockdown Schwann cells in vitro.  A possible 
explanation for this discrepancy, as acknowledged by the authors, was that the level 
of N-cadherin knockdown achieved was only partial, which they suggest was due to 
the incomplete transfection of N-cadherin siRNA into Schwann cells.   
 
While cadherins mediate cell-cell adhesive contacts, it is still unclear how they (or 
associated intracellular and/or membrane proteins) signal to convey that information 
to the cell nucleus in order to effect cell-cycle inhibition (Perrais et al., 2007).  In 
addition, there is some degree of conjecture as to whether cadherin ligation promotes 
or inhibits proliferation.  For example, a study by Gess et al. (2008) found that β-
catenin signalling elicited a mitogenic effect on Schwann cells, where nuclear 
translocation of β-catenin was sufficient to transactivate various pro-mitotic genes 
including LEF/TCF transcription factors and cyclin-D1 (Shtutman et al., 1999).  
However, these findings are contradictory to the earlier study by Perrais et al. (2007), 
who showed that cadherin homophilic ligation was inhibitory to cell proliferation 
through modulation (and subsequent inactivation) of growth factor receptors, for 
example the EGF receptor.  In addition, the localisation of Merlin/NF2 to mature 
cadherin-based adherens junctions has also been shown to be inhibitory to cell 
proliferation (Curto et al., 2007; McClatchey & Fehon, 2009).  The importance of 
this tumour suppressor in Schwann cell proliferation is demonstrated by its loss, 
which is implicated in elevated proliferation in a number of cell-types (Lallemand et 
al., 2009) as well as tumorigenicity, for example the formation of homogenous 
Schwann cell tumours termed schwannomas that are a hallmark of 
Neurofibromatosis Type II (Begnami et al., 2007).  Merlin/NF2 functions to suppress 
cell proliferation in addition to its shared role with other ERM (ezrin, radixin, 
moesin) proteins as an organiser of the actin cytoskeleton (Lallemand et al., 2009).  
Importantly, a functional role for Merlin in CIP relies on extracellular cues to gauge 
cell-density, of which the cadherins, known to interact with Merlin, are ideally 
placed.  Thus, it is plausible that loss of N-cadherin prevents correct Merlin function 
in Schwann cells, which might explain continued cell proliferation at cell confluence.  
Clearly, further studies are required to understand the complexities involved and 
indeed, the functional relevance of this to the nerve - although in terms of the latter, 
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it is clearly advantageous to have a cell-density dependent mechanism to attenuate 
hyper-proliferation. 
 
6.5 Early mediators of heterotypic Schwann cell/axonal 
interactions 
 
Heterotypic interactions between Schwann cells and axons are a central defining 
feature of Schwann cells.  Initial interactions between Schwann cell and axons occur 
early in development and, in the healthy nerve, are maintained for life (Jessen & 
Mirsky, 2005).  However, these interactions are recapitulated in damaged nerve, 
where dedifferentiated  'injury' Schwann cells are required to re-discover and re-
associate with axons following axonal regeneration (Chen et al., 2007).  In the 
current thesis, I described the role of two early mediators of Schwann cell/axonal 
interactions, N-cadherin and Semaphorin-4F (Sema4F) and suggest how both CAMs 
are operating at distinct stages of the interaction process.  
 
6.5.1 A role for N-cadherin 
 
In the current thesis, I showed that homophilic trans-ligation between N-cadherin 
dimers, expressed on both Schwann cells and axons, was important for mediating an 
initial adhesive interaction between these cells.  This initial interaction is fairly weak, 
consistent with N-cadherin mediating a transient cell-cell interaction, as reported in 
other cell systems (Gumbiner, 2005; Patel et al., 2003), and later strengthens as the 
junction matures (Bayas et al., 2006).  The evidence I presented suggests that N-
cadherin operates at cell protrusions as part of a mechanism, orchestrated by these 
sub-cellular structures, for mediating contact-dependent recognition between 
Schwann cells and axons.   
 
The cellular environment of the nerve is heterogeneous, comprising of multiple  cell-
types all of which react differently to encounters with one another (homotypically) or 
with different cell-types (heterotypically).  The behavioural response to an encounter 
depends on the repertoire of cell-surface expressed molecules, which can elicit 
neural, attractive or repulsive responses.  For instance, in low-density cultures, 
Schwann cell/Schwann cell encounters generally lead to repulsion, Schwann 
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cell/axonal encounters lead to attraction, fibroblast/axonal encounters are neutral and 
fibroblast/Schwann cell encounters are repulsive.  In addition, the behavioural 
response to cell encounters can be altered by previous heterotypic signalling, as 
demonstrated by Schwann cell/fibroblast interactions (discussed previously).  Thus, 
there is a plausible case for recognition mechanism in order that Schwann cells can 
discern axons from other cell types in the nerve.  Recognition is logically an 
important first-step in the Schwann cell/axonal interaction programme, both in 
development and following nerve injury.  For instance, early Schwann cell 
progenitors, for example SCPs, need to distinguish axons from other cell-types 
present in the milieu of the prospective nerve.  Similarly, dissociated Schwann cells, 
found in the injured nerve, need to identify new axonal targets from the 
heterogeneous environment of the lesion, in order to re-associate and regenerate 
myelinated fibres.   
 
Evidence to support the role of N-cadherin and Schwann cell protrusions in contact 
recognition are several fold.  First, the unique bi- and tri-polar morphology of non-
associated Schwann cells, which typically project several expansive lamellipodia-like 
protrusions, is indicative of searching behaviour.  As shown by time-lapse videos, 
when Schwann cells are seeded onto DRG-axonal cultures, they will migrate, 
apparently in random directions, in order to locate axons to associate with.  The first 
point of contact is usually the tip of one of these Schwann cells protrusions, which 
elicits an immediate behavioural response by the Schwann cell, resulting in axonal-
'grasping' followed by Schwann cell/axonal association.  Therefore, it is likely that 
these structures primarily function in Schwann cell-directed acquisition and 
recognition of axons.  Second, I showed that N-cadherin was asymmetrically 
localised to the cytoplasmic lamellipodia-like protrusions of non-associated Schwann 
cells prior to contacting axons, which implicates N-cadherin as playing a role in 
these structures for mediating interaction with axons.  Consistent with this, I showed 
that the depletion of N-cadherin from Schwann cells severely affected their ability to 
associate and align with DRG-axons in vitro and time-lapse analysis showed that this 
defect was caused by a failure of Schwann cell recognition for axons in their 
cytoplasmic protrusions.  Lastly, heterologous expression of N-cadherin in 
fibroblasts was sufficient to cause an otherwise non-axonal-interacting cell-type to 
radically alter its behaviour and grasp, manipulate and partially associate with axons.  
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Thus, N-cadherin expression alone is not only sufficient to change the behaviour of 
the fibroblast/axonal encounter from neutral to attractive but also allows the 
fibroblast to pull, grab and manipulate axons in a similar fashion to Schwann cells.  
This suggests that fibroblasts have all the necessary components to interact with 
axons apart from N-cadherin.    
 
Collectively, these findings raises an intriguing question - if both Schwann 
cell/Schwann cell and Schwann cell/axonal interactions are initiated following 
homophilic N-cadherin-N-cadherin ligation, then how do Schwann cells differentiate 
their response to both encounters, i.e. repulsion in the case of the former and 
association in terms of the latter? Heterologous expression of N-cadherin in 
fibroblasts suggest that N-cadherin is sufficient for otherwise non-interacting cells to 
associate with axons.  However, it is likely that other CAMs or the cylindrical 
morphology of the axon is required for the Schwann cell/axonal specific response 
whereas in the case of Schwann cell/Schwann cell encounters there are likely to be 
surface expressed molecules that instigate repulsion.  If this were correct, then these 
molecules are likely to be inactivated or over-expressed upon Sox2 expression, 
which is permissive for Schwann cell cluster formation.  Thus, there are likely to be 
other molecules involved in these interactions and future studies should aim to 
identify the additional molecules involved in mediating the distinct responses 
exhibited by Schwann cell/Schwann cell and Schwann cell/axonal interactions. 
 
6.5.2 Distinct roles for Semaphorin-4F and N-cadherin 
 
While N-cadherin is an important mediator of early Schwann cell/axonal 
interactions, its loss from Schwann cells only accounts for a 40% reduction in 
Schwann cell/axonal association.  This implies that an additional CAM (or CAMs) 
were partially compensating for the loss of N-cadherin.  In addition, time-lapse 
videos of N-cadherin-depleted Schwann cells, showed that a proportion of these cells 
were able to associate with axons, albeit with less efficiency, despite the ablation of 
Schwann cell/axonal 'grabbing-like' behaviour at Schwann cell protrusions.  These 
interactions appeared to be mediated not by Schwann cell/axonal contact at cell 
protrusions but with the 'bulk' of the cell, which appears to adhere to the axon.  In the 
current work, I investigated the dual roles of Sema4F, which is also down-regulated 
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in LTD cells, and N-cadherin in the normal Schwann cell/axonal interaction 
programme.   
 
We previously showed that Sema4F expression by Schwann cells was important in 
both mediating interactions with axons and for the stability of existing interactions 
(Parrinello et al., 2008).  In terms of the latter, we found that Sema4F was down-
regulated in Schwann cells upon Ras/Raf/ERK activation, a signalling pathway 
dysregulated in Neurofibromatosis type 1, and that loss of Sema4F was instrumental 
to loss of Schwann cell/axonal interactions, which is an important first stage in 
tumourgenesis. Importantly, Sema4F expression is lost from at least three different 
human neurofibroma cell-lines, NF88-3, NF90-8, and ST88-14, with all three tumour 
lines exhibiting defective Schwann cell/axonal interaction in vitro (Parrinello et al., 
2008).  The semaphorins are a large family of axon guidance molecules that 
classically operate to direct axons by providing either attractive or repulsive signals 
to growing axonal growth-cones (Kruger et al., 2005).  The discovery that Sema4F 
was performing a cell-adhesion function by mediating relatively stable interactions 
between Schwann cells and axons was a surprising finding as they have not typically 
been reported in the literature as functioning as a CAM.   
 
In the current work, I showed, consistent with Parrinello et al., (2008)'s study, that 
depletion of Sema4F from Schwann cells was sufficient to disrupt axonal association 
and alignment to a similar extent to that observed in N-cadherin depleted Schwann 
cell/DRG-axon cocultures.  Moreover, the action of both N-cadherin and Sema4F 
appeared to be mutually exclusive in that loss of both alone resulted in a similar 
degree of interaction impairment, while combined loss of N-cadherin and Sema4F 
resulted in an additive increase in phenotypic severity.  This suggested that both 
molecules were mediating distinct parts of the interaction.  As previously discussed, 
N-cadherin mediates the recognition of axons by Schwann cells; however, a 
proportion of N-cadherin depleted cells are able to associate, presumably through 
compensatory mechanisms, and these Schwann cell/axonal associations are generally 
maintained.  On the other hand, depletion of Sema4F did not affect recognition as 
Schwann cells were still capable of grasping axons with their cytoplasmic 
protrusions.  However, as with the Ras-activated Schwann cells, Sema4F depleted 
Schwann cells were prone to spontaneous dissociation from axons. Together, these 
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findings suggested that while N-cadherin mediates contact recognition between 
Schwann cells and axons, Sema4F is likely to be involved in stabilising early 
heterotypic interactions rather than mediating recognition.  Importantly, Sema4F was 
not compensating by fulfilling the same functional role as N-cadherin, i.e. in axonal 
recognition at cell protrusions.  Rather, Sema4F had a distinct role in stabilising the 
interaction, while N-cadherin had a distinct role at cytoplasmic protrusions to 
mediate recognition.  In the absence of studies to determine the developmental 
expression of semaphorins in Schwann cells and axons, it still remains to be 
determined whether Sema4F plays a significant role in myelination and the 
homeostatic nerve; however, semaphorins are expressed in myelinated nerve 
(Spiegel et al., 2006) and we have demonstrated that loss of Sema4F, following 
Ras/Raf/ERK signalling, initiates Schwann cell/axonal dissociation in NF1 patients - 
implicating its involvement in the stability of homeostatic nerve (Parrinello et al., 
2008).    
 
A remaining question to address is whether N-cadherin and Sema4F are sufficient 
alone to mediate early Schwann cell/axonal interactions or whether other CAMs are 
needed.  In the current work, I showed that combined loss of N-cadherin and Sema4F 
resulted in ca. 70% disruption in normal interactions, although approximately half of 
these double-knockdown Schwann cells were still associated (although not aligned).  
However, an important caveat for these experiments is that double siRNA 
knockdown transfections for N-cadherin and Sema4F may not result in the complete 
knockdown of both genes in Schwann cells.  Thus, the reported 70% impairment 
might underplay the actual involvement of these CAMs.  Nevertheless, when 
interactions were quantified for LTD (non-interacting) cells, the results show that 
over 95% of interactions were disrupted and, of these, 85% were found not 
associated with axons.  Thus, while both N-cadherin and Sema4F are clearly the 
main mediators of early Schwann cell/axonal interactions, there are likely to be other 
CAMs which are compensating for their loss in the double knockdown condition.  
Given this, future studies should consider the role of additional CAMs in mediating 
Schwann cell/axonal interactions (discussed in the next section).  In addition, in light 
of the caveat discussed earlier, it would be advantageous to study N-cadherin and 
Sema4F using Schwann cells derived from mouse knockout models where depletion 
of both N-cadherin and Sema4F can be guaranteed.  In terms of the former, Lewallen 
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et al. (2011) have since developed a Schwann cell specific N-cadherin knockout 
mouse; however, to our knowledge, a Sema4F Schwann cell knockout has not been 
developed.  Another useful tool would be to develop a Sema4F antibody, which 
would allow confirmation of Sema4F knockdown at the protein level, as well as 
provide clarity on its cellular localisation. 
 
6.5.3 Identifying CAMs as mediators of heterotypic interaction 
 
In Chapter Three, I described a microarray experiment to analyse expression changes 
between LT interacting Schwann cells (LTNS) and LT non-interacting Schwann 
cells (LTD).  One important finding from this work was that a large group of CAMs 
had become dysregulated, including N-cadherin and Sema4F, both of which were 
investigated in this thesis.  In order to examine these results further, I sought to 
validate my approach by cross-referencing my data with data from a screen 
conducted by Spiegel et al., (2006), who used a signal-sequence-trap (SST) 
technique in order to identify the repertoire of CAMs expressed by axons and 
differentiated (myelinated) Schwann cells.  In this pioneering work, the authors 
screened for mRNA that contained the eukaryotic cell-surface localisation signal, 
which encodes a short amino-terminal hydrophobic peptide thought to direct the 
transport of proteins towards the cell surface for membrane tethering or secretion.  
The authors obtained RNA from differentiated Schwann cells, which had been 
treated with the cAMP analogue dibutyryl cAMP (dbcAMP), and from rat sciatic 
nerve, and thus does not directly examine mediators of early Schwann cell/axonal 
interaction.  There were some caveats to this work as discussed by the authors, for 
instance the SST method is less reliable at detecting some extracellular proteins, for 
example tetra-spanning transmembrane proteins.  Nonetheless, the study expanded 
the number of putative candidates for Schwann cell/axonal interactions; for example, 
data from this study led the authors to identify the nectin-like (Necl/SynCAM) 
proteins, in which they and others later found that axonal expressed Necl-1 and 
Schwann cell expressed Necl-4 were essential mediators of Schwann cell/axonal 
interaction that were required for myelination (Maurel et al., 2007; Spiegel et al., 
2007).  In their SST screen, Spiegel et al. (2006) identified 159 cDNA clones 
corresponding to cell-surface expressed molecules, of which 36% were expressed 
exclusively in Schwann cells and 46% in sciatic nerve, while 18% were expressed by 
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both Schwann cells and axon.  The study revealed a number of functional groups 
including genes involved in cell adhesion, extracellular matrix, receptor signalling, 
growth and differentiation, endoplasmic reticulum (ER), golgi and ectoenzymes.  
The two main groups of CAMs identified included tetraspanin proteins, for example 
PMP-22, Claudin-19, and the IgCAMs, for example MPZ/P0, MAG, neurofascin and 
nrCAM. 
 
As this study provides an authoritative list of CAMs in myelinated Schwann cells, I 
decided to examine their findings in the context of my LT microarray data (described 
in Chapter Three).  In particular I wanted to examine adhesion genes down-regulated 
in LTD cells as this implies that they are normally expressed by interacting Schwann 
cells.  Prior to performing the analysis, I re-annotated the gene list from the CAM 
Table published by Spiegel et al. (2006), using DAVID (as described) in order to 
ensure that both datasets were using the most recent gene annotations.  This process 
inevitably led to the removal of some genes (see Table 6.1 legend for full details).  I 
then cross-referenced the Spiegel et al. (2006) CAM list with the significant gene list 
from the LT microarray (Dataset E) and presented the corresponding genes present 
in both studies (yellow highlight indicates correspondence) (Table 6.1). 
 
 
Table 6.1 A comparison of CAMs identified in the Speigel et al., (2006)  
study against dysregulated genes in the LT microarray   
 
Official Gene Name/Description LT Array fold-change FDR 
CD24 molecule n.s.  
CD34 molecule -  
CD164 molecule, sialomucin n.s.  
Endoglin n.s.  
similar to cDNA sequence BC013529 n.s.  
similar to HTGN29 protein  n.s.  
syndecan 2 n.s.  
syndecan 3 n.s.  
syndecan 4 n.s.  
Cd63 molecule n.s.  
Cd81 molecule n.s.  
Cd82 molecule n.s.  
claudin 19 -2.7890 0.00343 
epithelial membrane protein 1 n.s.  
peripheral myelin protein 22 -140.8386 0.00050 
Cd44 molecule n.s.  
CD97 molecule n.s.  
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glycoprotein (transmembrane) nmb/Osteoactivin 6.0693 0.00579 
[Obsolete Record  'similar to AU040320 (PKD1-
like)] 
-  
myelin protein zero -189.8566 0.00112 
inducible T-cell co-stimulator ligand -  
Basigin n.s.  
[obsolete record 'Zig-1'] -  
Neurotrimin n.s.  
interleukin 1 receptor accessory protein -3.8390 0.00195 
cell adhesion molecule 3/Necl-1 n.s.  
cell adhesion molecule 1/Necl-2 2.2333 0.01138 
cell adhesion molecule 4/Necl-4* -10.6866 0.00073 
myelin-associated glycoprotein n.s.  
activated leukocyte cell adhesion molecule n.s.  
melanoma cell adhesion molecule -17.2076 0.00122 
neuronal cell adhesion molecule 16.8809 0.00196 
Neurofascin n.s.  
DiGeorge syndrome critical region gene 2* n.s.  
FXYD domain-containing ion transport regulator 5 -3.8938 0.00142 
integrin alpha 7 4.1901 0.00573 
integrin beta 8 -  
low density lipoprotein-related protein 12 n.s.  
milk fat globule-EGF factor 8 protein n.s.  
cadherin 2/N-cadherin -9.1274 0.00060 
neuropilin 2 n.s.  
Notch homolog 2 (Drosophila) n.s.  
olfactomedin-like 2B -2.1604 0.05719 
sema domain, immunoglobulin domain (Ig), short 
basic domain, secreted, (semaphorin) 3B 
-8.4867 0.00221 
sema domain, transmembrane domain (TM), and 
cytoplasmic domain, (semaphorin) 6D 
-26.7105 0.00590 
phosphoinositide-3-kinase interacting protein 1 -2.2706 0.03686 
pituitary tumor-transforming 1 interacting protein n.s.  
plexin domain containing 2 n.s.  
amyloid beta (A4) precursor protein -6.4600 0.00100 
Vasorin n.s.  
delta-like 1 homolog (Drosophila) n.s.  
 
Table of analysis: cross-referencing data from Spiegel et al., (2006) study  to the current 
microarray findings.  Validating genes are highlighted in yellow.  For completeness, the 
stringency of the FDR (false-discovery rate) has been lowered to 0.1 (the FDR for each gene 
is stated next to the Fold-Change value). ( - ): not-present (the gene was not included in the 
probesets for the Rat230-2 array; NS: not-significant (the gene was not significantly 
detected).  [ ] denote genes from the Spiegel study which no longer have valid Entrez Ids and 
* denotes genes derived from ESTs (from  the Spiegel et al., (2006) study) with GenBank 
accession numbers that have since become obsolete or rescinded - however, they are 
included in the analysis for completeness. 
 
This analysis showed that of the 51 CAMs identified in Spiegel et al., (2006)'s SST 
screen as being expressed by myelinating Schwann cells and axons, 17 CAMs (33%) 
were also found to be significantly dysregulated in LTD cells.  These include, N-
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cadherin/cadherin-2, Sema3B, Sema6D, melanoma (m)CAM, nrCAM and Necl4/cell 
adhesion molecule-4 as well as a number of myelin genes: MPZ, PMP-22 and 
claudin-19.  These findings validate the methodology and approach adopted in this 
thesis for identifying adhesion molecules, normally expressed by Schwann cells, that 
are also important for mediating Schwann cell/axonal interactions.  Interestingly, 
while a number of semaphorins and their receptors, i.e. plexin and neuropillin-2, 
were identified, Sema4F was not detected in the SST screen.  A significant finding 
from the SST screen was the asymmetric expression of Necl proteins between 
Schwann cells and axons, which led to the subsequent identification of this group of 
CAMs as mediators of Schwann cell/axonal interactions (Maurel et al., 2007; Spiegel 
et al., 2007).  These studies showed that Schwann cell-expressed Necl-4 (cell 
adhesion molecul-4) and axonal-expressed Necl-1 (cell adhesion molecule-3), were 
important mediators of heterotypic Schwann cell/axonal interactions in myelinated 
nerves.  Moreover, this interaction was required for myelination.  Consistent with 
their findings, the LT microarray data indicate that Necl-4 was down-regulated 10-
fold in LTD non-interacting cells.  Therefore, Necl-4 (and other Necl members) are 
promising candidates for further study in relation to early mediators of Schwann 
cell/axonal interaction.  It would also be interesting to investigate the function of 
mCAM, which has been shown to bind the ECM component laminin-411  (Flanagan 
et al., 2012) as well as nrCAM, which is involved in Sodium channel clustering at 
the Node of Ranvier (Feinberg et al., 2010). 
 
In addition to CAMs validated by the SST screen, there were also a number of 
dysregulated CAMs in LTD cells that were not discovered by the SST screen, many 
of which have not previously been associated with Schwann cell/axonal interactions.  
These include a number of cadherins, for example cadherin-6 and cadherin-15, as 
well as protocadherins α4, α7 and α21.  There were also two atypical flamingo-like 
cadherins identified (Celsr1/flamingo homolog-1 and Celsr2), which are seven-pass 
transmembrane adhesion proteins (Hadjantonakis et al., 1997).  Another interesting 
discovery was the identification of ninjurin 1 (down-regulated 3-fold in LTD cells), 
which has recently been implicated in leprosy (Graca et al., 2012) - a disease whose 
aetiology is linked to Schwann cells.  CD9 (down-regulated 2-fold in LTD cells) - a 
tetraspanin adhesion molecule - was also identified and has previously been shown to 
interact with various integrins, and moreover is expressed by denervated Schwann 
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cells in regenerating nerve (Cavalcanti et al., 2009).  Finally, two genes which were 
substantially down-regulated in LTD cells were periostin (osteoblast specific factor) 
(down-regulated 88-fold in LTD cells) and fibulin 5 (down-regulated 74-fold in LTD 
cells).  Fibulin-5 is an extracellular glycoprotein, involved in the regulation of the 
ECM and is part of large number of ECM related genes dysregulated in LTD cells 
(functional cluster analysis showed that ECM genes were the second most 
dysregulated functional group after cell adhesion).  Periostin is a secreted molecule 
that interacts with Wnt ligands to elevate Wnt signalling.  Interestingly, a recent 
study has discovered an important role for the wnt/β-catenin signalling pathway in 
Schwann cell myelination, with inhibition of the pathway leading to hypomyelinated 
nerves (Tawk et al., 2011). 
 
In terms of investigating these genes further in relation to early mediators of 
Schwann cell axonal interaction, it would be interesting to determine if any of these 
genes were acting with N-cadherin and Sema4F to mediate early interactions.  
Further studies could aim to clarify their role by adopting the siRNA approach and 
DRG association assay described in this thesis.  In addition to this, future studies 
should also examine further the role played by transcription factors.  In terms of the 
interaction defect exhibited by LTD cells, findings from this thesis suggest that Sox2 
is most likely not responsible for the axonal interaction deficiency.  However,   
dysregulation of transcription factors in LTD cells remains a plausible explanation as 
to how LTD cells possess an aberrant adhesion gene profile that is not permissive for 
axonal recognition and association.  Future studies should attempt to identify the 
defective regulator in LTD cells by considering the other 54 genes dysregulated in 
LTD (refer to Table 3.5), which have a function in transcriptional regulation.  
Possible regulators could be selected for further study following analysis of 
transcription factor binding sites on genes involved in adhesion.  However, one 
obvious example is Sox10, which was down-regulated 24-fold in LTD cells and is an 
important regulator of many aspects of Schwann cell biology.  A role for Sox10 
could be tested using an adenovirus expression system in order to drive Sox10 
expression in LTD cells.  DRG association assays could then be employed to 
determine if Sox10 re-expression could revert the LTD interaction impairment. 
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6.6 N-cadherin and stable Schwann cell/axonal interactions: 
polarisation and myelination 
 
I have previously described a model for the various processes involved in Schwann 
cell/axonal interactions.  Early interactions include recognition, association and 
alignment, where I have shown that N-cadherin mediates contact-recognition and is 
an important early mediator of association and alignment. Maturing interactions 
involve elongation, i.e. growth, and cellular polarisation, while later stable 
interactions are embodied by the differentiation of Schwann cells, the concentric 
wrapping of the axon by the Schwann cell and lastly the myelination of the axonal 
fibre.  Previous studies have shown that N-cadherin is asymmetrically localised in 
Schwann cells during the radial polarisation of the nerve fibre, where N-cadherin was 
found colocalised with the Par-3 protein along the adaxonal (inner) Schwann cell 
membrane which interfaces the axon (Chan et al., 2006; Lewallen et al., 2011).  
Several studies have also shown that N-cadherin expression persists in the nerve up 
until myelination (Crawford et al., 2008; Wanner et al., 2006a).  Moreover, N-
cadherin, as well as other CAMs including NCAM, are re-expressed in denervated 
Schwann cells (Thornton et al., 2005; Zelano et al., 2006) and expression of N-
cadherin during re-association and re-myelination is likely to mirror its role in 
development.  Thus, collectively, there is a compelling case for the involvement of 
N-cadherin in all parts of the interaction programme.   
 
Myelination is the culmination of a multi-step process of Schwann cell axonal 
interactions that includes polarisation but which is initiated by Schwann cell/axonal 
recognition.  In terms of polarisation, a role for N-cadherin has previously been 
investigated.  The aforementioned study by Chan et al. (2006) demonstrated the 
importance for the correct localisation of Par-3, which they found was required to 
enrich the adaxonal (axon-facing) membrane of the Schwann cell with the p75 
neurotrophin receptor (p75NTR), for which ligand-binding by BDNF is required for 
myelination (Chan et al., 2001).  Consistent with BDNF's function, they showed that 
disrupted Par-3 and therefore p75NTR localisation inhibited myelination; however, 
importantly for the current thesis, they also observed that N-cadherin was colocalised 
with Par-3 along the longitudinal axis of the axo-glial interface.  This was consistent 
with my findings, where I similarly found N-cadherin to be asymmetrically localised 
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at the Schwann cell/axonal interface of pre-myelinating cocultures.  This raises the 
intriguing question as to whether N-cadherin was involved in Schwann cell/axonal 
polarisation.  For instance, if homophilic N-cadherin ligation is required for initial 
contact between Schwann cells and axons, then it is plausible that this initial 
interaction could provide the first cellular cue as to the spatial orientation of the 
Schwann cell membrane with respect to the axon.   
 
A key question I attempted to address in the current thesis, was to what extent N-
cadherin loss in Schwann cells, prior to associating with axons, would have on the 
later myelination of axons.  For instance, does loss of Schwann cell/axonal 
recognition impair the efficiency of myelination?  To address this, I used an shRNA 
system to generate stable Schwann cell-lines in which N-cadherin was substantially 
reduced.  In subsequent myelination assays with shRNA-Schwann cell/DRG-axon 
cocultures, I found that N-cadherin depleted Schwann cells myelinated significantly 
less-efficiently than controls, which suggested that N-cadherin was required for 
normal myelination in vitro.  However, these finding were contradicted in a recent 
study by Lewallen et al. (2011), who also used an shRNA system to stably deplete 
N-cadherin from Schwann cells.  In this study, N-cadherin shRNA cells appeared 
align to axons and myelinate normally.  In addition, they used an N-cadherin 
lentivirus to introduce N-cadherin shRNA into axons and, following coculture with 
normal Schwann cells, found that axonal N-cadherin depletion did not affect Par-3 
localisation or myelination.  While their results appear to suggest that N-cadherin 
was not required for polarisation or myelination, they did report, in shRNA 
experiments, that myelination was delayed in N-cadherin deficient Schwann cells.  
For instance,  10-day old myelinating N-cadherin shRNA Schwann cell/DRG 
cocultures exhibited a significant two-fold reduction in myelination compared to 
control cocultures.  However, by day-15 this difference was no longer significant.  
Therefore, they concluded that the onset of myelination was delayed by at least five 
days in N-cadherin deficient Schwann cell/DRG cocultures in vitro.   
 
There are several reasons that might explain the discrepancy between the shRNA 
results from the current work (stated in Chapter Four) and the N-cadherin 
shRNA/myelinating study conducted by (Lewallen et al., 2011).  First, the age at 
which the myelinating cocultures were fixed differed slightly and, moreover the 
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culture systems and conditions adopted between the studies were also different.  For 
example, the study by Lewallen et al. (2011) used embryonic (E15) dissociated DRG 
cultures, while in the current thesis, I used postnatal (P1) explanted DRG cultures. 
These discrepancies may have impinged on the timing of myelination in the 
respective coculture systems. As discussed, in the Lewallen et al. (2011) paper, an 
important finding was that Schwann cell N-cadherin-loss was associated with the 
delayed-onset to myelination, with day-10 cocultures myelinating less-efficiently 
when compared to equivalent day-10 controls.  In this study, cocultures were fixed at 
day-10 and day-15, while in the current study cocultures were fixed at day-14.  
Therefore, one explanation for this discrepancy could have been in the choice of 
time-points used in the respective studies, i.e. the time at which the cocultures were 
fixed and myelination assayed.  Thus, in the current work, in which N-cadherin loss 
was shown to impair myelination, this might be mirroring the delayed myelination 
observed in the earlier day-10 cocultures of the Lewallen et al. (2011) study.   
Second, in the current study, although unlikely, it is possible that the selected shRNA 
N-cadherin Schwann cell line had unforeseen off-target affects not related to N-
cadherin knockdown.  Ideally, to control for this possibility, several shRNA cell lines 
should be incorporated into the experimental design; however, while three 
independent N-cadherin shRNA cell lines were developed, only one of these was 
found to reliably and efficiently knockdown N-cadherin (as discussed in Chapter 
Four) and thus, only one shRNA cell line was amenable for use in our myelination 
assay.  
 
In addition to their in vitro investigations, the authors of the Lewallen et al. (2011) 
study also developed two separate mouse models to investigate N-cadherin in 
polarisation and myelination.  The first model was a Schwann cell specific N-
cadherin knockout, which was generated by introducing loxP sites that flanked the 
first intron of the N-cadherin gene.  These mice were then crossed with cre 
(recombinase) mouse transgenics, in which cre expression was driven by the Dhh 
promoter.  As Dhh expression is induced at the transition from neural crest to SCPs 
at about E10-11 (in rodent) (Jessen & Mirsky, 2005), all subsequent Schwann cell 
lineage progeny up to and including mature adult Schwann cells should carry the 
ablated N-cadherin gene.  The data from these studies were found to replicate the 
previous in vitro shRNA analysis, in that myelination was delayed but overall was 
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unaffected.  The second mouse model was a Schwann cell specific β-catenin 
knockout generated from loxP sites that flanked intron 2 to intron 6 of the β-catenin 
gene.  These mice were similarly crossed with cre transgenics under the regulatory 
control of Dhh.  In these mice the delay to myelination was greater than with N-
cadherin ablation alone suggesting that β-catenin was compensating for N-cadherin 
loss although normal myelination was eventually achieved.  Taken together, it is 
likely that N-cadherin is important for the timing of myelination but is not required 
for myelination.  This suggests that while N-cadherin mediates contact recognition 
for axons, there are likely to be additional compensatory CAMs, for instance, 
Sema4F, that given sufficient time will allow Schwann cells to eventually associate 
with axons and achieve normal myelination. 
 
6.8 Conclusion 
 
The establishment of the complex, three-dimensional tissue architecture of the 
peripheral nerve, is critically dependent on cell-cell interactions mediated by the 
correct repertoire of cell-surface expressed CAMs.  These adhesion molecules are 
required for early neural development, for instance directing processes of cell 
migration, cell-sorting and Schwann cell/axonal interactions, and are also later 
required for tissue homeostasis in the functional adult nerve, where they maintain 
stable Schwann cell/axonal associations.  In addition, CAMs play pivotal roles 
during injury, in allowing the dissociation and re-association of Schwann cells with 
axons, which is fundamental to the repair process.  Dysregulation of cellular 
signalling pathways - and resulting aberrant expression of CAMs - has significant 
implications for otherwise stable, Schwann cell/axonal associations, which is 
demonstrated by the phenotypic severity of de-myelinating inherited neuropathies 
and nerve sheath tumours, for example neurofibroma.  In this thesis, I have 
highlighted a number of CAMs that play important roles in these processes, 
including N-cadherin and semaphorin-4F.  Understanding how these, and other 
CAMs, interact will have implications for our understanding of neuropathies and 
tumours, and may yield insights into enhancing regenerative outcomes following 
nerve injury.  Further work should continue to decipher the complexities of the 
reciprocal relationship between Schwann cells and axons, in order to truly 
understand their role in human health and disease.  
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Appendix 
 
Media & datasets located on the attached CD-ROM at the back of this thesis 
 
 
Time-lapse videos 
 
 
Video 3.1 NS interactions with DRGs 
 
Video 3.2 LTD interactions with DRGs 
 
Video 4.1 NS Ncad siRNA interactions with DRGs 
 
Video 4.2 Fb AdGFP interactions with DRGs 
 
Video 4.3 Fb AdNcad interactions with DRGs 
 
Video 5.1 NR Tmx Scram interactions with DRGs 
 
Video 5.2 NR Tmx siNcad interactions with DRGs 
 
 
Array datasets 
 
 
Dataset-A Full array list   
 
Dataset-B Annotated array 
 
Dataset-C Annotated array with reduced redundancy 
 
Dataset-D Significant genes: FDR<0.01, FC> 2 (up/down) 
 
Dataset-E Unique significant genes 
 
Dataset-F Gene cluster analysis 
 
Dataset-G Functional enrichment analysis 
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Appendix Tables 
 
 
(A)  Table showing the first 120 genes with (i) the greatest down-
regulation and (ii) the greatest up-regulation (from Dataset-E) 
 
 
Accession ID Gene Fold-change 
(i)   120 most down-regulated genes  
  
NM_017027 myelin protein zero -189.9 
AA943163 peripheral myelin protein 22 -140.8 
AI412746 tweety homolog 1 (Drosophila) -117.9 
AW532566 PDZ domain containing RING finger 3 -113.8 
NM_012610 nerve growth factor receptor (TNFR superfamily, member 16) -111.3 
AA925924 cytokine receptor-like factor 1 -103.5 
BI283881 actin filament associated protein 1-like 2 -91.4 
BM389026 periostin, osteoblast specific factor -87.6 
NM_019153 fibulin 5 -74.2 
AI599143 collagen, type XIV, alpha 1 -73.2 
NM_013191 S100 calcium binding protein B -67.1 
NM_130738 SNRPN upstream reading frame -64.9 
BF285019 sodium channel, voltage-gated, type VII, alpha -64.1 
AJ131902 growth arrest specific 7 -60.1 
AA892798 sclerostin domain containing 1 -57.2 
AA925717 apoptosis-associated tyrosine kinase -54.2 
X57764 endothelin receptor type B -53.1 
BM389001 procollagen, type IX, alpha 3 -51.6 
AW530272 EGF-like-domain, multiple 8 -48.1 
AW144676 similar to RNA binding motif, single stranded interacting protein 3 isoform 1 -44.9 
AW144660 secreted frizzled-related protein 1 -44.3 
AI385260 hypothetical LOC310540 -44.1 
AI059603 DEP domain containing 6 -43.9 
AF228917 zinc finger, DHHC-type containing 2 -43.5 
BF406693 laminin, alpha 4 -42.2 
BI288690 ectonucleoside triphosphate diphosphohydrolase 2 -42.1 
NM_031069 NEL-like 1 (chicken) -36.7 
BI286015 Ras association (RalGDS/AF-6) domain family member 4 -36.2 
AI230625 similar to Protein C8orf4 (Thyroid cancer protein 1) (TC-1) -35.5 
NM_022297 dimethylarginine dimethylaminohydrolase 1 -35.1 
M29294 small nuclear ribonucleoprotein polypeptide N -34.2 
AI717472 tyrosinase-related protein 1 -33.0 
AI071251 glypican 4 -32.4 
BF388057 hairy/enhancer-of-split related with YRPW motif 2 -30.3 
AI705040 CKLF-like MARVEL transmembrane domain containing 5 -30.2 
NM_017009 glial fibrillary acidic protein -29.6 
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NM_017229 phosphodiesterase 3B, cGMP-inhibited -29.5 
NM_012886 TIMP metallopeptidase inhibitor 3 -29.2 
AA996943 phosphatase and actin regulator 1 -28.8 
AI598833 LIM domain 7 -28.8 
AI171093 protein kinase C, theta -28.5 
BM386525 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D -26.7 
BM389302 nidogen 2 -25.7 
AI043817 pellino 2 -25.2 
NM_031783 neurofilament, light polypeptide -24.0 
NM_019193 SRY (sex determining region Y)-box 10 -23.8 
AI235948 nidogen 1 -22.9 
AI058424 leucine-rich repeat LGI family, member 4 -22.1 
AI176034 tenascin C -21.9 
BE108345 collagen, type XII, alpha 1 -20.8 
AI556075 frizzled homolog 8 (Drosophila) -20.6 
AW919178 Palmdelphin -20.1 
AI177031 phosphatidic acid phosphatase type 2B -19.5 
NM_012750 GDNF family receptor alpha 2 -19.5 
NM_012935 crystallin, alpha B -19.4 
BM387419 matrilin 2 -18.8 
BM388456 collagen, type XI, alpha 1 -18.7 
AW535310 ADAM metallopeptidase with thrombospondin type 1 motif, 5 -18.6 
BE111706 myristoylated alanine rich protein kinase C substrate -18.4 
BF557676 family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 -18.4 
AW533483 peripheral myelin protein 2 -18.1 
BI296384 KN motif and ankyrin repeat domains 4 -17.8 
AB035507 melanoma cell adhesion molecule -17.2 
AF081582 pleckstrin homology domain containing, family B (evectins) member 1 -16.9 
AW529672 zinc finger protein 536 -16.5 
NM_012880 superoxide dismutase 3, extracellular -16.4 
BG379319 transforming growth factor, beta induced -16.4 
BG380570 similar to RIKEN cDNA 1200009O22; EST AI316813 -16.3 
AA944398 fibulin 2 -16.3 
NM_021760 collagen, type V, alpha 3 -15.9 
AI013730 similar to hypothetical protein -15.4 
AI233246 insulin-like growth factor binding protein 7 -15.3 
BM388427 transmembrane protein 45A -15.2 
AF159103 tumor necrosis factor alpha induced protein 6 -15.0 
BE116590 adherens junction associated protein 1 -14.6 
NM_130429 lymphoid enhancer binding factor 1 -14.5 
AI179828 kelch-like 13 (Drosophila) -14.5 
BF283122 SH3 domain and tetratricopeptide repeats 2 -14.1 
BI287851 collagen, type VI, alpha 2 -14.0 
NM_017345 L1 cell adhesion molecule -14.0 
BI284296 G protein-coupled receptor 126 -13.5 
BG377201 Rho GTPase activating protein 24 -13.5 
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BI294932 similar to uncharacterized hypothalamus protein HSMNP1 -13.3 
AW522302 
similar to Galactosylceramide sulfotransferase (GalCer sulfotransferase) 
(Cerebroside sulfotransferase) (3-phosphoadenylylsulfate:galactosylceramide 
3-sulfotransferase) (3-phosphoadenosine-5phosphosulfate:GalCer 
sulfotransferase) 
-13.0 
BG381587 beta-site APP-cleaving enzyme 2 -12.9 
BG663483 protocadherin alpha 4 -12.8 
M94043 RAB38, member RAS oncogene family -12.8 
BI295963 similar to Protein C20orf158 -12.6 
BI295878 kynurenine aminotransferase III -12.1 
AA800701 similar to limb-bud and heart -12.0 
X04440 protein kinase C, beta -12.0 
AW529714 desert hedgehog homolog (Drosophila) -11.8 
BI274101 prostate transmembrane protein, androgen induced 1 -11.7 
NM_012817 insulin-like growth factor binding protein 5 -10.9 
BG671865 necdin homolog (mouse) -10.8 
BF407272 RPE-spondin -10.8 
NM_012959 GDNF family receptor alpha 1 -10.7 
AA943034 cell adhesion molecule 4 -10.7 
NM_053927 erythrocyte protein band 4.1-like 3 -10.5 
AI407898 immunoglobulin superfamily, member 11 -10.5 
AI176393 collagen, type IV, alpha 1 -10.5 
BE107450 neuronal regeneration related protein -10.3 
Z78279 collagen, type I, alpha 1 -10.3 
AW521619 ubiquitin specific protease 13 (isopeptidase T-3) -10.3 
L02530 frizzled homolog 2 (Drosophila) -10.2 
AB000779 phospholipase D1 -10.0 
BE108253 kinesin family member 5C -9.8 
BI302544 tandem C2 domains, nuclear -9.8 
AI180408 feline leukemia virus subgroup C cellular receptor family, member 2 -9.7 
BM389644 ras homolog gene family, member J -9.7 
BF546934 leucine rich repeat containing 4B -9.7 
U44948 cysteine and glycine-rich protein 2 -9.4 
AI072336 naked cuticle homolog 2 (Drosophila) -9.2 
NM_031333 cadherin 2 -9.1 
BI281705 collagen, type IV, alpha 2 -9.0 
BG380414 chemokine (C-X-C motif) ligand 14 -8.9 
NM_054008 response gene to complement 32 -8.8 
AW252169 lipoma HMGIC fusion partner -8.7 
BI295776 sorbin and SH3 domain containing 1 -8.6 
BI275485 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B -8.5 
(ii)   120 most up-regulated Genes  
  
U22520 chemokine (C-X-C motif) ligand 10 83.2 
NM_031518 Cd200 molecule 79.1 
AA819034 putative ISG12(b) protein 72.4 
AI409634 radical S-adenosyl methionine domain containing 2 62.1 
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AB001382 secreted phosphoprotein 1 58.2 
NM_053352 chemokine (C-X-C motif) receptor 7 50.8 
BF419319 2'-5'-oligoadenylate synthetase-like 48.8 
BI289546 brain expressed gene 4 47.6 
NM_017043 prostaglandin-endoperoxide synthase 1 47.5 
BE096523 interferon, alpha-inducible protein (clone IFI-15K) 43.1 
NM_016991 adrenergic, alpha-1B-, receptor 39.5 
NM_033237 galanin prepropeptide 37.8 
BE107296 ribosomal protein S6 kinase polypeptide 6 34.8 
NM_053779 serine (or cysteine) peptidase inhibitor, clade I, member 1 34.6 
AI603408 serum deprivation response 32.5 
BI290559 microsomal glutathione S-transferase 2 31.9 
AI072459 Eph receptor A4 30.2 
AI579422 brain expressed gene 1 28.2 
NM_030856 leucine rich repeat neuronal 3 28.1 
NM_053502 ATP-binding cassette, sub-family G (WHITE), member 1 27.7 
L09752 cyclin D2 26.5 
AI175048 SIX homeobox 1 25.7 
NM_133523 matrix metallopeptidase 3 25.6 
NM_053572 protocadherin 21 24.8 
AI716912 popeye domain-containing 3 22.0 
BG664080 similar to transmembrane 4 superfamily member 10 21.9 
D88250 complement component 1, s subcomponent 21.7 
BI303019 Periplakin 21.2 
L32601 aldo-keto reductase family 1, member C18 21.0 
AI716211 hypothetical LOC302884 19.6 
NM_031556 caveolin 1, caveolae protein 18.9 
AA901088 family with sequence similarity 167, member A 17.5 
AF177430 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 16.7 
BI290063 pleiomorphic adenoma gene 1 16.1 
AA819788 receptor (chemosensory) transporter protein 4 16.1 
BI286417 SIX homeobox 4 16.0 
BI275896 adipocyte-specific adhesion molecule 16.0 
BE098317 tumor necrosis factor receptor superfamily, member 26 15.8 
AI178793 mannosidase, alpha, class 2A, member 1 15.2 
BI276370 insulin-like growth factor 2 mRNA binding protein 1 14.9 
NM_032069 glutamate receptor interacting protein 1 14.8 
BI289459 similar to apolipoprotein L2; apolipoprotein L-II 14.8 
AA964219 lipase, endothelial 14.8 
AA963184 melanoma associated antigen (mutated) 1-like 1 14.6 
BI303853 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 14.4 
NM_053843 Fc fragment of IgG, low affinity IIa, receptor (CD32) 14.2 
NM_057191 kelch repeat and BTB (POZ) domain containing 10 14.0 
AI408343 similar to hypothetical protein LOC340061 13.6 
NM_013004 phosphate regulating endopeptidase homolog, X-linked 13.3 
NM_053573 olfactomedin 1 13.3 
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BG380684 reticulon 2 13.2 
AW526982 toll-like receptor 2 12.5 
NM_031544 adenosine monophosphate deaminase 3 12.5 
AF323608 fibrinogen-like 2 11.9 
BF419320 WNT1 inducible signaling pathway protein 1 11.3 
BF291123 similar to KIAA1217 11.2 
NM_012527 cholinergic receptor, muscarinic 3 11.2 
AA819458 chromodomain protein, Y chromosome-like 2 10.9 
AI599177 teashirt zinc finger homeobox 3 10.8 
NM_053897 coagulation factor II (thrombin) receptor-like 1 10.7 
U18772 neuronal pentraxin 1 10.7 
L07268 aquaporin 1 10.7 
BF289229 phospholipase A2 receptor 1 10.5 
BF288508 transmembrane protein 16A 10.1 
AI101388 B cell RAG associated protein 10.0 
BF281337 keratin 8 10.0 
AW530225 neuropeptide W 10.0 
AI233740 aldo-keto reductase family 1, member B8 9.7 
AW534737 basonuclin 2 9.6 
NM_080688 phospholipase C, delta 4 9.4 
D78610 protein tyrosine phosphatase, receptor type, E 9.2 
NM_134455 chemokine (C-X3-C motif) ligand 1 8.9 
AI234287 MAM domain containing 2 8.8 
AW523000 cadherin 15 8.6 
BF282370 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial 8.5 
NM_053346 neuritin 1 8.4 
AI575264 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 8.2 
AA963276 ets variant 1 8.1 
BE101834 laminin, beta 3 7.9 
BF393945 Ral GEF with PH domain and SH3 binding motif 2 7.9 
BI298356 four and a half LIM domains 1 7.9 
AW140991 regulator of G-protein signaling 17 7.8 
BI283829 transmembrane 6 superfamily member 1 7.7 
BF284360 X-linked Kx blood group (McLeod syndrome) homolog 7.4 
AA012755 tropomyosin 2 7.3 
BI289088 heat shock transcription factor 2 binding protein 7.2 
NM_021693 SNF1-like kinase 7.2 
AI232036 ATPase, Na+/K+ transporting, beta 1 polypeptide 7.1 
NM_053968 metallothionein 3 6.6 
NM_053530 twist homolog 1 (Drosophila) 6.5 
NM_012627 protein kinase inhibitor beta, (cAMP-dependent, catalytic) inhibitor beta 6.4 
BI288816 Ras-related GTP binding D 6.4 
BF398531 B-cell CLL/lymphoma 11B (zinc finger protein) 6.4 
AW531805 interferon-induced protein with tetratricopeptide repeats 3 6.4 
AF075704 solute carrier family 38, member 1 6.3 
BI279663 desmocollin 2 6.2 
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AI232065 Rho GTPase activating protein 18 6.1 
NM_133298 glycoprotein (transmembrane) nmb 6.1 
AI555447 RGD1565975 6.0 
AI179321 dual specificity phosphatase 9 6.0 
BE102693 solute carrier family 35, member F2 5.9 
NM_012673 Thy-1 cell surface antigen 5.9 
BE109193 translocation associated membrane protein 1-like 1 5.9 
NM_012528 cholinergic receptor, nicotinic, beta 1 (muscle) 5.8 
AI717736 apolipoprotein L 9a 5.7 
NM_031802 gamma-aminobutyric acid (GABA) B receptor 2 5.7 
AI716026 myotubularin related protein 11 5.7 
BG371594 fibroblast growth factor 9 5.6 
BI292425 complement component 1, r subcomponent 5.6 
AI410264 tetraspanin 12 5.5 
AW915529 schlafen 2 5.4 
AF474979 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 5.4 
BF414160 insulin-like growth factor 2 mRNA binding protein 3 5.4 
BM384457 Rho GTPase activating protein 22 5.3 
BE117444 teashirt zinc finger homeobox 1 5.3 
BE099622 obscurin-like 1 5.3 
NM_012907 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 5.3 
NM_130419 discoidin, CUB and LCCL domain containing 2 5.3 
M37394 epidermal growth factor receptor 5.2 
NM_053687 schlafen 3 5.2 
 
Gene list illustrating (part i) the greatest 120 down-regulated genes, and (part ii) the greatest 120 up-
regulated genes. (FDR<0.01, FC>2 up/down). Genes of special interest are highlighted in yellow. 
 
 
 
(B)  Analysis of probesets and target sequences comprising the Rat 
230-2 array 
 
 
Code Source Type Entire dataset Non-annotated only Annotated only 
    %  %  % 
AA GenBank EST 2341 7.5 875 8.1 1466 7.2 
AB DDBJ Direct sub 132 0.4 2 0.0 130 0.6 
AF GenBank Direct sub 494 1.6 8 0.1 486 2.4 
AI GenBank EST 6821 22.0 2579 23.9 4242 20.9 
AJ EMBL Direct sub 65 0.2 1 0.0 64 0.3 
AT DDBJ EST 7 0.0 7 0.1 0 0.0 
AW GenBank EST 2229 7.2 963 8.9 1266 6.2 
AY GenBank Direct sub 35 0.1 0 0.0 35 0.2 
BE GenBank EST 2958 9.5 1324 12.3 1634 8.1 
BF GenBank EST 5728 18.5 3082 28.6 2646 13.1 
BG GenBank EST 1453 4.7 482 4.5 971 4.8 
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BI GenBank EST 3155 10.2 957 8.9 2198 10.8 
BM GenBank EST 1474 4.7 417 3.9 1057 5.2 
C DDBJ EST 10 0.0 5 0.0 5 0.0 
D DDBJ Direct sub 100 0.3 2 0.0 98 0.5 
H GenBank EST 108 0.3 36 0.3 72 0.4 
J GenBank GSDB direct sub 40 0.1 1 0.0 39 0.2 
K GenBank GSDB direct sub 4 0.0 0 0.0 4 0.0 
L GenBank GSDB direct sub 106 0.3 5 0.0 101 0.5 
M GenBank GSDB direct sub 208 0.7 5 0.0 203 1.0 
N GenBank & DDBJ 
EST, since been 
removed 1 0.0 0 0.0 1 0.0 
NM RefSeq mRNA validated 3170 10.2 5 0.0 3165 15.6 
R GenBank EST 2 0.0 1 0.0 1 0.0 
S GenBank Journal scanning 5 0.0 1 0.0 4 0.0 
U GenBank Direct sub 274 0.9 6 0.1 268 1.3 
V EMBL Direct sub 1 0.0 0 0.0 1 0.0 
X EMBL Direct sub 86 0.3 5 0.0 81 0.4 
Y EMBL Direct sub 25 0.1 0 0.0 25 0.1 
Z EMBL Direct sub 10 0.0 2 0.0 8 0.0 
  Totals: 31042 100 10771 100 20271 100 
 
Depositories include EMBL (European Molecular Biology Laboratory), DDBJ (DNA Data 
Bank of Japan), GenBank (Genetic Sequence database) and RefSeq (Reference Sequence) 
database. 
 
 
(C)  List of databases/resources used for functional annotation 
 
 
 Database/resource Genes with term % 
    
Functional categories   
 *COG_ONTOLOGY    71 7.8% 
 PIR_SEQ_FEATURE    59 6.5% 
 SP_COMMENT_TYPE    503 55.3% 
 *SP_PIR_KEYWORDS    541 59.5% 
 *UP_SEQ_FEATURE    459 50.5% 
Gene ontology   
 GOTERM_BP_1    611 67.2% 
 GOTERM_BP_2    609 67.0% 
 GOTERM_BP_3    573 63.0% 
 GOTERM_BP_4    560 61.6% 
 GOTERM_BP_5    523 57.5% 
 GOTERM_BP_ALL    613 67.4% 
 *GOTERM_BP_FAT     583 64.1% 
 GOTERM_CC_1    648 71.3% 
 GOTERM_CC_2    626 68.9% 
 GOTERM_CC_3    625 68.8% 
 GOTERM_CC_4    585 64.4% 
 GOTERM_CC_5    570 62.7% 
 GOTERM_CC_ALL    648 71.3% 
 *GOTERM_CC_FAT     546 60.1% 
 GOTERM_MF_1    688 75.7% 
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 GOTERM_MF_2    674 74.1% 
 GOTERM_MF_3    560 61.6% 
 GOTERM_MF_4    503 55.3% 
 GOTERM_MF_5    409 45.0% 
 GOTERM_MF_ALL    688 75.7% 
 *GOTERM_MF_FAT     561 61.7% 
 PANTHER_BP_ALL    646 71.1% 
 PANTHER_MF_ALL    651 71.6% 
General annotations   
 CHROMOSOME    906 99.7% 
 CYTOBAND    897 98.7% 
 ENTREZ_GENE_SUMMARY    382 42.0% 
 HOMOLOGOUS_GENE    840 92.4% 
 OFFICIAL_GENE_SYMBOL    908 99.9% 
 PIR_SUMMARY    297 32.7% 
 SP_COMMENT    498 54.8% 
Literature   
 GENERIF_SUMMARY    346 38.1% 
 PUBMED_ID    692 76.1% 
Main accessions   
 ENSEMBL_GENE_ID    845 93.0% 
 ENTREZ_GENE_ID    908 99.9% 
Pathways   
 *BBID    1 0.1% 
 EC_NUMBER    129 14.2% 
 *KEGG_PATHWAY    257 28.3% 
 PANTHER_PATHWAY    197 21.7% 
Protein domains   
 BLOCKS    295 32.5% 
 COG_NAME    71 7.8% 
 *INTERPRO    603 66.3% 
 PANTHER_FAMILY    813 89.4% 
 PANTHER_SUBFAMILY    643 70.7% 
 PFAM    592 65.1% 
 *PIR_SUPERFAMILY    280 30.8% 
 PRINTS    213 23.4% 
 PRODOM    92 10.1% 
 PROFILE    319 35.1% 
 PROSITE    387 42.6% 
 SCOP_CLASS    25 2.8% 
 SCOP_FAMILY    25 2.8% 
 SCOP_FOLD    25 2.8% 
 SCOP_SUPERFAMILY    24 2.6% 
 *SMART    339 37.3% 
 SSF    153 16.8% 
 TIGRFAMS    45 5.0% 
Protein interactions   
 BIND    37 4.1% 
 DIP    14 1.5% 
 MINT    38 4.2% 
 REACTOME_INTERACTION    4 0.4% 
Tissue expression   
 PIR_TISSUE_SPECIFICITY    135 14.9% 
 UP_TISSUE    579 63.7% 
 
The gene list contained 912 entries, which were cross-references against the ten database 
ontology and annotation resources (asterisk in bold).  The table also shows the number and 
percentage of genes that could be annotated by all the given resources available to DAVID.  
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(D)  Expanded summary of functional annotation analysis c.f. Table 
3.4 
 
Category Term No. % P-value BG Fold 
       
Annotation Cluster 1 Enrichment Score: 14.5      
GOTERM_BP_FAT GO:0022610~biological adhesion 71 7.81 3.53E-18 463 3.18 
GOTERM_BP_FAT GO:0007155~cell adhesion 71 7.81 3.53E-18 463 3.18 
SP_PIR_KEYWORDS cell adhesion 35 3.85 1.67E-09 180 3.23 
       
Annotation Cluster 2 Enrichment Score: 13.48      
GOTERM_CC_FAT GO:0031012~extracellular matrix 55 6.05 2.96E-20 252 4.31 
GOTERM_CC_FAT GO:0005578~proteinaceous extracellular matrix 48 5.28 1.05E-17 220 4.31 
GOTERM_CC_FAT GO:0044420~extracellular matrix part 30 3.30 2.15E-15 97 6.10 
GOTERM_CC_FAT GO:0044421~extracellular region part 83 9.13 1.76E-13 693 2.36 
GOTERM_CC_FAT GO:0005604~basement membrane 24 2.64 3.74E-13 72 6.58 
GOTERM_CC_FAT GO:0005576~extracellular region 123 13.53 9.53E-13 1281 1.90 
SP_PIR_KEYWORDS extracellular matrix 20 2.20 1.01E-06 89 3.73 
       
Annotation Cluster 3 Enrichment Score: 7.14      
GOTERM_BP_FAT GO:0032989~cellular component morphogenesis 49 5.39 5.00E-10 376 2.70 
GOTERM_BP_FAT GO:0048666~neuron development 45 4.95 3.32E-09 347 2.69 
GOTERM_BP_FAT GO:0030182~neuron differentiation 53 5.83 5.63E-09 457 2.41 
GOTERM_BP_FAT GO:0031175~neuron projection development 38 4.18 1.04E-08 273 2.89 
GOTERM_BP_FAT GO:0048812~neuron projection morphogenesis 33 3.63 1.09E-08 215 3.18 
GOTERM_BP_FAT GO:0030030~cell projection organization 45 4.95 1.14E-08 361 2.59 
GOTERM_BP_FAT GO:0000902~cell morphogenesis 43 4.73 1.68E-08 340 2.62 
GOTERM_BP_FAT GO:0032990~cell part morphogenesis 35 3.85 3.13E-08 248 2.93 
GOTERM_BP_FAT GO:0048858~cell projection morphogenesis 34 3.74 3.80E-08 238 2.96 
GOTERM_BP_FAT 
GO:0000904~cell 
morphogenesis involved in 
differentiation 
32 3.52 5.92E-07 242 2.74 
GOTERM_BP_FAT 
GO:0048667~cell 
morphogenesis involved in 
neuron differentiation 
27 2.97 6.90E-06 207 2.71 
GOTERM_BP_FAT GO:0007409~axonogenesis 25 2.75 9.78E-06 186 2.79 
GOTERM_BP_FAT GO:0007411~axon guidance 16 1.76 1.44E-04 105 3.16 
       
Annotation Cluster 4 Enrichment Score: 6.62      
GOTERM_BP_FAT GO:0007517~muscle organ development 28 3.08 3.43E-08 169 3.44 
GOTERM_BP_FAT GO:0060537~muscle tissue development 24 2.64 1.62E-07 138 3.61 
GOTERM_BP_FAT GO:0014706~striated muscle tissue development 23 2.53 2.62E-07 131 3.64 
GOTERM_BP_FAT GO:0060538~skeletal muscle organ development 17 1.87 7.20E-07 78 4.52 
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GOTERM_BP_FAT GO:0007519~skeletal muscle tissue development 17 1.87 7.20E-07 78 4.52 
       
Annotation Cluster 5 Enrichment Score: 5.64      
GOTERM_MF_FAT GO:0005539~glycosaminoglycan binding 22 2.42 7.65E-09 102 4.60 
GOTERM_MF_FAT GO:0030247~polysaccharide binding 23 2.53 1.66E-08 116 4.23 
GOTERM_MF_FAT GO:0001871~pattern binding 23 2.53 1.66E-08 116 4.23 
GOTERM_MF_FAT GO:0008201~heparin binding 15 1.65 5.00E-06 72 4.44 
GOTERM_MF_FAT GO:0030246~carbohydrate binding 29 3.19 0.0023379 337 1.84 
SP_PIR_KEYWORDS heparin-binding 8 0.88 0.00581103 37 3.59 
       
Annotation Cluster 6 Enrichment Score: 4.43      
GOTERM_CC_FAT GO:0005624~membrane fraction 63 6.93 1.81E-05 716 1.74 
GOTERM_CC_FAT GO:0005626~insoluble fraction 65 7.15 2.61E-05 755 1.70 
GOTERM_CC_FAT GO:0000267~cell fraction 76 8.36 1.03E-04 967 1.55 
       
Annotation Cluster 7 Enrichment Score: 3.82      
GOTERM_BP_FAT GO:0001944~vasculature development 29 3.19 1.01E-05 237 2.54 
GOTERM_BP_FAT GO:0001568~blood vessel development 28 3.08 1.63E-05 230 2.52 
GOTERM_BP_FAT GO:0048514~blood vessel morphogenesis 23 2.53 8.70E-05 186 2.56 
GOTERM_BP_FAT GO:0001525~angiogenesis 12 1.32 0.03477 123 2.02 
       
Annotation Cluster 8 Enrichment Score: 3.67      
GOTERM_MF_FAT GO:0019901~protein kinase binding 20 2.20 1.34E-04 157 2.72 
GOTERM_MF_FAT GO:0019899~enzyme binding 42 4.62 2.35E-04 492 1.82 
GOTERM_MF_FAT GO:0019900~kinase binding 21 2.31 2.90E-04 180 2.49 
       
Annotation Cluster 9 Enrichment Score: 3.22      
GOTERM_BP_FAT GO:0010033~response to organic substance 71 7.81 9.93E-05 928 1.59 
GOTERM_BP_FAT GO:0048545~response to steroid hormone stimulus 29 3.19 3.76E-04 291 2.07 
GOTERM_BP_FAT GO:0009719~response to endogenous stimulus 47 5.17 4.36E-04 573 1.70 
GOTERM_BP_FAT GO:0009725~response to hormone stimulus 42 4.62 8.70E-04 510 1.71 
GOTERM_BP_FAT GO:0043627~response to estrogen stimulus 16 1.76 0.00509 148 2.24 
       
Annotation Cluster 10 Enrichment Score: 3.13      GOTERM_BP_FAT GO:0006928~cell motion 44 4.84 1.74E-06 416 2.19 
GOTERM_BP_FAT GO:0016477~cell migration 26 2.86 7.28E-04 259 2.08 
GOTERM_BP_FAT GO:0051674~localization of cell 26 2.86 0.01513 327 1.65 
GOTERM_BP_FAT GO:0048870~cell motility 26 2.86 0.01513 327 1.65 
       
Annotation Cluster 11 Enrichment Score: 3.08      SP_PIR_KEYWORDS Signal 139 15.29 9.44E-08 1517 1.52 
SP_PIR_KEYWORDS Glycoprotein 169 18.59 9.68E-08 1949 1.44 
UP_SEQ_FEATURE signal peptide 139 15.29 5.65E-07 1516 1.46 
UP_SEQ_FEATURE glycosylation site:N-linked (GlcNAc...) 155 17.05 1.27E-05 1831 1.35 
SP_PIR_KEYWORDS disulfide bond 116 12.76 2.68E-05 1340 1.44 
UP_SEQ_FEATURE disulfide bond 105 11.55 0.00154 1272 1.32 
SP_PIR_KEYWORDS Secreted 66 7.26 0.00242 765 1.43 
SP_PIR_KEYWORDS Membrane 215 23.65 0.00329 3063 1.16 
UP_SEQ_FEATURE topological domain:Extracellular 95 10.45 0.00616 1181 1.28 
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UP_SEQ_FEATURE topological domain:Cytoplasmic 113 12.43 0.02556 1516 1.19 
SP_PIR_KEYWORDS Transmembrane 162 17.82 0.12788 2478 1.09 
UP_SEQ_FEATURE transmembrane region 143 15.73 0.13745 2097 1.09 
GOTERM_CC_FAT GO:0031224~intrinsic to membrane 193 21.23 0.99902 4467 0.85 
GOTERM_CC_FAT GO:0016021~integral to membrane 178 19.58 0.99995 4336 0.81 
       
Annotation Cluster 12 Enrichment Score: 2.97      
GOTERM_BP_FAT GO:0030029~actin filament-based process 21 2.31 5.15E-04 183 2.38 
GOTERM_BP_FAT GO:0030036~actin cytoskeleton organization 20 2.20 7.64E-04 175 2.37 
GOTERM_BP_FAT GO:0007010~cytoskeleton organization 28 3.08 0.00302 318 1.83 
 
 
 
E)  Gene cluster analysis (showing first 13 out of 28 gene groups) 
 
 
Affy ID Gene Name Fold-change 
Gene Group 1 Enrichment Score: 9.04  
BF406693 laminin, alpha 4 -42.18 
BE108345 collagen, type XII, alpha 1 -20.83 
BM387419 matrilin 2 -18.76 
BM388456 collagen, type XI, alpha 1 -18.73 
BG379319 transforming growth factor, beta induced -16.40 
NM_021760 collagen, type V, alpha 3 -15.88 
AI176393 collagen, type IV, alpha 1 -10.47 
BI281705 collagen, type IV, alpha 2 -8.97 
AI598402 collagen, type VI, alpha 1 -8.03 
AA817826 similar to Glypican-6 precursor -7.65 
NM_134452 collagen, type V, alpha 1 -7.24 
AA997129 laminin, gamma 1 -3.45 
AA891834 collagen, type IV, alpha 5 -2.59 
BF392901 collagen, type XXVII, alpha 1 -2.38 
AI179399 collagen, type V, alpha 2 -2.27 
BF412281 ADAMTS-like 5 -2.04 
BF412784 Fras1 related extracellular matrix 1; tetratricopeptide repeat domain 39B 4.35 
BE101834 laminin, beta 3 7.93 
   
Gene Group 2 Enrichment Score: 7.90  
AI235948 nidogen 1 -22.91 
AI144872 EGF-like, fibronectin type III and laminin G domains -8.39 
BF413643 similar to ribosomal protein L27a; von Willebrand factor A domain containing 1 -7.58 
AI235465 coiled-coil domain containing 80 -5.24 
AA958001 collagen triple helix repeat containing 1 -3.21 
AF065438 lectin, galactoside-binding, soluble, 3 binding protein 2.11 
AI407838 hypothetical gene supported by NM_017187; extracellular matrix protein 1 4.38 
NM_022230 stanniocalcin 2 4.98 
   
Gene Group 3 Enrichment Score: 6.79  
BM389026 periostin, osteoblast specific factor -87.60 
AA944162 olfactomedin-like 2A -7.55 
AI235465 coiled-coil domain containing 80 -5.24 
AF109674 cysteine-rich secretory protein LCCL domain containing 2 -2.24 
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Gene Group 4 Enrichment Score: 6.01  
AA892798 sclerostin domain containing 1 -57.23 
AI113146 acid phosphatase-like 2 -3.97 
AW251360 C1q and tumor necrosis factor related protein 6 -3.54 
AF140346 secreted frizzled-related protein 4 -2.93 
BM384311 platelet-derived growth factor receptor-like -2.08 
NM_022230 stanniocalcin 2 4.98 
   
Gene Group 5 Enrichment Score: 5.64  
NM_017027 myelin protein zero -189.86 
AI412746 tweety homolog 1 (Drosophila) -117.93 
AI385260 hypothetical LOC310540 -44.10 
AI556075 frizzled homolog 8 (Drosophila) -20.56 
AB035507 melanoma cell adhesion molecule -17.21 
BG380570 similar to RIKEN cDNA 1200009O22; EST AI316813 -16.33 
BE116590 adherens junction associated protein 1 -14.57 
NM_017345 L1 cell adhesion molecule -14.00 
BG663483 protocadherin alpha 4 -12.80 
NM_012959 GDNF family receptor alpha 1 -10.75 
AA943034 cell adhesion molecule 4 -10.69 
AI407898 immunoglobulin superfamily, member 11 -10.52 
AI180408 feline leukemia virus subgroup C cellular receptor family, member 2 -9.70 
BF546934 leucine rich repeat containing 4B -9.67 
NM_031333 cadherin 2 -9.13 
AW252169 lipoma HMGIC fusion partner -8.69 
NM_053492 CDW92 antigen -8.30 
L15011 cortexin 1 -7.81 
BI301193 tyrosylprotein sulfotransferase 2 -6.81 
AF387513 BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) -6.23 
BG671466 F-box only protein 23 -6.18 
NM_013016 signal-regulatory protein alpha -5.69 
NM_031521 neural cell adhesion molecule 1 -5.21 
BE103601 cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) -5.04 
AA956340 protocadherin 7 -4.55 
BG665934 membrane bound O-acyltransferase domain containing 2 -4.34 
NM_021909 FXYD domain-containing ion transport regulator 5 -3.89 
NM_012968 interleukin 1 receptor accessory protein -3.84 
AA891414 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 -3.69 
BM390970 fibroblast growth factor receptor-like 1 -3.51 
BF283018 DnaJ (Hsp40) homolog, subfamily C, member 22 -3.32 
NM_017087 Biglycan -3.30 
AA851945 similar to Tetraspanin-15 (Tspan-15) (Transmembrane 4 superfamily member 15) (Tetraspan NET-7) -3.28 
BG380515 transmembrane protein 59-like -3.18 
BI300274 leucine-rich repeat-containing G protein-coupled receptor 4 -3.02 
BE113263 metallophosphoesterase 1 -2.93 
D25290 cadherin 6 -2.91 
M83143 ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 -2.87 
BG378563 claudin 19 -2.79 
NM_031337 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 -2.66 
AI412938 G protein-coupled receptor 56 -2.53 
U72660 ninjurin 1 -2.53 
NM_139107 transmembrane protein 150 -2.43 
AI232414 peroxisomal membrane protein 4 -2.08 
BM384311 platelet-derived growth factor receptor-like -2.08 
BG668228 integral membrane protein 2C -2.06 
AA851939 FXYD domain-containing ion transport regulator 6 -2.04 
BF402765 cadherin 10 2.05 
BI296264 glycosyltransferase-like 1B 2.13 
AI408279 CKLF-like MARVEL transmembrane domain containing 8 2.18 
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BI275715 transmembrane protein 19 2.22 
NM_031646 receptor (G protein-coupled) activity modifying protein 2 2.25 
NM_134459 CD99 molecule-like 2 2.26 
AI180275 angiotensin II receptor-associated protein 2.30 
BF415817 neogenin homolog 1 (chicken) 2.34 
BF413152 similar to chromosome 20 open reading frame 39 2.54 
AI408095 small cell adhesion glycoprotein 2.55 
NM_022926 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) 2.62 
BI296215 solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 2.68 
NM_053714 ankylosis, progressive homolog (mouse) 2.68 
BG376410 epithelial cell adhesion molecule 2.78 
NM_031738 solute carrier family 29 (nucleoside transporters), member 2 2.89 
BI295949 stomatin; ABO-family member 5 3.16 
NM_031740 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 3.36 
AW525904 TLC domain containing 1 3.43 
NM_057118 contactin 1 3.59 
NM_030834 solute carrier family 16, member 3 (monocarboxylic acid transporter 4) 4.12 
X74293 integrin alpha 7 4.19 
NM_031645 receptor (G protein-coupled) activity modifying protein 1 4.80 
NM_130419 discoidin, CUB and LCCL domain containing 2 5.27 
AI410264 tetraspanin 12 5.45 
NM_031802 gamma-aminobutyric acid (GABA) B receptor 2 5.73 
NM_133298 glycoprotein (transmembrane) nmb 6.07 
BI279663 desmocollin 2 6.19 
BF284360 X-linked Kx blood group (McLeod syndrome) homolog 7.37 
NM_053346 neuritin 1 8.35 
AW523000 cadherin 15 8.55 
AI101388 B cell RAG associated protein 9.98 
L07268 aquaporin 1 10.66 
BI275896 adipocyte-specific adhesion molecule 15.99 
NM_053572 protocadherin 21 24.81 
NM_030856 leucine rich repeat neuronal 3 28.15 
NM_031518 Cd200 molecule 79.07 
   
Gene Group 6 Enrichment Score: 4.90  
NM_019153 fibulin 5 -74.16 
AW530272 EGF-like-domain, multiple 8 -48.07 
NM_031069 NEL-like 1 (chicken) -36.69 
BM389302 nidogen 2; similar to nidogen 2 protein -25.71 
AA944398 fibulin 2 -16.28 
NM_057100 growth arrest specific 6 -2.73 
AB012139 bone morphogenetic protein 1 -2.51 
NM_031825 fibrillin 1 -2.18 
BI292425 complement component 1, r subcomponent 5.58 
   
Gene Group 7 Enrichment Score: 3.00  
BI275818 serine (or cysteine) peptidase inhibitor, clade E, member 2 -5.85 
NM_017200 tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) -3.38 
AI411527 WAP four-disulfide core domain 2 -2.11 
NM_053779 serine (or cysteine) peptidase inhibitor, clade I, member 1 34.59 
   
Gene Group 8 Enrichment Score: 2.85  
BI283881 actin filament associated protein 1-like 2 -91.35 
BF388057 hairy/enhancer-of-split related with YRPW motif 2 -30.28 
NM_019193 SRY (sex determining region Y)-box 10 -23.76 
NM_130429 lymphoid enhancer binding factor 1 -14.54 
AI177143 homeo box D9 -6.69 
BI284495 transcription factor AP-2, gamma -5.35 
NM_013154 CCAAT/enhancer binding protein (C/EBP), delta -5.04 
BE107033 ecotropic viral integration site 1 -4.40 
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BF415939 FBJ osteosarcoma oncogene -3.47 
NM_053369 transcription factor 4 -3.45 
BE104219 myocyte enhancer factor 2C -3.36 
AI045857 Kruppel-like factor 13 -3.21 
BF548737 SRY (sex determining region Y)-box 2 -3.19 
BM390477 similar to CCAAT displacement protein isoform b; cut-like homeobox 1 -3.06 
BI289559 SRY (sex determining region Y)-box 6 -2.98 
NM_053894 Jun dimerization protein 2 -2.39 
BE104098 Meis homeobox 2 -2.36 
BM386654 SCAN domain-containing 1 -2.33 
BE113920 signal transducer and activator of transcription 3 -2.17 
BM392093 WW domain containing transcription regulator 1 -2.12 
AI175992 catenin, beta-interacting protein 1 2.12 
AA998296 recombination signal binding protein for immunoglobulin kappa J region; recombining binding protein suppressor of hairless (Drosophila) 2.14 
NM_031789 nuclear factor, erythroid derived 2, like 2 2.33 
NM_053412 interleukin enhancer binding factor 3 2.35 
BE099050 nuclear factor I/B 2.48 
NM_053720 apoptosis antagonizing transcription factor 2.50 
BE108745 
nucleosomal binding protein 1; similar to Nucleosome binding protein 1 
(Nucleosome binding protein 45) (NBP-45) (GARP45 protein); 
nucleosome binding protein 1 (predicted) 
2.90 
NM_053349 SRY (sex determining region Y)-box 11 4.36 
NM_013060 inhibitor of DNA binding 2 4.85 
BF398531 B-cell CLL/lymphoma 11B (zinc finger protein) 6.39 
AA963276 ets variant 1 8.06 
BI286417 SIX homeobox 4 16.04 
AI175048 SIX homeobox 1 25.73 
   
Gene Group 9 Enrichment Score: 2.51  
AW532566 PDZ domain containing RING finger 3 -113.78 
AF228917 zinc finger, DHHC-type containing 2 -43.53 
AI598833 LIM domain 7 -28.81 
BM387419 matrilin 2 -18.76 
AW535310 ADAM metallopeptidase with thrombospondin type 1 motif, 5 -18.59 
AI013730 similar to hypothetical protein -15.41 
U44948 cysteine and glycine-rich protein 2 -9.42 
BG373522 MICAL-like 2 -7.83 
BM386413 tripartite motif protein 2 -7.51 
AI104117 PDZ and LIM domain 7 -7.12 
BM384701 peroxidasin homolog (Drosophila) -6.54 
BG673169 similar to SMAD-interacting zinc finger protein 2 -4.75 
AA962978 family with sequence similarity 149, member A -4.75 
BF416285 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 9 -4.10 
BE109520 family with sequence similarity 134, member B -3.77 
NM_017062 reversion induced LIM gene -3.63 
AI030916 similar to arginyl aminopeptidase (aminopeptidase B)-like 1 -3.47 
NM_017148 cysteine and glycine-rich protein 1 -2.96 
BE113263 metallophosphoesterase 1 -2.93 
BI284849 vesicle amine transport protein 1 homolog (T californica) -2.52 
BG375362 latent transforming growth factor beta binding protein 4 -2.32 
NM_031975 Parathymosin -2.27 
AW527799 LIM domain containing preferred translocation partner in lipoma -2.17 
AW528458 zinc finger, DHHC-type containing 8 -2.13 
BM383785 zinc finger, AN1-type domain 3 -2.06 
BF412281 ADAMTS-like 5 -2.04 
BI296586 zinc finger, DHHC-type containing 14 2.03 
NM_053681 S100 calcium binding protein A3 2.20 
AI028875 tripartite motif-containing 26 2.20 
AW533683 zinc finger protein 770 2.32 
AW522661 ligand of numb-protein X 1 2.40 
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BE102096 jumonji domain containing 1C 2.42 
BE104149 testis derived transcript 2.46 
BM390663 dystrobrevin, beta 2.73 
U66322 prostaglandin reductase 1 2.81 
BF391522 ring finger protein 139 2.95 
BF416560 ring finger protein 217 3.26 
BG375352 carbonic anhydrase 5b, mitochondrial 4.15 
BF412784 tetratricopeptide repeat domain 39B 4.35 
BI298356 four and a half LIM domains 1 7.86 
AW534737 basonuclin 2 9.59 
NM_013004 phosphate regulating endopeptidase homolog, X-linked 13.29 
   
Gene Group 10 Enrichment Score: 2.49  
BE107450 neuronal regeneration related protein -10.32 
AF069525 ankyrin 3, epithelial -4.04 
AF389425 dihydropyrimidinase-like 3 -3.67 
NM_031066 fasciculation and elongation protein zeta 1 (zygin I) -2.38 
NM_017195 growth associated protein 43 3.51 
AA963276 ets variant 1 8.06 
   
Gene Group 11 Enrichment Score: 2.47  
AI412746 tweety homolog 1 (Drosophila) -117.93 
BF285019 sodium channel, voltage-gated, type VII, alpha -64.10 
NM_017348 solute carrier family 6 (neurotransmitter transporter, creatine), member 8 -5.48 
AY028605 potassium large conductance calcium-activated channel, subfamily M, beta member 4 -4.06 
NM_021909 FXYD domain-containing ion transport regulator 5 -3.89 
NM_139107 transmembrane protein 150 -2.43 
NM_053327 chloride channel Ka -2.33 
AA851939 FXYD domain-containing ion transport regulator 6 -2.04 
BI296215 solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 2.68 
AB013454 solute carrier family 34 (sodium phosphate), member 1 3.07 
NM_013125 sodium channel, voltage-gated, type V, alpha subunit 3.17 
NM_030834 solute carrier family 16, member 3 (monocarboxylic acid transporter 4) 4.12 
AF075704 solute carrier family 38, member 1 6.29 
AI232036 ATPase, Na+/K+ transporting, beta 1 polypeptide 7.08 
   
Gene Group 12 Enrichment Score: 2.32  
AW433901 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) -5.63 
AI028942 cordon-bleu homolog (mouse) -4.10 
AI406386 LIM domain only 4 -3.90 
BF410961 shroom family member 3 -3.12 
AW917849 frizzled homolog 6 (Drosophila) 3.50 
NM_053530 twist homolog 1 (Drosophila) 6.46 
   
Gene Group 13 Enrichment Score: 1.94  
NM_012610 nerve growth factor receptor (TNFR superfamily, member 16) -111.28 
AF016296 neuropilin 1 -6.18 
NM_019272 semaphorin-4F -2.92 
NM_017310 semaphorin-3A 3.37 
 
312 genes were analysed and 311 were organised into 28 clusters of genes enriched for 
similar function (shown are the first 13 such related groups ranked by enrichment score). 
 
 
 
 
